Synthesis of new sugar derivatives containing an α, β-unsaturated carbonyl system in their structure and biological evaluation by Xavier, Nuno M.
Universidade de Lisboa 
Faculdade de Ciências 
Departamento de Química e Bioquímica 
 
Institut National des 
Sciences Appliquées de Lyon 




Synthesis of New Sugar Derivatives Containing 
an α,β-Unsaturated Carbonyl System in Their 
Structure and Biological Evaluation 
 
 
Nuno Manuel Ribeiro Martins Xavier 
 
 
Doutoramento em Química 
(Química Orgânica) 








Universidade de Lisboa 
Faculdade de Ciências 
Departamento de Química e Bioquímica 
 
Institut National des 
Sciences Appliquées de Lyon 
                
 
 
Synthesis of New Sugar Derivatives Containing 
an α,β-Unsaturated Carbonyl System in Their 
Structure and Biological Evaluation 
 
Nuno Manuel Ribeiro Martins Xavier 
 
Doutoramento em Química 
(Química Orgânica) 





Amélia Pilar Rauter, Professora Associada com Agregação 














































During the last three years as a PhD student I had t e opportunity to benefit from the 
contribution of many people. Here I would like to thank all of them.  
 
First, I wish to express my respect and gratitude to my two supervisors: Prof. Dr. 
Amélia Pilar Rauter from the Faculdade de Ciências da Universidade de Lisboa 
(FCUL) and Dr. Yves Queneau from the Institut National des Sciences Appliquées de 
Lyon (INSA-Lyon). Prof. Rauter first taught me carbohydrate chemistry during my 
undergraduate studies, and motivated me to undertake doctoral studies in this field. I 
thank her for receiving me in a pleasant scientific environment, providing me guidance, 
encouragement and freedom to develop my ideas. Dr. Queneau has received me in his 
laboratory in July 2007 under a collaborative Luso-French project co-supervised by 
Prof. Rauter and encouraged the continuation of such collaboration in a PhD program. I 
acknowledge his active supervision and his invaluable enthusiasm which resulted in 
many excellent suggestions for my subject.  
 
I would like to thank Prof. Dr. Joachim Thiem from the Universität Hamburg, who has 
kindly given me the opportunity to join his group, for helpful advice and fruitful 
discussions.  
 
I gratefully acknowledge Prof. Dr. Alain Doutheau, director of the Laboratoire de 
Chimie Organique de l’INSA Lyon (LCO-INSA) for having received me in the team. I 
am grateful to Dr. Stéphane Chambert, Maître de Conferences at INSA-Lyon for his 
collaboration in part of the work developed during the research program in Lyon.  
 
I would like to thank Prof. Jorge Justino and his re earch team at the Escola Superior 
Agrária de Santarém, especially Dr. Ana Neves, Dr. Margarida Goulart and Dr. Filipa 
Silva for the biological activity assays performed with our compounds.  
 
Within the Centro de Química e Bioquímica of FCUL, I would like to express my 
gratitude to Prof. Helena Florêncio and to my colleague Paulo Madeira from the 
Environmental and Biological Mass Spectrometry Group for the mass spectrometry 
ii 
 
analysis and their collaboration in investigating the ionization fragmentation 
mechanisms of some of our compounds.  
 
I would like to thank my dear lab colleagues at the Carbohydrate Chemistry Group of 
FCUL in Lisbon and at the Laboratory of Organic Chemistry of INSA-Lyon for their 
kindness, friendship and support all the time. In particular I thank Ana Rita Jesus, 
Madan Kumar Singh, Susana Dias Lucas and Sandrina Silva with whom I have shared 
the lab bench.  
 
Last but not least I would like to thank my parents and my sister for their unwavering 
care and support through these years, being there whenever I needed and giving me 
































































This PhD research work was focused on the synthesis and uses of bicyclic carbohydrate 
lactones, in the context of the access to new sugar derivatives containing an α,β-
unsaturated carbonyl function. These molecular targe s, chosen for the intrinsic 
bioactivity associated to the conjugated carbonyl sstem, were synthesized and 
submitted to biological evaluation, particularly their effect towards fungi and bacteria. 
Moreover, the inclusion of conjugated carbonyl systems in carbohydrates provides 
suitable templates for further derivatization, to which a variety of reactions may be 
applied. Three types of bicyclic sugar lactones were investigated: furanose C-C-linked 
butenolides (compounds type I ), pyranose-fused butenolides, including S- or NH-
analogues (compounds type II −IV ), and carboxymethyl glycoside-derived lactones 




The access to butenolide containing-sugars was explored. The synthetic methodology 
was based on the Wittig olefination of easily prepad 3- or 5-keto sugars and 
spontaneous intramolecular lactonization of the intrmediate γ-hydroxy α,β-unsaturated 
esters. In the case of the bicyclic fused derivatives, furanos-3-uloses containing acid 
labile 5-O or 5,6-di-O-protecting groups were used as precursors and converted into the 
corresponding (Z)- or (E)-3-C-(ethoxycarbonyl)methylene furanoses. Further acid-
mediated hydrolysis made possible their isomerization to the pyranose ring and 
concomitant intramolecular transesterification leading directly to the target compounds 
in good overall yields. Such bicyclic systems featured the butenolide moiety annelated 
at C-2-C-3 (compounds type II ) or at C-3-C-4 of the sugar backbone, depending on the 
stereochemistry of the C3-C3’double bond. The introduction of a sulfur function at C-5 
of the furanoid 3-C-α,β-unsaturated esters, widened the scope of this methodology to  
thiosugar analogues of type III . When this approach was applied to related 5-azido 
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furanoid esters aiming at imino sugar-based molecules of type IV , different 
carbohydrate derivatives comprising both an amide functionality and an α,β-unsaturated 
carbonyl system were obtained. The (E)- and (Z)-3-C-(ethoxycarbonyl)methylene 5-
amino furanoses were converted to a furanose-fused α,β-unsaturated δ-lactam and to a 
butenolide-containing N-ethylformamide, respectively. Moreover, the hydrolysis of the 
1,2-O-isopropylidene group of the (Z)-5-azido furanose precursor, followed by azide 
reduction, provided a 2-keto iminopyranose, which led to the 1,2-dihydropyridin-3-one 
system upon acetylation. 
  
CMGLs (compounds type V) were used as precursors for 3-enopyranosid-2-uloses 
(compounds type VI ). The opening of the lactone moiety by amines provided tri-O-
acylated 2-hydroxy pyranosides which by oxidation/elimination generated the enone 
system. Further Wittig olefination afforded 2-C-branched-chain conjugated 
dienepyranosides (compounds type VII ). Glycosides bearing a propargyl moiety were 
engaged in “click” chemistry reactions leading to the corresponding 1,2,3-triazoles 
(compounds type VIII −IX ). 
 
VI    X = O


















VIII  X = O
IX    X = CHCO2Et  
 
Among the molecular targets obtained, the furanose-link d butenolides, the pyranose-
fused butenolides, the conjugated carbonyl sugar derivatives synthesized from CMGLs 
and the triazole-containing glycosides were submitted o antimicrobial activity assays.  
 
The butenolide-containing sugars did not show satisfactory antibacterial or antifungal 
activities. Such weak effect is probably due to the pr sence of a quaternary β-carbon in 
the conjugated system of these molecules, which is specially hindered in the fused 
systems, reducing their Michael acceptor ability.  
 
In contrast, significant efficacy was observed for 3-enopyranosid-2-uloses and 





displayed strong and very strong activities against some of the pathogen microbes 
tested, being in some cases similar to those of the standard antibiotics. The α-enuloside 
exhibited very strong effect towards Bacillus cereus and Bacillus subtillis and strong 
activity against Enterococcus faecalis and the fungal pathogen Penicillium 
aurantiogriseum. The β-anomer presented a very strong inhibitory effect against the 
fungi Aspergillus niger and Penicillium aurantiogriseum. Dienepyranosides exhibited a 
strong activity selectively towards Enterococcus faecalis. Triazole derivatives were 
virtually ineffective. Three of the bioactive compounds, including the most active one, 
i.e. the α-(N-dodecylcarbamoyl)methyl enuloside, showed low acute toxicity in 


























O trabalho desenvolvido no âmbito deste Doutoramento centrou-se na síntese e no uso 
de biciclolactonas glicídicas com o objectivo de se obterem novos derivados de açúcares 
contendo um sistema carbonílico α,β-insaturado na sua estrutura. Estes alvos 
moleculares foram sintetizados no sentido de se avaliarem posteriormente as suas 
propriedades biológicas, nomeadamente a nível de activid de antifúngica e 
antibacteriana. 
 
O sistema carbonílico α,β-insaturado é frequentemente encontrado em produtos na urais 
e de síntese que possuem uma variedade de actividades biológicas. A bioactividade 
exibida por estes compostos está geralmente associada à capacidade da função 
conjugada para reagir segundo adição de Michael comnucleófilos existentes em 
proteínas. Em particular, derivados de açúcares contendo lactonas α,β-insaturadas foram 
descritos como fungicidas ou como insecticidas potentes. Por outro lado, a inclusão 
destas unidades em carbo-hidratos conduz a moléculas funcionalizadas que poderão ser 
úteis para posterior derivatização, devido à reactividade do sistema conjugado. 
 
As moléculas-alvo tiveram como base três tipos de lactonas bicíclicas (Fig. 1): 
butenolidas ligadas a anéis de furanose (compostos tipo I ), butenolidas fundidas a anéis 
de pyranose, incluindo tio- e iminoaçúcares análogos (c mpostos tipo II −IV ), e lactonas 




Fig. 1. Estrutura geral das biciclolactonas glicídicas exploradas no presente trabalho. 
 
 A síntese de açúcares contendo butenolidas foi desenvolvida e implementada uma 
metodologia que envolveu a olefinação de Wittig de 3- ou 5-cetoaçúcares e a 
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lactonização intramolecular expontânea de intermediários γ-hidroxiésters α,β-
insaturados formados. Os 5-cetoaçúcares precursores de butenolidas ligadas a furanoses 
foram obtidos por meio de oxidação selectiva do grupo hidroxilo secundário de 5,6-
dióis derivados de 1,2-O isopropilideno-α-D-glucofuranose e/ou -alofuranose (1−4, 
Esquema 1). O oxidante utilizado foi o sistema Bu2OSn/NBS (N-bromosuccinimida), 
dando origem às α-hidroxicetonas desejadas 5−8 com bons rendimentos. A 
estereoselectividade da reacção de Wittig subsequente com 
[(etoxicarbonil)metileno]trifenilfosforano foi influenciada pela configuração do 
substituinte em C-3. Os derivados com configuração xilo 5 e 6 originaram apenas γ-
hidroxiésteres insaturados (9, 10) com estereoquímica (Z). Contudo, utilizando as α-
hidroxicetonas com configuração ribo 7 e 8, a reacção de Wittig foi estereosseletiva 
para a formação dos (E)-isómeros, cuja transesterificação intramolecular espontânea deu 
origem às correspondentes lactonas α,β-insaturadas 13 e 14. Os (Z)-isómeros (11 e 12) 
foram neste caso produtos minoritários da reacção. 
 
 
Esquema 1. Síntese de butenolidas ligadas a furanoses por uma ligação C-C ou dos 
respectivos ésteres a partir dos 5-cetoaçúcares 5−8. 
 
A estratégia implementada para a síntese de butenolidas fundidas a piranoses 
(compostos tipo II, Fig. 1) baseou-se na olefinação de Wittig de derivados 1,2-O-
isopropilideno-α-D-pento- ou-hexofuranos-3-ulose, 5-O- ou 5,6-di-O-protegidos com 
grupos lábeis em meio ácido, seguida de hidrólise ácida. Nestas condições, com a 
remoção dos grupos protectores, além da reacção de transesterificação intramolecular 
que leva à formação da lactona, também ocorre isomerização furanose → piranose, 






A olefinação de Wittig dos 3-cetoaçúcares 15 e 16 foi estereosselectiva para a formação 
dos respectivos ésteres (Z)-α,β-insaturados 17a e 18a (Esquema 2). O tratamento de 17a 
e 18a com a resina ácida Amberlite em refluxo de metanol durante 16 h levou à 
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Esquema 2. Via de síntese de butenolidas fundidas a piranoses. 
 
As condições experimentais de hidrólise de 17a foram optimizadas de modo a reduzir o 
tempo de reacção para a obtenção do composto bicíclico 19 e também para permitir a 
formação do correspondente glicósido de metilo 20. A hidrólise de 17a com uma 
solução aquosa de ácido trifluoroacético (TFA) a 60%, à temperatura ambiente, 
conduziu ao composto bicíclico desejado 19 em apenas 5 min, com um rendimento de 
90%. Utilizando a resina Dowex 50-W, a conversão de 17a em 19 foi completa ao fim 
de 2 h e, após 16 h de reacção, obteve-se o glicósido de metilo 20. 
 
A síntese de um derivado bicíclico regiosselectivamente protegido no grupo hidroxilo 
primário (composto 25, Esquema 3) foi realizada a partir da monoprotecção selectiva do 









AcOH  60% aq.











R1 = R2 = Piv  27%
R1 = H, R2 = Piv  57%
AcOH 70% aq
refluxo






22  95% 23
24
25  86%
t. a., 1 h
 
 
Esquema 3. Síntese do derivado 25 regiosselectivamente protegido em OH-6. 
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Analogamente e seguindo a mesma estratégia de síntese, a partir dos ésteres (E)-
insaturados 17b e 18b, foram obtidos, com sucesso, os compostos 26−28, nos quais a 




Fig. 2. Estrutura dos derivados de açúcares sintetizados nos quais a unidade butenolida 
se encontra fundida ao anel de piranose nas posições 3 e 4. 
 
No entanto não se verificou lactonização após remoção do grupo 1,2-isopropilideno do 
derivado 5,6-di-O-pivaloílado 24, e dos derivados pentofuranóides com configuração 
erythro, possuindo um grupo pivaloilo em C-5 (29) ou desoxigenado em C-5 (30), nas 
condições hidrolíticas descritas e obtiveram-se os respectivos dióis 31−33 (Esquema 4). 
Estes resultados indicam que a fusão de lactonas ins turadas de cinco membros a anéis 
















24 31  62%R1 = OPiv, R2 = CH2OPiv
AcOH 70% aq., refluxo
29 R1 = OPiv, R2 = H
30 R1, R2 = H 33  56%
TFA  60% aq., t.a.
2-5h (para 24 e 29)
5 min (para 30)
 
 
Esquema 4. Hidrólise de 24, 29 e 30 dando origem aos dióis 31−33. 
 
A eficácia e a conveniência desta metodologia para a obtenção de análogos tioaçúcares 
e iminoaçúcares (compostos tipo III e IV , Fig. 1), a partir de furanos-3-uloses, foram 
também investigadas. A estas duas classes de miméticos de carbo-hidratos está 
frequentemente associada uma variedade de propriedades biológicas, nomeadamente a 





também no seu potencial sintético como precursores para novos derivados de tio- e 
iminoaçúcares. 
 
A síntese de butenolidas fundidas a tioaçúcares involveu a introdução de uma função 
sulfidrílica em C-5 nos derivados (Z)-3-C-(etoxicarbonil)metileno  pento- ou 
hexofuranóides 34 e 35 por meio de substituição nucleófila de um grupo tosilato ou de 
um triflato, respectivamente, por um grupo tioacetilo (Esquema 5). A remoção dos 
grupos éster de 36, 37 seguida de hidrólise ácida deu origem aos compostos bicíclicos 
desejados 38 e 39. A posterior acetilação de 38 e 39 conduziu aos derivados acetilados 
40 e 41 e aos tioglicais correspondentes 42 e 43, por eliminação de ácido acético. A 
acetilação de 39 conduziu maioritariamente ao tioglical 43, o que pode ser explicado 
pela baixa estabilidade conformacional de 41, devido à presença de um grupo 
acetoximetilo pseudoaxial. A eliminação em C-1,C-2 não só resulta num sistema 
conjugado altamente estável, mas no caso de 41 permite a adopção de uma conformação 























35  R1 = H, R2 = CH2OTBDMS






37  R = CH2OTBDMS
36  R = H
39  R = CH2OH
38  R = H
43  R = CH2OAc
42  R = H
41  R = CH2OAc
40  R = H
KSAc, DMF
40 ºC, 1h 45 min
84%
(para 34)
a) Tf2O, py/CH2Cl2, 0 ºC




b) AcOH, 70% aq
refluxo, 2 h (para 36)
TFA  60% aq. r.t











Esquema 5. Síntese de butenolidas fundidas a 5-tiopent - e 5-tiohexopiranoses. 
 
Para a investigação da síntese de iminoaçúcares do tipo IV  foram sintetizados os 
precursores 5-azido-3-C (etoxicarbonil)metileno furanoses (44, Esquema 6). A redução 
do grupo azida do éster (Z)-α,β-insaturado 44a pelo método de Staudinger resultou na 
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respectiva amina 45.  A hidrólise de 45 em meio ácido seguida de adição de base para 
neutralizar o ácido em excesso, resultou no derivado da etilformamida contendo uma 
butenolida 47. A formação do composto 47 involve o intermediário bicíclico 46, o qual 
em meio básico é desprotonado no grupo hidroxilo anmérico. O ião resultante 
rearranja para um ião enolato estabilizado por ressonância, que é protonado em C-2.  
 
A hidrólise ácida do grupo 1,2-O isopropilideno de 44a e posterior redução da função 
azida do diol 48, de modo a permitir a isomerização 5-aminofuranose/iminopiranose em 
meio neutro, resultou num 2-cetoiminoaçúcar que por acetilação originou a 1,2-di-
hidropiridin-3-ona 49. A redução do grupo azida do (E)-isómero (44b) deu origem à δ-
lactama bicíclica 51 por ciclização intramolecular expontânea do δ-aminoéster α,β-




Esquema 6. Exploração de 5-azido-3-C-(etoxicarbonil)metileno furanose como sintão 
para uma variedade de derivados de açúcares contend um sistema carbonílico α,β-
insaturado. 
 
 Os derivados 5-aminofuranóides revelaram portanto uma reactividade distinta 
relativamente aos análogos 5-O e 5-S, que em condições reaccionais semelhantes 





As biciclolactonas derivadas de glicósidos de carboximetilo (CMGLs, compostos tipo 
V, Fig. 1), cuja preparação envolve 2-3 etapas a partir de açúcares livres, foram 
utilizadas como precursores de cetonas piranóides α,β-insaturadas do tipo hex-3-
enopiranosid-2-ulose  e de dienopiranósidos conjugados (compostos tipo VI −VII , Fig. 
3). A inclusão de uma unidade 1,2,3-triazole, um heterociclo com potencial para 
conferir bioactividade, para a obtenção de derivados  tipo VIII −IX,  foi também 
investigada.  
 
VI    X = O


















VIII  X = O
IX    X = CHCO2Et  
 
Fig. 3. Estrutura geral dos compostos-alvo contendo uma função carbonílica conjugada 
e uma unidade 1,2,3-triazole cuja síntese envolveu pr cursores CMGLs. 
 
A preparação de cetonas α,β-insaturadas do tipo VI   consistiu na abertura nucleófila de 
CMGLs 52-54 com aminas primárias, seguida de oxidação dos aductos resultantes e 
eliminação concomitante de ácido acético nas posiçõe  3,4 (Esquema 7). O método de 
oxidação utilizando o sistema dimetilsulfóxido (DMSO)/anidrido acético (Ac2O) 
revelou ser o mais eficaz em experiências preliminares e permitiu a obtenção do sistema 
enona com melhores rendimentos, em relação a outros métodos de oxidação mais 
suaves.  
 
Os 2-hidroxipyranósidos tri-O-acetilados 55−57, 61 com configuração α, conduziram às 
respectivas enonas 62−64 com bons rendimentos. No entanto, os rendimentos para a 
oxidação/eliminação dos aductos β (58-60) foram baixos e as respectivas enonas 65−67 
demonstraram a sua tendência para a decomposição. Estes resultados devem-se à 
conformação adoptada por estes compostos, tal como verificado por 1H RMN. Enquanto 
as enonas 62−64 adoptam uma conformação do tipo envelope OE (sofá), os respectivos 
anómeros β adoptam uma conformação EO, que é menos estável devido às interacções 
1,3-diaxiais. As cetonas α,β-insaturadas foram posteriormente convertidas nos  
correspondentes dienopiranósidos de cadeia ramificada em C-2 (68−70) por olefinação 
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de Wittig com [(etoxicarbonil)metileno]trifenilfosforano. A configuração (E) da ligação 
dupla exocíclica foi demonstrada através de NOESY.  
 
As reacções de cicloadição dos glicósidos de (N-propargilcarbamoil)metilo 55, 58 e 61 
com azoteto de benzilo por meio de um protocolo alternativo de ‘click’ chemistry, tendo 
como base um catalisador heterogéneo de CuI suportado em Amberlist A-21, deu 
origem aos triazoles correspondentes 71-73. Os derivados desprotegidos 74-76 foram 




Esquema 7. Investigação de CMGLs como precursores de 3-enopiranosid-2-uloses, 
dieno piranósidos conjugados e glicósidos contendo um anel 1,2,3-triazole. 
 
A síntese dos compostos do tipo VIII  e IX , os quais associam numa molécula um 
sistema carbonílico conjugado a uma unidade triazole, f i realizada posteriormente 
(Esquema 8). A oxidação/eliminação de 71 conduziu à 3-enopiranosid-2-ulose 77. O 
acoplamento do dieno piranósido conjugado 68 com azoteto de benzilo originou o 








Esquema 8. Síntese de derivados piranosídicos contendo um sistema carbonílico 
conjugado e uma unidade 1,2,3-triazole.  
 
Entre os alvos moleculares obtidos, os derivados bicíclicos nos quais uma butenolida se 
encontra ligada a um anel de furanose (compostos tip  I ), as butenolidas fundidas a 
anéis de piranose (compostos tipo II ), os derivados piranóides contendo um sistema 
carbonílico conjugado sintetizados a partir dos precursores CMGLs (compostos tipo 
VI −VII ) e os glicósidos contendo uma unidade triazole (compostos tipo VIII −IX ), 
foram submetidos a testes de actividade antimicrobiana. Foi investigada a inibição de 
fungos fitopatogénicos e de fungos patogénicos parase es humanos e animais. Foi 
também feito um estudo sobre a actividade inibidora dos compostos relativamente a 
bactérias Gram-negativas e Gram-positivas. 
 
Os derivados de açúcares contendo butenolidas apresentaram fraca actividade 
antimicrobiana ou não a exibiram de modo significativo. Estes resultados sugerem uma 
reduzida aptidão destas moléculas para reagir segundo a adição de Michael, o que se 
explica pela presença de um C-β quaternário no sistema conjugado, que é 
estereoquimicamente impedido nas estruturas fundidas.  
 
No entanto, os resultados da avaliação biológica das 3-enopiranosid-2-uloses e dos 
dienopiranósidos de cadeia ramificada revelaram actividades antimicrobianas 
significativas. Os enulósidos de (N-dodecilcarbamoil)metilo 64 e 67 exibiram 
actividades fortes ou muito fortes contra alguns do micróbios testados, demonstrando 
nalguns casos efeitos inibitórios comparáveis aos dos antibióticos de referência. O 
enulósido-α (64) revelou actividade muito forte relativamente às bactérias Bacillus 
cereus e Bacillus subtillis e actividade forte contra Enterococcus faecalis e o fungo 
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Penicillium aurantiogriseum. O anómero-β (67) exibiu um efeito inibitório muito forte 
contra os fungos Aspergillus niger e Penicillium aurantiogriseum. Os dienopiranósidos 
conjugados 68−70 revelaram actividade selectiva e forte relativamente a Enterococcus 
faecalis. Os derivados contendo triazole não demonstraram actividade antimicrobiana 
significativa. Três dos compostos considerados bioactivos, o α-enulósido de (N-
dodecilcarbamoil)metilo 64, e os dienopiranósidos 68 e 69, mostraram ser pouco 


































Le travail développé dans le cadre de ce sujet de thèse porte sur la synthèse et utilisation 
de bicyclolactones glycidiques, de façon à accéder des nouveaux dérivés de sucres 
contenant un système carbonylé α,β-insaturé dans leur structure. Ces cibles moléculaires 
ont été synthétisées afin d'évaluer certaines propriétés biologiques, notamment leur 
activité antibactérienne et fongicide. 
 
Le système carbonylé α,β-insaturé est présent dans un grand nombre de produits 
naturels et synthétiques possédant une variété d’activités biologiques. La bioactivité de 
ces composés est souvent associée à la capacité du système conjugué à réagir comme 
accepteur de Michael pour l'addition de fonctions nucléophiles des protéines. En 
particulier, les dérivés glucidiques contenant des lactones α,β-insaturées ont été décrites 
comme puissantes fongicides et insecticides. De plus, l'inclusion de ces unités dans les 
carbohydrates conduit à des molécules fonctionnalisées qui peuvent être utiles pour 
dérivatisation, en raison de la réactivité du système conjugué. 
 
Les molécules cibles sont basées sur trois types de lactones bicycliques (Fig. 1): 
butenolides liés à des cycles furanose (composés du type I ), butenolides fusionnés à des 
cycles pyranose, comprenant aussi leurs analogues tio- et iminosucres (composés du 





Fig. 1. Structure générale des bicyclolactones glycidiques explorées dans ce travail. 
 
Une méthodologie de synthèse de butenolides construits s r châssis glucidique a été 
développée. Elle est basée sur l’oléfination de Wittig de 3 ou 5-cétosucres et 
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lactonisation intramoléculaire spontanée de γ-hydroxyesters α,β-insaturés 
intermédiaires. Les 5-cétosucres précurseurs de butenolides liés à des cycles furanose 
ont été obtenus par oxydation sélective de la foncti  secondaire des diols-5,6 dérivés 
du 1,2-O-isopropylidène-α-D-glucofuranose et/ou -allofuranose (1−4, Schéma 2). 
L’oxydant utilisé est le système Bu2SnO/NBS (N-bromosuccinimide), ce qui a conduit 
aux hydroxycétones desirées 5−8 avec des bons rendements. La stéréosélectivité de la
réaction suivante, une réaction de Wittig avec  l’ylure stabilisé, 
[(éthoxycarbonyl)metilène]triphénylphosphorane, dépend de la configuration du 
substituant en C-3. Les dérivés de configuration xylo 5 et 6 ont conduit uniquement aux 
hydroxyesters insaturés 9, 10 de stéréochimie (Z). Par contre, les α-hydroxycétones de 
configuration ribo (7 et 8), conduisent majoritairement aux isomères (E), dont la 
transestérification intramoléculaire spontanée a permis d’obtenir les lactones  α,β-




Schéma 1. Synthèse de butenolides liées aux furanoses par une liaison C-C ou des γ-
hydroxyesters α,β-insaturés à partir des 5-cétosucres 5−8. 
 
La stratégie mise en pratique pour la synthèse de but nolides fusionnés aux pyranoses 
est basée sur l’oléfination de Wittig de dérives 1,2-O-isopropylidène-α-D-pento- ou -
hexofuranos-3-uloses 5-O  ou 5,6-di-O-protégés avec des groupements labiles en 
millieu acide, suivie d’une hydrolyse acide. En conséquence, la suppression des 
groupements protecteurs permet la transestérification intramoléculaire qui conduit à la 
formation de la lactone, et l’isomérization furanose → pyranose, conduisant en une 






L’oléfination de Wittig des 3-cétosucres 15 et 16 s’est révélée stéréosélective pour la 
formation des correspondants esters (Z)-α,β-insaturés 17 et 18 (Schéma 2). Le 
traitement de 17a et 18a avec de la résine acide Amberlite dans du méthanol u reflux 
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Schéma 2. Voie de synthèse de butenolides fusionnés à de  cycles pyranose. 
 
Les conditions expérimentales de l'hydrolyse de 17a ont été optimisées pour réduire le 
temps de réaction et pour orienter vers la formation du composé bicyclique 19 ou du 
glycoside de méthyle 20. L'hydrolyse de 17a avec du TFA (acide trifluoroacétique) 
aqueux à 60% à température ambiante conduit au composé 19 en 5 min, avec un 
rendement de 90%. En utilisant la résine Dowex 50-W, la conversion de 17a en 19 a été 
complète en 2 h, et après 16 heures de réaction, le glycoside de méthyle 20 a été obtenu. 
 
La synthèse d'un dérivé bicyclique régiosélectivement protégé sur l’hydroxyle primaire 
(composé 25, Schéma 3) a été réalisée par monoprotection sélective du diol 22 avec du 
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De la même façon, en suivant la même stratégie de synthèse, à partir des esters insaturés 
17b et 18b de géometrie (E), les composés 26−28, dans lesquels l’unité butenolide est 




Fig. 2. Structures des dérivés glycidiques dans lesqu l l’unité butenolide est fusionnée à 
un cycle pyranose en positions 3 et 4. 
 
Cependant, après la supression du groupe 1,2-O-isopropylidène du derivé 5,6-di-O
pivaloylé 24 et des dérivés pentofuranosidiques de configuration erythro, possédant un 
groupement pivaloyle en C-5 (29) ou désoxygénée en C-5 (30), la lactonisation n’a pas 
été observée dans les conditions d’hydrolyse précédemment utilisées et les diols 
correspondants 31−33 ont été obtenus (Schéma 4). Ces résultats indiquent que la fusion 
des lactones insaturées à cinq chaînons à des cycles furanose est défavorable, mais 















24 31  62%R1 = OPiv, R2 = CH2OPiv
AcOH 70% aq., reflux
29 R1 = OPiv, R2 = H
30 R1, R2 = H 33  56%
TFA  60% aq., t.a.
2-5h (pour 24 e 29)
5 min (pour 30)
 
 
Schéma 4. Hydrolyse de 24, 29 et 30 conduisant aux diols 31−33. 
 
L'efficacité de cette méthode pour obtenir des analogues thiosucres et imino sucres 
(composés du type III  et IV , Fig. 1) à partir de furanos-3-uloses a ensuite été étudiée. 
Ces deux classes de mimes de sucres (« carbohydrate mim tics »)  sont souvent 






L'intérêt pour ces structures réside aussi sur leur potentiel synthétique comme 
précurseurs de nouveaux dérivés de thio-  et iminosucre . 
 
La synthèse de butenolides fusionnés à des thiosucre  a impliqué l'introduction d'une 
fonction sulfhydryle en position 5 des dérivés (Z)-3-C-(éthoxycarbonyl)metilène pento- 
ou hexofuranosidiques 34 et 35 par substitution nucléophile d'un groupement tosylate 
ou d’un triflate, respectivement, par un groupement tioacetyle (Schéma 5). La 
déprotection des groupements ester de 36, 37 suivie de l’hydrolyse acide a donné les 
composés bicycliques desirés 38 et 39. L'acétylation subséquente de 38 et 39 a conduit 
aux dérivés 40 et 41 et aux  thioglycals correspondants 42 et 43, par élimination d'acide 
acétique. L'acétylation de 39 à  conduit majoritairement au thioglycal 43, ce qui peut 
s'expliquer par la faible stabilité conformationnelle de 41, en raison de la présence d'un 
groupement acétoxyméthyle pseudoaxial. L'élimination en C-1,C-2 dans le cas de 40 ou 
de 41, donne un système conjugué très stable. De plus, pour  41, la molécule peut 























35  R1 = H, R2 = CH2OTBDMS






37  R = CH2OTBDMS
36  R = H
39  R = CH2OH
38  R = H
43  R = CH2OAc
42  R = H
41  R = CH2OAc
40  R = H
KSAc, DMF
40 ºC, 1h 45 min
84%
(pour 34)
a) Tf2O, py/CH2Cl2, 0 ºC




b) AcOH, 70% aq
refluxo, 2 h (pour 36)
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Schéma 5. Synthèse de butenolides fusionnés à des motifs 5-thiopento- et 5-
thiohexopyranoses. 
 
Pour étudier la synthèse des iminosucres du type IV , des précurseurs 5-azido-3-C-
(éthoxycarbonyl)méthylène furanosidiques ont été synthétisés (44, Schéma 6). La 
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réduction du groupement azide de l'ester (Z)-α,β-insaturé 44e par la méthode de 
Staudinger a donnée l’amine correspondante 45. L'hydrolyse de 45 en milieu acide 
suivie d'addition de base pour neutraliser l'acide en excès, a conduit à un dérivé de 
l’éthylformamide contenant un butenolide (47). La formation du composé 47 implique 
l’intermédiaire bicyclique 46, dont l’hydroxyle anomérique est déprotoné en milieu 
basique. L'ion résultant se réarrange pour donner u ion énolate, stabilisé par résonance, 
qui est ensuite protoné en C-2. 
 
Après hydrolyse acide du groupement 1,2-O-isopropylidène du composé 44a, et la 
réduction de la fonction azide du diol 48, qui permet l’isomérisation 5-
aminofuranose/iminopiranose en milieu neutre, qui conduit à un 2-céto iminosucre, une 
acétylation finale forme la 1,2-dihydropyridine-3-one 49. La réduction du groupe azide 
de l'isomère (E) (44b) a conduit à la δ-lactame bicyclique 51 par cyclisation 
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 Schéma 6. Exploration de 5-azido-3-C-(éthoxycarbonyl)méthylène furanoses comme 







Les dérivés 5-amino furanosidiques ont donc montré une réactivité distincte par rapport  
aux analogues 5-O et 5-S, qui, dans des conditions réactionelles similaires, ont conduit 
aux butenolides bicycliques attendues. 
 
Les bicyclolactones dérivées de glycosides de carboxyméthyle (CMGLs, composés de 
type V, Fig. 1), dont la préparation comporte 2- à 3 étapes à partir de sucres libres, ont 
été utilisés comme précurseurs de cétones pyranoïdes α,β-insaturées du type hex-3- 
enopyranosid-2-ulose et de diènepyranosides conjugués (composés de type VI −VII , 
Fig. 3). L'inclusion d'une unité 1,2,3-triazole, unhétérocycle susceptible de conférer 
bioactivité, afin d'obtenir les dérivés du type VIII −IX , a également été étudiée. 
 
VI    X = O


















VIII  X = O
IX    X = CHCO2Et  
 
Fig. 3. Structure général des molécules cible contenant un système carbonylé conjugué 
et un cycle 1,2,3-triazole, dont la préparation impl que des précurseurs CMGLs. 
 
La préparation des cétones α,β-insaturées de type VI  a été basée sur l'ouverture 
nucléophile des CMGLs 52−54 avec des amines primaires, suivie d'oxydation des 
adduits et d’élimination concomitante d’acide acétique en positions 3,4. (Schéma 7). La 
méthode d'oxydation par le système diméthylsulfoxyde (DMSO)/anhydride acétique 
(Ac2O) s’est révélée la plus efficace lors d’expériences préliminaires, et a permis 
d'obtenir le système énone avec de meilleurs rendements, par rapport à d'autres 
méthodes d'oxydation plus douces.  
 
Les 2-hydroxy pyranosides tri-O acétylés 55−57, 61 possédant configuration α ont 
conduit aux énones 62−64 correspondantes avec de bons rendements. Cependant, les 
rendements de l'oxydation/élimination des adduits β (58−60) ont été faibles et les 
énones 65−67 ont montré leur tendance à se décomposer. Cela peut êtr  expliqué par la 
conformation adoptée par ces composés, vérifiée par 1H RMN. Tandis que les énones 
62−64 (de configuration α) adoptent une conformation envelope OE (sofa), les anomères 
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β adoptent une conformation EO, qui est habituellement considérée moins stable à cause 
des interactions 1,3-diaxiales. Les cétones α,β-insaturées ont ensuite été converties en 
diènepyranosides conjugués de chaîne ramifiée en C-2 (68-70) par oléfination de Wittig 
avec le réactif [(éthoxycarbonyl)metilène]triphénylphosphorane. La configuration (E) 
de la double liaison exocyclique a été vérifiée par NOESY. 
 
Les réactions de cycloaddition des glycosides de (N-propargylcarbamoyl)méthyle 55, 
58 et 61 avec l'azoture de benzyle en utilisant un protocole a ternatif de ‘click’ 
chemistry, basé sur un catalyseur hétérogène CuI appuyé sur Amberlist A-21, ont donné 
les triazoles correspondant 71−73. Les dérivés déprotégés 74−76 ont ensuite été obtenus 
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Schéma 7. Exploration de CMGLs comme précurseurs de 3-énopyranosid-2-uloses, 
diènepyranosides conjugués et de glycosides contenant un cycle 1,2,3-triazole. 
 
La préparation des composés de type VIII  et IX , qui associent dans une molécule un 
système carbonylé conjugué à une unité de triazole a ensuite été réalisée (Schéma 8). 










Schéma 8. Synthèse de dérivés pyranosidiques contenant un système carbonylé 
conjugué et un cycle 1,2,3-triazole.  
 
Parmi les produits obtenues, les dérivés bicycliques dans lesquels un motif butenolide 
est lié à un cycle furanose (composés de type I ), les butenolides fusionnés à un cycle 
pyranose (composés de type II ), les dérivés pyranoïdes contenant un système carbonylé 
conjugué synthétisés à partir des précurseurs CMGLs (composés de type VI −VII ) et les 
glycosides contenant une unité triazole (composés de type VIII −IX ), ont été testés pour 
leur activité antimicrobienne. L'activité vis à vis de champignons phytopathogènes et de 
champignons pathogènes pour les humains et pour les animaux a été étudiée. Enfin, une 
étude sur l'activité sur des bactéries Gram négatif et Gram-positif a été réalisée.  
 
Les dérivés de sucres contenant un motif butenolide ont montré des faibles activités 
antimicrobiennes ou n’ont pas montré d’activités signif catives. Ces résultats suggèrent 
que ces molécules ont une capacité réduite à réagir comme accepteurs de Michael, ce 
qui peut être lié à la présence d'un C-β quaternaire dans le système conjugué, lequel est 
particulièrement encombré dans les structures fusionnées.  
 
Cependant, l'évaluation biologique des 3-enopiranosid-2-uloses et des diènepyranosides 
de chaîne ramifiée a révélé des activités antimicrob ennes intéressantes. Les énulosides 
de (N-dodécylcarbamoyl)méthyle 64 et 67, en particulier, ont montré des activités fortes 
ou très fortes contre quelques microbes testés, dans certains cas possédant des effets 
inhibiteurs comparables à ceux des antibiotiques de référence. L’enuloside-α (64) a 
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montré une très forte activité contre la bactérie Bacillus cereus et contre Bacillus 
subtilis et une forte activité contre Enterococcus faecalis et Penicillium 
aurantiogriseum. L‘anomére-β (67) a présenté un fort effet inhibiteur contre les 
champignons Aspergillus niger et Penicillium aurantiogriseum. Les diènepyranosides 
conjugués 68−70 ont révélé une activité forte et sélective contre Enterococcus faecalis. 
Les dérivés contenant un cycle triazole n'ont montré aucune activité antimicrobienne 
significative. Trois des composés considérés comme bioactifs, l’α-énuloside de (N-
dodécylcarbamoyl)méthyle 64 et les diènepyranosides 68 et 69, se sont avérés peu 
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This PhD work was based on the synthesis and the use of carbohydrate bicyclic lactones 
for the access of sugar derivatives comprising an α,β-unsaturated carbonyl functionality, 
notably a butenolide moiety or an enone system. The motivation for the research on this 
type of compounds came from the known biological activity associated with the α,β-
unsaturated carbonyl motif, which is frequently present in bioactive natural products. 
Their insertion in carbohydrates may thus provide potential bioactive substances. 
Moreover, taking into account the propensity of such conjugated systems to undergo a 
variety of reactions, these molecular targets may constitute functionalized chiral 
templates for derivatization. The biological activity of some of the synthesized 
molecules, namely the antimicrobial effect, was asses ed.  
 
The present manuscript is organized in subchapters which contain published papers 
achieved within the scope of this subject. The original work presented therein was 
developed and accomplished by the author of this the is (N. M. Xavier) as well as the 
writing of the articles. When the article contains other co-authors besides the 
supervisors of this thesis, their role is specified at the beginning of each chapter.  
 
Since sugar lactones constitute the key skeleton of the molecules investigated, as 
precursors or as final products, a general survey on carbohydrate-based lactones is given 
in the introduction, which was recently published in Topics in Current Chemistry. The 
thesis introduction, i.e. the state of art of the subject here explored, is therefore 
composed by the latter review along with the one published in Carbohydrate Research, 
covering the synthesis and usefulness of sugar derivatives containing α,β-unsaturated 
carbonyl systems, the target molecules of this PhD research work.  
 
The results and discussion include the papers published on Organic Letters and on the 
European Journal of Organic Chemistry concerning the synthesis and biological 
activity of sugar-linked and sugar-fused butenolides and thiosugar bicyclic fused 
analogues. The paper concerning the exploitation of the methodologies previously 
developed towards imino sugar derivatives is already in press in the European Journal 
of Organic Chemistry. The last section, comprising a paper also in press in Bioorganic 
& Medicinal Chemistry, is dedicated to the use of carboxymethyl glycoside lactones as 
synthons for the preparation of sugar enones, conjugated diene pyranosides and related 




In General Conclusions, the last chapter of this manuscript, a summary of the work 
developed in this PhD research program is presented. Emphasis is given on the efficacy 
of the synthetic methodologies developed, demonstrated by the variety of novel 
chemical targets which could be accessed, and on their interest from either chemical or 































1.1. Carbohydrate-Based Lactones 
 
 
The following subchapter was published as: 
 
“Carbohydrate-Based Lactones: Synthesis and Applications” Xavier, N. M.;  
Rauter, A. P.; Queneau, Y. Topics Curr. Chem. 2010, 295, 19–62.  
 
and gives a general survey on the synthesis and uses of carbohydrate-based lactones. A 
special section gives emphasis to bicyclic systems, which is the type of compounds 
explored in this PhD work, as targets or as precursors, aiming at the insertion of α,β-
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Abstract    
 
The synthesis and uses of different kinds of carbohydrate-based lactones are described. 
This group of compounds includes aldonolactones, other related monocyclic lactones 
and bicyclic systems. The latter can arise from uronic acids, carboxymethyl ethers or 
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Carbohydrate lactones have found broad applications as building blocks for the 
synthesis of important bioactive compounds and natural products, and constitute a 
valuable family of synthons for diverse types of transformations. Previous survey 
articles were published by De Lederkremer [1], Lundt [2–4] and Fleet [5]. In this 
revision, emphasis will be given to sustainable approaches involving a limited number 
of steps, to environmentally friendly synthetic methodologies for conversion of these 
molecules into functional compounds, and to multi-step sequences for the preparation of 
more complex targets. Starting with simple and avail ble aldonolactones, the chemistry 
of more elaborated carbohydrate-based lactones, such as α,β-unsaturated δ-lactones as 
well as other types of bicyclic systems will then be presented and discussed. Allying the 
chirality inherent to the sugar to the reactivity of the lactone functionality turns these 








2. Aldonolactone Synthesis 
 
2.1. General Aspects 
 
Aldonolactones are commercially avalailable at low cost, when compared to most of the 
common monosaccharides. They are typically synthesized by selective anomeric 
oxidation of unprotected aldoses with bromine [6]. Usually, the thermodynamically 
more stable five-membered lactone (γ-lactone) predominates over the six-membered 
form, with the exception of D-gluconolactone, which crystallizes as the 1,5-
pyranolactone (δ-lactone) [17] (Scheme 1). Another method for the preparation of sugar 
lactones is the dehydrogenation of unprotected or partially protected alditols and aldoses 
catalyzed by a transition metal complex in the presence of a hydrogen acceptor [8–10]. 
Protected aldoses with a free anomeric hydroxyl group can be converted into the 
corresponding aldonolactones by common oxidation prtocols, such as those employing 
chromium(VI) reagents [11] or DMSO-based oxidizing systems [12, 13]. Methods for 
aerobic oxidation of unprotected aldoses over heterogeneous catalysts, including Pd/C, 
Au/C or a combination of Bi-Pd/C, have also been developed [14–17]. However 






























Glucono-1,5-lactone (δ-D-gluconolactone, 1) is the cyclic ester of D-gluconic acid, 
which is produced on the industrial scale by enzymatic oxidation of glucose (for a 




review of the production, properties, and applications of gluconic acid and its 
derivatives see [18]). This process is mediated by enzymes from selected 
microorganisms, including bacteria such as Pseudomonas or Gluconobacter oxydans 
and fungi such as Aspergillus niger. The method involving A. niger is widely used and 
is based on glucose oxidase. The oxidation pathway consists in the oxidation of glucose 
to δ-D-gluconolactone, which is mediated by the latter enzyme, followed by hydrolysis 
to gluconic acid, which may occur spontaneously or be promoted by the lactonase 
enzyme (Scheme 2). After the fermentation process, the lactone can simply be 
recovered from the broth by crystallization. Under appropriate conditions, glucose can 
be quantitatively converted into gluconic acid. About 100 000 tons of D-gluconic acid, 
mainly used in food industry, are produced annually worldwide [19]. Glucono-1,5-
lactone (1) has widespread application as a food additive, particularly in dairy products, 



























Scheme 2. Oxidation of D-glucose by Aspergillus niger. 
 
2.3. Other Aldono-1,5-Lactones 
 
Glycosyl azides have been shown to be useful precursors for the synthesis of 
aldonolactones. A viable one pot-procedure for the conversion of per-O-alkylated 
glycopyranosides into the corresponding aldono-1,5-lactones is based on the formation 
of glycosyl azide intermediates by treatment of the substrates with trimethylsilyl (TMS) 
azide in the presence of tin(IV) chloride, followed by hydrolysis [20]. In other work, 
aldono-1,4-lactones and aldono-1,5-lactones could be prepared from glycosyl azides via 
a two-step methodology consisting in the N-bromosuccinimide (NBS) mediated 
bromination and subsequent hydrolysis of corresponding N-bromoiminolactone 
intermediates [21]. 
 




Bierenstiel and Schlaf [22] were able to prepare and isolate for the first time the less 
stable δ-D-galactonolactone by oxidation of galactose with the Schvo’s catalytic system, 
which is based on the dimeric ruthenium complex [(C4Ph4CO)(CO)2Ru]2. The 
transformation led to the δ-galactonolactone in 93% yield, against 7% of the isolated γ-
lactone isomer. This procedure also allowed the preparation of δ-D-mannonolactone in a 
much better yield (94%) than that reported in an early procedure [23] based on 
crystallization from a solution of calcium mannonate in aq. oxalic acid.  
 
O‘Doherty and co-workers have explored the use of 2,4-dienoates as precursors for δ-
galactonolactones [24, 25]. The synthetic approach involved sequential dihydroxylation 
steps of the dienoates (2a–c) double bonds by Sharpless AD-mix reagent systems 
(Scheme 3). After the first enantioselective dihydroxylation step, the resulting γ,δ-
dihydroxyenoate intermediates (3a–c) were protected at the γ-hydroxyl group as cyclic 
carbonates, which were then treated with p-methoxyphenol (PMPOH) in the presence of 
a Pd(0) catalyst. The resulting 4-O-protected derivatives (4a–c) were submitted to 
diastereoselective dihydroxylation affording triols possessing galacto configuration, 
which were then lactonized to give the target L-galactono-1,5-lactones (5a–c) or their 























     0.5 % Pd2(DBA)3.CHCl3











AD−α∗ = 2% OsO4, 4% (DHQ)2PHAL, 3 eq K3Fe(CN)6, 3 eq K2CO3, 1 eq MeSO2NH2
AD−β∗ = 2% OsO4, 4% (DHQD)2PHAL, 3 eq K3Fe(CN)6, 3 eq K2CO3, 1 eq MeSO2NH2  
 
Scheme 3. Synthesis of L-galactono-1,5-lactones from 2,4-hexadienoates. 
 






An efficient method for preparing aldono-1,4-lactones (γ-aldonolactones) as the single 
products from oxidation of unprotected or partially protected monosaccharides was 
reported [9]. It consisted in treatment of the latter by catalytic amounts of 
[RuH2(PPh3)4], in the presence of an excess of benzalacetone (trans-4-phenylbut-3-en-
2-one) as the hydrogen acceptor, in DMF. The corresponding γ-lactones were obtained 
in excellent yields, even in the case of D-glucose, for which no 1,5-lactone was 
observed. The results suggested that the oxidation s ep is followed by a ring contraction 
mechanism, probably promoted by coordination of the catalyst to the endocyclic oxygen 
and to the carbonyl group, facilitating ring opening and its closure into the more 
thermodynamically stable five-membered form.  
 
L-Aldonolactones are much less available than their D-enantiomers. Their potential to 
serve as chiral building blocks for L-sugar derivatives also makes them molecular 
targets of interest.  
 
Stereoselective approaches involving few steps leading to 2,3-O-isopropylidene-L-
ribonolactones and L-lyxono-1,4-lactones were reported by Rao and Lahiri [26]. The L-
ribono derivative could be synthesized in three steps starting from the easily available 
isopropylidene-D-erythrose (6) (Scheme 4). It was converted into the unsaturated ci  7 
by Wittig olefination and further oxidation. Epoxidation of the latter afforded the 
desired 1,4-lactone (8) in 40% yield, due to cyclization of the intermediate epoxide 
promoted by silica gel when attempting product separation by column chromatography. 
The synthesis of the L-lyxono-1,4-lactone derivative (12) was accomplished starting 
from D-ribono-1,4-lactone (9), of which 5-O-tosyl derivative 10 was treated with the 
potassium salt of benzyl alcohol to give the epoxy benzyl ester 11, furnishing directly 
on catalytic hydrogenation  the target compound in 44% yield. 
 













































Scheme 4. Synthesis of 2,3-O-isopropylidene L-ribono- and L-lyxono-1,4-lactones. 
 
More recently, a simple synthetic route for a large scale production of 12 (2,3-O-
isopropylidene-L-lyxonolactone) was described [27]. The chosen starting material was 
D-ribose (13), which was oxidized to the corresponding lactone 14 (Scheme 5). The 
latter was submitted in situ to acetonation to provide the 2,3-O-isopropylidene 
derivative 9, which was then mesylated at OH-5. Treatment of the crude 5-O-mesylate 
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(65%, 13 9) (59%, 9 12)
 
 
Scheme 5. Process for a large scale production of 2,3-O-isopropylidene L-lyxono-1,4-
lactone. 
 
L-Galactono-1,4-lactone (16) is prepared in three steps (51%, overall yield) from  2a 
applying two successive asymmetric dihydroxylations (ADs) [25] (Scheme 6). 
 
























Scheme 6. L-Galactono-1,5-lactones from 2,4-hexadienoates. 
 
L-Aldono-1,4-lactones can be prepared from D-aldose perpivaloates and peracetates 
(compounds of type 17) [28]. The method implies formation of aldoximes (18), 
followed by mesylation (Scheme 7). The resulting 5-O-mesyl glyconitrile derivatives 














































Scheme 7. L-Aldono-1,4-lactones from D-aldose perpivaloates and peracetates. 
 
3. Aldonolactone as Useful Chirons 
 
The use of aldonolactones for the preparation of carbasugars and iminosugars has been 
well explored and documented, particularly by Lundt’s group [2–4, 29–31]. Fleet has 
also given an overview of the utility of sugar lactones as synthons for biologically 
active compounds [5] and his research group has made major contributions to the 
synthesis of sugar amino acids from aldonolactones [32–34]. We review here the 
syntheses of C-glycosyl compounds, L-sugars, imino- and thiosugars, natural products 




and of surfactants and related polymers that make use of aldonolactones as starting 
materials. 
 
As shown in chapter, “Synthetic polymers from readily available monosaccharides” by 
J.A. Galbis and M.G. Garcia-Martin,1 aldonolactones are useful monomeric materials 
for the synthesis of biodegradable polymers and bio-compatible polymers for medicinal 
applications. 
 
3.1. Synthesis of Surfactants and Polymers 
 
Among the aldonolactone-based surfactants are aldonolactone-linked fatty esters which 
have been prepared by selective acylation of unprotected aldono-1,4-lactones or aldono-
1,5-lactones. One of the first reported examples of this type of surfactants was applied 
to the enzymatic synthesis of 6-O-alkanoylgluconolact nes [35]. Thus, 6-O-decanoyl- 
and 6-O-dodecanoyl- derivatives (21a and 21b, respectively, Scheme 8) were obtained 
in 26–27% yield by esterification of glucono-l,5-1actone (1) at C-6 with the 
corresponding 2,2,2-trichloroethyl carboxylate in the presence of porcine pancreatic 
lipase (PPL) as catalyst. Compounds 21a,b are soluble in water at 90–96 ºC but 
precipitate when cooled to 30–37 ºC. NMR and GC-MS analysis after dissolution and 
precipitation indicated the presence in the mixture of compound 21b, the glucono-l,4-
1actone-derived ester 22, and the acyclic dodecanoylgluconic acid 23, the latter being 
the major compound. This demonstrates that dissolution of 21b occurs with hydrolysis 
of the lactone moiety giving a more soluble mixture of compounds that are more 
appropriate for detergent applications than the dodecanoylglucono-1,5-lactone itself.  
 
Acylation of D-glucono-1,4- and D-glucono-1,5-lactone with N-(11-undecenoyl)-1,3-
thiazolidine-2-thione in the presence of triethylamine gave 6-O-undecenoyl ester as the 
single product. In the case of the 1,5-lactone, isomerization to the 1,4-lactone-derived 
ester was observed, and quantitative conversion was att ined when sodium hydride was 
used as base. In contrast with the expected regioselectivity at OH-6, acylation of L-
galactono-1,4-lactone proceeded only at OH-2 althoug  with a rather low yield (ca. 
20%). Alternatively, the enzymatic route, employing Candida antartica and an ester, 
                                                           
1 Topics Curr. Chem. 2010, 295, 147–176. 




proved to be more efficient, affording only 6-O-acylated-1,4-lactone derivatives in 
yields up to 76 and 85%, by acylation of D-glucono-1,5-lactone and L-galactono-1,4-
lactone, respectively. The conversion was shown to increase with the electron-
withdrawing character of the ester, while acids proved to be virtually unreactive as 









R = (CH2)8CH3 or









1 21a  R = (CH2)8CH3




















Scheme 8. Enzymatic synthesis of 6-O-alkanoylgluconolactones. 
 
Another type of amphiphilic-like structure in which an aldonolactone moiety is present 
was prepared by acetalization of D-glucono-1,4-lactone (24) and D-glucono-1,5-lactone 
(1) with dodecanal or tetradecanal in the presence of methanesulfonic acid (Scheme 9) 
[37]. Both lactone isomers led to 1,4-lactone acetal derivatives 26a,b in optimized 
yields up to 60–79%. A mechanism for the ring contraction was proposed, involving a 
hemi-orthoester (25) as a key intermediate in the addition to the aldehy . Then, 
opening of an intermediate bicyclic-fused system and concomitant cyclization led to the 
acetal 26. 
 

















































R = (CH2)10CH3 or











26b  R = (CH2)12CH3
 
Scheme 9. Acetalization of D-glucono-1,4- lactone and D-glucono-1,5-lactone with 
dodecanal or tetradecanal. 
 
In the context of the synthesis of carbohydrate-based amphiphilic 
(alkylsulfanyl)polyols, Beaupère and co-workers explored the access to 5- and 6- 
alkylsulfanyl derivatives of pentono- and hexonolactones and their corresponding 1- 
(alkylsulfanyl)pentitols or 1- (alkylsulfanyl)hexitols [38, 39]. Bromolactones 27 and 30 
were treated with alkanethiol in the presence of sodium hydride (Scheme 10) giving 
compounds 28 and 31, respectively, in good yields (72–95%). Subsequent lac one 
reduction with NaBH4 provided the 1-S-alkyl-1-thio-alditol derivatives 29 and 32, 
respectively. Physico-chemical studies demonstrated surface activity for all compounds 
28, except for the D-ribono derivatives for which no critical micellar concentration 
(CMC) value was detected [40]. Apart from the lyxitol series, the pentitol derivatives of 
type 29 were shown to be more fficient in reducing the surface tension than their cyclic 
counterparts 28. The mesophasic properties of 28 and 29 were also evaluated [41]. Most 
of the compounds gave lyotropic and thermotropic liquid crystals, except for the series 
of D-ribonolactones. This singular behavior for the ribono derivatives 28 was ascribed 
to the position of the vicinal hydroxyl groups whic are in the same side of the cycle, 
favouring intramolecular hydrogen bonding. 
 






































       C8H17
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       C10H21
       C11H23
       C12H25  
Scheme 10. Amphiphilic (alkylsulfanyl)aldonolactones and corresponding alditols. 
 
It has been known for more than fifty years that carbohydrate lactones undergo ring 
opening by amines. Using long chain primary amines gives access to amphiphilic 
structures that are emulsifying agents [42, 43] or liquid crystals [44–47]. The 
preparation of N-arylgluconoamides and N-alkylgluconoamides by opening of D-
glucono-1,5-lactone, and their subsequent conversion int  thiogluconamide derivatives, 
are reported [48]. Some amphiphilic alkyl aldonamides and diacetylenic aldonamides 
have the propensity to aggregate into supramolecular assemblies, leading to different 
structural morphologies [49–52]. Amphiphilic glycodendrimers containing aldonoamide 
moieties at their molecular surfaces have been prepared by coupling polyamine 
dendrimers with 1,5-D-glucono-1,4-lactone [53–55]. Such macromolecules ar  shown to 
behave as unimolecular micelles in water able to solubilize hydrophobic compounds in 
the dendritic cavities [55]. Highly enantioselective ketone reduction has been carried out 
in the presence of these systems. 
 
In a recent work [56] aldonoamides (33, 34) have been synthesized in moderate to good 
yields by addition of long-chain N-monoalkylated diamines to D-glucono-1,5-lactone 1
or D-ribono-1,4-lactone 14 (Scheme 11). In addition, hydrazones 36 have been obtained 
by treatment of the intermediate ribonohydrazide 35 with octanal or decanal. All 
compounds derived from ribonolactone showed moderate ctivity against M. 
tuberculosis. Some ribonoamides were also active against Staphylococcus aureus. The 
activities increased somewhat with the elongation of their hydrocarbon chains. 









































m = 7, 9, 11, 13
n = 2, 3
CH3(CH2)mNH(CH2)nNH2
CH3(CH2)mCHO
m = 6, 8
33
34
35 36  
Scheme 11. Amphiphilic compounds by ring-opening of aldonolactones. 
 
The use of carbohydrates as raw materials for the generation of polymers has attracted 
particular interest in the last two decades not only because of concerns related with 
sustainability and biocompatibility, but also due to the unique mechanical and physical 
properties that the sugar units may provide to the material [for reviews on carbohydrate-
based polymers see [57–59]). The hydrophilic sugar moiety contributes to the specific 
three-dimensional structure of the polymer and increases its hydrophilicity and water 
solubility. Due to their particular characteristics, glycopolymers have found interesting 
applications as floculating agents, detergents, surface modifiers, and also in the 
biomedical field as biomaterials for tissue regeneration, as drugs and for gene delivery 
systems (See chapter, “From natural polysaccharides to materials for catalysis, 
adsorption and remediation”, by F. Quignard, F. Di Renzo and E. Guibal,2 and chapter, 
“Synthetic polymers from readily available monosaccharides”, by J.A. Galbis and M.G. 
Garcia-Martin1).  
 
One of the approaches employed to achieve sugar-based polymers consists in the 
preparation of monomers comprising the sugar moiety and a polymerizable double 
bond. Aldonolactones can be useful starting materials for this type of monomers, 
allowing the introduction of the polymerizable part hrough selective 
monofunctionalization of the lactone, without the use of protecting groups. The 
connection of both parts can be accomplished, for example, through amide linkages. 
                                                           
2 Topics Curr. Chem. 2010, 294, 165–197. 




One of the first reported examples applying this approach [60] involved the addition of 
an aminoalkyl ammonium methacrylate salt, derived from a diamine and methacrylic 
acid, to D-glucono-1,5-lactone 1 (Scheme 12). The resulting ionic monomers 37 were 
then subjected to homopolymerization in the presence of a free-radical initiator to give 
the corresponding polymers 38 in good yields. Studies of the viscosity of their aqueous 
solution showed a decrease of this parameter when increasing the concentration, 
proving their polyelectrolyte nature. NMR analysis of polymers 38 revealed their 
predominant syndiotatic structure. The monomer 37a (n = 2) was also copolymerized 
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Scheme 12. Gluconolactone-derived vinyl monomers and their polymerization. 
 
Aldonolactones serve as suitable monomers for the generation of homo- and 
copolymers, especially through ring-opening polymerization (ROP). Among them are 
the carbohydrate-analogues of ε-caprolactone, i.e. aldono-1,6-lactones. The first 
example of such derivatives and further ROP was report d by Galbis and co-workers 
[61] (See also chapter, “Synthetic polymers from readily available monosaccharides” by 
J.A. Galbis and M.G. Garcia-Martin1). Two alternative routes leading to tetra-O-methyl-
D-glucono-1,6-lactone 43 were employed, one of them involving the intermediate 
protected glucono-1,5-lactone 40, which was prepared from methyl D-glucopyranoside 
39. Opening of the lactone ring of 40, methylation and hydrogenation led to the ω-
hydroxygluconic acid derivative 42, which was subsequently converted into 43 by 
lactonization (Scheme 13). Attempts to homopolymerize 43 failed. However, its 




copolymerization by bulk ROP with L-lactide Z, using stannous octoate as initiator, 




















































Scheme 13. Synthesis of a ω-hydroxygluconic acid from a protected glucono-1,5-
lactone derivative and further copolymerization with L-lactide. 
 
Williams and co-workers [62] have recently explored the ROP of acetylated aldono-1,5-
lactones to investigate their propensity to oligomerize/polymerize by a metal alkoxide 
initiator. Hence, treatment of tetra-O-acetyl-D-glucono-1,5-lactone with 1,4-butanediol 
and stannous octanoate produced only a mixture of mono-, di-, and trialdaric esters. The 
latter were then subjected to copolymerization with [R,S]-lactide using an alkyl zinc 
initiator, which furnished triblock ABA copolyesters. Soon afterwards, the same group 
reported the ROP of 3,4-dideoxy-aldonolactones 45, which were prepared in two steps 
from D-glucono-1,5-lactone (1) [63]. The polymerization was performed in the presence 
of Sn(OBu)2, providing mainly cyclic polyesters 46 (Scheme 14).  
 




































Scheme 14. Ring-opening polymerization (ROP) of acetylated aldono-1,5-lactones. 
 
An interesting type of polymeric network has been obtained by polymerization of D-
gluconolactone (1) and citric acid (47) (Scheme 15) [64]. Instead of proceeding by a 
ROP mechanism, this polymerization was shown to occur through the esterification 
reaction between the hydroxyl groups of gluconolactne or citric acid and the 























































47 48  
Scheme 15. Polymerization ofD-gluconolactone and citric acid. 
Polyhydroxypolyamides have attracted significant atention since they are more 
hydrophilic and biodegradable than nylons. Sugar amino acids [65] or aldaric acid 
derivatives [66, 67] are among the carbohydrate precursors that have been employed for 
the synthesis of these polyamides.  
 
Simple syntheses of suitable monomers for nylon 5 ad nylon 6 analogues, such as 5-
amino-5-deoxy- and 6-amino-6-deoxyaldonic acids (51, 54), have been achieved 
starting from unprotected D-pentono- and hexono-1,4-lactones [68, 69]. Saponification 




of 5- or 6-azido-D-aldonolactones (ribo-, arabino-, xylo-, galacto-, manno-, compound 
types 49 and 52) provided the corresponding 5- or 6-azido-aldonic acid sodium salts (50 
and 53). A catalytic hydrogenation after or before treatment with acidic resin afforded 





























































Scheme 16. Synthesis of 5-amino-6-deoxy- or 6-amino-6-deoxyaldonic acid monomers. 
  
More recently, a similar synthetic strategy involving 2-azido-2-deoxy-D-xylono-1,4-
lactone and 2-azido-2-deoxy-D-lyxono-1,4-lactone precursors has been applied for the 
synthesis of polyhydroxy α-amino acids, namely (–)-polyoxamic acid and 3,4-
diepipolyoxamic acid [70]. 
 
Aldonolactone-based fluorinated surfactants have also been reported [71]. 
 
3.2. Synthesis of C-Glycosyl Compounds 
 
C-Glycosyl compounds are important molecular targets as they occur in Nature and 
have interesting biological properties (for reviews on C-glycosylation, see [72–75]). 
Chain extensions of aldonolactones have been employed to create C-C bond formation 
at the anomeric center. Claisen-type reactions of aldono-1,4-lactones (e.g., 9 55) with 
acetone or acetophenone (Scheme 17) generate hemiacetals of type 56a–c [76]. 
Similarly, lactone, 55b reacts with CH3CN/NaH to give hemiacetal 57. 




























R1 = CH2OBn, H








Scheme 17. C-Glycosylation by Claisen-type reaction of aldono-1,4 lactones with 
acetone, acetophenone, or acetonitrile. 
 
Using the enolate of tert-butyl bromoacetate with 1,5-lactones 58 (Scheme 18) led 
directly to exocyclic epoxides 59, which were subsequently transformed into C-
ketosides 60 [77]. Alternatively, cationic reduction of epoxides 59a–c provided C-
glycosyl compounds 61a–c. Upon esterification of the latter as 

















































Scheme 18. Claisen condensation of aldono-1,5-lactones leading to exocyclic epoxides 
and further conversion into C-glycosyl derivatives. 
 




Olefination of protected aldonolactones is a convenient approach to C-glycosylation 
that furnishes C-glycosylidene derivatives, often referred as “exo-glycals” [78]. 
Activated olefins, such as 1-C dichloromethylene [79], 1-C-methoxycarbonylmethylene 
[80] and 1-C-cyanomethylene derivatives [81] have been obtained by irect Wittig-type 
olefination of aldonolactones. Hydrogenation of the C-glycosylidene compounds 
produces the corresponding C-glycosyl derivatives with high stereocontrol. However, 
exo-glycals resulting from partially protected aldonolactones, and that possess free 
hydroxyl groups appropriately located in the sugar ring, were shown to undergo 1,4-
addition within the activated double bond to give bicyclic derivatives [82]. This 
propensity for activated exo-glycals to act as Michael acceptors permits the synthesis of 
N-glycosyl β-amino esters through stereoselective 1,4-addition of benzylamine, 
followed by reduction [83]. The latter compounds can be manipulated as standard 
amino acids and can enter into peptide synthesis. The synthesis of a variety of tri- and 
tetrasubstituted exo-glycals was accomplished from tetra-O-benzyl-D-glucono-1,5-
lactone applying a modified Julia olefination procedure [84]. 
 
Another method for the alkylidenation of aldonolactones uses additions of 
organometallic reagents [78]. For example, Lin et al. [85] described an efficient route to 
conjugated anomeric dienes (64a,b) or aldehydes (66) based on the reaction of aldono-
1,4- and 1,5-lactones (1, 62) with allylmagnesium chloride (Scheme 19), giving allyl 
hemiacetals (e.g.: 63a,b). Hemiacetal can be dehydrated [e.g.: with (CF3 O)2O] to 












































65 66, 50%, 3 steps
69%, 2 steps
64b 61%, 2 steps
 
 
Scheme 19. C-Glycosyl derivatives by addition of allylmagnesium chloride to 
aldonolactones. 




C-Glycosyl aromatic compounds are particularly relevant owing to their presence in a 
variety of biologically important natural products, including antibiotics (for reviews 
concerning the synthesis and biological profile of C-glycosyl aromatic compounds, see 
[86–89]). Based on the method of Sulikowski and co-workers [90], Li et al. [91] 
developed an efficient one-pot procedure for the synthesis of a series of C-aryl glycals 
in 75–92% yields. It consisted in the addition of aryllithium reagents to variously 
protected 2-deoxy-aldono-1,5-lactones, followed by treatment with a mixture of 
pyridine (py), 4-dimethylaminopyridine (DMAP), and trifluoroacetic anhydride 
(TFAA).  
 
3.3. Synthesis of L-Aldoses 
 
L-aldoses are scarcely available from natural resources. However, their utility as 
building blocks for natural products and analogues ha  prompted the search for efficient 
methods for their synthesis. Lipták and co-workers [92] have prepared L-glucose 
through standard manipulations starting from D-gulono-1,4-lactone. The synthetic 
pathway included conversion of the lactone into 1,2,3,4,5-penta-O-benzyl-D-gulitol, 
1,2,3,4,5-penta-acetyl-D gulitol, or 1,2,3,4,5-penta-benzoyl-D-gulitol, oxidation at C-6 
to the corresponding aldehydes, and further deprotecti n with concomitant pyranose 
ring closure. Yields in L-glucose ranged from 34 to 53% overall yield, the best one 
being obtained from the penta-O-acetyl-D-gulitol derivative. 
 
A general and effective four-step procedure for the conversion of D-hexono-1,5-lactones 
into L-hexoses was developed [93]. It involved alkoxyamination of tetra-O-benzyl-
aldono-1,5-lactones 58a–c mediated by AlMe3 to provide the corresponding δ-
hydroxyalkoxamates 67a–c, which were then engaged into an intramolecular cyclization 
under Mitsunobu displacement conditions (Scheme 20). This cyclization occurred 
mainly via O-alkylation, affording the corresponding oxime derivat ves 68a–c in good 
yields, all with the expected inversion of configuration at C-5. At this stage, the acid-
catalyzed hydrolysis of the oximes to the parent L-glycono-1,5-lactones 69a–c provided, 
after reduction with diisobutylaluminum hydride (DIBAL-H), the corresponding tetra-
O-benzyl-L-hexoses 70a–c. 
 

































R = Bn, Me, Et, t-Bu (gluco)





















Scheme 20. Conversion of D-hexono-1,5-lactones into L-hexoses via δ-
hydroxyalkoxamate derivatives. 
 
A relatively short route has been presented to convert D-glucono-1,5-lactone (1) into L-
xylose and L-gulose [94] (Scheme 21). Acetalization of 1 gave 71, the reduction of 
which with NaBH4 and subsequent silylation afforded 72. Deacetylation with SnCl2 








































1 R = TBDMS71
a) NaBH4
b) TBDMSOTf






















Scheme 21. Synthesis of L-aldoses from D-glucono-1,5-lactone. 
 
 




3.4. Synthesis of Iminoalditols and Analogues 
 
Imino sugars (or imino-dideoxyalditols) are alditols in which the ring ethereal moiety 
has been replaced by an amino group. These sugar mimetics are potential therapeutic 
agents, particularly due to their ability to act as glycosidase inhibitors [95]. Among 
them are found the naturally occurring 1-deoxynojirimycin (DNJ) and 1-
deoxymannojirimycin (DMJ) [96].  
 
Practical syntheses of DNJ and DMJ start from L-gulono-1,4-lactone (20b) and D-
mannono-1,4-lactone (74), respectively [97]. Key intermediates are 2,6-dibromo-2,6-
dideoxy-D-alditol derivatives 75a and 75b obtained by 2,6-dibromination of the starting 
lactones, followed by reduction with NaBH4 [98, 99]. Then a five-step sequence 
involving selective partial protection, introduction of an amine functionality, and 






























Scheme 22. Synthesis of 1-deoxynojirimycin (DNJ) and 1-deoxymannojirimycin 
(DMJ). 
 
Related imino alditols such as azepanes or lactam derivatives have been obtained and 
have shown to be glycosidase inhibitors [96, 100]. Both D- and L-gulonolactone have 
been converted into polyhydroxylated 1,6-aldonolactams of type 79 in a sequence of 
straightforward functional transformations, including sulfinylation of the corresponding 
aldonolactone-derived acetonides 76 that gave 5,6-cyclic sulfites 77 (Scheme 23) [101]. 
The latter reacted with sodium azide giving 6-azido derivatives 78. In situ reduction of 
78 and N-cyclization led to the targeted azepanes 79. 







































Scheme 23. Synthesis of di-hydroxylated 1,6-aldonolactams via aldonolactone-derived 
sulfites. 
 
A concise synthesis of tetra-O-ethyl aldonolactam 83 starting from 1 has been reported 
[102]. After protection of its primary alcoholic moiety as a trityl ether, saponification 
and treatment with EtBr generated 80. Acidic hydrolysis liberated 81 that was esterified 
(tosylate). The latter was displaced with NaN3 to give azide 82. Reduction of 82 






































Scheme 24. Synthesis of a tetra-O-ethylaldonolactam from D-glucono-1,5-lactone. 
 
Quite often N-alkylated imino sugars exhibit stronger glycosidase inhibitory activity 
than the corresponding non-alkylated derivatives [96, 103]. The synthesis of a series of 
hydroxylated N-alkyl aldonolactam derivatives was recently accomplished in a four-step 
sequence and good overall yields starting from D-ribono-1,4-lactone (14) [104]. 
Treatment of 14 with primary amines, and subsequent selective bromination of the 




resulting amides 84 and acetylation, provided the corresponding bromoaide 
derivatives 85. The latter were then submitted to intramolecular cyclization to afford the 
corresponding N-alkyl ribonolactams, the transmethanolyse of which led to the final 
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a) NaH
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Scheme 25. Synthesis of a N-alkylated aldonolactam from ribono-1,4-lactone. 
 
3.5. Synthesis of Thiosugars 
 
Thiosugars constitute another class of carbohydrate analogues presenting interesting 
biological and pharmacological properties [105, 106].  
 
4-Thio-L-lyxono-1,4-lactone (89) has been prepared starting from 2,3-O-
isopropylidene-5-O-tosyl-D-ribonolactone (10, D-ribo). 10 was converted first into 
epoxide 87 (Scheme 26) and then into episulfide 88 on treatment with thiourea. 
Regioselective opening of the thiirane ring of 88 and simultaneous lactonization, 
followed by removal of the protecting groups, furnished enantiomerically pure 89. A 
similar synthetic pathway was employed for the synthesis of 4-thio-D-ribono-1,4-
lactone starting from D-gulono-1,4-lactone [104]. 
 






























Scheme 26. Synthesis of 4-thio-L-lyxono-1,4-lactone from 2,3-O-isopropylidene-5-O-
tosyl-D-ribonolactone. 
 
Beaupère and co-workers have proposed a short synthesis of 5-thio-D-pentopyranoses 
93 applying a sequence of simple reactions starting from 5-bromopentono-1,4-lactones 
of type 27 (Scheme 27) [108, 109]. The latter were acetylated and subsequently 
converted into their corresponding 5-S-acetyl-5-thio derivatives 91. Reduction of 91 
into lactols 92 was followed by deprotection, furnishing the desird pentose derivatives 





























Scheme 27. Synthesis of thio-D-pentopyranoses from 5-bromo-D-pentono-1,4-lactones. 
 
3.6. Synthesis of Bioactive Natural Products 
 
Selected examples of the synthesis of natural products starting from aldonolactones are 
presented in this section. 
 
Spirocyclic C-aryl glycosides are central structural skeletons of papulacandins that 
constitute a family of novel antifungal antibiotics isolated from a strain of Papularia 




sphaerosperna. They have shown potent in vitro antifungal activity against Candida 
albicans, Candida tropicalis, Pneumocystis carinii, among other microorganisms [110].  
 
One route to spirocyclic C-glycosyl aromatic compounds is based on the addition of 
functionalized organolithium reagents to D-glucono-1,5-lactone (for example [111–
113]). For instance addition of 2-(trimethylsily1)ethynyllithium to tetra-O-benzyl-D-
glucono-1,5-lactone (58a) gave the hemiacetalic 1-C-ethynyl derivative 94 as an 
anomeric mixture (Scheme 28). Acetylation of the tertiary hydroxyl group was followed 
by Lewis acid-mediated propargylation to give diyne 96. Desilylation of 96 followed by 
cyclotrimerization in the presence of Wilkinson’s catalyst gave the desired spiroketal 








































 50% aq. NaOHR = TMS








Scheme 28. Synthesis of a spirocyclic C-aryl glycoside from tetra-O-benzyl-D-glucono-
1,5-lactone. 
 
Spirocyclic C-ribosyl aromatic compounds have also been derived from D-ribono-1,4-
lactone by a similar strategy. In this case a mild cylopentadienyl ruthenium complex 
was used as catalyst for the cycloaddition step [114]. 
 
Gabosines which have been isolated from Streptomyces trains constitute a family of 
keto carbasugars, most of them possessing a trihydrox lated cyclohexenone structure. 
Because of their interesting bioactivities, a large number of synthetic approaches to 
these compounds have been proposed (for example [115, 1 6]).  




The shortest route (four to five steps) to gabosines I and G was accomplished starting 
from D-glucono-1,5-lactone (Scheme 29) [117]. Thus, acetalization of 1 with 2-
methoxypropene resulted in the mixed acetal derivative 99 which underwent 
nucleophilic addition by the anion of diethyl methylphosphonate to afford the β-
ketophosphonate 100. The latter compound was subsequently submitted to a one-pot 
tetrapropylammonium perruthenate (TPAP) oxidation/K2CO3-mediated intramolecular 
Horner-Wadsworth-Emmons olefination, providing enone 101 in 43% yield. Other 
oxidation/cyclization conditions were less efficient. Deprotection of 101 furnished (–)-











































a) TPAP, NMO, 3 Å MS
b) K2CO3
TFA, H2OAcCl, collidine










Scheme 29. Synthesis of (–)-gabosine I and gabosine G from D-glucono-1,5-lactone. 
 
3.7. α,β-Unsaturated Aldonolactones 
 
Sugar-based lactones comprising an α,β-unsaturation are carbohydrate chiral building 
blocks with biological potential. Rauter and co-workers have reported the first synthesis 
of α,β-unsaturated lactones linked/fused to sugars and the field was broadly covered in a 
recent review [118–120]. Concerning monocyclic derivatives, i.e., α,β-unsaturated 
aldonolactones, a readily available 2,3-unsaturated aldonolactone is L-ascorbic acid 
(Vitamin C). Its chemistry and usefulness as chiral synthon has been reviewed very 




recently [121]. It is a versatile starting material for the synthesis of L-hexoses [122, 
123].  
 
Both aldono-1,4-lactones and aldono-1,5-lactones have the tendency to undergo β-
elimination on acylation to give butenolides or pyranoid α,β-unsaturated 
aldonolactones, respectively [1]. 2,3-Unsaturated aldono-1,4-lactones are also easily 
obtained from 2-bromo-2-deoxyaldono-1,4-lactones through a mild reductive 
elimination of the C-2 bromine and a trans-vicinal acetoxy group that uses sodium 
sulfite in methanol [124,125]. 2-Deoxysugar lactones are intermediates for ulosonic 
acids [126–128]. 
 
Most of the methodologies applied to prepare pyranoid α,β-unsaturated lactones start 
with glycals [129–132]. The Lichtentaler’s group developed a one-pot procedure 
consisting in the oxidation of glycals and 2-acyloxglycal esters with m-
chloroperbenzoic acid in the presence of boron trifluoride etherate [133–136]. Another 
major contribution to this field was realized by Chmielewski and co-workers. Their 
method was based on the oxidation of protected glycals with hydrogen peroxide in the 
presence of molybdenum trioxide catalyst to the corresponding anomeric 
hydroperoxides, which could then be readily converted into the pyranoid unsaturated 
lactones on treatment with Ac2O/py [137–140]. This group has explored the ability of 
sugar-based α,β-unsaturated lactones to react as Michael acceptors or a  dipolarophiles 
in cycloaddition reactions, for the synthesis of important molecular targets, including 
imino sugars and natural compounds of biological interest (for example [141–146]). 
 
4. Bicyclic Carbohydrate-Based Lactones 
 
Bicyclic carbohydrate-based lactones can be divided into three classes: (1) lactones 
involving a carboxy group present on the sugar moiety (uronic and sialic acid lactones), 
(2) lactones involving a carboxy group formed by derivatization of a sugar hydroxyl 
group (carboxyalkyl ethers and glycosides), and (3) lactones involving a carboxy group 
present on a C-branched appendage. 
 




When the lactone function of such bicyclic systems is consumed in a ring opening 
reaction, the main carbohydrate cyclic backbone is maintained in the product, unlike 
aldonolactones. Selected recent examples will be giv n in this section. 
 
4.1. Uronic Acid Derived Lactones 
 
The occurrence of uronic acid provides another means of easy access to bicyclic 
lactones, which can be used for the synthesis of various targets, such as surfactants or 
pseudo glycopeptides. 
 
Alkyl furanosides can be obtained stereoselectively from the readily available D-
glucofuranurono-6,3-lactone 102 arising from D-glucuronic acid, or from D-
mannofuranurono-6,3-lactone 103, which is obtained by acidic hydrolysis of alginic 
acid (Scheme 30) [147–149]. The lactone function of alkyl glucosides 104 can be 
opened by amines leading to new amphiphilic derivatives [42]. Pseudo macrocyclic 
bola-amphiphiles 105 are accessible by treatment of the lactone with a long-chain 
diamine [150]. Selective monoacylation of diamines can be followed by 
functionalization of the second amino group with different functional moieties, such as 
a nitroxide for ESR (electron spin resonance) studies (e.g., 106a) or a cationic glycine 


































































Scheme 30. Bolaphiles derived from uronic acid 3,6-lactones. 




Variations of the self-assembly properties of the latter compound was studied as a 
function of the length and nature of the alkyl chain spacer connecting both polar heads 
[151–153]. 
 
If the anomeric hydroxyl group is involved in the lactone ring (6,1-lactones) such as in 
compound 107, the lactone is rapidly opened in the presence of a Lewis acid (Scheme 
31). As in Hoffmann’s systems arising from [4+3] cycloaddition methodology [154, 
155], such lactones can be seen as tethered anomeric ac tates acting as intramolecular 
leaving groups. Stereoselective glycosylations can thus be achieved with different 
selectivities depending on the nature of the substituent at C-2 and on the reaction 
conditions [catalyst, microwave irradiation (MW)]. In some cases, concomitant 
esterification of the released carboxylic acid is ob erved (Scheme 31) [156–158]. When 
the released carboxylic group reacts with diamines, more elaborated systems such as 
dienes 108 or diynes 109 can be obtained and used in subsequent intramolecular ring-











































































Scheme 31. Opening of glucuronic acid 6,1-lactone. 
 




Rauter and co-workers demonstrated that C-5-alkylidene derivatives 112 of D-
hexofuranurono-6,3-lactone can be obtained by Wittig olefination of the α-ketolactone 
111 [160]. The related α-methylene lactone 114 was prepared in three steps from 3,6-

























111 X = CHCO2Et




Scheme 32. Alkylidene derivatives of glucuronic acid 6,3-lactone. 
 
In a similar manner, sialic acids are liable to lactone formation. In some cases the 
observed lactones have been suggested to possess enhanc d biological properties with 
respect to the corresponding open hydroxyacids [161– 3]. Sialic acid 1,7-lactone 115 
is readily obtained [164]. It is present in many glcoproteins [165, 166].  
 
Under various acetylation conditions, sialic acid leads to either 1,4-lactone 116 or to the 
1,7-lactone 117 depending upon the equatorial or axial orientation of the carboxyl group 
(Scheme 33). In the presence of a more hindered acylating agent, e.g., CbzCl (benzyl 
chloroformate), an activated acyl intermediate can be formed and quantitative 
chemoselective 1,7-ring closure into compound 115 has been observed. Lactone 116, as 
well as lactone 120 arising from the glycol glycoside 119, were suggested to be the 
intermediates in the formation of NeuAc-aminoacid hybrids 117 and 121. These 
compounds were designed as potential sialidase inhibitors [161, 167]. 
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Scheme 33. Sialic acid lactones and derivatives. 
 
4.2. Lactonized Carboxyalkyl Ethers and Glycosides 
 
4.2.1. Non-Anomeric Carboxyalkyl Ethers 
 
Various carboxyalkyl ethers at non-anomeric positions have been shown to give 
bicyclic systems which link positions 2,3 or 3,4 of sugars with various configurations 
through lactone formation. Examples are 122 and 123 (gluco), 124 (manno) and 125 
(galacto), which were derived from 3-O-(1-carboxyethyl) substituted methyl glycosides 
[168, 169] (Scheme 34). Another example is the bicycli  caprolactone 126, derived 
from 1,2,5,6-di-O-isopropylidene-α-D-glucofuranose in six steps [170]. Modified 
cyclodextrins of type 127 that involve lactonization of a carboxymethyl ether r sidue 
have also been reported [171].  
 




















































Scheme 34. Non-anomeric bicyclic lactones from carboxyalkyl ethers. 
 
4.2.2.  Anomeric Carboxymethyl Glycoside Lactones (CMGLs) 
 
Queneau and co-workers have developed the chemistry of lactones involving the 
carboxymethyl residues linked to the anomeric hydroxy group and to OH-2 in several 
sugars [172–176]. Isomaltulose (Scheme 35) is obtained by bioconversion from sucrose 
and has been shown to be an interesting starting material for various applications [177–
182]. Like isomaltulose, trehalulose, another glucose-fructose disaccharide, and the 
hydrogenated derivative of isomaltulose, Isomalt®, were all shown to lead to the same 
compound 128 (CMGGlu) by oxidation [183–185]. Acetylation of the latter compound 
led to bicyclic lactone 129. Another lactone 130 was also observed as side product when 
the oxidative degradation of the fructose moiety of is maltulose was incomplete [186]. 
The scope of the method was extended to bicyclic lactones other than the α-D-gluco one 
arising from isomaltulose. The oxidation of allyl glycosides and the anomeric alkylation 
of various sugars with tert-butyl bromoacetate allowed many structural variations, 
leading to a full toolbox of carbohydrate-containing synthons in both their anomeric 
forms, in most cases, including disaccharides [186, 187]. Moreover, the selective 
opening of the lactone ring of these compounds releas s the free 2-OH position which is 
available for a second functionalization, leading to 1,2-bisfunctionalized carbohydrate 
derivatives. An explanation for these observations is that a mixed anhydride is formed 
by reaction of CMG with Ac2O, followed by nucleophilic attack of OH-2. A similar 
structure, derived from β-lactoside, had been suggested [188] and a comparable system 
has been reported in a recent patent [189]. Not only were acetylated products prepared, 




but also chloroacetyl, pivaloyl (Piv) or benzoyl (Bz) lactones 131–133. The allyl 
glycoside route also permitted the preparation of lactones bearing another protecting 

































































129 R = Ac
131 R = ClCH2CO
132 R = Piv
133 R = Bz
134 R = Bn130  
 
Scheme 35. Accesss to carboxymethyl glycoside lactones. 
 
Non-protected aldoses or those peracetylated on all position except the anomeric 
hydroxy group react with tert-butyl bromoacetate (DMF, K2CO3) giving the 
corresponding O-glycosides [190, 191]. A significant selectivity for α anomers was 
observed for the reaction on the partially acetylated sugars, whereas some β selectivity 
(α:β from 1:1 to 1:2) was observed from free sugars. Galactose gives more complex 
mixtures in which the α-furanosides are the major products [192]. Lactones 129–145 
have been prepared according to this route with subsequent treatment with Ac2O in py 
(Scheme 36).  
 





















































































































Scheme 36. Mono- and disaccharidic carboxymethyl glycoside lactones. 
 
4.2.3. Use of CMGLs  
 
Alcohols react with carboxymethyl glycoside lactones (CMGLs) under either basic or 
acidic catalysis. However, the method is limited for acetylated targets, since 
deprotection of the acetyl groups cannot be achieved without substantial cleavage of the 
newly formed ester. Amines give stable amides (Scheme 37). Pseudo glycoamino acid 
hybrids of type 146 [184, 185], pseudo disaccharides 147, and nucleotide sugars 148 
[193] were thus obtained. With the idea that attaching a carbohydrate moiety can 
provide increased polarity and water solubility, other types of compounds were prepared 
by this method, such as polymerizable compounds of type 149–151, and 
glycoporphyrins 152 designed as photosensitizers for cancer photochemotherapy [194, 
195]. Pseudo glycolipids 153 were also prepared by this method [196], and more 




recently new glycoprobes of type 154 for membranes nonlinear imaging have been 















































































































































Scheme 37. Examples of conjugates obtained from carboxymethyl glycoside lactones. 




Further functionalization at OH-2 was also explored [187]. From monosaccharidic (α-
gluco, 129) and disaccharidic (α-malto, 143) CMGLs, several types of bisfunctionalized 
systems were synthesized by reaction with allylamine or propargylamine. For example, 
compound 155 was prepared and used in a synthesis of the nucleotide sugar analog 156 
(Scheme 38). In the context of studies on the physicochemical behavior of synthetic 
glycolipids [198–204], new bisfunctionalized compounds such as 157 were recently 
obtained and found to possess very peculiar hysteretic thermotropic properties [205]. 
Reactions at OH-2 included carbamatations, etherificat ons leading to diynes, enynes 
and carboxy-ynes 158–160 [187]. Substitution by an azide after intermediate triflate 
formation led to azido alkenes or alkynes 161 and 162, respectively. The reactivity of 
the latter compounds as AB monomers is presently being studied. Oxidation of OH-2 






































































































Scheme 38. Bisfunctional compounds at C-1 and C-2 from CMGLs. 
 




1-C-Allyl sugars have been transformed into spirobicycli  lactones which are the 
analogous synthons allowing the formation of C-glycosyl conjugates. For example, 
Araújo et al. prepared the intermediate 165 by C-allylation of the fully benzylated D-
fructose followed by oxidation of the allyl group (Scheme 39) in the context of the 
evaluation of sugar-fused γ-butyrolactones and lactams as new potential γ-aminobutyric 

















Scheme 39. C-Glycosidic anomeric lactone from fructose. 
 
4.3. Fused C-Branched Lactones 
 
Five-membered lactones (γ-butyrolactones) fused to carbohydrates have proven to be 
convenient synthons towards branched-chain sugars through opening of the lactone unit.  
 
Veláskes et al. [208] described the synthesis of γ-butyrolactones 2,3-fused to 
ribonucleosides by radical intramolecular addition n nucleosides comprising an α,β-
unsaturated ester moiety at C-2 or at C-3 of the furanose ring. These bicyclic derivatives 
were further converted into 2-C or 3-C-branched chain nucleosides by opening of the 
lactone moiety with isobutylamine. Font and co-workers [209, 210] made use of 
homochiral butenolides as precursors for a stereosel ctive synthesis of γ-butyrolactones 
2,3-fused to lyxofuranose units. Thus, photocycloaddition of vinylene carbonate to 
substituted butenolides (compounds type 166, Scheme 40), gave selectively the 
corresponding anti cycloadducts 167 in moderate yields. The latter, when treated under 
basic conditions (0.5 M NaOH in water/dioxane or MeONa in MeOH), underwent 
rearrangement to afford the target bicyclic compounds 168 in modest to moderate 
yields.  





























R1, R2 = H or CH3
hν
R3 = H, CH2OTBDPS or CH2OPiv
166








Scheme 40. Synthesis of furanose-fused γ-butyrolactones by photocycloaddition of 
vinylene carbonate to substituted butenolides. 
 
The intramolecular cyclopropanation of 4,6-di-O-protected glycals (such as 169) has 
been explored as a key step for the synthesis of advanced intermediates for bislactone 
natural products [211] (Scheme 41). The glycal-fused cyclopropane 171 was obtained 
by copper-catalyzed intramolecular cyclopropanation of the glycal-derived diazoacetate 
170 in very good yield. It could then be converted into furanose-fused butyrolactone 
175 in few steps, including selective monodeprotection  the alcohol 172 and further 
iodination. The resulting iodine derivative 173 was subjected to a zinc-mediated 
reductive ring opening cascade to furnish aldehyde 174. Its desilylation provided 



























































Canadensolide, R = n-Bu













Scheme 41. Synthesis of a furanose-fused butyrolactone from a glycal-derived 
cyclopropane. 




With respect to five-membered lactones fused to hexopyranose units, some approaches 
have been reported so far and the exploitation of their synthetic potential has led to the 
access of new carbohydrate derivatives. Bicyclic derivatives of this type are key 
intermediates in the synthesis of the epimer at C-3 of the sugar moiety contained in 
miharamycins [212, 213]. The latter are antibiotics known to inhibit strongly 
Pyricularia oryzae, which produces the rice blast disease and is considered a 
bioterrorism agent. Hence, the 3,3-spiroepoxide 176 was converted into the 3-C
cyanomethyl derivative 177, the hydrolysis of which led to spontaneous cyclization in 
the presence of silica gel, giving the sugar-fused lactone 178 (Scheme 42). A 
stereoselective hydroxylation of the latter compound followed by reduction led to the 





























BzO 0.5M in DMF
a) LDA, −78ºC, then MoO5⋅py⋅HMPA







Scheme 42. Sugar moiety of miharamycins from hexopyranoside-fused butyrolactones. 
 
The previously mentioned glycal cyclopropanation method was also applied to the 
synthesis of γ-butyrolactones 2,3-fused to glycopyranosides (Scheme 43) [214]. Hence, 
ring opening of the cyclopropane derivative 171 by TiCl4, which was followed by in 
situ addition of alcohol, furnished glycoside-fused butyrolactones 180a–d, in high 

















b) ROH, cat. TfOH
180 a-d




Scheme 43. Pyranoside 2,3-fused-γ-butyrolactones from a glycal derived cyclopropane. 
 




More recently, another methodology for sugar-fused butyrolactones employing glycal-
derived cyclopropane precursors has been described by Chandrasekaran and co-workers 
(Scheme 44) [215]. In this case, hexofuranoid or hexopyranoid glycals were 
cyclopropanated into compounds of type 181. After saponification with LiOH, giving 





























Scheme 44. Synthesis of sugar-1,2-fused iodobutyrolact nes from sugar-1,2-fused 
cyclopropanated esters. 
 
On their side, Yin and Linker [216] made use of a 2-C-branched hexopyranoside, the 
synthesis of which was achieved by addition of dimethyl malonate to tri-O-benzyl-D-
glucal (IUPAC name: 3,4,6-tri-O-benzyl-1,5-anhydro-2-deoxy-D arabino-hex-1-enitol, 
Scheme 45) [217]. Thus, saponification of the 2-C-[bis(methoxycarbonyl)]methyl 
derivative 184 to the corresponding malonic acid 185 was followed by heating in 
refluxing toluene. This led to decarboxylation and lactonization giving 186. The method 




























Scheme 45. Synthesis of a hexopyranose-1,2-fused butyrolactone from a 2-C-malonyl 
glucoside. 
 
α,β-Unsaturated lactones are relevant motifs considering their ability to act as 
functionalized substrates for a variety of transformations. Some of them are bioactive 
[218–222].  An early synthesis of the enantiomer of (+)-altholactone (Scheme 46), a 




natural product with cytotoxic and antitumor activities (for a review on the bioactivity 
of styryllactones see [223, 224]), involves the preparation of a furanose-fused α,β-
unsaturated δ-lactone intermediate 189 [225]. Starting from a α-D-xylo-
pentodialdofuranose derivative 187, a Reformatsky reaction with ethyl bromoacetate 
































Scheme 46. Synthesis of the non-natural enantiomer f (+)-altholactone via a furanose-
fused unsaturated δ-lactone. 
 
A pentopyranoside-fused butenolide is the key intermediate for the synthesis of the 
natural micotoxin patulin [226, 227]. Its synthesis involves Wittig olefination of a 3,4-
di-O-protected arabinopyran-2-uloside, followed by protecting group removal and 
dehydration (Scheme 47). In another research, the glucopyranosid-2-uloside 190 was 
converted into the butenolide derivative 191 by aldol condensation with diethyl 
malonate and transesterification [228]. The latter was shown to be prone to 
autoxidation, leading to 192. Subsequent Michael addition with hydroxide ion, followed 































Scheme 47. Synthesis of a 2-C-branched-chain sugar via a pyranose-fused butenolide. 




An elegant stereocontrolled route for pyranose-fused butenolides starting from easily 
synthesized protected furanos-3-uloses (compounds of type 194) has been reported 
[229, 230] (Scheme 48). It consisted of the synthesis of 3-C-branched α,β-unsaturated 
esters (195) by Wittig olefination, followed by acid hydrolysis. Within this latter step, 
cleavage of the protecting groups (PG), intramolecular transesterification, and furanose-
pyranose isomerization occurred, furnishing directly the target bicyclic compounds 
(196, 197) in good overall yields. This approach was convenient for achieving in few 
steps both pento- and hexopyranose-based bicyclic systems comprising the butenolide 
moiety anchored at C2-C3 or at C3-C4 of the sugar ring, depending on the configuration 
around the C3-C3’ double bond. The feasibility and scope of this methodology were 
then investigated for the preparation of 5-thiopento or hexopyranose analogues of type 
198 [231]. Thus, after introduction of an additional sulphydryl functionality at C-5 at 
the intermediate α,β-unsaturated esters, acid hydrolysis also allowed ring expansion to 
the thiopyranose form with accompanying butenolide formation, generating new highly 





























R = PG or H
R' = H or CH2OH or CH2OPG
R = PG













Scheme 48. Synthesis of butenolides fused to pento- or hexopyranoses and thiosugar 
analogues from furanos-3-uloses. 
 
Fused C-glycosyl lactones are also suitable synthons for further elaboration into more 
complex C-glycosyl compounds, including glycoconjugates. In o e of the few 
published methods to afford these bicyclic lactones, protected 1-phenylseleno glycosyl 
donors possessing a free OH-2 (compounds of type 199) were converted into the 




corresponding 2-hydrazonoesters 200. The latter were then subjected to radical 
cyclization (Scheme 49) [232] giving α-hydrazino lactones 201 that could be 




































Scheme 49. Synthesis of furanose-fused C-glycosyl α-hydrazino lactones from phenyl-




Lactones derived from carbohydrates are building blocks of high synthetic potential. 
Next to the readily available aldonolactones and uronic acid lactones, some bicyclic 
systems have recently emerged as useful synthons. Examples of applications encompass 
functional derivatives such as polymers, as well as more elaborated compounds of 
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2008, 343, 1523–1539. 
 
It covers the synthetic approaches developed for this type of compounds as well their 
relevance as scaffolds for a variety of important sugar derivatives. Their potential as 

















Sugars Containing α,β-Unsaturated Carbonyl Systems: Synthesis and 
Their Usefulness as Scaffolds in Carbohydrate Chemistry 
 
Nuno M. Xavier and Amélia P. Rauter* 
 
Departmento de Química e Bioquímica/Centro de Química e Bioquímica, Faculdade de 
Ciências da Universidade de Lisboa, Edificio C8, 5º Piso, Campo Grande 
1749-016 Lisboa, Portugal 
 
Keywords: α,β-Unsaturated carbonyl systems / Sugar-fused unsaturated lactones / 





The α,β-unsaturated carbonyl function occurs in a wide variety of bioactive natural 
products. It is usually associated with the bioactivities of these compounds and acts as 
Michael acceptors for the addition of protein nucleophilic groups. The design and 
synthesis of sugars containing this functionality has provided a wide range of 
compounds, which can serve as building blocks of high synthetic versatility. This 
review deals with the chemistry of sugar-based molecules bearing singly linked or fused 
unsaturated lactones and ketones along with that of pyranoid enones and enonolactones. 
Examples are given of their syntheses and transformations into a variety of complex 
sugar derivatives such as branched-chain sugars, C-nucleosides, C-glycosyl derivatives, 
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The α,β-unsaturated carbonyl moiety is present in a large number of natural and 
synthetic products exhibiting a variety of biological properties. Compounds containing 
such an unsaturated system, notably lactones or cyclic ketones, were described as 
cytotoxic [1a-e] and anti-tumor agents [1b], antimicrobials [1f] or as possessing 
significant antiviral [1b], gastric anti-ulcer activi es [1g], among others. Furthermore, it 
has been shown that the conjugated system plays a fundamental role in determining 
bioactivity, due to its ability to act as a Michael acceptor for the addition of protein 
functional groups [2]. In particular, sugars incorprating unsaturated carbonyl motifs 
have become important synthetic targets not only due to their potential biological 
profile but also for their use as precursors for the synthesis of many bioactive 
compounds such as branched-chain sugars or nucleosides.  
 
This review attempts to cover the synthetic strategies used to obtain sugar derivatives 
containing unsaturated carbonyl moieties in their structure, namely α,β-unsaturated 
lactones and cyclic ketones. It focuses on the natural occurrence and biological 




relevance of these compounds, as well as on their us  as important intermediates in 
carbohydrate chemistry. 
 
2. Sugar Derivatives Containing α,β-Unsaturated Lactones  
 
The ring system of α,β-unsaturated lactones, specially γ- and δ- lactones, constitutes the 
central skeleton of many natural products and is comm nly related to a wide range of 
pharmacological activities. This biological behavior has prompted the investigation of 
synthetic methodologies for the generation of such motifs over the years [3]. Examples 
of naturally occurring glycosides containing α,β-unsaturated lactones include the 
cardiotonic digitoxin [4], which possesses a butenolide ring at position C17β in the 



























Figure 1. Two examples of naturally occurring glycosides containing α,β-unsaturated 
lactones. 
 
We discuss below the methods that have been employed f r the preparation of sugar-
linked, sugar-fused or sugar-based unsaturated lactones, focusing on five- and six-
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2.1. γ-Lactones  
 
2.1.1. γ-Lactones Fused to Sugars  
 
Five-membered ring unsaturated lactones fused to carbohydrates, namely butenolides 
[2(5H)-furanones], have been used as intermediates for the synthesis of bioactive 
natural products and branched-chain sugars. This moiety is a structural unit of the 
mycotoxin patulin (Scheme 1), produced by different species of Penicillium, 
Aspergillus, and Byssochlamys, which shows significant antibiotic and antibacterial 
properties, despite being a food contaminant and a general plant toxin [6]. Its synthesis 
involved oxidation of methyl 3,4-O-isopropylidene-β-L-arabinopyranoside 1, easily 
prepared from L-arabinose, followed by Wittig olefination of the rsulting keto sugar to 
afford an approximately 3:l mixture of the (E)- and (Z)-unsaturated esters 2a,b. The (E)-
isomer was subsequently converted into the sugar-fused butenolide 3 after hydrolysis 
with dilute hydrochloric acid in methanol under reflux. Dehydration of 3 by 
mesylation–elimination provided (S)-O-methylpatulin, which was then deprotected by 



























Patulin1 2a,b 3  
 
Scheme 1. Synthesis of patulin. 
 
Liu et al. [7] reported the autoxidation of a hexopyranoside-fused butenolide 5, which 
was isolated as an intermediate in the one-pot synthesis of the 2-C-branched-chain sugar 
7. Insights into the mechanism of this transformation clarified the three main steps 
involved. Thus, aldol condensation of the glucopyranosid-2-ulose 4 with diethyl 
malonate proceeded via the butenolide 5, which was obtained by transesterification and 
intramolecular cyclization (Scheme 2). This compound was then transformed into 6 by 
autoxidation. The latter underwent Michael addition in the presence of water, which was 
followed by decarboxylation, leading to the corresponding branched-chain sugar 7. 
 


























4 5 6 7





Scheme 2. Steps involved in the synthesis of the 2-C-branched-chain sugar 7.
 
We have also demonstrated an efficient preparative access to butenolides fused to 
pento- and hexopyranoses (compounds-type 10) in a few steps starting from 
commercially available furanose derivatives (Scheme 3) [8a]. The methodology consists 
on the Wittig olefination of furanos-3-uloses (compounds of the general type 8), which 
are easily obtained, followed by acid hydrolysis. This step leads to the cleavage of the 
acid labile protecting groups (PG), intramolecular lactonization and isomerization to the 
pyranose form. Using this synthetic pathway, good overall yields were obtained for the 















R = PG or H
O
R'
R' = H or CH2OH or CH2OPG
R = PG





Scheme 3. Synthesis of butenolides fused to pento- a d hexopyranoses using furanos-3-
uloses as precursors. 
 
Synthesis of this type of sugar-fused butenolides, u ing a similar strategy, was 
published soon afterwards by Goddard-Borger et al. [8b]. These molecules were 
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2.1.2. γ-Lactones Linked to Sugars  
 
Sugar linked α,β-unsaturated γ-lactones, notably butenolides and α-methylene-γ-
butyrolactones, have attracted much attention owing to their biological and 
pharmacological properties and their role as synthons f r useful sugar derivatives. Our 
research group has contributed to this field using two different approaches. The 
introduction of an α-methylene-γ-butyrolactone on a furanose residue (12a,b) was 
achieved by a Reformatsky-type reaction of a dialdofuranose 11 with ethyl 
bromomethylacrylate and zinc to give both C-5 epimers which were easily separated by 
liquid chromatography (Scheme 4) [9]. Some of these compounds proved to have 
significant fungicidal activity and were particularly effective against Puccinia 
recondita, Botrytis cinerea and Plasmopara viticola, being considered to be wheat-, 






















Scheme 4. Synthesis of antifungal sugar-linked α-methylene-γ-lactones. 
 
The other approach led to the synthesis of a sugar containing an endocyclic unsaturated 
lactone functionality, starting from sugar epoxides having the gluco- or allo-
configuration (13a,b, Scheme 5). Reaction with the dianion of phenylselenoacetic or -
propionic acids, or their thioanalogues, followed by oxidation and elimination afforded 
the target molecules (15a,b). The configuration of the single diastereoisomer formed is 
determined by that of the epoxide starting material [9b,c]. Biological testing of these 
compounds has demonstrated their efficacy as insecticides for a number of arthropode 
species such as Musca domestica L. (housefly), Trialeurodes vaporariorum 
(Westwood) (glasshouse whitefly), Drosophila melanogaster Meig (fruitfly), being 
particularly potent and selective against fruitflies, and much more active than 
imidacloprid, the insecticide commercially used. In addition, the compounds were not 




toxic to Artemia salina L. (brine shrimps), a reference organism for the evaluation of 























m-CPBA for X = S or
H2O2, H
+ for X = SeLDA
13a, b 14a, b 15a, b  
 
Scheme 5. Synthesis of sugar-linked butenolides from epoxide precursors. 
 
The ring-closing metathesis (RCM) of acrylates derived from allylic and homoallylic 
alcohols has been a convenient reaction to form five-and six-membered unsaturated 
lactones [3b]. The method has been successfully employed in sugar scaffolds to give C-
linked γ- and δ-unsaturated lactones (Scheme 6). The methodology published by Gosh 
et al. [11] started from the pentodialdose 16, which was treated with vinylmagnesium 
bromide or allyltrimethylsilane to give the homoallylic alcohol 17, which when acylated 
with acryloyl chloride afforded the acrylate esters 18. These compounds were subjected 
to RCM in the presence of Grubbs' catalyst to furnish α,β-unsaturated γ- or δ-lactones 
19. A similar procedure was used for the formation of unsaturated macrocyclic (nine- to 































n = 0 or 1
Cl
O Grubb's catalyst
16 17 18 19  
 
Scheme 6. Synthesis of sugar-linked γ and δ-unsaturated lactones by RCM starting from 
dialdofuranoses. 
 
An alternative route to sugar-linked butenolides was b sed on the conversion of the 
precursor dialdofuranose (16) into Baylis-Hillman adducts (Scheme 7) [13]. Reduction 
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of the resulting alkene 20 to the corresponding diol 21, followed by monoacryloylation 
at the primary or at the secondary hydroxyl group, gave the corresponding acrylate 
esters 22–23. The latter compounds, upon RCM, led to the sugar-linked 4-substituted-γ
































































Scheme 7. Synthesis of sugar-linked butenolides by combinatio of Baylis-Hillman 
reaction with RCM.  
 
Another useful synthetic tool involved Wittig and iodolactonization reactions using 
dialdofuranoses as the starting materials (Scheme 8), aiming at sugar-linked 
butenolides, which were then converted into the corresponding isoxazolidine derivatives 
[14]. Thus, Wittig olefination of 26 with ethyl 3-oxo(triphenylphosphorylidene)-
butanoate gave the alkene 27 as an inseparable keto–enol mixture,  which on reduction, 
followed by hydrolysis resulted in the formation of 28. This compound was converted 
into the lactone 29 by reaction with I2 in the presence of aq. NaHCO3. Subsequent 
deiodination of 29 with catalytic NaCNBH3–tributyltin chloride, followed by 
acetylation, provided the butenolide 30.  
 


















































Scheme 8. Synthesis of sugar-linked butenolides by the Wittig olefination-
iodolactonization approach. 
 
Maeba et al. [15] also made use of the versatility of the butenolide moiety to be 
converted in heterocyclic systems for the synthesis of C-nucleosides. The α,β-
unsaturated lactone 32, C-linked to the anomeric position, was prepared by Jones 
oxidation of the β-D-ribofuranosyl derivative 31 (Scheme 9). The key intermediate 32 
was further transformed into C-nucleosides 33–35 possessing pyrrolinone, 


































Scheme 9. Synthesis of a C-glycosyl butenolide and its conversion into C-nucleosides.  
Carbohydr. Res. 2008, 343, 1523−1539 
74 
 
2.2. δ-Lactones  
 
2.2.1. δ-Lactones Fused to Sugars  
 
Sugar-derived unsaturated δ-lactones have been used as precursors in the synthe is of 
some naturally occurring compounds, because of their natural product-like profiles, and 
the possibility of taking advantage of the chirality resident in the sugar moiety. For 
example, a furanose-fused α,β-unsaturated δ-lactone was a key intermediate for the 
preparation of the enantiomer of (+)-altholactone, as reported by Gesson et al. [16] 
(Scheme 10). This sugar-derived bicyclic lactone was isolated from an unknown 
Polyalthea species and from various Goniothalamus species and is known to be 
cytotoxic in vitro showing considerable antitumor activity in vivo [17]. The procedure 
consisted of a Reformatsky reaction of the aldehyde 36 with ethyl bromoacetate. The 
resulting β-hydroxy ester 37 was converted into a dihydroxy acid 38 after ester 
hydrolysis and debenzylation. This latter compound was dehydrated to the furanose-








































Scheme 10. Synthesis of the non-natural enantiomer f (+)-altholactone via a furanose 
fused unsaturated δ-lactone. 
 
An alternative procedure for the synthesis of the unsaturated-δ-lactone 39 was based on 
a Wittig reaction of 1,2-O-isopropylidene-α-D-xylo-pentodialdofuranose 40 with 
[(ethoxycarbonyl)methylene]triphenylphosphorane, followed by intramolecular  






















Scheme 11. Synthesis of the furanose-fused unsaturated δ-lactone 39 by the Wittig 
olefination–intramolecular cyclization approach. 
 
2.2.2. δ-Lactones Linked to Sugars  
 
We have previously cited the synthesis of α,β-unsaturated δ-lactones linked to sugars by 
RCM (see Scheme 6). Another approach to these compounds consists of reaction of the 
epoxide 42 with (1-methoxybenzyloxy)propyne in the presence of n-BuLi to afford the 
alkyne 43, which, after deprotection of the primary position, gave diol 44 (Scheme 12). 
Subsequent alkyne reduction with Lindlar’s reagent followed by oxidation furnished the 
α,β-unsaturated δ-lactone 45, which was successfully used to prepare the C–C-linked 




Scheme 12. Synthesis of furanose-linked α,β-unsaturated δ-lactone and its conversion 
into C(4)–C(5)-linked disaccharides. 
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The RCM protocol also proved useful in providing a short route to disaccharides 
(Scheme 13) [20]. Accordingly, the reaction of the aldehyde 47 with allyl bromide and 
activated zinc gave the alcohol 48, which acroylation, followed by RCM, led to the 
unsaturated δ-lactone 49. The target molecule 50 was obtained by cis-dihydroxylation 






































Scheme 13. Synthesis of C(1)–C(5)-linked disaccharides from furanose-linked α,β-
unsaturated δ-lactones.  
 
2.2.3. Pyranoid δ-Lactones 
 
Sugar-derived pyranoid α,β-unsaturated δ-lactones (5,6-dihydropyran-2-ones) are easily 
synthesized from glycals, and have been widely used a  key chiral intermediates for the 
preparation of biologically active natural products [3a, 21]. In 1982, Jarglis and 
Lichtenthaler described a one-step procedure for 2,3-unsaturated lactones by oxidation 
of glycals and 2-acyloxyglycal esters with m-chloroperbenzoic acid (m-CPBA) or 
pyridinium chlorochromate (PCC) in the presence of b ron trifluoride etherate [22]. 
This straightforward transformation was a key-step for the synthesis of (+)-parasorbic 




Scheme 14. Synthesis of (+)-parasorbic acid via enonolactone 52, which was obtained 
by BF3.Et2O-induced peroxidation of the L-rhamnose-derived glycal 51. 
 




The BF3-mediated peroxidation of a glycal proceeds via a generation of an 
allylcarboxonium ion, which undergoes subsequent peroxidation to give an intermediate 
1-peroxyacyl-hex-2-enopyranose, which upon fragmentation affords the pyranoid 
enonolactone [22, 24].   
 
The oxidation of glycals involving anomeric hydroperoxides as intermediates has been 
carried out using other catalysts. Fehlhaber et al. reported the oxidation of 1,5-anhydro-
3,4,6-tri-O-acetyl-2-deoxy-D-arabino-hex-1-enitol (non-preferred trivial name: 3,4,6-
tri-O-acetyl-D-glucal) to the corresponding hydroperoxide with 85% hydrogen peroxide 
in dioxane, in the presence of sulphuric acid [25]. A different approach, starting from 
the correponding benzoyl protected glycal (53), also employed hydrogen peroxide as 
oxidizing agent and made use of molybdenium trioxide as catalyst. The obtained 
hydroperoxide (54) could be converted into unsaturated lactone 55 via dehydration on 
treatment with Ac2O/py (Scheme 15) [26a,b]. In addition, 2-C-methylene-
hydroperoxides could also be converted into the corresponding exocyclic α,β-




















Scheme 15. Synthesis of the pyranoid 2-enono-1,5-lactone 55 by oxidation of tri-O-
benzoyl-D-glycal 53 to the hydroperoxide 54, followed by dehydration. 
 
PCC oxidation has also been commonly used for the direct synthesis of sugar-derived 
pyranoid α,β-unsaturated δ-lactones from glycals [27]. A different methodology for the 
conversion of glycals to enonolactones has been reported by Rauter et al. [28]. Thus, 
reaction of the glycal 56 with NBS and water, followed by oxidation of the intermediate 
2-bromolactol 57 with PCC, afforded the 2-bromo-enonolactone 58. Further biological 
assays demonstrated the high insecticidal activity of this compound against fruitflies 
[10]. 
 























Scheme 16. Synthesis of the insecticidal pyranoid 2-bromo-enonolactone 58. 
 
The mild oxidizing agent iodoxybenzoic acid (IBX), in combination with indium 
trichloride, proved to be an efficient system for the one-pot conversion of glycals to 
enonolactones (Scheme 17) [29]. The reaction involves most likely an indium mediated 








10 % InCl3, IBX
CH3CN, H2O
 
Scheme 17. Synthesis of enonolactone 59 by InCl3–mediated oxidation of the glycal 56 
with IBX. 
 
The versatility of these sugar derivatives as syntho s has encouraged their use as 
precursors for the preparation of bioactive compounds and natural products, typically as 
Michael acceptors or dipolarophiles in cycloaddition reactions [30]. In particular, the 
conjugate addition of hydroxylamines and hydrazines to ugar enonolactones has been a 
suitable method to access various optically active heterocycles such as pyrazolidin-3-
ones and isoxazolidin-5-ones, which are useful intermediates for the synthesis of β-
lactam antibiotics. Chmielevski and co-workers [30a,b] described the preparation of 
pyrazolidin-3-ones 61 and isoxazolidin-5-ones 63 by treatment of the enonolactone 59 
with hydrazine, hydroxylamine or their N-substituted derivatives, resulting from the 
spontaneous intramolecular cyclization of the Michael adducts 60 and 62 (Scheme 18). 
 







































Scheme 18. Michael addition of hydrazines and hydroxilamines (R = H, Me, Bn) 
 to sugar enonolactone 59, leading to pyrazolidin-3-ones and isoxazolidin-5-ones. 
 
3. Sugars Containing α,β-Unsaturated Ketones  
 
Like their lactone counterparts, carbohydrate-derived α,β-enones, namely cyclic 
derivatives, are versatile building blocks for the synthesis of natural products and have 
been employed for the generation of a diversity of chiral molecules. With respect to the 
naturally occurring enone-containing sugars, we can underline Vineomycin B2 [31], an 
anthracycline antibiotic, containing two hex-2-enosyl hexose disaccharide moieties, and 
the antioxidant Ascopyrone P (APP), a metabolite from fungi which displays 

























Figure 2. Some naturally occurring α,β-enone-containing sugars. 
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3.1. α,β-Unsaturated Ketones Linked to Sugars 
 
Concerning cyclic α,β-unsaturated ketones linked to sugars, only a few examples have 
been described in the literature, and those report mainly the use of these compounds as 
templates for the synthesis of C-C-linked disaccharides [33].  
 
Two different approaches for C-C-linked disaccharides via α,β-enones, starting from 
dialdofuranoses, were developed by Sharma et al. [33]. In one of them (path A, Scheme 
19), the sugar-linked enone was prepared by reaction of the aldehyde 26 with furyl 
lithium and further oxidation and methylation of the furanyl sugar-intermediate 64 
[33a]. The second methodology (path B) consisted of the Wittig olefination of 26 to 
give the α,β-unsaturated ester 66, which was subjected to DIBAL-H reduction and 
subsequent oxidation with pyridinium dichromate (PDC) to afford the enal 67 [33b]. 
The crucial [3+3] annulation reaction of 67 with ethyl 3-oxo-4-
(triphenylphosphorylidene)butanoate in the presence of NaH and a drop of water 
resulted in the formation of sugar-linked α,β-enones 68 as a mixture of 
diastereoisomers. The desired dissacharides were obtained after enone reduction of 65























































Scheme 19. Synthesis of furanose-linked α,β-unsaturated ketones as templates for C-C-
linked disaccharides. 




3.2. α,β-Unsaturated Pyranuloses  
 
α,β-Unsaturated pyranuloses continue to serve as reliabl  scaffolds for the generation of 
branched-chain sugars and C-glycosyl derivatives, highlighted among a diversity of 
molecular targets.  
 
Most of the methodologies to obtain α,β-unsaturated pyranuloses use readily available 
glycals as starting materials. It is not our intentio  to give an exhaustive coverage of the 
chemistry of pyranuloses (classical methods were reviewed in 1978 and 1982) [34] but 
rather to focus on the recent advances in the field, as well on the synthetic utility of 




Protected 1-enopyranos-3-uloses are of particular interest, mainly for their ability to 
allow chain extension at the anomeric carbon through 1,4-additions, leading to 2-deoxy-
C-glycosyl derivatives after reduction of the resulting ketone at the position 3. The 
direct oxidation of allylic alcohols has actually become the most common method for 
the preparation of hex-1-enopyran-3-uloses. In 1986 Czernecki et al. described a 
convenient route to these sugar enones by selective oxidation of unprotected glycals 












69 70  
 
Scheme 20. Synthesis of the hex-1-enopyranos-3-ulose 70 by selective PDC oxidation 
of the unprotected glycal 69. 
 
Some years latter this research group reported the oxidation of the D-glycal 69 with a 
stoichiometric amount of Pd(OAc)2 in aq. DMF [36]. In an alternative approach, 
Pd(OAc)2 was used as a catalyst and the transformation carried out in the absence of
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molecular oxygen. The reaction was performed under an ethylene atmosphere to avoid 
formation of the glycal reduced product, leading to the desired enones in good to 
excellent yields [37]. 
 
Palladium catalysts have also been used for further key transformations of hex-1-
enopyranos-3-uloses, namely in C-glycosylation reactions. For example, treatment of 
peracetylated glycal-derived enones 71 with benzene in the presence of acetic acid and 
palladium acetate led to mixtures of 2-deoxy-C-glycopyranosyl derivatives 72 and 






71a R = H; R' = OAc
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Scheme 21. Palladium-mediated arylation of hex-1-enopyranos-3-uloses. 
 
In other research, acetylated and unprotected enones derived from the D-glycal 69 
reacted via 1,4-addition with trimethylsilyl cyanide in the presence of a catalytic amount 
of a Pd(OAc)2 to afford the corresponding 3-keto glycosyl cyanides. Heterogeneous 
catalysis (Pd/C) also worked in the cyanation reaction of 70 [39]. 
 
In extension to the unprotected glycals oxidation, the use of hypervalent iodine reagents 
for the oxidation of 3-O-protected derivatives has been developed [40]. In the work 
described by Kirschning et al., glycals 74, containing different protective groups, were 
directly converted to the corresponding hex-1-enopyran-3-uloses 75 by 
[hydroxy(tosyloxy)iodo]benzene in the presence of mlecular sieves (Scheme 22) [40a-
b]. Moreover, the stereochemistry at C-3 in the starting material as well as the nature 
and the number of protecting groups on the pyran ring do not seem to be determinant 
factors for the reaction efficiency [40b]. 
 

















Scheme 22. Synthesis of the enopyranos-3-uloses by oxidation of fully protected glycals 
with [hydroxy(tosyloxy)iodo]benzene.  
 
Another hypervalent iodine reagent used for the oxidation of 3-O-protected glycals to 
enopyranos-3-uloses is iodobenzene diacetate [PhI(OAc)2] [40c]. 
 
Besides glycal oxidation, other methods, such as cyclo ondensation reactions of 
functionalized dienes with aldehydes, have been report d for the synthesis of 
enopyranos-3-uloses [41]. Danishefsky et al. described the Lewis acid catalyzed 
cycloadditions of siloxy dienes with aldehydes as a general route to these hexenuloses 
[41a]. Hence, reaction of diverse aldehydes with trans-l-methoxy-3-
[(trimethyl)silyloxy]-1,3-butadiene 76 in the presence of zinc chloride afforded the 
desired enones 78, which may arise via 1:l cycloadducts 77 (Scheme 23). These 
transformations were also carried out with boron trifluoride etherate as catalyst, 

















76 77 78  
 
Scheme 23. Synthesis of the enopyranos-3-uloses 78 by cycloaddition of a silyloxy 
diene to aldehydes catalized by a Lewis acid. 
 
1-Enopyranos-3-uloses are attractive starting materials for the formation of C-glycosyl 
derivatives and branched-chain sugars due to their tendency to undergo 1,4-additions or 
1,2- additions (Scheme 24) [42].  
 




















Scheme 24. Nucleophilic additions to hex-1-enopyranos-3-uloses. 
 
Michael-type additions of O- and S-nucleophiles to hex-l-en-3-uloses have been  
described using ZnI2, DBU and KCN/18-crown-6 as catalysts to afford the 
corresponding ulosides in moderate yields [42a]. Recently, 2-deoxy-1-thio-α-
hexopyranosid-3-uloses were synthesized with high dastereoselectivity by 1,4-addition 
of aryl and alkyl thiols to the enone system, promoted by cesium carbonate [42b]. Silyl- 
and sulfur-stabilized carbanions and their propensity to afford products of 1,2- or 1,4-
additions, varying the combination of substituents attached to the C-l-anion, have also 
been studied [42c]. Conjugate addition of organometallic reagents to these heterocyclic 
enones, namely Grignard or organocopper reagents, ad insights onto the reaction 
stereoselectivity have been reported [42d,e]. Leonelli et al. showed that Michael-type 
organocopper addition to 2-(diethoxyphosphoryl)hex-1-en-3-uloses (79) lead 
preferentially to α-anomers (Scheme 25) [42e]. These compounds can be direct 


















R = Me, Et, Bn80a, b, c  
 
Scheme 25. Michael-type addition of organocopper reagents to 2-(diethoxyphosphoryl) 










Due to their functionality, 2-enopyranos-4-uloses have been used as starting materials 
for nucleophilic additions [43] or cycloaddition reactions [44] to the double bond, and 
therefore for the generation of branched-chain sugars, isonucleosides or 3-deoxy-
(1→2)-disaccharides. These enuloses are generally synthesized using the well-known 
Ferrier rearrangement of 3-O acyl-glycals [45], followed by allylic oxidation at C-4 [34, 
43b–c, 44b]. In the following example (Scheme 26), iodine catalized O-glycosylation of 
the glycal 56, followed by hydrolysis, afforded unprotected 2,3-unsaturated glycosides 
81 [43b]. The latter were selectively protected at the primary hydroxyl group, being the 
resulted silyl ethers subjected to PDC oxidation to furnish the hex-2-enopyranosid-4-
uloses 82. Compound 82b was used for the preparation of new sugar-modified 
nucleosides by Michael-type addition of silylated bases in the presence of trimethylsilyl 
triflate as a Lewis acid. The thus obtained adducts 83 were submitted to reduction and 




Scheme 26. Synthesis of hex-2-enopyranosid-4-uloses via 2,3-unsaturated pyranosides 
and their conversion into isonucleosides. 
 
Alternatively, unprotected 2,3-unsaturated pyranoside  can be directly converted to the 
corresponding 2-en-4-uloses by allylic oxidation with activated manganese dioxide, in 
good yields, as reported by de Freitas Filho et al. (Scheme 27) [44b]. The reported 1,3-
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dipolar cycloaddition of methylideneaniline N-oxide to 86 occurred from the opposite 
side to the aglycone to afford the phenylisoxazolidin-4-uloses 87. Hydrogenation of 
these compounds provided branched-chain amino sugar 88, due to the simultaneous 



































Scheme 27.  Synthesis of hex-2-enopyranosid-4-uloses 86 by oxidation of unprotected 
2,3-unsaturated pyranosides 85, and their conversion into branched-chain amino sugars 
88. 
 
A different approach for the synthesis of 3-C-branched deoxy sugars from hex-2-
enopyranosid-4-uloses was developed by Sagar et al.[46]. It consisted of the Morita–
Baylis–Hillman (MBH) reaction [47] of various aldehydes with the enuloside 89 in the 
presence of TiCl4 and TBAI (Scheme 28).  By this procedure, C-3-alkylated 2,3-













RR = o, m, and p-NO2Ph; p-FPh;
CH3(CH2)2; CH3(CH2)8; p-CF3Ph; Ph.
89a-g 90a-g  
 
Scheme 28.  Hex-2-enopyranosid-4-uloses as substrates for MBH reaction with 
aldehydes, leading to 3-C branched deoxy sugars. 
 
The fully unprotected glycal 69 was used by Witczak et al. as a suitable precursor of 
isolevoglucosenone, the hex-2-enopyranos-4-ulose isomer of levoglucosenone (Scheme 
29) [43c]. This latter hex-3-enopyranosid-2-ulose is prepared by acid catalyzed 
pyrolysis of cellulose and can be a versatile scaffold or important sugar derivatives 




[48]. Hence, Ferrier rearrangement of the unprotected D-glycal 69, promoted by 
anhydrous copper sulfate and molecular sieves, resulted in the allyl alcohol 91, which 
was subsequently oxidized with MnO2 to give the target isolevoglucosenone [43c]. This 
compound could be then functionalized into 3-deoxy-(1→2)-2-S-thiodisaccharides 93 
by  base-catalyzed conjugate addition of 1-thiosugars, followed by reduction of the C-4 




























b R = 2,3,4,6-tetra-O-acetyl-D-galactopyranosil-







92a, b, c93a, b, c  
 
Scheme 29. Synthesis of isolevoglucosenone from the unprotected D-glycal 69 and 
Michael addition of 1-thiosugars to afford S-thiodisaccharides 93. 
 
Another methodology for the synthesis of hex-2-enopyranos-4-uloses involves the 
oxidation of non-carbohydrate furanyl alcohols [34, 48]. Ogasawara and co-workers 
made use of this approach for the preparation of isolevoglucosenone and its enantiomer 
[49]. For this purpose, 2-vinylfuran 94 was subjected to asymmetric dihydroxylation to 
give diols 95, which were oxidized to enones 96 by treatment with m-CPBA. 
Dehydration of 96 in acidic medium provided the desired (+)- and (–)- 
isolevoglucosenones (Scheme 30). 
 





Scheme 30. Synthesis of (+)- and (-)-isolevoglucosenone via oxidation of furanyl diol 
95.  
 
The oxidation of a furanyl alcohol was also employed by Zhou and O’Doherty [4a] for 
the preparation of hex-2-enopyranos-4-ulose 100, which was a key compound for the 
synthesis of the already mentioned natural product digitoxin (Figure 1), a cardiac 
glycoside widely used for the treatment of congestiv  heart failure and cardiac 
arrhythmia [4], and its trisaccharide digoxose. In addition, digitoxin has been reported 
to possess potential anticancer activities [4d–g]. Hence, oxidation of the alcohol 99 gave 
the enulose 100, which was then protected to the t rt-butyloxycarbonyl esters 101 
(Scheme 31). Palladium-catalyzed glycosylation of 101 β with benzyl alcohol or 
digitoxigenin (Dig), the aglycon of digitoxin, provided the glycosides 102. The latter 
compounds were subjected to reduction to the corresponding allylic alcohols 103, 
followed by reductive transposition to afford the alkenes 104. Further dihydroxylation 
led to the diols 105, which were regioselectively protected at the axial hydroxyl group 
by treatment with trimethyl orthoacetate in the presence of p-toluenesulfonic acid and 
subsequent acid hydrolysis. The synthetic pathway proceeded iteratively, with the same 
palladium-catalyzed glycosylation conditions of theresulting alcohols 106 with 101 β, 
followed by the same steps as described above, and allowing the generation of 
disaccharides and trisaccharides. The target molecules, digoxose and digitoxin, were 
obtained after removal of the benzyl and acetyl groups, respectively. 
 












































102a, b103a, b104a, b105a, b
106a, b R = H, digoxose
R = Dig, digitoxin  
 
Scheme 31. Iterative synthesis of digoxose and digitoxin based on the Pd-catalyzed 




3-Enopyranos-2-uloses comprise another class of α,β-unsaturated pyranuloses in which 
the α,β-unsaturated keto system can be generated by synthetic transformations on 
simple glycals with 2-hydroxy glycals generally used for this purpose. Varela and co-
workers have made several contributions to this field [50]. An early straightforward 
procedure for the preparation of these compounds con isted of glycosylation of alcohols 
with 2-acyloxy-glycals (e.g., 107) in the presence of a Lewis acid. The latter is, 
therefore, responsible for the double allylic rearrangement that occurs in the 
glycosylation reaction [50a]. Various catalysts have been used in such reactions, namely 
boron trifluoride diethyl etherate [50a] (Scheme 32) or tin(IV) chloride [50b,c]. 
 
















Scheme 32. Synthesis of hex-3-enopyranosid-2-ulose (108) by alcohol glycosylation 
with 2-acyloxy glycal (107) using boron trifluoride diethyl etherate as catalyst. 
 
Iodine or electrophilic iodine-releasing agents such as N-iodosuccinimide also proved to 
be effective by mediating the glycosylation of alcohols with 2-hydroxyglycal esters to 
provide enopyranosiduloses [50d]. 
 
The synthesis of 2-keto α,β-unsaturated C-glycosyl derivatives has been described by 
Herscovici  et al. [51] via reaction of peracetylated 2-hydroxy glycals with silyloxy 
allylic ethers. Condensation of several glycals (109) with hexyldimethylsiloxy ether in 
the presence of zinc bromide led stereoselectively to α-C-glycosyl compounds (110) 
(Scheme 33). Insights onto the mechanism of this transformation suggest an attack of 
the olefin to the glycal at C-1, followed by rearrangement of the resulting carbocation. 
Further acetolysis of the resulting 2-acetyloxy derivatives in the enol ester proceeded 












R = H, CH2OAc 110a, b, c
109a, b, c  
 
Scheme 33. Synthesis of 3-enopyranos-2-uloses (110) by reaction of 2-hydroxy glycals 
(109) with thexyldimethylsiloxy ether in the presence of ZnBr2. 
 
In addition to glycals, glycopyranosyl 2-uloses possessing an ester function at the 
position α to the carbonyl group, for example, 111 (Scheme 34) [52a], can be easily 
converted into 3-enopyranos-2-uloses (112). This arises from the keto–enol 




tautomerism of the carbonyl compound followed by β-elimination, which frequently 
















Scheme 34. Facile elimination of AcOH from 3-O-acetyl-2-uloside (111) to the 
corresponding enone (112). 
 
The tendency for β-elimination was also found to be general in the oxidation of 
partially-protected sugars possessing a free primary or anomeric hydroxyl group, 
allowing the formation of a variety of α,β-unsaturated carbonyl sugar derivatives. In an 
early report by Mackie and Perlin [52c], oxidation f O-acyl and O-benzoyl protected 
hexopyranoses containing a free OH-6 with methyl sulfoxide in the presence of sulfur 
trioxide and triethylamine occurred with elimination either of the 4-acetoxy or the 4-
benzoyloxy group to yield 4-deoxy-6-aldehydo-hex-4-enopyranoses.  Under the same 
conditions, oxidation of 2,3,4,6-tetra-O-acetyl-β-D-glucopyranose afforded the 
corresponding pyranoid α,β-unsaturated δ-lactone.  
 
3-Enopyranosid-2-uloses can undergo similar conjugate 1,4-addition reactions as 
previously discussed for the other classes of enuloses. Their usefulness as Michael 
acceptors has given rise to the formation of 3-deoxy-4-thiopyranosid-2-uloses such as 
113 (Scheme 35), by addition of thiols to the enone system [53], being these compounds 
precursors of C-2-branched-chain 4-thiopyranosides [53a] or heteroanell ted 











Scheme 35. Michael addition of ethanethiol to hex-3-enopyranosid-2-ulose 108. 
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Michael addition to the important sugar precursor levoglucosenone has been reported 
[54]. One of the most attractive applications of these reactions has been the synthesis of  
thiodisaccharides [54b-f]. Witczak et al. [54b-c] described the stereoselective synthesis 
of 3-deoxy-4-S-(1→4)thiodisaccharides by Michael addition of 1-thiosugars to 
levoglucosenone. Analogous additions of per-O-acetyl-1-thioglucose to this substrate 
and other sugar enones have been studied by Thiem and co-workers [54d]. Synthesis of 
non-glycosidic 4,6´-thioether-linked disaccharides ha  also been developed, the key step 
of which was a highly diastereoselective Michael addition of a 6-thiohexopyranoside to 
a sugar enone [54f]. 
 
Diels-Alder cycloadditions of pent- or hex-3-enopyranosid-2-ulose with dienes, and 
studies related to their stereoselectivity have been published [50b-c,55]. Thus, the 
treatment of enones 114 with common dienes under thermal and Lewis acid catalyzed 
conditions led to bicyclic compounds 115 with diastereofacial selectivities (Scheme 36) 
[50b]. Noteworthy in these syntheses is the fact tha ese enones are better dienophiles 
than their cyclohexenones counterparts, which is probably due to the presence of the 
ring oxygen atom [50b].  Moreover, pent-3-enopyranosid-2-uloses exhibited higher 







R = PhCH2, 2-(R)-octyl,





Scheme 36. Diels-Alder cycloadditions of pent-3-enopyranosid-2-uloses (114) with 2,3-




Pent- or hex-4-enopyranos-3-uloses are practical scffolds for preparing pyranosides 
containing a diversity of substituents at C-5, leading to 4-deoxy sugar derivatives. 
 




Witczak et al. have recently explored the synthesis of 1,5-C-thiodisaccharides by 
Michael addition of a 1-thiosugar 116 to 4-deoxy-1,2-O-isopropylidene-L-glycero-pent-
4-enopyranos-3-ulose (117) (Scheme 37) [56]. The reaction proceeded with the 
stereoselective formation of β-(1→5)-4-deoxy-5-C-thiodisaccharide 118 which results 

























Scheme 37.  Stereolelective Michael addition of thiosugar 116 to pent-4-enopyranos-3-




A remarkable amount of work has been reported during the last two decades towards the 
synthesis of α,β-unsaturated carbonyl sugar derivatives. The natural occurrence and the 
biological activities inherent to the α,β-unsaturated carbonyl moiety has been the 
driving force for several research groups to incorporate this functionality in 
carbohydrates. Furthermore, sugars containing α,β-unsaturated lactones or ketones have 
been attractive building blocks for natural products and new bioactive substances, as 
well as templates for key transformations due to the variety of reactions that the 
conjugated system may undergo. This review has illutrated recent advances on the 
synthesis of this type of compounds, as well as their significance in carbohydrate 
chemistry, demonstrated by the range of chemical targe s they can provide. 
 
Neverthless, as new apllications for α,β-unsaturated carbonyl carbohydrate-based 
compounds are found, the exploitation of novel synthetic and efficient methods for their 
preparation and transformation will continue to encourage the research in the area.  
____________ 
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The following subchapter includes the published papers concerning the synthesis of 
sugar derivatives containg butenolides, namely pyranose-fused butenolides and furanose 
C-C-linked butenolides. The biological activity of some of these molecules, namely 
















2.1.1. Pyranose-Fused Butenolides 
 
 
This section includes the paper: 
 
 “Easy and Stereoselective Approach to α,β-Unsaturated-γ-Lactones Fused to Pyranoses 
from Furanose Scaffolds”, Xavier, N. M.; Rauter, A. P. Org. Lett. 2007, 9, 3339−3341. 
 
and shows the synthetic work on butenolides fused to pentopyranose or hexopyranose 
moieties.  
 
The additional information contains the experimental details not described in this paper. 
It includes procedures reported in the paper given b low, which was published to 
further establish the novelty of the work and the originality of these carbohydrate-based 
scaffolds: 
 
Xavier, N. M.; Kopitzki, S.; Rauter, A. P., “Pyranose-Fused Butenolides: An Expedient 
Preparation from Furanose Synthons” in Proven Synthetic Methods (Ed. P. Kovac), 
Taylor & Francis, Boca Raton, Florida, 2010, Vol. 1, in press. 
 
The aim of Proven Synthetic Methods is to report simple, reliable and effective synthetic 
protocols in carbohydrate chemistry. Hence, the reproducibility of the method 
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Easy and Stereoselective Approach to α,β-Unsaturated-γ-Lactones 
Fused to Pyranoses From Furanose Scaffolds 
 
Nuno M. Xavier and Amélia P. Rauter* 
 
Departamento de Química e Bioquímica/Centro de Química e Bioquímica da 





The first facile and efficient route to pyranose-fused butenolides from furanose 
scaffolds, convenient for scaling up production, is de cribed. Wittig olefination of 1,2-
O-isopropylidene pentofuranos- or hexofuranos-3-uloses with a resonance stabilised 
ylide led to the stereoselective formation of the (Z)-α,β-unsaturated ester. In the 
presence of  acid labile 5-O  or 5,6-di-O-protecting groups, acid hydrolysis of the Wittig 
product resulted in isomerisation to the pyranose frm and spontaneous lactonization to 















R = PG or H
O
R'
R' = H or CH2OH or CH2OPG
R = PG




The α,β-unsaturated γ-lactone motif is found in many natural products exhibiting a wide 
range of biological properties, namely, phytotoxic, antibacterial, or anti-inflammatory 
activities, with some of those compounds being described as potential anticancer agents, 
phospholipase A2 and cyclooxygenase inhibitors [1]. Furthermore, sugars comprising 
this structural moiety have been reported as fungicides or highly potent and selective 
insecticides (Figure 1) [2]. This biological profile encourages the search for efficient 
and straightforward approaches leading to new sugar based-butenolides.  
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Five-membered ring lactones fused to carbohydrate templates are known mainly in 
furanose systems.  These  compounds are useful intermediates for the preparation of  
nucleosides and branched-chain sugars [3]. Concerning sugar-fused α,β-unsaturated γ-
lactones, only a few were reported, and those are fus d to six-membered rings at  
positions 2 and 3 of the sugar [4]. However, their synthesis was implemented in a very 
low global yield using pyranos-2-uloses as starting materials, which are in general  
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Figure 1. Structures of sugar-based α,β-unsaturated γ-lactones possessing fungicidal 
(A)  and insecticidal properties (B).   
 
We report herein an easy and direct method to prepare yranose-fused butenolides 
starting from readily available pentofuranos- or hexofuranos-3-uloses. 
 
Butenolides fused to hexopyranoses were synthesized as illustrated in Scheme 1. The 3-
keto sugar 1 was obtained by oxidation of commercially available 1,2:5,6-di-O-
isopropylidene-α-D-glucofuranose with PDC/Ac2O in CH2Cl2 in nearly quantitative 
yield [5a], using a different workup than that described in the literature [5b]. It was 
subjected to Wittig reaction with [(ethoxycarbonyl)methylene]triphenylphosphorane in 
refluxing chloroform, affording the known (E)- and  (Z)-α,β-unsaturated esters 2a and 
2b [6], in  12% yield and 68% yield, respectively. The 5,6-O-isopropylidene group of 
2b was selectively removed by treatment with aq. acetic acid (60%) affording the 5,6-
diol 3b in 95% yield. Selective protection of the primary h droxyl group of 3b was  
successful  even when the substate was treated  with pivaloyl chloride in excess (2.4 
equiv.) in py/CH2Cl2. The 6-O-pivaloyl derivative 4 was the major reaction product, 
isolated in 57% yield, and the 5,6-di-O-pivaloyl protected derivative 5 was obtained in 
only 27% yield. However, benzoylation afforded under similar conditions the 5,6-di-O-
benzoyl derivative 6 in 83% yield, and no monoprotection was observed. The 6-O-
Org. Lett. 2007, 9, 3339−3341 
107 
 
pivaloyl (Z)-α,β-unsaturated ester 4 was then submitted to hydrolysis with aq. acetic 
acid (70%) under reflux to give the target molecule 7 as a mixture of both anomers (α/β 
ratio 1:0.7) in 83% yield, resulting from deprotection of the 1,2-acetonide, furanose ring 
opening, its closure into the pyranose form, and intramolecular lactonization, in one 
single step. When compound 3b was subjected to similar hydrolytic conditions, 
followed by acetylation with Ac2O in pyridine, the triacetate derived-butenolide 9 was 
obtained in 78% overall yield (ratio α/β, 2:1). Direct synthesis of the intermediate 
deprotected butenolide 8 was successfully and readly achieved (90% yield) by acid 
hydrolysis of 2b with IR-120 H+ resin [7] in refluxing methanol (ratio α/β, 3:1). 
Moreover, the butenolide fused to positions 3 and 4 of a pyranose moiety 10 was 
successfully obtained by resin acid hydrolysis of the (E)-α,β-unsaturated ester 2a, which 
after acetylation gave the triacetate derivative 11 as a 1:1 mixture of α,β-anomers in 






























5   R1 =  R2 = Piv














7     R1 = Piv, R2 = R3 =  H
8     R1 = R2 =  R3 =  H
9     R1 =  R2 =  R3 =  Ac
12
2a, 2b














10    R1 = R2 =  R3 =  H
11    R1 =  R2 =  R3 =  Ac
e)
a) Ph3P=CHCO2Et, CHCl3, reflux, 4 h.
b) AcOH 60% aq., rt, 20 h.
c) BzCl, py or PivCl, py/CH2Cl2 (2.5:1), 0 ºC, 1 h.
d) AcOH 70% aq., reflux, 1 h for 3b, 1 h 45 min for 4, 5 h for 5.
e) Ac2O/pyridine, 5 min.
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However, no intramolecular cyclization was observed by removal of the 1,2-O-
isopropylidene group of  5, which comprises a nonacid labile and bulky pivaloyl 
protecting group at position 5, being the 1,2-diol 12 isolated in 62% yield. This result 
suggests that the formation of butenolides 2,3-fused to carbohydrates under these 
experimental conditions is favored in pyranose system  rather than in furanose forms. 
Confirmation of this finding was possible when the p ntofuranosid-3-ulose 13 [18] 
(Scheme 2), with the acid resistant 5-O-pivaloyl group, was used as starting material. Its 
synthesis was accomplished by PDC/Ac2O oxidation  of  1,2-O-isopropylidene -5-O-
pivaloyl-α-D-xylofuranose [9]  in 81% yield.  Wittig olefination of 13 was 
stereoselective, leading to the (Z)-α,β-unsaturated ester 14b in 70% yield, with the (E)-
adduct 14a being isolated in 12% yield. As expected, intramolecu ar lactonization to 16 
did not occur by treatment with aq. acid acetic, resulting in the 1,2-diol 15 in 70% yield 
(ratio α/β, 1:0.7), thereby reinforcing that butenolides are difficult to fuse at positions 






























The preparation of butenolides 2,3-fused to pentopyranose units (Scheme 3) was 
accomplished following a synthetic pathway similar to that described above for the 
hexopyranose moieties. The primary hydroxyl group of 1,2-O-isopropylidene-α-D-
xylofuranose, easily prepared from D-xylose and commercially available, was 
selectively protected with the acid labile t rt-butyldimethylsilyl group in quantitative 
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yield, the resulting silyl ether being oxidized to the pentofuranos-3-ulose derivative 17
[10] with  PDC/Ac2O for the first time, in 97% yield. When this 3-keto sugar reacted 
with [(ethoxycarbonyl)methylene]triphenylphosphorane in chloroform under reflux, 
stereoselectivity to the (Z)-α,β-unsaturated ester 18b [11] was achieved, with this isomer 
being isolated in 81% yield and the (E)-isomer being obtained in 8% yield. Selective 
hydrolysis of 18b with aq. acid acetic (70%) at 70 ºC afforded the desilylated derivative 
19 in 85% yield, and IR-120 H+ resin promoted total hydrolysis with the formation f 
































In conclusion, a reliable and facile method is described for the stereoselective synthesis 
of potentially bioactive carbohydrate-based butenolides fused to pento- and 
hexopyranose rings. The synthetic strategy followed h rein involves a short number of 
steps leading to the target molecules in good overall yield, with the added value of a 
possible regioselective protection for further derivatization. The readily avaliable 
starting materials obtained from inexpensive sugars (D-glucose and D-xylose) and the 
easy and efficient experimental procedures, make this methodology useful for the 
preparation of new sugar derivatives of biological nterest. 
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The conversion of 2a into 8 could also be carried out using an aq. TFA solution (60%) 




General methods and procedures as well as full chara terization of compounds 1, 2a, 
2b, 3a, 4, 5, 7, 8, 9, 17, 18a, 18b and 20 published in:  
 
Xavier, N. M.; Kopitzki, S.; Rauter, A. P., “Pyranose-Fused Butenolides: An Expedient 
Preparation from Furanose Synthons” in Proven Synthetic Methods (Ed. P. Kovac), 
Taylor & Francis, Boca Raton, Florida, 2010, Vol. 1, in press. 
 
 
General Methods: 1,2:5,6-di-O-Isopropylidene-α-D-glucofuranose (DAG) and 1,2-O
isopropylidene-α-D-xylofuranose were purchased from Sigma-Aldrich. Melting points 
were determined with a Stuart Scientific SMP 3 apparatus and are uncorrected. Optical 
rotations were measured on a Perkin–Elmer 343 polarimeter at 20 ºC. 1H and 13C NMR 
spectra were recorded with a BRUKER Avance 400 spectrometer operating at 400.13 
MHz for 1H or 100.62 MHz for 13C. Chemical shifts are expressed in parts per million 
and are reported relative to internal TMS or relative to the respective solvent peak. 
Signal assignments were made with the help of DEPT, COSY, HMQC and HMBC 
experiments. HRMS spectra were acquired with an Apex Ultra FTICR Mass 
Spectrometer equipped with an Apollo II Dual ESI/MALDI ion source (Bruker 
Daltonics), and a 7T actively shielded magnet (Magnex Scientific). Elemental analyses 
were performed at the Microanalyses Service of Instituto Superior Técnico-
Universidade Técnica de Lisboa. 
All reactions were monitored by TLC on Merck 60 F254 silica gel-coated aluminium 
plates with detection under UV light (254 nm) and/or by charring with 10% H2SO4 in 
EtOH. Column chromatography (CC) was performed on silica gel 60 G (0.040–0.063 
mm, E. Merck). Concentration of solutions was done at reduced pressu .  
 





1,2:5,6-di-O-isopropylidene-α-D-ribo-hexofuranosid-3-ulose (1): A solution of 
1,2:5,6-di-O-isopropylidene-α-D-glucofuranose (4.00 g, 15.4 mmol) in dry CH2Cl2 (24 
mL) was added under argon to a mixture of PDC (4.32 g, 11.4 mmol) and Ac2O (4.4 
mL, 46.5 mmol) in dry CH2Cl2 (48 mL). The mixture was stirred under reflux for 2 h, 
cooled to room temp. and concentrated. The gummy residu  was triturated with Et2O 
(3×150 mL), and the ethereal extract was filtered through Florisil. The eluate was 
concentrated to afford the title compound (3.78 g, 95%) as a colorless oil. Rf = 0.37 
(EtOAc/petroleum ether, 2:3).1H NMR (400 MHz, CDCl3): δ = 6.15 (d, 1H, H-1, J1,2 = 
4.3 Hz), 4.42-4.34 (m, 3H, H-2, H-4, H-5), 4.06-4.01 (m, 2 H, H-6a, H-6b), 1.46 (s, 3H, 
Me, isopr.), 1.44 (s, 3H, Me, isopr.), 1.34 (s, 6H, 2 × Me, isopr.) ppm. 
 
3-Deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]- 1,2:5,6-di-O-isopropylidene-α-D-
ribo-hexofuranose (2a) and 3-deoxy- 3-C-[(E)-(ethoxycarbonyl)methylene]-1,2:5,6-
di-O-isopropylidene-α-D-ribo-hexofuranose (2b):   
[(Ethoxycarbonyl)methylene]triphenylphosphorane (5.23 g, 15 mmol) was added to a 
solution of  3-ulose 1 (2.27 g, 8.78 mmol) in dry CHCl3 (70 mL), and the mixture was 
stirred under reflux for 2 h. After concentration, the residue was chromatographed 
(EtOAc/petroleum ether, 1:9) to afford 2-(Z) as a white solid (1.70–1.95 g, 59–68%) 
and its (E)-isomer as a colorless oil (0.34 g, 12%). Physical data were in agreement with 
those reported [6b].  
Data for 2a: Rf = 0.27 (EtOAc/cyclohexane, 1:9).
 m. p. 68–70 °C. 1H NMR (400 MHz, 
CDCl3): δ = 6.34 (br. d, 1 H, H-3’), 5.85 (d, 1 H, H-1 J1,2, = 4.3 Hz,), 5.75 (brd, 1H, H-
2), 4.68 (brdd, 1H, H-4), 4.25 (q, 2H, CH2CH3, J = 7.1 Hz), 4.13-3.98 (m, 3H, H-5, H-
6a, H-6b),  1.50,  1.45, 1.41, 1.37 (4 s, 4 × 3H, 4 × Me, isopr.), 1.32 (t, 3H, CH2CH3) 
ppm. 13C NMR (100 MHz, CDCl3): δ = 165.1 (CO), 155.7 (C-3), 117.9 (C-3’), 112.8, 
110.1, (2 × Cq, isopr.), 104.9 (C-1), 79.9 (C-4), 78.4 (C-2), 76.8 (C-5), 67.3 (C-6), 60.7 
(CH2CH3), 27.3, 27.1, 26.7, 25.4 (4 × Me), 14.2 (CH2 3) ppm. 
Data for 2b: Rf = 0.35 (EtOAc/cyclohexane, 1:9). 
1H NMR (400 MHz, CDCl3): δ  = 
6.23 (br. d, 1 H, H-3’), 5.94 (d, 1H, H-1, J1,2 = 4.8 Hz), 5.76 (brd, 1H, H-4), 5.11 (brdd, 
1H, H-2), 4.35 (ddd, 1H, H-5, J4,5 = 2.3 Hz), 4.19 (qd, 2H, CH2CH3), 3.97 (dd, 1H, H-
6a, J5,6a = 6.3 Hz), 3.57 (t, 1H, H-6b, J6a,6b = 8.6 Hz,), 1.43, 1.39, 1.33, 1.32 (4 s, 4 × 3 
H, 4 × Me, isopr.), 1.31 (t, 3H, CH2CH3, J = 7.1 Hz) ppm. 
13C NMR (100 MHz, CDCl3): 
δ = 165.6 (CO), 158 (C-3), 118.1 (C-3’), 113.7, 109.1 (2 × Cq, isopr.), 103.8 (C-1), 82.3 
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(C-2), 80.0 (C-4), 79.0 (C-5), 65.4 (C-6), 60.8 (CH2CH3), 27.9,  27.9, 26.2, 25.7 (4 × 
Me), 14.2 (CH2CH3) ppm.  
 
3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2-O-isopropylidene-α-D-ribo-
hexofuranose (3a): A solution of 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-
1,2:5,6-di-O-isopropylidene-α-D-ribo-hexofuranose (2a, 0.79 g, 2.41 mmol) in aq. 
AcOH (60%, 9.6 mL) was stirred at room temp. for 20h.  The mixture was 
concentrated, the residue was co-evaporated with toluene (3×) and the crude product 
was chromatographed (EtOAc/petroleum ether, 2:3) to aff rd the title compound as a 
colorless oil (0.66 g, 95%). Rf = 0.25 (EtOAc/petroleum ether, 2:3). [ ]20Dα = +165 (c = 
1.2, in CH2Cl2).
 1H NMR (400 MHz, CDCl3): δ = 6.30 (br. dd, 1H, H-3’), 5.87 (d, 1H, 
H-1, J1,2 = 4.0 Hz), 5.73 (brd, 1H, H-2), 4.80 (br. d, 1H, H-4), 4.24 (q, 2H, CH2CH3), 
3.79-3.70 (m, 3H, H-5, H-6a, H-6b), 1.49 (s, 3H, Me, isopr.), 1.41 (s, 3H, Me, isopr.), 
1.31 (t, 3H, CH2CH3, J = 7.1 Hz) ppm. 
13C NMR (100 MHz, CDCl3): δ = 165.3 (CO), 
155.7 (C-3), 117.6 (C-3’), 113.0 (Cq, isopr.), 104.8 (C-1), 79.9 (C-4), 78.4 (C-2), 73.5 




α-D-ribo-hexofuranose (4) and 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2-
O-isopropylidene-5,6-di-O-pivaloyl-α-D-ribo-hexofuranose (5): A solution of 
pivaloyl chloride (2.12 mmol, 0.26 mL) in dry CH2Cl2 (1 mL) was added under argon to 
a solution of 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2-O isopropylidene-α-D-
ribo-hexofuranose (3a, 0.24 g, 0.85 mmol) in dry pyridine (2.5 mL). The solution was 
stirred at room temp. for 1 h and concentrated. Theresidue was partitioned between 
water (10 mL) and CH2Cl2 (3 × 5 mL). Organic layers were washed with a sat.aq. 
NaHCO3 solution, water and brine, and dried over MgSO4. After filtration and 
evaporation of the solvent, the residue was chromatgr phed (EtOAc/cyclohexane, 1:4) 
to afford 6 and 7 as white solids [0.18 g (57 %) and 0.10 g (27%), respectively].  
Data for 4: Rf = 0.35 (EtOAc/cyclohexane, 1:4). [ ]20Dα = +87 (c = 0.8, in CH2Cl2). m.p. 
97−99 ºC (cyclohexane). 1H NMR (400 MHz, CDCl3): δ = 6.32 (br. s, 1 H, H-3’), 5.88 
(d, 1H, H-1, J1,2 = 4.3 Hz), 5.74 (brd, 1H, H-2), 4.78 (brd, 1H, H-4, J4,5 = 6.6 Hz), 4.33, 
4.32, 4.30, 4.29 (dd, part AX of ABX system, 1H, H-6a, J5,6a = 3.0 Hz, J6a,6b = 11.6 Hz), 





4.27-4.21 (m, 3H, H-6b, CH2CH3), 3.89 (ddd, H-5), 2.79 (d, OH-5, J5,OH = 3.8 Hz), 1.49 
(s, 3 H, Me, isopr.), 1.42 (s, 3H, Me, isopr.), 1.31 (t, 3H, CH2CH3, J = 7.1 Hz), 1.22 
(9H, Me, Piv) ppm. 13C NMR (100 MHz, CDCl3): δ 179.4 (CO, Piv), 165.2 (CO), 155.3 
(C-3), 117.9 (C-3’), 113.0 (Cq, isopr.), 105.0 (C-1), 79.6 (C-4), 78.5 (C-2), 72.3 (C-5), 
65.8 (C-6), 60.8 (CH2CH3), 39.0 (Cq, Piv), 27.5 (Me, isopr.), 27.3 (Me, isopr.), 27.3 
(Me, Piv), 14.3 (CH2CH3) ppm. Anal. Cald for C18H28O8: C, 58.05; H, 7.58. Found: C, 
57.92; H, 7.91. 
Data for 5: Rf = 0.24 (EtOAc/cyclohexane, 1:9). [ ]20Dα = +91 (c = 0 1, in CH2Cl2). m.p.  
94−96 ºC (hexane). 1H NMR (400 MHz, CDCl3): δ = 6.03 (t, 1H, H-3’), 5.89 (d, 1H, H-
1, J1,2 = 4.3 Hz), 5.72 (brd, 1H, H-2), 5.12 (ddd, 1H, H-5), 4.98 (brd, 1H, H-4), 4.34, 
4.33, 4.31, 4.30 (dd, part AX of ABX system, 1H, H-6a, J5,6a = 3.0 Hz, J6a,6b = 12.1 Hz), 
4.28-4.15 (m, 3H, H-6b, CH2CH3, J5,6b = 6.8, J = 7.1 Hz), 1.48 (s, 3H, Me, isopr.), 1.43 
(s, 3H, Me), 1.30 (t, 3H, CH2CH3), 1.23 (9H, Me, Piv), 1.18 (9H, Me, Piv) ppm. 
13C 
NMR (100 MHz, CDCl3): δ = 178.1 (CO, Piv), 177.6 (CO, Piv), 164.6 (CO), 154.4 (C-
3), 118.1 (C-3’), 113.2 (Cq, isopr.), 105.2 (C-1), 78.8 (C-4), 78.3 (C-2), 72.4 (C-5), 62.0 
(C-6), 61.0 (CH2CH3), 39.0 (Cq, Piv), 38.9 (Cq, Piv), 27.5 (Me, isopr.), 27.3 (Me, 
isopr.), 27.2 (Me, Piv), 27.2 (Me, Piv) 14.2 (CH2CH3) ppm. Anal. Cald for C23H36O9: C, 
60.51; H, 7.95. Found: C, 60.48; H, 8.39. 
 
3-C-(Carboxymethylene)-3-deoxy-6-O-pivaloyl-D-ribo-hexopyranose-3’,2-lactone 
(7): A solution of 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2-O isopropylidene-
6-O-pivaloyl-α-D-ribo-hexofuranose (4, 0.08 g, 0.22 mmol) in aq. AcOH (70%, 1.2 
mL) was stirred under reflux for 1 h 45 min. After concentration, the residue was 
coevaporated with toluene (3×) and the crude product was chromatographed 
(EtOAc/petroleum ether, 3:2) to afford the title compound as a colorless oil (51 mg, 83 
%). Rf  = 0.33 (EtOAc/petroleum ether, 3:2). 
1H NMR (400 MHz, CDCl3): δ = 6.13 (br. 
s, H-3’), 5.66 (d, H-1α, J1,2(α) = 4.2 Hz), 4.88 (dd, H-2α, J2,3’(α) = 1.3 Hz),  4.67 (dd, H-
2β, J1,2 (β) = 7.1, J2,3’ (β) = 1.3 Hz), 4.57-4.47 (m, H-1β, H-6aα, H-6aβ, J5,6a (α) = 3.5 Hz, 
J6a,6b (α) = 12.5 Hz), 4.46-4.35 (m, H-6bα, H-4α, H-4β, H-6bβ), 3.97 (ddd, H-5α), 3.47 
(ddd, H-5β), 1.23 (s, Me, Piv, α, Me, Piv, β) ppm. 13C NMR (100 MHz, CDCl3): δ = 
180.0 (CO, Piv, β), 179.8 (CO, Piv, α), 174.3 (CO, lact., α), 173.6 (CO, lact., β), 169.3 
(C-3β), 168.0 (C-3α),  113.8 (C-3’α, C-3’β), 99.0 (C-1β), 90.9 (C-1α), 82.4 (C-2β), 79.1 
(C-2α), 78.2 (C-5β), 72.2 (C-5α), 67.2 (C-4β), 66.9 (C-4α), 62.9 (C-6β), 62.7 (C-6α), 
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39.2 (Cq, Piv), 27.3 (Me, Piv) ppm. HRMS: calcd. for C13H18O7 [M + H]
+ 287.1125, 
found 287.1127; calcd. for [M + Na]+ 309.0945, found 309.0947; calcd. for [M + K]+ 
325.0684, found 325.0684.  
 
3-C-(Carboxymethylene)-3-deoxy-D-ribo-hexopyranose-3’,2-lactone (8): Amberlite 
IR-120 H+ resin (100 mg) was added to a solution of 3-deoxy-3-C-[(Z)-
(ethoxycarbonyl)methylene]-1,2:5,6-di-O-isopropylidene-α-D-ribo-hexofuranose (2a, 
0.3 g, 0.913 mmol) in MeOH–H2O (5:1, 12 mL). The mixture was gently stirred under 
reflux for 16 h, the resin was filtered and the solvent was evaporated. The crude product 
was chromatographed using AcOEt as eluent to afford 4 as a white solid (165 mg, 
90%). Rf = 0.22 (EtOAc). m.p. 168−174 ºC (AcOEt). 
1H NMR (400 MHz, [D6]DMSO): 
δ = 7.56 (d, OH-1β, J = 5.6), 7.04 (d, OH-1α, J = 4.6 Hz), 6.00 (d, OH-4β, J = 5.8 Hz), 
5.95-5.87 (m, H-3’α, H-3’β, OH-4α), 5.47 (t, H-1α), 4.96 (d, H-2α, J1,2 (α) = 4.1 Hz), 
4.89 (t, OH-6β), 4.79 (t, OH-6α), 4.65 (d, H-2β, J1,2 (β) = 7.1 Hz) 4.37-4.30 (m, H1-β, H-
4α, H-4β), 3.79-3.52 (m, H-6aα, H-6aβ, H-6bα, H-6bβ, H-5α, J5,6a (β) = 5.3 Hz, J6a,6b (β) = 
12.1 Hz, J5,6a (α) = 5.3 Hz, J6a,6b (α) = 11.6 Hz) 3.12 (ddd, H-5β) ppm. 
13C NMR (100 
MHz, [D6]DMSO): δ = 172.9, 172.6, 172.4 171.1 (CO-α, CO-β, C-3α, C-3β), 111.7 (C-
3’α, C-3’β), 98.7 (C-1β), 90.4 (C-1α), 82.0 (C-2β), 80.2 (C-5β), 78.6 (C-2α), 74.4 (C-
5α), 66.1 (C-4β), 65.7 (C-4α), 60.1 (C-6α, C-6β) ppm. HRMS: calcd. for C8H10O6 [M + 
H]+ 203.0550, found 203.0550; calcd. for [M + Na]+ 225.0370, found 225.0369; calcd. 
for [M + K]+ 241.0109, found 241.0109. Anal. Cald. for C8H10O6: C, 47.53; H, 4.99. 
Found: C, 47.60; H, 4.90. 
 
Alternative Method for the conversion of 2a into 8 (unpublished): 
A solution of 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2:5,6-di-O-
isopropylidene-α-D-ribo-hexofuranose (2a, 0.17 g, 0.51 mmol) in aq. TFA (60%, 3.4 
mL) was stirred at room temp. for 5 min. The mixture was concentrated, the residue was 
co-evaporated with toluene (3×) and the crude product was cristalized from EtOAc to 
afford compound 8 as white solid (91mg, 90%).  
 
1,4,6-Tri-O-acetyl-3-C-(carboxymethylene)-3-deoxy-D-ribo-hexopyranose-3’,2-
lactone (9): A solution of 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2-O
isopropylidene-α-D-ribo-hexofuranose (3a, 0.07 g, 0.23 mmol) in aq. AcOH (70%, 1.2 
mL) was stirred under reflux for 1 h. After concentration, Ac2O (1 mL) and py (2 mL) 





were added to the residue and the mixture was stirred for 5 min. After coevaporation 
with toluene (3×), the crude product was chromatographed (EtOAc/petroleum ether, 
1:1) to afford the title compound as a colorless oil (0.06 g, 78 %). Rf = 0.32 
(EtOAc/petroleum ether, 1:1). [ ]20Dα = +178 (c = 1.2, in CH2Cl2). 1H NMR (400 MHz, 
CDCl3): δ = 6.60 (d, H-1α, J1,2 = 4.6 Hz), 6.02-5.96 (m, H-3’α, H-3’β), 5.71 (dd, H-4α, 
J3’,4 (α) = 1.5, J4,5 (α) = 9.6 Hz,), 5.66 (dd, H-4β, J3’,4 (β) = 1.5, J4,5 (β)  = 9.6 Hz), 5.40 (d, H-
1β, J1,2 (β) = 7.6 Hz), 5.10 (dd, H-2α, J2,3’ (α) = 1.5 Hz), 4.90 (dd, H-2β, J2,3’(β) = 1.5 Hz), 
4.40-4.32 (m, H-6aα, H-6aβ) 4.28-4.19 (m, H-6bα, H-6bβ), 4.00 (ddd, H-5α), 3.77 (ddd, 
H-5β), 2.22 (s, Me, Ac, α, Me, Ac, β), 2.21 (s, Me, Ac, β), 2.11 (s,  Me, Ac, α, Me, Ac, 
β), 2.09 (s, Me, Ac, α) ppm.13C NMR (CDCl3): δ = 171.0 (CO, Ac, α), 170.6 (CO, Ac, 
β, CO, lact., α, CO, lact., β), 169.1 (CO, Ac, β), 169.1 (CO, Ac, α), 168.7 (CO, Ac, β), 
168.2 (CO, Ac, α),  163.2 (C-3β),  161.6 (C-3α), 115.3 (C-3’α), 114.7 (C-3’β), 95.4 (C-
1β), 88.8 (C-1α), 78.9 (C-2β), 76.4 (C-2α), 76.2 (C-5β), 71.9 (C-5α), 66.4 (C-4β), 66.0 
(C-4α), 61.4 (C-6α), 61.3 (C-6β), 20.9, 20.8, 20.7, 20.6 (Me, Ac) ppm. HRMS: calcd. 
for C14H16O9 [M + H]
+ 329.0867, found 329.0864; calcd. for [M + Na]+ 351.0687, found 
351.0690; calcd. for [M + K]+ 367.0426, found 367.0417. 
 
5-O-tert-Butyldimethylsilyl-1,2-O-isopropylidene-α-D-erythro-pentofuranos-3-ulose 
(17)10: A solution of 5-O-TBDMS-1,2-O-isopropylidene-α-D-xylofuranose10 (1.05 g, 
3.47 mmol) in dry CH2Cl2 (6 mL) was added under argon to a mixture of PDC (0.96 g, 
2.57 mmol) and Ac2O (1.1 mL, 11.6 mmol) in dry CH2Cl2 (12 mL), under argon. The 
mixture was stirred under reflux for 1 h 30 min, cooled to room temp., and 
concentrated. Diethyl ether (3×50 mL) was added to the gummy residue, mixture was 
filtered over Florisil and concentrated to afford the title compound as a waxy white 
solid (0.872 g, 97%). 1H NMR (CDCl3): δ 6.14 (d, 1H, J1,2 4.6 Hz, H-1), 4.37 (br. d, 1H, 
H-4), 4.28 (d, 1 H, H-2), 3.91, 3.90, 3.88, 3.87 (dd, part A of ABX system, H-5a J4,5a = 
1.8, J5a,5b = 10.9 Hz,), 3.84, 3.83, 3.81, 3.80 (dd, part B of ABX system, J4,5b  2.0 Hz, H-
5b), 1.46 (s, 3H, Me, isopr.), 1.45 (s, 3H, Me, isopr.), 0.86 (s, 9H, t-Bu, TBDMS), 0.06 
(s, 3H, Me, TBDMS), 0.03 (s, 3H, Me, TBDMS); 13C NMR (100 MHz, CDCl3): δ 211.2 
(CO), 114.2 (Cq, isop), 103.9 (C-1), 81.9 (C-4), 77.2 (C-2), 64.0 (C-5), 27.8 (Me), 27.3 
(Me), 25.9 (3×Me, t-Bu), 18.3 (Cq, t-Bu), -5.4 (Me, TBDMS), -5.6 (Me, TBDMS). 
 




isopropylidene-α-D-erythro-pentofuranose (18a) and 5-O-tert-butyldimethylsilyl-3-
deoxy-3-C-[(E)-(ethoxycarbonyl)methylene]-1,2-O-isopropylidene-α-D-erythro- 
pentofuranose (18b): [(Ethoxycarbonyl)methylene]triphenylphosphorane (1.63 g, 4.67 
mmol) was added to a solution of  3-ulose (17)  (0.83 g, 2.7 mmol) in dry CHCl3 (22 
mL) and the mixture was stirred under reflux for 2 h. After concentration, the residue 
was chromatographed (EtOAc/cyclohexane, 1:9) as eluent to afford the (Z)-adduct 11 
and its (E)-isomer 12 as colorless oils [0.806 g (81%) and 0.084 g (8%), respectively]. 




erythro-pentofuranose (11, 0.11g, 0.29 mmol) was treated under reflux with  Amberlite 
IR-120 H+ resin as described for preparation of 4. After filtration and concentration, the 
crude product was chromatographed (EtOAc/petroleum ther, 4:1) to afford the title 
compound (39 mg, 79%, anomeric mixture) as a white solid. Rf = 0.32 
(EtOAc/petroleum ether, 4:1). m.p. 143-147 ºC (diethyl ether). 1H NMR (400 MHz, 
[D6]DMSO): δ  = 7.56 (d, OH-1β, J = 6.6 Hz,), 6.99 (d, OH-1α, J = 4.6 Hz), 5.99 (d, 
OH-4β, J = 5.1 Hz), 5.94-5.89 (m, H-3’β, OH-4α), 5.88 (br. s, H-3’α), 5.44 (t, H-1α), 
4.96 (d, H-2α, J1,2 (α) = 3.5 Hz), 4.63 (d, H-2β, J1,2 (β) = 6.8 Hz), 4.56-4.55 (m, H-4α,  H-
4β), 4.27 (t, H-1β),   4.05 (dd, , H-5aβ, J4,5a(β) = 8.1 Hz, J5a,5b(β) = 10.2 Hz), 3.75 (dd, H-
5aα, J4,5a(α) = 8.1 Hz, J5a,5b(α) = 9.4 Hz), 3.42 (t, H-5bα, J4,5b (α) = 10.1 Hz), 3.02 (t, H-
5bβ) ppm. 13C NMR (100 MHz, [D6]DMSO, major anomer): δ = 172.8 (CO), 170.4 (C-
3), 111.1 (C-3’), 90.3 (C-1), 78.4 (C-2), 65.5 (C-4), 62.6 (C-5) ppm. HRMS: calcd. for 
C7H8O5 [M + H]
+ 173.0445, found 173.0443. 
 
Experimental Procedures and Characterization of Compounds 10, 11, 12, 14a, 14b, 
15 and 19 
 
3-C-(Carboxymethylene)-3-deoxy-D-ribo-hexopyranose-3’,4-lactone (10) and 1,2,6-
Tri- O-acetyl-3-C-(carboxymethylene)-3-deoxy-D-ribo-hexopyranose-3’,4-lactone 
(11): To a solution of 3-deoxy-3-C-[(E)-(ethoxycarbonyl)methylene]-1,2:5,6-di-O-
isopropylidene-α-D-ribo-hexofuranose (2a, 0.11g, 0.33 mmol) in MeOH (1.8 mL) was 
added  Amberlite IR-120 H+ resin (35 mg). The mixture was moderately stirred un er 





reflux overnight. After filtration of the resin and evaporation of the solvent, the crude 
was purified by CC (column chromatography) using AcOEt as eluent to afford 10 as a 
white solid. Ac2O (1 mL) and py (2 mL) were then added to compound 10 and the 
mixture was stirred for 5 min. After co-evaporation with toluene (3×), the crude product 
was purified by CC (EtOAc/petroleum ether, 7:3) to afford 11 (67 mg, 63%, 2 steps) as 
a colorless oil. 
Data for 10: Rf = 0.21 (EtOAc).
 1H NMR (400 MHz, [D6]DMSO): δ = 7.36 (d, OH-1β, 
J = 6.3 Hz), 6.94 (d, OH-1α, J = 4.6 Hz), 6.15 (d, OH-2β, J = 5.3 Hz), 5.95−5.91 (m, H-
3’α, H-3’β), 5.63 (d, OH−2α, J = 7.8), 5.24 (t, H−1α), 5.06 (t, OH-6), 4.99 (t, OH-6), 
4.84 (d, H-4, J4,5 = 9.4 Hz), 4.82 (d, H-4, J4,5 = 9.9 Hz), 4.45 (ddd, H-2α), 4.33 (t, H-
1β), 4.14 (ddd, H-2β), 3.73−3.49 (m, H-6aα, H-6aβ, H-6bα, H-6bβ, H-5), 3.13 (ddd, H-
5) ppm. 13C NMR (100 MHz, [D6]DMSO): δ = 173.1 (CO), 172.4 (C-3α, C-3β), 112.1, 
111.5 (C-3’α, C-3’β), 100.1 (C-1β), 93.5 (C-1α), 78.5 (C-5), 76.7 (C-4α, C-4β), 73.8 (C-
5), 71.8 (C-2β), 69.4 (C-2α), 61.0 (C-6α, C-6β) ppm. 
Data for 11: Rf = 0.31 (EtOAc/petroleum ether, 7:3). [ ]20Dα = − 53 (c = 1.0, in CH2Cl2). 
IR (neat): 1777 cm-1 (C=O, lactone). 1H NMR (400 MHz, CDCl3): δ = 6.51 (d, H-1α, 
J1,2(α) = 4.3 Hz), 6.08 (t, H-3’α, J2,3’ (α) = J3’,4 (α) = 1.8), 6.01 (t, H-3’β, J2,3’(β) = J,3’,4(β) =  
1.8 Hz), 5.83 (dd, H-2α), 5.73, 5.71 (d, part A of ABX system, H-2β, J1,2 (β) = 7.6 Hz), 
5.62, 5.60 (d, part B of ABX system, H-1β), 4.91 (m, H-4α, H-4β, J4,5 (α) = J4,5 (β) = 9.4 
Hz), 4.50−4.44 (m, H-6aα, H-6aβ) 4.37−4.29 (m, H-6bα, H-6bβ, J6a,6b(α) = J6a,6b(β) = 
12.4, J5,6b(α) = J5,6b(β) = 2.5 Hz), 3.88 (ddd, H-5α), 3.58 (ddd, H-5β), 2.21, 2.17, 2.16, 
2.13, 2.12 (5s, Me, Ac, α, β) ppm. 13C NMR (100 MHz, CDCl3): δ = 171.0, 170.6, (CO, 
Ac), 170.4 (CO, lact., α, CO, lact., β) 169.2, 169.0, 168.8, 168.6 (CO, Ac, α, β),  163.8, 
161.9 (C-3β, C-3α), 115.2 (C-3’β) 115.0 (C-3’α), 94.0 (C-1β), 89.4 (C-1α), 76.4 (C-5β), 
76.0 (C-4α, C-4β), 74.0 (C-5α) 69.5 (C-2β), 67.9 (C-2α), 62.5, 62.5 (C-6α, C-6β),  20.8,  
20.7, 20.5, 20.4 (Me, Ac) ppm. HRMS: calcd. for C7H8O5 [M + Na]
+ 351.0670, found 
351.0687; C7H8O5 [M + K]
+ 367.0417, found 367.0426. 
 
3-Deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-5,6-di-O-pivaloyl-D-ribo-
hexofuranose (12): A solution of 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2-
O-isopropylidene-5,6-di-O-pivaloyl-α-D-ribo-hexofuranose (5, 55 mg, 0.12 mmol) in 
aq. AcOH (70%, 0.7 mL) was stirred under reflux for 5 h. The solvent was 
coevaporated with toluene (3×) and the crude product was purified by CC 
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(EtOAc/petroleum ether, 1:4) to afford 12 (31 mg, 62 %) as a colorless oil. Rf = 0.25 
(EtOAc/petroleum ether, 1:4). [ ]20Dα = +23 (c = 0.8, in CH2Cl2). IR (neat): 3571 cm-1 
(OH), 1728 cm-1 (C=O). 1H NMR (400 MHz, CDCl3): δ = 6.12 (d, H-3’β), 6.04 (brs, H-
3’α), 5.57-5.52 (m, H-1α, H-1β), 5.21 (ddd, H-5α, J5,6a(α) =  2.5, J5,6b(α) = 5.6 Hz), 5.09 
(ddd, H-5β, J4,5(β) = 8.8, J5,6a(β) = 3.3, J5,6b(β) = 5.6) 4.98 (br. dd, H-2β), 4.94 (br. s, H-2α), 
4.92−4.88 (m, H-4β), 4.85 (dt, H-4α, J4,5(α) = 8.3 Hz), 4.54, 4.51 (part A of ABX 
system, H-6aα, J6a,6b(α) = 12.4), 4.40−4.30 (m, OH-2α, H-6aβ, J6a,6b (β) = 12.1 Hz), 4.28-
4.17 (m,  H-6bα, H-6bβ, CH2CH3 α, CH2CH3 β),  3.97 (brs, OH-1β), 3.88 (brs, OH-1α), 
1,31 (t, CH2CH3 α,  J = 7.1 Hz), 1.30 (t, CH2CH3 β, J = 7.1 Hz), 1.24 (s, Me, piv, α, Me, 
Piv, β), 1.19 (s, Me, Piv, α), 1.18 (s, Me, Piv, β) ppm. 13C NMR (100 MHz, CDCl3): δ = 
178.4 (CO, Piv, α), 178.1 (CO, Piv, β), 177.6 (CO, Piv, β), 177.3 (CO, Piv, α), 167.7 
167.0 (CO, α, CO, β),  161.5 (C-3α), 161.1 (C-3β),  117.2 (C-3’α), 116.9 (C-3’β), 103.7 
(C-1α), 96.9 (C-1β), 79.2 (C-4α), 77.9 (C-4β), 76.8 (C-2α), 73.1 (C-5α), 72.6, 72.5 (C-
5β, C-2β), 62.7 (C-6α), 62.0, 61.9 (C-6β, CH2CH3 β), 61.4 (CH2CH3 α), 39.0, 38.9 (Cq, 




α-D-erythro-pentofuranose (14a) and 3-Deoxy-3-C-[(Z)-(ethoxycarbonyl)-
methylene]-1,2-O-isopropylidene-5-O-pivaloyl-α-D-erythro-pentofuranose (14b): To 
a solution of 1,2-O-isopropylidene-5-O-pivaloyl-α-D-xylofuranos-3-ulose (13, 0.17 g, 
0.63 mmol) in dry CHCl3 (5 mL) was added [(ethoxycarbonyl)-
methylene]triphenylphosphorane (0.37 g, 1.06 mmol).  The mixture was stirred under 
reflux for 1 h 15 min. After evaporation of the solvent, the residue was purified by 
chromatography on silica-gel with EtOAc/cyclohexane (1:9) as eluent to afford (E)-14a 
(0.025 g, 12%) and its (Z)-isomer (14b, 0.15 g, 70%) as colorless oils. 
Data for 14a: Rf = 0.29 (EtOAc/cyclohexane, 1:9). [ ]20Dα = +160 (c = 1.2, in CH2Cl2). 
IR (neat): 1728 cm-1 (C=O). 1H NMR (400 MHz, CDCl3): δ = 6.18 (br. d, 1H, H-3’), 
5.94 (d, 1H, H-1, J1,2 = 4.6 Hz), 5.76 (br. s, 1H, H-4), 5.11 (br. d, 1H, H-2), 4.43, 4.42, 
4.403, 4.39 (dd, part A of ABX system, 1H, H-5a, J4,5a = 2.0, J5a,5b = 11.6), 4.22−4.16 
(m, 3H, H-5b, CH2CH3), 1.44 (s, 3H, Me, isopr.), 1.42 (s, 3H, Me, isopr.), 1,31 (t, 3H, 
CH2CH3, J = 7.1 Hz), 1.19 (s, 9H, Me, Piv) ppm.
 13C NMR (100 MHz CDCl3): δ = 
178.0 (CO, Piv), 165.3 (CO), 158.3 (C-3), 118.0 (C-3’), 113.7 (Cq, isopr.), 104.4 (C-1), 





81.9 (C-2), 79.3 (C-4), 66.7 (C-5), 61.0 (CH2CH3), 38.7 (Cq, Piv), 28.1 (Me, isopr.), 
27.8 (Me, isopr.), 27.4 (Me, Piv), 14.3 (CH2CH3) ppm. 
Data for 14b: Rf = 0.18 (EtOAc/cyclohexane, 1:9). [ ]20Dα = +143 (c = 1.0, in CH2Cl2). 
IR (neat): 1725 cm-1 (C=O). 1H NMR (400 MHz, CDCl3): δ = 5.93 (br. d, 1H, H-3’), 
5.93 (d, 1H, H-1), 5.72 (br. d, 1H, H-2, J1,2 = 3.8), 5.05 (br. s, 1H, H-4), 4.32−4.21 (m, 
4H, H-5a, H-5b, CH2CH3, J4,5a = 4.0 Hz), 1.50 (s, 3H, Me, isopr.), 1.43 (s, 3H, Me, 
isopr.), 1,31 (t, 3H, CH2CH3, J = 7.1 Hz), 1.19 (s, 9H, Me, Piv) ppm.
 13C NMR (100 
MHz, CDCl3): δ = 178.0 (CO, Piv), 164.6 (CO), 154.8 (C-3), 117.2 (C-3’), 113.0 (Cq, 
isopr.), 105.2 (C-1), 78.3 (C-4), 78.2 (C-2), 64.7 (C-5), 60.8 (CH2CH3), 38.8 (Cq, Piv), 
27.5 (Me, isopr.), 27.2 (Me, isopr.), 27.1 (Me, Piv), 14.3 (CH2CH3) ppm. Anal. Cald for 
C17H26O7 (342.38): C, 59.64; H, 7.65. Found: C, 59.17; H, 8.01. 
 
3-Deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-5-O-pivaloyl-α-D-erythro-
pentofuranose (15): A solution of 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2-
O-isopropylidene-5-O-pivaloyl-α-D-erythro-pentofuranose (14b, 0.074 g, 0.22 mmol) in  
aq. AcOH (70%, 1.2 mL) was stirred under reflux for 2 h 15 min. The solvent was co-
evaporated with toluene (3×) and the crude product was purified by CC 
(EtOAc/petroleum ether, 2:3) to afford 15 (0.046 g, 70 %) as a colorless oil. Rf = 0.35 
(EtOAc/ petroleum ether, 2:3); [ ]20Dα = +90 (c = 1.3, in CH2Cl2). IR (neat):  3525 cm-1 
(OH), 1724 cm-1 (C=O). 1H NMR (400 MHz, CDCl3): δ = 6.04-5.99 (m, 1H, H-3’α), 
5.98 (brs, H-3’β), 5.62−5.57 (brd, H-1β), 5.50 (brs, 1H, H-1α), 5.05-4.92 (m, H-2α, H-
4α, H-2β, H-4β), 4.43 (dd, H-5aα, J4,5a(α)  = 6.8, J5a,5b(α)  = 11.6 Hz), 4.29−4.21 (m, 
CH2CH3 α, CH2CH3 β, H-5aβ, H-5bβ), 4.18−4.11 (m, H-5bα, OH-2α), 4.01 (brs, OH-
1α), 3.77 (brs, OH-1β), 1,32 (t, CH2CH3 α, CH2CH3 β, J = 7.1 Hz), 1.22 (s, 9H, Me, Piv, 
α), 1.19 (s, Me, Piv, β) ppm. 13C NMR (100 MHz, CDCl3): δ = 178.6, 178.2 (CO, Piv, 
α, CO, Piv, β), 167.8, 166.8 (CO, α, CO, β), 161.6, 161.1 (C-3α, C-3β), 116.8 (C-3’β), 
115.9 (C-3’α), 103.3 (C-1α), 96.8 (C-1β), 79.8, 77.7, 76.6, 72.9 (C-4α, C-4β, C-2α, C-
2β), 66.9, 65.0 (C-5α, C-5β), 61.8, 61.5 (CH2CH3), 39.0, 38.9 (Cq, Piv,α  Cq, Piv, β), 
27.2 (Me, Piv), 14.3, 14.2 (CH2CH3). 
 
3-Deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2-O-isopropylidene-α-D-erythro-
pentofuranose (19): A solution of 5-O-TBDMS-3-deoxy-3-C-[(Z)-(ethoxycarbonyl)-
methylene]-1,2-O-isopropylidene-α-D-erythro-pentofuranose (18b, 0.28 g, 0.75 mmol) 
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in aq. AcOH (70%, 3.4 mL) was stirred at 70 ºC for 2 h 30 min.    The solvent was co-
evaporated with toluene (3×) and the residue was purified by CC (EtOAc/cyclohexane, 
3:2) to afford 19 (0.16 g, 85 %) as a colorless oil. Rf = 0.27 (EtOAc/cyclohexane, 3:2). 
[ ]20Dα = +216 (c = 1.2, in CH2Cl2). IR (neat): 3571 cm-1 (OH), 1722 cm-1 (C=O). 1H 
NMR (400 MHz, CDCl3): δ = 5.98-5.90 (m, 2H, H-1, H-3’), 5.75 (brs, 1H, H-2), 4.91 
(brs, 1H, H-4), 4.24 (q, 2H, CH2CH3, J = 7.1 Hz), 3.94, 3.91 (d, part A of ABX system, 
1H, H-5a, J4,5a = 2.0, J5a,5b = 12.1 Hz), 3.75, 3.72 (d, part B of ABX system, 1H, H-5b, 
J4,5b = 3.5 Hz), 1.51 (s, 3H, Me, isopr.), 1.43 (s, 3H, Me, isopr.), 1,31 (t, 3H, CH2CH3) 
ppm. 13C NMR (100 MHz, CDCl3): δ = 164.9 (CO), 154.7 (C-3), 116.9 (C-3’), 113.0 
(Cq, isop), 105.0 (C-1), 80.5 (C-4), 78.5 (C-2), 63.1 (C-5), 60.9 (CH2CH3), 27.4 (Me), 
27.2 (Me), 14.3 (CH2CH3). 
Results and Discussion – Furanose C-C-Linked Butenolides,  





2.1.2. Furanose C-C-Linked Butenolides, 




The following section includes the paper: 
 
“Synthesis and Biological Evaluation of Sugars Containing α,β-Unsaturated  
γ-Lactones”, Xavier, N. M.; Silva, S.; Madeira, P. J. A.;  Florêncio, M. H.; Silva, F. V. 
M.; Justino, J.; Thiem, J.; Rauter, A. P Eur. J. Org. Chem. 2008, 2008, 6134–6143. 
 
and shows the synthetic work on furanose C-C-linked butenolides and pentopyranose- 
or hexopyranose-fused butenolides. The bioactivity of some of the new molecules is 
reported. 
 
The role of the co-autors (besides the supervisors Rauter, A. P. and Thiem, J.) is 
specified as follows: 
 
- Silva, S. made a contribution on the synthesis of the 5-keto sugar precursors; 
 
- Madeira, P. J. A. and Florêncio, M. H. were responsible for the HRMS analysis; 
 
- Silva, F. V. M. and Justino, J. carried out the biological tests. 
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The stereocontrolled synthesis of new sugar derivatives carrying the α,β-unsaturated-δ-
lactone (butenolide) moiety is described. Sugar-fused or sugar-linked butenolides can be 
constructed by an efficient reaction sequence involving Wittig olefination of 3- or 5-
keto sugars, and intramolecular cyclization of the intermediate γ-hydroxy-α,β-
unsaturated esters. The antimicrobial activities of the products and that of a known 
sugar-derived pyranoid α,β-unsaturated-δ-lactone were investigated against six 
pathogenic bacteria and six fungi. The pyranoid α,β-unsaturated δ-lactone 29 proved to 
be the most active compound in this series towards the plant pathogenic fungi 













α,β-Unsaturated-γ-lactones are abundant in both naturally occurring and synthetic 
products and are known to show a variety of antimicrobial [1] or cytotoxic [2] 
properties. Some of these compounds were reported to be potential antitumor agents [3], 
cyclooxygenase or phospholipase A2 inhibitors [4], or antibiotics [5]. 
 
In particular sugars bearing this moiety have become i portant molecular targets with 
respect to their significant biological profile and their functionalized nature, which make 
them suitable intermediates of distinct synthetic versatility [6].  
 
The practice of incorporating unsaturated lactones i to carbohydrates has been achieved 
with success in our laboratory. Some of these compounds (exocyclic unsaturated γ-
lactones, compounds of type A, Figure 1) showed significant antifungal activity and are 
particularly effective against Puccinia recondita (wheat), Botrytis cinerea (pepper) and 
Plasmopara viticola (gravepine). They are considered potential wheat-, pepper-, or 
wine-protective agents [7]. Moreover, sugar-linked butenolides (endocyclic unsaturated 
γ-lactones, compounds of type B, Figure 1) have demonstrated their efficacy as potent 
and selective insecticides against Drosophila melanogaster Meig (fruitfly), and proved 
to be much more active than imidacloprid, the insecticide that is commercially used [8]. 
The fungicidal lactones were synthesized via Reformatsky-type reaction with a 
dialdofuranose as starting material [7, 9]. The approach described for the synthesis of 
the insecticidal compounds relied on the reaction of sugar epoxides with the dianion of 
phenylselenoacetic and -propionic acids, or their thioanalogues, followed by oxidation 
and elimination [7, 10]. Various routes leading to sugar C-linked butenolides have also 
been reported, including Wittig and iodo-lactonization reactions starting from a 
dialdofuranose and recently, ring-closing metathesis via sugar-derived Baylis-Hillman 
adducts [11, 12].  
 
With respect to sugar-fused α,β-unsaturated γ-lactones, some literature reports describe 
their use for the preparation of bioactive natural products and branched-chain sugars 
[13,14].  
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We have recently demonstrated an effective route to access various butenolides fused to 
pento- and hexopyranoses [15]. The strategy is based on the Wittig olefination of 
furanos-3-uloses containing acid-labile 5-O- or 5,6-di-O- protecting groups, followed by 
acid hydrolysis. According to our previous findings and as part of our ongoing search 
for strategies to insert these structural motifs into carbohydrate templates for the design 
of new potentially biologically active substances, we have planned the synthesis of 
















R1 = OBn or H
R2 = OBn or H
R3 = CH3 or H
R1 = OBn or H




Figure 1. Structure of sugar-linked α,β-unsaturated-γ lactones possessing fungicidal (A) 
and insecticidal (B) properties. 
 
The developed methodology makes use of the Wittig reaction of 5-keto sugars with a 
resonance stabilized ylide to give α,β-unsaturated esters. The latter are spontaneously 
converted into the corresponding lactones in the presence of a γ-hydroxyl group, by 
controlling the stereochemistry of the Wittig products. Derivatives which differ in the 
steric bulk of the substituent at C-3 or in the C-3 configuration were synthesized in 
order to investigate the influence of these structural factors on the stereoselectivity. 
Moreover, to broaden the structural diversity of these sugar derivatives, we explored our 
recently reported methodology for the synthesis of new butenolides fused to pento- and 
hexopyranoses. One of the prospective applications of these bicyclolactones is the 
synthesis of fused-disaccharides by diol addition.  
 
The results of the antimicrobial activity evaluation performed on the newly synthesized 
sugar-C-C-linked butenolides as well as on the previously reported bicyclic fused 
derivatives are presented here. To extend the range of the sugar-based unsaturated 
lactones tested, a pyranoid α,β-unsaturated γ-lactone [16] was included in our set of 




compounds. In addition, we compared these results wi h related data for known 
antifungal α-methylene-γ-butyrolactones in order to rationalize, in terms of structure, 
the influence of the lactone system on the observed bioactivities. For this purpose we 
especially want to emphasize a possible relationship between the Michael-accepting 
ability of the tested compounds and their biological activities. 
 




1.1. Sugar-C-C-Linked Butenolides 
 
The synthesis of 5-keto sugars 5−8 (Scheme 1) was achieved by regioselective 
oxidation of the secondary hydroxyl group of the 5,6-diol precursors 1–4 with the 
system Bu2SnO/NBS [17] in 90, 78, 60 and 61% yield, respectively. The 
1H-NMR 
spectra of the α-hydroxy ketone products show AB-system patterns for H-6a, H-6b, 
with geminal coupling constants from 20.2 to 20.5 Hz. The carbonyl groups of 5-8 give 
rise to characteristic signals in the 13C-NMR spectra (δ = 208.2, 208.2, 207.1 and  207.3 
ppm, respectively) and show IR band absorptions at 1725 and 1730 cm-1. The lower 
yield obtained for the ribo derivatives may result from dimerization of the α-hydroxy 
ketones, which must depend on the stereochemistry at C-3, as suggested in the literature 
[17]. Hence dimerization occurs to a larger extent in ribo than in xylo compounds in 
which the orientation of the C-3 substituent results on increased steric hindrance to the 
formation of dimers. The 5-keto substrates were subjected to Wittig reaction with 
[(ethoxycarbonyl)methylene]triphenylphosphorane in refluxing chloroform to give 
compounds 9–12. Starting from 3-O-benzyl- and 3-O-allyl-1,2-O-isopropylidene-α-D-
xylo-hexofuranos-5-ulose (5, 6), the (Z)-α,β-unsaturated esters 9, 10 were obtained in 
74% and 60 % yield, respectively, and no cyclization was observed. In the 1H NMR 
spectra, the signals of the olefinic protons appear at δ 6.02 and δ 6.08 ppm, respectively, 
as broad singlets. Diagnostic signals for the configuration assignment of these 
molecules are the H-4 protons, which are relatively downfield shifted (δ = 5.83 and δ = 
5.84 ppm), thus reflecting the orientation of the ethoxycarbonyl group. Furthermore, the 
(Z)- configuration around the double bond could be confirmed by NOESY experiments, 
due to the correlations of H-3and H-4 with CH3 (Et) protons and those of H-6 with H-
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5’a, H-5’b. However, when the ribo-hexofuranos-5-ulose derivatives 7–8 were used as 
starting materials, the corresponding Wittig reaction provided mainly the formation of 
the (E)-adducts, the spontaneous cyclization of which gave the α,β-unsaturated-γ
lactones 13, 14 in 47% and 49% yield, respectively. The carbonyl groups of the 
butenolide moeties were confirmed by the signals at δ = 173.3 ppm in their 13C NMR 
spectra. In the 1H NMR spectra, olefinic protons give rise to signals t δ = 6.06 and δ = 
6.12 ppm, respectively, and as a consequence of lact nization, chemical shifts values for 
H-4 around δ = 4.85 ppm are much smaller than those observed for their acyclic (Z)-
aducts 11 and 12, which were isolated in only 12% and 11% yield, resp ctively. These 
results suggest that the stereoselectivity of the Wittig reaction to the formation of the 
(E)-isomers and consequently, to their spontaneous lactonization, depends on the 
orientation of the C-3 substituent. A possible steric hindrance due to C-3 configuration 
in xylo-hexofuranose derivatives with a bulky benzyloxy group or with allyl ether 
protection at position 3 may be envisaged. The 5-keto sugars 5, 6 were also used as 
precursors for a Reformatsky reaction with ethyl bromoacetate to afford the sugar-
linked β-hydroxy lactones 15, 16, formed in low yield (16 and 19 %, respectively), 
together with a complex mixture of degradation products. A salient feature of the 1H 
NMR spectra of 15 and 16 is the two separate sets of AB systems for the fiv-
membered ring lactone unit, assigned for H-5’a, H-5’b, and H-6a, H-6b, the latter 
shifted upfield. The presence of the signals at δ = 174.8 and δ = 175.1 ppm for the 
carbonyl groups of 15 and 16, respectively, in their 13C NMR spectra confirmed the 
lactone skeleton. Our proposed configuration for the stereogenic centre (C-5) of the 
formed lactone is based on the assumption that the nucleophilic attack of the 
Reformatsky reagent to 5-6 should occur from the less hindered face of the carbonyl 
group. 
 






Scheme 1. Reactions and conditions: a) Bu2SnO, toluene, reflux overnight, then NBS, 
CH2Cl2, 5 min; b) Ph3P=CHCO2Et, CHCl3, reflux; c) BrCH2CO2Et, Zn, THF, 50 ºC. 
 
1.2. Sugar-Fused Butenolides 
 
The synthesis of sugar-fused butenolides was accomplished following the approach 
previously reported by us, starting from readily available furanos-3-uloses [15]. Thus, 
Wittig reaction of 1,2;5,6-di-O-isopropylidene-α-D-ribo-hexofuranosid-3-ulose [9] with 
[(ethoxycarbonyl)methylene]triphenylphosphorane in refluxing chloroform afforded the 
known (E)- and (Z)-α,β-unsaturated esters 17a,b [18] (Scheme 2) in 12% yield and 68% 
yield, respectively. The (E)-adduct 17b was partially hydrolysed at the primary 
acetonide with aq. acetic acid (60%) to the corresponding diol 18b which was 
subsequently treated with pivaloyl chloride in py/CH2 l2 at 0 °C. The mono-pivaloyl 
derivative 19, selectively obtained in 81% yield, was submitted o hydrolysis with aq. 
acetic acid (70%) under reflux to provide the hexopyranose-fused butenolide 21 as a 
mixture of α,β-anomers in 58% yield. Noteworthy in this step, in which cleavage of the 
acetal, isomerization to the pyranose form, and accompanying intramolecular 
lactonization occur, is that the pivaloyl group unexp ctedly remains in the final product 
and no migration was observed. This feature could indeed be confirmed by the observed 
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HMBC correlation between H-6a,b and the carbonyl carbon of the pivaloyl group. On 
the other hand, conversion of the (Z)-α,β-unsaturated ester 17a to the butenolide 22 in 
one single step was initially performed by treatment with IR-120 H+ resin in refluxing 
methanol overnight in 90% yield. Manipulation of the reaction conditions using an ion-
exchange resin with stronger acidic properties, Dowex-50W, the reaction time was 
reduced to 2 h, whereas the corresponding methyl glycoside 24 was formed in 57% 
yield after overnight stirring. Dihydroxylation of the triacetate-derived butenolide 23
with osmium tetroxide gave the α/β-cis-diols 25a,b which could be separated by column 
chromatography and isolated in 33 and 23% yield, respectively. The (S)-configuration 
of the new stereocenter could be assigned by 2D-NOESY analysis of the β-anomer, 
with the detection of NOEs between H-3–H-5 and H-3–-1 (Scheme 2). These 
compounds constitute non-natural fused disaccharides which comprise a butyrolactone 




Scheme 2. Reactions and conditions: a) AcOH 60% aq., room temp.; b) PivCl, 
CH2Cl2/py, 0 ºC; c) AcOH 70% aq., reflux; d) Amberlite IR-120 H
+, MeOH, reflux 
overnight; e) DOWEX 50W H+, MeOH, reflux, 2 h; f) DOWEX 50W H+, MeOH, 
reflux, overnight; g) Ac2O, py, room temp., 5 min; h) OsO4, py, room temp. 




Similarly to the hexofuranose derivatives, the (E)-α,β-unsaturated ester 26b, a minor 
stereoisomer, prepared by Wittig olefination of 1,2-O-isopropylidene-5-O-tert-
butyldimethylsilyl-α-D-erythro-furanos-3-ulose [15], was subjected to an analogous 
acid hydrolysis, which was followed by acetylation (Scheme 3). The bicyclolactone 27, 
the structure of which comprises the butenolide moiety fused to a pentopyranose unit at 
















Scheme 3. Reactions and conditions: a) AcOH 70%, reflux; b) Ac2O, py, room temp., 5 
min. 
 
1.3. Synthesis of a Sugar Pyranoid α,β-Unsaturated δ-Lactone 
 
The hex-2-enono-1,5-lactone 29 was synthesized by reaction of 1,5-anhydro-3,4,6-tri-
O-acetyl-2-deoxy-D-arabino-hex-1-enitol (28) (non-preferred trivial name: 3,4,6-tri-O
acetyl-D-glucal) with N-bromosuccinimide (NBS) and water followed by oxidat on of 
the 2-bromolactol formed, according to the approach previously reported (Scheme 4) 
[16]. Two different chromium-based reagents were used at the oxidation step: 
pyridinium chlorochromate (PCC) as in the original procedure and pyridinium 
dichromate (PDC). In both cases, after reaction completion, the mixture was filtered 
through a short Florisil plug, which efficiently retained the green CrIII  species, 
facilitating the purification of the enonolactone 29 by column chromatography. 
However the first oxidizing methodology provided the best result in this one-pot, two-
step procedure, forming the target compound in 43% overall yield, when compared to 
31% yield using PDC. 
 





Scheme 4. Reactions and conditions: a) NBS, H2O/THF; b) PCC, molecular sieves (3 
Å), CH2Cl2, room temp.; c) PDC, Ac2O, CH2Cl2, room temp. 
 
2. Antibacterial and Antifungal Screening 
 
The antimicrobial activities of sugar-linked butenolides 13, 14, sugar-fused butenolides 
22, 23, 30 [15] and 31 [15] (Figure 2) and pyranoid α,β-unsaturated δ-lactone 29 were 
investigated using the paper disk diffusion method [19, 20]. These compounds were 
evaluated for their in vitro antibacterial activity against pathogens such as Bacillus 
cereus, Bacillus subtilis, Enterococcus faecalis, Escherichia coli, Pseudomonas 
aeruginosa and Staphylococcus aureus. Their antifungal activity was studied on a panel 
of plant pathogenic fungi which may also cause human allergies including Botrytis spp., 
Colletotrichum coffeanum, Fusarium culmorum, Pyricularia oryzae, and Rhizopus spp., 
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Table 1. Antimicrobial activities of compounds 13, 14, 22, 23, 29, 30 and 31 [a]. 
 
        Control [b] 
 13 14 22 23 29 30 31 I II 
Bacteria          
Bacillus cereus      <6.4 <6.4 <6.4 <6.4 11 <6.4 <6.4 24 38 
Bacillus subtilis     <6.4 9 10 16 <6.4 10 <6.4 30 46 
Enterococcus faecalis <6.4 <6.4 <6.4 <6.4 9 <6.4 <6.4 26 40 
Escherichia coli      <6.4 <6.4 <6.4 <6.4 9 <6.4 <6.4 28 42 
Pseudomonas 
aeruginosa  
<6.4 <6.4 <6.4 <6.4 9 <6.4 <6.4 <6.4 22 
Staphylococcus aureus <6.4 <6.4 <6.4 <6.4 9 <6.4 <6.4 27 40 
Fungi          
Botrytis spp. <6.4 <6.4 8 8 11 <6.4 <6.4 <6.4 20 
Candida albicans      <6.4 9 8 8 10 8 8 <6.4 16 
Colletotrichum 
coffeanum  
<6.4 <6.4 <6.4 <6.4 16 <6.4 <6.4 16 24 
Fusarium culmorum     <6.4 <6.4 <6.4 <6.4 <6.4 <6.4 <6.4 12 18 
Pyricularia oryzae        <6.4 <6.4 <6.4 <6.4 15 <6.4 <6.4 39 63 
Rhizopus spp. <6.4 <6.4 <6.4 <6.4 <6.4 <6.4 <6.4 11 18 
 
[a] Compounds’ solutions tested [300 µg compound in DMSO (15 µL)]. [b] Chloramphenicol 
was used for all bacteria and for C. albicans, whereas actidione was used for the filamentous 
fungi; a solution of the control (I-30 µg; II -300 µg) in DMSO (15 µL) was used. 
 
 The sugar-linked butenolide 14 exhibited weak effects toward Bacillus subtilis and 
Candida albicans while the 3-O-benzyl counterpart 13, showed virtually no activity at 
all. Regarding these results and in contrast with those of the analogues possessing an α-
methylene-γ-lactone moiety (compounds type B, Figure 1), particularly against Botrytis 
spp., Fusarium culmorum and Pyricularia oryzae, it is clear that the exocylic double 
bond in the lactone enhances the antifungal activity of these compounds. Given their 
structure, the exocyclic α,β-unsaturated γ-lactones have greater ability than the 
endocyclic derivatives to act as Michael acceptors, which is commonly related to the 
bioactivity of α,β-unsaturated carbonyl compounds [21]. Hence, the presence of the 
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quaternary hindered β-carbon in the lactone system of 13 and 14, considerably reduces 
their propensity to a nucleophilic attack, especially by sulfhydryl groups of enzymes. 
 
Sugar-fused butenolides 22, 23 and 30 displayed selective antibacterial activity against 
Bacillus subtilis; the highest activity was observed for the triacette derivative 23 with 
moderate effect. The antibacterial effect of compound 31 is practically negligible. With 
respect to the antifungal activity assays, all the butenolide derivatives showed similar 
and weak activities toward Candida albicans. Compounds 22 and 23 exhibited weak 
activities against Botrytis spp., although butenolides 30 and 31 were inactive against 
these pathogens. The results of the antimicrobial ev luation made on this series may be 
also related to the presence of the hindered double bond in the lactone conjugated 
system, which is now fused to a six-membered ring, making the system less susceptible 
to Michael addition. The pyranoid α,β-unsaturated δ-lactone 29 proved to be the most 
active compound of this set; 29 is active against all the bacteria tested, except for 
Bacillus subtilis, for which no effect was detected. Regarding the tested fungi, lactone 
29 shows weak activities against Botrytis spp and Candida albicans and moderate 
activity against Colletotrichum coffeanum (coffee berry disease) and Pyricularia oryzae 
(rice blast disease).  The greater Michael-accepting ability of 29 when compared to that 
of the previous lactones, due to the electron withdrawing influence of the bromine atom 
and absence of steric hindrance in the reactive double bond, may indeed contribute to 




A series of novel sugar-containing butenolides was synthesized. C-C-Linked sugar- 
butenolides were prepared by Wittig olefination of hexofuranos-5-uloses followed by 
intramolecular lactonization of the intermediate γ-hydroxy-α,β-unsaturated esters. The 
configuration at C-3 seems to be an important structu al factor to control the cyclization 
step. Hence, butenolides were prepared from ibo-furanos-5-ulose derivatives, while 
olefination of xylo-5-uloses did not afford the appropriate stereoisomer for spontaneous 
cyclization. The synthesis of sugar-fused butenolides was accomplished starting from 
pento- and hexofuranos-3-uloses, using our previously reported Wittig olefination-acid 
hydrolysis approach [15]. The biological evaluation performed on some of the new 
targets, suggested that the presence of a non-hindered double bond in the conjugated 




system is essential for the biological activity. The low molecular flexibility of the new 
sugar-linked and sugar-fused butenolides possessing a quaternary Cβ does not allow 
their expression as Michael acceptors and probably explains the weak antimicrobial 
effect observed for these compounds.  The pyranoid α,β-unsaturated δ-lactone 29, 
which is undoubtedly more susceptible to Michael addition, displays activity against 
most of the bacteria studied and moderate antifungal effect toward Colletotrichum 







General Methods: Melting points were determined with a Stuart Scientific SMP 3 
apparatus or a Leitz apparatus and are uncorrected. Optical rotations were measured on 
a Perkin–Elmer 343 polarimeter at 20 ºC. IR spectra were acquired using a Hitachi 270-
50. 1H and 13C NMR spectra were recorded with a BRUKER Avance 400 spectrometer 
or a Bruker AMX-400 spectrometer, both operating at 400.13 MHz for 1H or 100.62 
MHz for 13C. Chemical shifts are expressed in parts per million and are referenced 
either to TMS as internal standart for 1H or to the solvent signal (13C NMR, δ = 77.16 
for CDCl3). Assignments were made, when needed, with the help of DEPT, COSY, 
HMQC, NOESY and HMBC experiments. HRMS spectra were acquired in an Apex 
Ultra FTICR Mass Spectrometer equipped with an Apollo II Dual ESI/MALDI ion 
source, from Bruker Daltonics, and a 7T actively shielded magnet from Magnex 
Scientific. 
All reactions were followed by TLC on Merck 60 F254 silica gel aluminum plates. UV 
at 254 nm and a solution of 10% H2SO4 in EtOH were used for detection. Column 
chromatography (CC) was carried out on silica gel 60 G (0.040–0.063 mm, E. Merck). 
 
General Procedure for the Synthesis of Hexofuranos-5 uloses 5–8: Dibutyltin oxide 
(0.221g, 0.89 mmol) was added to a solution of 5,6-diol (0.81 mmol) in toluene (5.4 
mL). The mixture was stirred under reflux with a Dean-Stark aparatus. The solvent was 
evaporated and the residue was dried in vacuum for 30 min. The crude was then taken 
up in dry CHCl3 (5.4 mL) and NBS (0.158g, 0.89 mmol) was added. The resulting 
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solution was stirred for 5 min. The solvent was removed in vacuum, and the residue was 
purified by column chromatography (CC) on silica gel. 
 
3-O-Benzyl-1,2-O-isopropylidene-α-D-xylo-hexofuranos-5-ulose (5): 3-O-Benzyl-
1,2-O-isopropylidene-α-D-glucofuranose [22] (1, 0.250 g, 0.81 mmol) gave 5 (0.220 g, 
90 %) as a white solid, after purification by CC (EtOAc/ petroleum ether, 3:7). NMR 
spectroscopic data were in full agreement with those reported in the literature [17]. 
 
3-O-Allyl-1,2-O-isopropylidene-α-D-xylo-hexofuranos-5-ulose (6): 3-O-Allyl-1,2-O-
isopropylidene-α-D-glucofuranose [23] (2, 0.374 g, 1.44 mmol) gave 6 (0.291 g, 78%)  
as a colorless oil, after purification by CC (EtOAc/cyclohexane, 3:7). Rf = 0.28 
(EtOAc/petroleum ether, 1:9).[ ]20Dα = –70 (c = 1, in CH2Cl2). IR (neat): 1725 cm-1 
(C=O). 1H NMR (400 MHz, CDCl3): δ = 6.05 (d, 1H, H-1, J1,2 = 3.5 Hz), 5.80−5.71 (m, 
1H, CH allylic), 5.25–5.17 (m, 2H, =CH2 allylic), 4.80 (d, 1H, H-4, J3,4 = 3.5 Hz), 4.58 
(d, 1H, H-2), 4.57, 4.56, 4.52, 4.51 (dd, part A of ABX system, 1H, H-6a, J6a,6b = 20.2, 
JOH,H-6b = 4.3 Hz), 4.49, 4.48, 4.44, 4.43 (dd, part B of ABX system, 1H, H-6b, JOH, H-6b 
= 4.0 Hz), 4.25 (d, 1H, H-3), 4.07, 4.06, 4.05, 4.03 (dd, part A of ABX system, 1H, H-a, 
OCH2 allylic, Ja,b = 12.6, Ja,H-all = 5.3 Hz), 3.95, 3.94, 3.92, 3.91 (dd, part B of ABX 
system, 1H, H-b, OCH2 allylic, Jb,H-all = 5.8 Hz), 2.93 (t, 1H, OH), 1.48 (s, 3H, Me), 
1.34 (s, 3H, Me) ppm. 13C NMR (100 MHz, CDCl3): δ = 208.2 (CO), 133.3 (CH 
allylic), 118.2 (=CH2 allylic), 112.7 (Cq, isopr.), 106.0 (C-1), 84.6 (C-4), 83.2 (C-3), 
81.9 (C-2), 71.5 (OCH2 allylic) 68.3 (C-6), 27.0 (Me), 26.3 (Me) ppm. HRMS: calcd. 
for C12H18O6 [M + H]
+ 259.1176, found 259.1177; calcd. for [M + Na]+ 281.0996, found 
281.0996 ; calcd. for [M + K]+ 297.0735, found 297.0735. 
 
3-O-Benzyl-1,2-O-isopropylidene-α-D-ribo-hexofuranos-5-ulose (7): 3-O-Benzyl-1,2-
O-isopropylidene-α-D-allofuranose [24] (3, 1.00 g, 3.22 mmol) gave 7 (0.595 g, 60%) 
as a colorless syrup after purification by CC (EtOAc/petroleum ether, 2:3). Rf = 0.36 
(EtOAc/petroleum ether, 2:3).[ ]20Dα = +24 (c = 0.4, in CH2Cl2). IR (neat): 1730 cm-1 
(C=O). 1H NMR (400 MHz, CDCl3): δ = 7.37–7. 27 (m, 5H, Ph), 5.81 (d, 1H, H-1, J1,2
= 3.4 Hz), 4.76, 4.73 (d, part A of AB system, 1H, H-a, OCH2Ph, Ja,b = 11.9 Hz), 4.64–
4.59 (m, 2H, H-b, H-4), 4.57 (br. t, 1H, H-2), 4.45,  4.40, (d, part A of AB system, 1H, 
H-6a, J6a,6b = 20.2 Hz),  4.38, 4.33, (d, part B of AB system, 1H H-6b), 3.81 (dd, 1H, H-




3, J2,3 = 4.4, J3,4 = 9.3 Hz), 1.59 (s, 3H, Me),1.36 (s, 3H, Me) ppm. 
13C NMR (100 MHz, 
CDCl3): δ = 207.1 (CO), 136.7 (Cq, Ph), 128.6, 128.3, 128.1 (CH, Ph), 113.8 (Cq, 
isopr.), 104.6 (C-1), 80.4 (C-4), 79.4 (C-3), 77.6 (C-2), 72.5 (OCH2Ph), 66.5 (C-6), 26.9 
(Me), 26.5 (Me) ppm. HRMS: calcd. for C16H20O6 [M + H]
+ 309.1333, found 309.1335; 




isopropylidene-α-D-allofuranose [25] (4, 0.473 g, 1.82 mmol) gave 8 (0.289 g, 61%) as 
a colorless oil after purification by CC (EtOAc/cyclohexane, 3:7). Rf = 0.23 (EtOAc/ 
cyclohexane, 2:3).[ ]20Dα = +56 (c = 0.7, in CH2Cl2). IR (neat): 1725 cm-1 (C=O). 1H 
NMR (400 MHz, CDCl3): δ = 6.00−5.87 (m, 1H, CH allylic), 5.87 (d, 1H, H-1, J1,2 = 
3.6 Hz), 5.37-5.24 (m, 2H, =CH2 allylic), 4.67 (br. t, 1H, H-2), 4.60 (d, 1H, H-4, J3,4 = 
9.1 Hz), 4.51, 4.46 (d, part A of AB system, 1H, H-6a, J6a,6b = 20.5 Hz), 4.46, 4.41 (d, 
part B of AB system, 1H, H-6b),  4.23, 4.22, 4.20, 4.19 (dd, part A of ABX system, 1H, 
H-a, OCH2 allylic, Ja,b = 12.6, Ja,H-all = 5.8 Hz), 4.14, 4.13, 4.11, 4.10 (dd, part B of ABX 
system, 1H, H-b, OCH2 allylic, Jb,H-all = 5.8 Hz), 3.83 (dd, 1H, H-3, J2,3 =  4.0 Hz), 3.09 
(br. s, 1H, OH), 1.59 (s, 3H, Me), 1.38 (s, 3H, Me) ppm. 13C NMR (100 MHz, CDCl3): 
δ = 207.3 (CO), 133.8 (CH allylic), 119.1 (=CH2 allylic), 113.9 (Cq, isop), 104.6 (C-1), 
80.3 (C-4), 79.8 (C-3), 77.8 (C-2), 72.0 (OCH2 allylic), 66.7 (C-6), 26.9 (Me), 26.6 
(Me) ppm. HRMS: calcd. for [M + Na]+ 281.0996, found 281.0996.  
 
General Procedure for the Preparation of the α,β-Unsaturated Esters 9–12 and 
Butenolides 13–14: [(Ethoxycarbonyl)methylene]triphenylphosphorane (0.153 g, 0.44 
mmol) was added to a solution of hexofuranos-5-ulose  (0.26 mmol) in dry CHCl3 (2.1 
mL). The mixture was stirred under reflux until complete conversion, as indicated by 
TLC. The solvent was removed and the residue was purified by column 
chromatography (CC) on silica gel. 
 
Ethyl (5Z)-3-O-Benzyl-5,6-dideoxy-5-C-hydroxymethyl-1,2-O-isopropylidene-α-D-
xylo-5-enoheptofuranuronate (9): Wittig olefination of 3-O-benzyl-1,2-O-
isopropylidene-α-D-xylo-hexofuranos-5-ulose (5, 0.080 g, 0.26 mmol) was completed 
within 4 h to give 9 (0.073 g, 75%) as a colorless syrup after purification by CC 
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(EtOAc/petroleum ether, 1:4). Rf = 0.47 (EtOAc/petroleum ether, 1:4). [ ]
20
Dα = − 91 (c = 
0.6, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 7.32−7.21 (m, 5H, Ph), 6.02 (s, 1H, 
H-6), 6.00 (d, 1H, H-1, J1,2 = 3.6 Hz), 5.83 (s, 1H, H-4), 4.65–4.59 (m, 2H, H-a, 
OCH2Ph, H-2, Ja,b = 11.6 Hz), 4.45-4.40 (m, 2H, H-b, OCH2Ph, H-3), 4.35 (br. s, 2H, 
H-5’a, H-5’b), 4.08 (q, 2H, CH2CH3, J = 7.2 Hz), 1.52 (s, 3H, Me), 1.34 (s, 3H), 1,25 (t, 
3H, CH2CH3) ppm. 
13C NMR (100 MHz, CDCl3): δ = 165.0 (CO), 156 (C-5), 137.1 
(Cq, Ph), 128.4, 128.0, 127.9, (CH, Ph), 117.0 (C-6), 112.1 (Cq, isopr.), 104.9 (C-1), 
83.2 (C-3), 82.5 (C-2), 80.0 (C-4), 72,4 (OCH2Ph), 64.5 (C-5’), 60.2 (CH2CH3), 26.9 
(Me), 26.4 (Me), 14.2 (CH2CH3) ppm. HRMS: calcd. for C20H26O7 [M + H]
+ 379.1751, 
found 379.1754; calcd. for [M + Na]+ 401.1571, found 401.1574; calcd. for [M + K]+ 
417.1310, found 417.1314. 
 
Ethyl (5Z)-3-O-Allyl-5,6-dideoxy-5-C-hydroxymethyl-1,2-O-isopropylidene-α-D- 
xylo-5-enoheptofuranuronate (10): Wittig olefination of 3-O-allyl-1,2-O-
isopropylidene-α-D-xylo-hexofuranos-5-ulose  (6, 0.184 g, 0.71 mmol) was completed 
within 4 h and gave 10 (0.139 g, 60%) as a colorless syrup, after purification by CC 
(EtOAc/cyclohexane, 1:4). Rf = 0.28 (EtOAc/ petroleum ether, 1:4).[ ]20Dα = –31 (c = 0.4, 
in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 6.08 (br. s, 1H, H-6), 5.99 (d, 1H, H-1, 
J1,2 = 3.8 Hz), 5.84 (s, 1H, H-4),  5.82–5.72 (m, 1H, CH allylic), 5.26-5.13 (m, 2H, 
=CH2 allylic), 4.57 (d, 1H, H-2), 4.38 (d, 1H, H-3, J3,4 = 3.3 Hz), 4.34 (br. d, 2H, H-5’a, 
H-5’b), 4.19 (q, 2H, CH2CH3, J = 7.1 Hz), 4.08, 4.06, 4.05, 4.03 (dd, part A of ABX 
system, 1H, H-a, OCH2 allylic, Ja,b = 12.9, Ja,H-all = 5.3 Hz), 3.95, 3.94, 3.92, 3.91 (dd, 
part B of ABX system, 1H, H-b, OCH2 allylic,  Jb,H-all = 5.8 Hz),  2.54 (t, 1H, OH, J = 
5.8 Hz), 1.53 (s, 3H, Me), 1.34 (s, 3H, Me), 1,29 (t, 3H,  CH2CH3) ppm. 
13C NMR (100 
MHz, CDCl3): δ = 165.9 (CO), 156.3 (C-5), 133.8 (CH allylic), 117.9 (=CH2 allylic),  
117.1 (C-6), 112.1 (Cq, isopr.), 105.0 (C-1), 83.6 (C-3), 82.9 (C-2), 79.9 (C-4), 71.5 
(OCH2 allylic ) 64.5 (C-5’), 60.4 (CH2CH3), 27.0 (Me), 26.5 (Me), 14.4 (CH2CH3) ppm. 
HRMS: calcd. for C16H24O7 [M + H]
+ 329.1595, found 329.1593; calcd. for [M + Na]+ 
351.1414, found 351.1410; calcd. for[M + K]+ 367.1154, found 367.1152. 
 
Ethyl (5Z)-3-O-Benzyl-5,6-dideoxy-5-C-hydroxymethyl-1,2-O-isopropylidene-α-D-
ribo-5-enoheptofuranuronate (11) and 3-O-Benzyl-5,6-dideoxy-1,2-O-
isopropylidene-α-D-ribo-5-enoheptofuranurono-7,5’-lactone (13): Wittig olefination 




of  3-O-benzyl-1,2-O-isopropylidene-α-D-ribo-hexofuranos-5-ulose  (7, 0.187 g, 0.61 
mmol) was completed within 1 h 30 min and gave 11 (0.027g, 12%) as a colorless syrup 
and 13 (0.096 g, 47%) as a white solid,  after purification by CC (EtOAc/petroleum 
ether, 1:4).  
Data for 11: Rf = 0.45 (EtOAc/petroleum ether, 2:3).[ ]20Dα = + 6 (c = 0.9, in CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ = 7.32–7.27 (m, 5H, Ph), 6.06 (s, 1H, H-6), 5.85 (d, 1H, H-
4, J3,4 = 9.9 Hz), 5.74 (d, 1H, H-1, J1,2 = 3.3 Hz), 4.70, 4.66 (d, part A of AB system, 
1H, H-a, OCH2Ph, Ja,b = 11.9 Hz), 4.58 (t, 1H, H-2), 4.56, 4.53 (d, part B of AB system, 
1H, H-b, OCH2Ph), 4.28–4.09 (m, 3H, H-5’a, CH2CH3), 4.03, 4.01, 3.99, 3.97 (dd, part 
B of AB system, 1H, H-5’b, J5a,5b= 14.9, J5b, OH = 7.1 Hz), 3.81 (dd, 1H, H-3, J2,3 = 3.8 
Hz), 1.65 (s, 3H, Me), 1.37 (s, 3H, Me), 1,26 (t, 3H, CH2CH3, J = 7.1 Hz) ppm. 
13C 
NMR (100 MHz, CDCl3): δ = 165.9 (CO), 152.2 (C-5), 137.6 (Cq, Ph), 128.5,  128.1, 
128.0 (CH, Ph), 120.0 (C-6), 113.6 (Cq, isopr.), 104.2 (C-1), 81.0 (C-3), 77.8 (C-2), 
75.0 (C-4), 72,3 (OCH2Ph), 62.5 (C-5’), 60.4 (CH2CH3), 27.0 (Me), 26.9 (Me), 14.3 
(CH2CH3) ppm. HRMS: calcd. for C20H26O7 [M + H]
+ 379.1751, found 379.1757; 
calcd. for [M + Na]+ 401.1571, found 401.1577; calcd. for [M + K]+ 417.1310, found 
417.1319.  
Data for 13: Rf = 0.21 (EtOAc/petroleum ether, 1:3). m.p. 158–159 ºC. [ ]20Dα = + 35 (c = 
0.4 in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 7.41–7.30 (m, 5H, Ph), 6.06 (br. d, 
1H, H-6), 5.83 (d, 1H, H-1, J1,2 = 3.6 Hz), 4.87 (d, 1H, H-4, J3,4 = 9.2 Hz), 4.84, 4.80 
(dd, part A of ABX system, 1H, H-5’a, J5’a,5’b = 18.2, J5’a, 6 = 1.6 Hz), 4.81, 4.78 (d, part 
A of AB system, 1H, H-a, OCH2Ph, Ja,b = 11.6 Hz), 4.72, 4.68 (d, part B of ABX 
system, 1H, H-5’b), 4.66 (t, 1H, H-2), 4.56, 4.53 (d, part B of AB system, 1H, H-b, 
OCH2Ph), 3.65 (dd, 1H, H-3, J2,3 = 4.1 Hz), 1.62 (s, 3H, Me), 1.39 (s, 3H, Me) ppm. 
13C
NMR (100 MHz, CDCl3): δ =  173.3 (C-7), 166.2 (C-5), 136.5 (Cq, Ph), 128.9,  128.7, 
128.4 (CH, Ph), 116.1 (C-6), 113.8 (Cq, isopr.), 104.5 (C-1), 81.5 (C-3), 76.9 (C-2), 
74.6 (C-4), 72.6 (OCH2Ph ), 70.9 (C-5’), 26.8 (Me), 26.5 (Me) ppm. HRMS: calcd. for 
C18H20O6 [M + H]
+ 333.1333, found 333.1333. 
 
Ethyl (5Z)-3-O-Allyl-5,6-dideoxy-5-C-hydroxymethyl-1,2-O-isopropylidene-α-D-
ribo-5-enoheptofuranuronate (12) and 3-O-Allyl-5,6-dideoxy-1,2-O-isopropylidene-
α-D-ribo-5-enoheptofuranurono-7,5’-lactone (14): Wittig olefination of 3-O-allyl-1,2- 
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O-isopropylidene-α-D-ribo-hexofuranos-5-ulose (8, 0.163 g, 0.63 mmol) was completed 
within 2 h and gave 12 (0.023 g, 11%) as a colorless syrup and 14 (0.087g, 49%) as a 
white solid, after purification by CC (EtOAc/cyclohexane, 1:4). Data for 12: Rf = 0.34 
(EtOAc/ petroleum ether, 2:3). [ ]
20
Dα = +3 (c = 0.3, in CH2Cl2). 
1H NMR (400 MHz, 
CDCl3): δ =  6.10 (s, 1H, H-6), 5.92–5.81 (m, 1H, CH allylic), 5.80–5.74 (m, 2H, H-1, 
H-4), 5.30–5.17 (m, 2H, =CH2 allylic), 4.64 (t, 1H, H-2, J1,2 = J2,3 = 4.8 Hz), 4.35, 4.34, 
4.31, 4.30 (dd, part A of ABX system, 1H, H-5’a, J5’a,5’b = 15.2, J5’a,OH  =  3.8 Hz), 4.22–
4.10 (m, 3H, H-5’b, CH2CH3, J = 7.1), 4.16, 4.14, 4.12, 4.11 (dd, part A of ABX 
system, 1H, H-a, OCH2 allylic, Ja,b = 13.4, Ja,H-all = 6.1 Hz), 4.06, 4.04, 4.02, 4.01 (dd, 
part B of ABX system, 1H,  H-b, OCH2 allylic, Jb,H-all = 5.6), 3.81 (dd, 1H, H-3, J3,4 = 
9.1 Hz), 3.36 (t, 1H, OH), 1.64 (s, 3H, Me), 1.37 (s, 3H, Me), 1,29 (t, 3H, CH2CH3) 
ppm. 13C NMR (100 MHz, CDCl3): δ = 165.9 (CO), 151.4 (C-5), 134.4 (CH allylic), 
120.3 (C-6), 118.1 (=CH2 allylic), 113.7 (Cq, isopr.), 104.1 (C-1), 81.4 (C-3), 77.9 (C-
2), 75.2 (C-4), 71.8 (OCH2 allylic), 63.1 (C-5’), 60.5 (CH2CH3), 27.0 (Me), 26.8 (Me), 
14.3 (CH2CH3) ppm. HRMS: calcd. for C16H24O7 [M + H]
+ 329.1595, found 329.1610; 
calcd. for [M + Na]+ 351.1414, found 351.1403.  
Data for 14: Rf = 0.18 (EtOAc/petroleum ether, 1:3); mp: 64–66 ºC. [ ]20Dα = +65 (c = 
1.2, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 6.12 (br. s, 1H, H-6), 5.98–5.86 (m, 
1H, CH allylic), 5.85 (d, 1H, H-1, J1,2 = 3.5 Hz), 5.37–5.25 (m, 2H, =CH2 allylic), 4.94, 
4.89 (dd, part A of ABX system, 1H, H-5’a, J5’a,5’b = 18.2 Hz, J5’a, 6 = 1.8 Hz), 4.87–4.79 
(m, 2H, H-4, H-5’b), 4.70 (t, 1H, H-2), 4.27, 4.26, 4.24, 4.22 (dd, part A of ABX 
system, 1H, H-a, OCH2 allylic, Ja,b = 12.4, Ja,H-all = 5.6 Hz), 4.09, 4.07, 4.06, 4.04 (dd, 
part B of ABX system, 1H, H-b, OCH2 allylic, Jb,H-all = 6.3 Hz), 3.66 (dd, 1H, H-3, J2,3 = 
4.1, J3,4 = 9.4 Hz), 1.61 (s, 3H, Me), 1.39 (s, 3H, Me) ppm. 
13C NMR (100 MHz, 
CDCl3): δ =  173.3 (C-7), 166.4 (C-5), 133.6 (CH allylic), 119.3 (=CH2 allylic), 115.8 
(C-6), 113.8 (Cq, isopr.), 104.5 (C-1), 82.0 (C-3), 77.0 (C-2), 74.5 (C-4), 71.9 (OCH2 
allylic), 71.0 (C-5’), 26.8 (Me), 26.5 (Me) ppm. HRMS: calcd. for C14H18O6 [M + H]
+ 
283.1176, found 283.1181. 
 
General Procedure for the Synthesis of β-Hydroxy  Lactones 15–16: To a mixture of 
previously activated granulated zinc 20 mesh (78 mg, 1.2 mmol) and hexofuranos-5-
ulose  (0.8 mmol) in anhydrous THF (0.6 mL) was added a solution of ethyl 
bromoacetate (0.13 mL, 1.1 mmol) in THF (0.7 mL) under argon. The mixture was 




stirred at 50 ºC for 1 h 30 min. After cooling to room temp., a 10% HCl solution (8 mL, 
cooled at 0 ºC) was added. The mixture was extracted with CH2Cl2 (3×4 mL), the 
organic phase was neutralized with a diluted NaHCO3 solution, washed with water and 
dried with anhydrous MgSO4. The solvent was evaporated and the residue was purified 
by column chromatography (CC) on silica gel. 
 
3-O-Benzyl-6-deoxy-5-C-hydroxymethyl-1,2-O-isopropylidene-α-L-ido-
heptofuranurono-7,5’-lactone (15): 3-O-Benzyl-1,2-O-isopropylidene-α-D-xylo- 
hexofuranos-5-ulose (5, 0.25 g, 0. 8 mmol) gave 15 (0.041 g, 15%) as a colorless oil, 
after purification by CC (EtOAc/petroleum, 3:7). Rf = 0.44 (EtOAc/petroleum ether, 
2:3). [ ]20Dα = –51 (c = 0.9, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ =  7.42–7.31 (m, 
5H, Ph), 6.01 (s, 1H, H-1, J1,2 = 3.8 Hz), 4.76, 4.73 (d, part A of AB system, 1H, H-a, 
OCH2Ph, Ja,b = 11.7 Hz), 4.67 (d, 1H, H-2), 4.49, 4.46 (d, part B of AB system, 1H, H-
b, OCH2Ph), 4.42, 4.39 (d, part A of AB system, 1H, H-5’a, CH2OCO, J5’a,5’b = 10.4 
Hz), 4.25, 4.22 (d, part B of AB system, 1H, H-5’b, CH2OCO), 4.21 (d, 1H, H-3), 4.14 
(d, 1H, H-4,  J3,4 = 3.8 Hz), 2.68, 2.64 (d, part A of AB system, 1H, H-6a, J6a,6b = 17.5 
Hz), 2.46, 2.42 (d, part B of AB system, 1H, H-6b), 1.49 (s, 3H, Me), 1.34 (s, 3H, Me) 
ppm. 13C NMR (100 MHz, CDCl3): δ = 174.8 (CO), 135.8 (Cq, Ph), 129.1, 128.9, 128.5 
(CH, Ph), 112.2 (Cq, isopr.), 105.2 (C-1), 82.3 (C-3), 81.8 (C-2), 81.0 (C-4), 76.9 (C-
5’), 76.6 (C-5), 72.2 (OCH2Ph), 40.6 (C-6), 26.8 (Me), 26.2 (Me) ppm. HRMS: calcd. 
for C18H22O7 [M + H]
+ 351.1438, found 351.1439. 
 
3-O-Allyl-6-deoxy-5-C-hydroxymethyl-1,2-O-isopropylidene-α-L-ido-
heptofuranurono-7,5’-lactone (16): 3-O-Allyl-1,2-O-isopropylidene-α-D-xylo- 
hexofuranos-5-ulose (6, 0.22 g, 0. 86 mmol) gave 16 (0.048 g, 19%) as a colorless oil, 
after purification by CC (EtOAc/cyclohexane, 1:4). Rf = 0.22 (EtOAc/petroleum ether, 
1:4). [ ]20Dα = –21 (c = 1.1, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ =   6.00 (s, 1H, H-
1, J1,2 = 3.8 Hz), 5.94–5.82 (m, 1H, CH allylic), 5.38–5.28 (m, 2H, =CH2 allylic), 4.60 
(d, 1H, H-2), 4.48, 4.46 (d, part A of AB system, 1H, H-5’a, CH2OCO, J5’a,5’b = 10.4 
Hz), 4.32, 4.29 (d, part B of AB system, 1H, H-5’b, CH2OCO), 4.26 (d, 1H, H-3, J3,4 = 
3.5 Hz), 4.24, 4.22, 4.21, 4.19 (dd, part A of ABX system, 1H, H-a, OCH2 allylic, Ja,b = 
12.6, Ja,H-all = 5.3 Hz), 4.11 (d, 1H, H-4), 4.03, 4.01, 4.00, 3.98 (dd, part B of ABX 
system, 1H, H-b, OCH2 allylic, Jb,H-all = 6.6 Hz), 2.85, 2.81 (d, part A of AB system, 1H, 
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H-6a, J6a,6b = 17.4 Hz), 2.61, 2.57 (d, part B of AB system, 1H, H-6b), 1.50 (s, 3H, Me), 
1.34 (s, 3H, Me) ppm. 13C NMR (100 MHz, CDCl3): δ = 175.1 (CO), 132.7 (CH 
allylic), 119.8 (=CH2 allylic), 112.3 (Cq, isopr.), 105.2 (C-1), 82.7 (C-4), 81.9 (C-2), 
81.2 (C-3), 77.2 (C-5’), 76.8 (C-5), 71.2 (OCH2 allylic), 40.8 (C-6), 26.9 (Me), 26.3 
(Me) ppm. HRMS: calcd. for C14H20O7 [M + H]
+ 301.1282, found 301.1287. 
 
3-Deoxy-3-C-[(E)-(ethoxycarbonyl)methylene]-1,2-O-isopropylidene-6-O-pivaloyl-
α-D-ribo-hexofuranose (19) and 3-Deoxy-3-C-[(E)-(ethoxycarbonyl)methylene]-1,2-
O-isopropylidene-5,6-di-O-pivaloyl-α-D-ribo-hexofuranose (20): To a solution of 3-
deoxy-3-C-[(E)-(ethoxycarbonyl)methylene]-1,2-O isopropylidene-α-D-ribo-
hexofuranose (18b, 66 mg, 0.23 mmol) in dry pyridine (1 mL) at 0 ºC was added a 
solution of pivaloyl chloride (0.25 mmol, 0.03 mL) in dry CH2Cl2 (0.4 mL), under N2. 
The whole solution was kept whilst stirring at 0 ºCfor 1 h. The solvent was then 
removed under vacuum. The residue was poured into wa er (10 mL) and extracted with 
CH2Cl2 (3 × 5 mL). Combined organic layers were washed with a sat. aq. NaHCO3 
solution, water and brine, and dried over MgSO4. After filtration and evaporation of the 
solvent, the residue was purified by CC (EtOAc/petrol um ether, 1:4) to afford the 
mono-O-pivaloyl derivative 19 (69 mg, 81%) and the di-O pivaloyl derivative 20 (6.5 
mg, 7%) derivatives as colorless oils.  
Data for 19: Rf = 0.16 (EtOAc/petroleum ether, 1:4). [ ]20Dα = +189 (c = 1.0, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 6.25 (t, 1H, H-3’, J2,3’ ~ J3’,4 ~ 1.9 Hz), 5.91 (d, 1H, H-
1, J1,2 = 4.8 Hz), 5.66 (dt, 1H, H-4, J2,4 ~ J3’,4, J4,5 = 5.9 Hz), 5.16 (dt, 1H, H-2), 4.27-
4.16 (m, 3H, H-6a, CH2CH3, J5,6a = 3.6, J6a,6b = 11.7 Hz), 4.06 (dd, 1H, H-6b, J5,6b = 6.1 
Hz), 3.89 (ddd, H-5), 1.43 (s, 3H, Me), 1.40 (s, 3H, Me), 1.31 (t, 3H, CH2CH3, J = 7.1 
hz), 1.22 (br. s, 9H, Me, Piv) ppm. 13C NMR (100 MHz, CDCl3): δ = 178.8 (CO, Piv), 
166.6 (CO), 158.0 (C-3), 118.9 (C-3’), 113.9 (Cq, isopr.), 103.7 (C-1), 81.8 (C-2), 80.7 
(C-4), 73.0 (C-5), 65.3 (C-6), 61.3 (CH2CH3), 39.0 (Cq, Piv), 28.0 (Me, isopr.), 27.9 
(Me, isopr.), 27.3 (Me, Piv), 14.2 (CH2CH3) ppm. HRMS: calcd. for C18H28O8 [M + 
Na]+ 395.1677, found 395.1687.  
Data for 20: Rf = 0.61 (EtOAc/petroleum ether, 2:3). [ ]20Dα = +18 (c = 0.3, in CH2Cl2). 
1H NMR (400 MHz, CDCl3):  δ =    6.19 (t, 1H, H-3’, J2,3’ ~ J3’,4 ~ 1.9), 5.89 (d, 1H, H-
1, J1,2 = 4.7 Hz), 5.79 (dt, 1H, H-4, J2,4 ~ J3’,4, J4,5 = 4.1 Hz), 5.25 (ddd, H-5), 5.12 (dt, 
1H, H-2), 4.29-4.17 (m, 3H, H-6a, CH2CH3, J5,6a = 3.8, J6a,6b = 11.7 Hz), 4.10, 4.08, 




4.07, 4.05 (dd, part B of ABX system, 1H, H-6b, J5,6b = 7.6 Hz), 1.42 (s, 3H, Me), 1.38 
(s, 3H, Me), 1.29 (t, 3H, CH2CH3, J = 7.1 Hz), 1.24 (br. s, 9H, Me, Piv), 1.18 (br. s, 9H, 
Me, Piv) ppm. 13C NMR (100 MHz, CDCl3): δ =  177.6 (CO, Piv), 165.0 (CO), 156.4 
(C-3), 119.3 (C-3’), 113.8 (Cq, isopr.), 103.9 (C-1), 81.6 (C-2), 79.5 (C-4), 72.9 (C-5), 
62.8 (C-6), 61.0 (CH2CH3), 38.9 (Cq, Piv), 38.6 (Cq, Piv), 28.0 (Me, isop), 27.9 (Me, 
isop), 27.3 (Me, Piv), 27.2 (Me, Piv), 14.2 (CH2CH3) ppm. HRMS: calcd. for C23H36O9 
[M + H]+ 457.2432, found 457.2446; calcd. for [M + Na]+ 479.2252, found 479.2267. 
 
3-C-(Carboxymethylene)-3-deoxy-6-O-pivaloyl-α-D-ribo-hexopyranose-3’,4-lactone 
(21): A solution of 3-deoxy-3-C-[(E)-(ethoxycarbonyl)methylene]-1,2-O
isopropylidene-6-O-pivaloyl-α-D-ribo-hexofuranose (19, 62 mg, 0.17 mmol) in aq. 
AcOH (70%, 1.46 mL) was stirred under reflux for 1 h 45 min.  The solvent was 
coevaporated with toluene (3×) and the crude product was purified by CC 
(EtOAc/petroleum ether, 3:2) to afford 21 (28 mg, 58 %) as a colorless oil. Rf = 0.21 
(EtOAc/petroleum ether, 4:1). [ ]20Dα = –5 (c = 0.8, in CH2Cl2). 1H NMR (400 MHz, 
CDCl3, α anomer): δ = 6.15 (br. s, H-3’), 5.50 (d, H-1, J1,2 = 3.8 Hz), 4.76 (d, H-4, J4,5 = 
9.2 Hz), 4.59 (br. d, H-2), 4.54, 4.53, 4.51, 4.50 (dd, part A of ABX system, H-6a, J5,6a 
= 2.5, J6a,6b = 12.2 Hz), 4.30, 4.29, 4.27, 4.26 (dd, part B of ABX system, H-6b, J5,6b = 
4.6 Hz), 3.93 (ddd, H-5), 1.22 (s, Me, Piv.) ppm. 13C NMR (100 MHz, CDCl3, α 
anomer): δ = 178.7 (CO, Piv), 172.4 (CO, lact.), 168.8 (C-3), 114.8 (C-3’), 92.9 (C-1), 
76.9 (C-4), 71.4 (C-5), 69.1 (C-2), (C-6), 39.2 (Cq, Piv), 27.3 (Me, Piv.) ppm. HRMS: 
calcd. for C13H18O7 [M + H]
+ 287.1125, found 287.1134; calcd. for [M + Na]+ 
309.0945, found 309.0953. 
 
3-C-(Carboxymethylene)-3-deoxy-D-ribo-hexopyranose-3’,2-lactone (22):  
Method A. To a solution of 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2:5,6-di-
O-isopropylidene-α-D-ribo-hexofuranose [18] (17a, 0.11 g, 0.33 mmol) in MeOH (1.8 
mL) was added Amberlite IR-120 H+ resin (35 mg). The mixture was moderately stirred 
under reflux overnight. After filtration of the resin and evaporation of the solvent, the 
crude product was purified by CC using AcOEt as eluent to afford 22 (60 mg, 90%) as a 
white solid.  
Method B: Alternatively, an analogous procedure using Dowex-50W (H+ form) resin 
led the reaction to completion within 2 h. After filtration of the resin and evaporation of 
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the solvent, compound 22 was crystallized from AcOEt (yield:  57%).  Rf = 0.22 
(EtOAc). m.p. 168–174 ºC. [ ]20Dα = +192 (c 0.9, in MeOH). 1H NMR (400 MHz, 
[D6]DMSO): δ = 7.56 (d, OH-1β, J = 5.6 Hz), 7.04 (d, OH-1α, J = 4.6 Hz), 6.00 (d, OH-
4β, J = 5.8 Hz), 5.95–5.87 (m, H-3’α, H-3’β, OH-4α), 5.47 (t, H-1α), 4.96 (d, H-2α, 
J1,2(α) = 4.1 Hz), 4.89 (t, OH-6β), 4.79 (t, OH-6α), 4.65 (d, H-2β, J1,2(β) = 7.1), 4.37–4.30 
(m, H-1β, H-4α, H-4β), 3.79–3.52 (m, H-6aα, H-6aβ, H-6bα, H-6bβ, H-5α, J5,6a (β) = 5.3, 
J6a,6b (β) = 12.1, J5,6a(α) = 5.3, J6a,6b (α) = 11.6 Hz), 3.12 (ddd, H-5β) ppm. 
13C NMR (100 
MHz, [D6]DMSO) δ = 172.9 (CO), 171.1 (C-3α), 111.7 (C-3’α, C-3’β), 98.7 (C-1β), 
90.4 (C-1α), 82.0 (C-2β), 80.2 (C-5β), 78.6 (C-2α), 74.4 (C-5α), 66.1 (C-4β), 65.7 (C-
4α), 60.1 (C-6α, C-6β) ppm. HRMS: calcd. for C8H10O6 [M + H]
+ 203.0550, found 
203.0550; calcd. for [M + Na]+ 225.0370, found 225.0369; calcd. for [M + K]+ 
241.0109, found 241.0109. C8H10O6 (202.16): C 47.53, H 4.99; found C 47.60, H, 4.90. 
 
1,4,6-Tri-O-acetyl-3-C-(carboxymethylene)-3-deoxy-α,β-D-ribo-hexopyranose-3’,2-
lactone (23): To a solution of 3-C-(carboxymethylene)-3-deoxy-D-ribo-hexopyranose-
3’,2-lactone (68 mg, 0.34 mmol) in py (2 mL), was added Ac2O (1 mL) and the mixture 
was stirred at room temp. for 5 min. After coevaporti n with toluene (3×), the crude 
product was purified by CC on silica gel (EtOAc/petroleum ether, 1:1) to afford 23 (94 
mg, 85%) as a colorless oil. Rf = 0.32 (EtOAc/petroleum ether, 1:1). [ ]20Dα =  +178 (c = 
1.2, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 6.60 (d, H-1α, J1,2 = 4.6 Hz), 6.02–
5.96 (m, H-3’α, H-3’β), 5.71 (dd, H-4α, J3’,4(α) = 1.5, J4,5(α) = 9.6 Hz), 5.66 (dd, H-4β, 
J3’,4(β) = 1.5, J4,5(β) = 9.6 Hz), 5.40 (d, H-1β, J1,2(β) = 7.6 Hz), 5.10 (dd, H-2α, J2,3’(α) = 1.5 
Hz), 4.90 (dd, H-2β, J2,3’(β) = 1.5), 4.40–4.32 (m, H-6aα, H-6aβ) 4.24 (t, H-6bα, H-6bβ), 
4.00 (ddd, H-5α), 3.77 (ddd, H-5β), 2.22 (s, Me, Ac, α, Me, Ac, β), 2.21 (s, Me, Ac, β), 
2.11 (s,  Me, Ac, α, Me, Ac, β), 2.09 (s, Me, Ac, α) ppm. 13C NMR (100 MHz CDCl3): 
δ = 171.0 (CO, Ac, α), 170.6 (CO, Ac, β, CO, lact., α, CO, lact., β), 169.1 (CO, Ac, β), 
169.1 (CO, Ac, α), 168.7 (CO, Ac, β), 168.2 (CO, Ac, α),  163.2 (C-3β),  161.6 (C-3α), 
115.3 (C-3’α) 114.7 (C-3’β), 95.4 (C-1β), 88.8 (C-1α), 78.9 (C-2β), 76.4 (C-2α), 76.2 
(C-5β), 71.9 (C-5α), 66.4 (C-4β), 66.0 (C-4α), 61.4 (C-6α), 61.3 (C-6β), 20.8,  20.7, 
20.7, 20.5 (Me, Ac) ppm. HRMS: calcd. for C14H16O9 [M + H]
+ 329.0867, found 
329.0864; calcd. for [M + Na]+ 351.0687, found 351.0690; calcd. for [M + K]+ 
367.0426, found 367.0417. 
 





(24): To a solution of 3-deoxy-3-C-[(Z)-(ethoxycarbonyl)methylene]-1,2:5,6-di-O- 
isopropylidene-α-D-ribo-hexofuranose [18] (0.14 g, 0.43 mmol) in MeOH (2 mL) was 
added  Dowex-50W (H+ form) resin (42 mg). The mixture was stirred under r flux 
overnight.  After filtration of the resin and evaporation of the solvent, the crude product 
was purified by CC on silica-gel (EtOAc/petroleum ether, 7:3) to afford 24 (52 mg, 
57%) as a colorless oil. Rf = 0.15 (EtOAc/petroleum ether, 7:3). [ ]20Dα = +14 (c 0.5, in 
CH2Cl2). 
1H NMR (400 MHz, [D6]acetone): δ = 5.98 (t, H-3’β), 5.92 (t, H-3’α, J = 1.5 
Hz), 5.24 (d, OH-4β, J = 6.3 Hz), 5.18–5.12 (m, H-1α, OH-4α), 4.97 (dd, 1H, H-2α, 
J1,2(α) = 4.5 Hz), 4.66–4.57 (m, H-4α, H-4β, H-2β, J1,2(β) = 7.3 Hz), 4.24 (d, H-1β), 3.96-
3.77 (m, H-6aα, H-6aβ, H-6bα,H-6bβ), 3.54–3.48 (m, Meβ, H-5α), 3.41 (s, Meα), 3.29 
(ddd, H-5β) ppm. 13C NMR (100 MHz, [D6]acetone): δ = 173.1 (COα), 172.6 (COβ), 
171.9 (C-3β), 170.3 (C-3α), 113.3 (C-3’β), 112.8 (C-3’α), 106.3 (C-1β), 98.5 (C-1α), 
81.5 (C-2β), 79.0 (C-2α), 75.8 (C-5α), 67.6 (C-4β), 67.0 (C-4α), 61.9 (C-6β), 61.8 (C-
6α), 56.9 (Meβ), 55.3 (Meα) ppm. HRMS: calcd. for C9H12O6 [M + H]
+ 217.0707, 
found 217.0700; calcd. for [M + Na]+ 239.0526, found 239.0518. 
 
1,4,6-Tri-O-acetyl-3-C-[(R)-(carboxy)hydroxymethyl]-α-D-glucopyranose-3’,2-
lactone (25a) and 1,4,6-Tri-O-acetyl-3-C-[(R)-(carboxy)hydroxymethyl]-β-D-
glucopyranose-3’,2-lactone (25b): To a solution of 1,4,6-tri-O-acetyl-3-C-
(carboxymethylene)-3-deoxy-α,β-D-ribo-hexopyranose-3’,2-lactone (94 mg, 0.29 
mmol) in pyridine (2.3 mL), was added osmium tetroxide (97 mg, 0.38 mmol) and the 
mixture was stirred at room temp. for 15 min. Saturated NaHSO3 solution (9 mL) and 
pyridine (3 mL) were added and the whole mixture was kept on stirring within 5 min to 
cleave the osmium complex. After extraction with CHl3 (3×15 mL), the combined 
organic layers were washed with water and dried with Na2SO4. After filtration and 
evaporation of the solvent, the residue was purified by CC (EtOAc/petroleum ether, 2:3) 
to afford the α-anomer 25a (33 mg, 33%) and the β-anomer 25b (23 mg, 23%) as white 
solids. Data for 25a: Rf = 0.27 (EtOAc/petroleum ether, 2:3). m.p.: 181.1–183.2 ºC. 
[ ]20Dα = +87 (c 2.0, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 6.43 (d, 1H, H-1, J1,2 = 
5.3 Hz), 5.03 (d, 1H, H-4, J4,5 = 10.4 Hz), 4.69 (s, 1H, OH), 4.67–4.63 (m, 2H, H-2, H-
3’), 4.37, 4.36, 4.35, 4.33 (dd, part A of ABX system, 1H, H-6a, J5,6a = 4.1, J6a,6b = 12.5 
Hz), 4.24, 4.24, 4.22, 4.21 (dd, part B of ABX system, 1H, H-6b, J5,6b = 2.3 Hz), 4.07 
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(ddd, 1H, H-5), 2.72-2.67 (m, 1H, OH), 2.17 (s, 3H, Ac), 2.14 (s, 3H, Ac), 2.11 (s, 3H, 
Ac) ppm.13C NMR (100 MHz, CDCl3, DEPT): δ = 87.5 (C-1), 77.7 (C-2), 72.6 (C-4), 
69.6 (C-3’), 67.0 (C-5), 61.9 (C-6), 20.9, 20.8, 20.7 (3 × CH3, Ac) ppm. HRMS: calcd. 
for C14H18O11 [M + Na]
+ 385.0741, found 385.0753.  
Data for 25b: Rf = 0.33 (EtOAc/petroleum ether, 2:3). m.p.: 139.0–140.7 ºC. [ ]20Dα = +35 
(c 1.1, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 5.54 (d, 1H, H-1, J1,2 = 8.4 Hz), 
5.00 (d, 1H, H-4, J4,5 = 10.4 Hz), 4.63 (s, 1H, OH), 4.52 (d, 1H, H-3’), 4.46 (d, 1H, H-
2), 4.36, 4.35, 4.34, 4.33 (dd, part A of ABX system, 1H, H-6a, J5,6a = 4.8, J6a,6b = 12.5 
Hz), 4.27, 4.25 (dd, part B of ABX system, 1H, H-6b, J5,6b = 2.3 Hz), 3.90 (ddd, 1H, H-
5), 2.81-2.76 (m, 1H, OH), 2.18 (s, 3H, Ac), 2.16 (s, 3H, Ac), 2.11 (s, 3H, Ac) ppm. 13C 
NMR (100 MHz, CDCl3, DEPT): δ = 92.6 (C-1), 81.0 (C-2), 73.1 (C-4), 72.7 (C-5), 
69.4 (C-3’), 62.0 (C-6), 20.9, 20.8, 20.7 (3 × CH3, Ac) ppm. HRMS: calcd. for 
C14H18O11 [M + Na]
+ 385.0741, found 385.0740. 
 
1,2-Di-O-acetyl-3-C-(carboxymethylene)-3-deoxy-α,β-D-erythro-pentopyranose-
3’,2-lactone (27): A solution of 5-O-TBDMS-3-deoxy-3-C-[(E)-(ethoxycarbonyl)-
methylene]-1,2-O-isopropylidene-α-D-erythro-pentofuranose [15] (26b, 51 mg, 0.14 
mmol) in aq. AcOH (70%, 1.1 mL) was stirred under reflux for 1 h 30 min. The solvent 
was then removed under vacuum. Ac2O (0.4 mL) and py (0.8 mL) were added to the 
residue and the mixture was stirred for 5 min. After coevaporation with toluene, the 
crude product was purified by CC on silica gel (EtOAc/petroleum ether, 1:3) to afford 
the title compound (26.3 mg, 74%) as a colorless oil. Rf = 0.23 (EtOAc/petroleum ether, 
1:3). [ ]20Dα = –12 (c 0.5, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 6.47 (d, H-1α, 
J1,2(α)  = 4.5 Hz), 6.05 (t, H-3’α, J2,3’(α) ~ J3’,4(α) ~ 2 Hz), 5.97 (t, H-3’β, J2,3’(β) ~ J3’,4(β) ~ 
2.0 Hz), 5.78 (ddd, H-2α, J2,3’(α) = 2.0, J2,4 (α) = 0.5 Hz), 5.69 (ddd, H-2β, J1,2(β) = 7.6, 
J2,3’(β) = 2.0, J2,4(β) = 0.5 Hz), 5.49 (d, H-1β, 5.02-4.96 (m, H-4α, H-4β), 4.57 (dd, H-5aβ, 
J4,5a(β) = 6.8, J5a,5b(β) = 10.8 Hz), 4.36 (dd, H-5aα,  J4,5a(α) = 6.8, J5a,5b(α) = 10.8 Hz), 3.56 
(t, H-5bα, J4,5b(α) ~ J5a,5b(α) = 10.5 Hz), 3.28 (dd, H-5bβ, J4,5b(β) = 10.0 Hz) 2.20, 2.16, 
2.16, 2.12 (4s, Me, Ac, α, β) ppm. 13C NMR (CDCl3, 100 MHz): δ = 114.9 (C-3’β) 
114.8 (C-3’α), 94.7 (C-1β), 89.3 (C-1α), 76.0 (C-4β), 75.6 (C-4α), 69.7 (C-2β), 68.5 (C-
5β), 68.3 (C-2α), 65.4 (C-5α), 20.9, 20.8, 20.6, 20.5 (Me, Ac) ppm. HRMS: calcd. for 
C11H12O7 [M + Na]
+ 279.0475, found 279.0469. 
 





Method A: The protocol described in ref. [16] was used, xcept the number of  
equiv. of PCC, which was reduced to 2.5, and slight modifications concerning the work-
up procedure. After total consumption of 28, as indicated by TLC, the solvent was 
evaporated under reduced pressure. Ethyl ether was added to the residue, in order to 
precipitating the CrIII  species and the resulting mixture was filtered over a short Florisil 
pad. The filtrate was concentrated in vacuum and the crude was purified by CC on silica 
gel (EtOAc/petroleum ether, 3:7) to afford 29 in 43% yield (0.24 g, starting from 0.5 g 
of 28) as a colorless oil. 1H NMR spectroscopic data were in fully agreement with the 
reported data [16].  
Method B. The oxidation step was carried out as follows. To the residue obtained from 
the first step in CH2Cl2 (6 mL), was added a mixture of PDC (1.38 g, 3.66 mmol) and 
Ac2O (1.4 mL, 14.8 mmol) in CH2Cl2 (15 mL) at room temp. under argon. The whole 
mixture was stirred at room temp. for 30 h. After a similar work up than that described 
above and purification by CC, compound 29 was obtained in 31% yield (345 mg 
starting from 1 g of 28). 
 
2. Biological assays 
 
The susceptibility of microorganisms to the unsaturted lactones 13, 14, 22, 23, 29, 30 
and 31 was evaluated by the disk diffusion method according to the standard procedure 
CLSI (Clinical Laboratory Standards Institute/National Committee for Clinical 
Laboratory Standards) [19, 20]. The microorganisms used in the tests belong to the 
American Type Culture Collection (ATCC) and Centraalbureau voor Schimmelcultures 
(CBS) collections, from United States and The Netherlands, respectively. Additional 
fungi kept in our lab were also used. The group of bacteria chosen for the study 
consisted of Gram-negative strains such as Escherichia coli (ATCC 8739) and 
Pseudomonas aeruginosa (ATCC 27853) and the following Gram-positive bacteria: 
Bacillus cereus (ATCC 11778), Bacillus subtilis (ATCC 6633), Enterococcus faecalis 
(ATCC 29212) and Staphylococcus aureus (ATCC 25923). For the antifungal 
bioassays, six fungi were tested: Botrytis spp., Candida albicans (ATCC 10231), 
Colletotrichum coffeanum (CBS 396.67), Fusarium culmorum (CBS 129.73), 
Pyricularia oryzae (CBS 433.70), and Rhizopus spp.. The culture medium and 
incubation temperature used for fungal growth was Potato Dextrose Agar and 25 ºC, 
Eur. J. Org. Chem. 2008, 2008, 6134–6143 
151 
 
whereas for bacteria, Nutrient Agar incubated at 37ºC was used. Paper disks of 6.4 mm 
were placed on the agar and the solution of each substance (300 µg) in DMSO (15 µL) 
was applied on each disk. Chloramphenicol was used a  control for all bacteria tested 
and C. albicans, whereas actidione was used for the filamentous fungi. After incubation, 
the nearest diameter of the inhibition zone was measured. Zones less than 15 mm in 
diameter and uniform growth in the disk were considere  indicative of weak 
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Results and Discussion – Thiopyranose Derivatives Containing an  





2.2. Thiopyranose Derivatives Containing an 
α,β-Unsaturated Carbonyl Functionality 
 
 
This subchapter includes the paper: 
 
“Synthetic Approaches to Novel Thiosugar Scaffolds Containing α,β-Unsaturated 
Carbonyl Groups”, Xavier, N. M.; Madeira, P. J. A.; Florêncio, M. H., Rauter, A. P. 
Eur. J. Org. Chem. 2009, 2009, 4983−4991. 
 
and shows the synthesis of new classes of thiosugar derivatives containing a conjugated 
carbonyl function. The methodology previously develop d for pyranose-fused 
butenolides was employed to attain thiopyranose-basd bicyclic analogues.  Moreover, 
the synthesis of an α,β-unsaturated 5-thiopyranulose was achieved using a masked 3-
ulose derived from 1,2:5,6-di-O isopropylidene-α-D-ribo-hexofuranos-3-ulose as 
precursor. 
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The synthesis of new classes of highly functionalized thiosugar derivatives containing 
α,β-unsaturated carbonyl functions has been accomplished t rough simple and efficient 
strategies. 5-Thiosugar-fused butenolides and a 5-thiohex-1-enopyranos-3-ulose were 
constructed from easily available starting 3-uloses by practical and reliable approaches. 
The reaction sequence used for the bicyclic fused drivatives involved Wittig 
olefination of protected pento- or hexofuranos-3-uloses, introduction of a sulfhydryl 
group at C-5 of the intermediate unsaturated ester and acid-promoted deprotection, 
which allowed intramolecular lactonization and conversion into the 5-thiopyranose 
form. For the synthesis of a 5-thio-hex-1-enopyranos-3-ulose, a sulfhydryl functionality 
was introduced at C-5 on a masked 3-ulose derived from 1,2:5,6-di-O-isopropylidene-α-
D-ribo-hexofuranos-3-ulose. Acid hydrolysis displaced the equilibrium towards the 5-
thiopentopyranos-3-ulose, which on pyridine-mediated acetylation underwent 1,2–
elimination of acetic acid to give the desired α,β-unsaturated 5-thiopyranulose. This 












Thiosugars containing sulfur as a heteroatom in the ring possess interesting chemical 
and biological properties and have attained considerabl  importance in glycobiology 
and in drug design as glycosidase inhibitors or as potential anticancer and anti-HIV 
agents [1, 2]. The different electronic properties of the sulfur and oxygen atoms (i.e., 
electronegativity and polarizability), and the changes in flexibility and conformation of 
the ring when an oxygen atom is replaced by sulfur, together with the distinct chemical 
reactivity of the sulfide function relative to the corresponding ether moiety, are assumed 
to contribute to the differences in the biological properties between thiosugars and their 
carbohydrate analogues [3, 4]. 
 
 A few examples of naturally occurring thiosugars have appeared in the literature [2]; 
the first isolated compound was 5-thio-D-mannose, from the marine sponge Clathria 
pyramida, in 1987 [5]. Since the first synthesis of 5-thio-α-D-xylopyranose in 1961 [6], 
a variety of approaches for the preparation of thiosugars by transformation of 
carbohydrate or non-carbohydrate precursors have been d veloped, and some reviews 
covering the methodologies have been published [3, 7].  
 
Owing to their potential value as bioactive compounds, the search for new classes of 
thiosugars remains highly relevant. In this context we turned our attention to the 
synthesis of thiosugar derivatives comprising α,β-unsaturated carbonyl functions, such 
as ketones and lactones. This functionality possesse  inherent bioactivity due to its 
ability to undergo Michael addition of enzymes’ nucleophilic components, specially 
cysteine sulfhydryl groups [8, 9]. Moreover, sugars containing such systems are 
building blocks of high synthetic versatility and have been used as intermediates for a 
variety of important sugar derivatives, including disaccharides, branched-chain sugars, 
and bioactive natural products [10]. In particular, p evious contributions in this field 
from our research group have shown the efficacy of furanose C-C-linked α,β-
unsaturated γ-lactones as antifungal [11] and insecticidal agents [12]. In addition, we 
were also able to use sugar-fused unsaturated lactones as starting materials for the 
synthesis of the sugar moiety, and its epimer, contained in miharamycins [13], 
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antibiotics known as potent inhibitors of Pyricularia oryzae, which produces the rice 
blast disease and is considered a bioterrorism agent. 
 
Combining thiosugar units to α,β-unsaturated carbonyl systems may therefore be a 
valuable tool for the design of new potentially biologically active substances, also 
providing highly functionalized templates for the synthesis of new thiosugar derivatives. 
The key structural feature of thiolactomycin and its analogues, based on an unsaturated 
thiolactone moiety, and their pharmacological propeties, namely activity against 
bacteria (e.g., Mycobacterium tuberculosis) [14] and parasitic organisms (e.g., 
Trypanosoma sp. and Plasmodium falciparum) [15], additionally support these 
considerations. 
 
With these motivations in mind we envisioned the synthesis of new thiosugar scaffolds 
containing such unsaturated system, namely, 5-thiopyranose-fused butenolides and a 1-
eno-5-thiopentopyranos-3-ulose. For this purpose, easily available furanos-3-uloses 
were used as starting materials and the methodologies used were based on 
intramolecular cyclization approaches, taking advantage of the ability of the free sugars 
to undergo furanose-pyranose isomerization. For the synthesis of thiosugar-fused 
butenolides we explored our recently reported Wittig olefination/intramolecular 
lactonization method [16], with the introduction of additional sulfhydryl functionality at 
C-5 of the intermediate α,β-unsaturated ester. The strategy for the preparation of a 5-
thiohex-1-enopyranos-3-ulose was based on the conversion of a hemiacetal, derived 
from 1,2:5,6-di-O-isopropylidene-α-D-ribo-hexofuranos-3-ulose by partial hydrolysis 
and intramolecular cyclization of the resulting primary alcohol with the carbonyl group,  
into the corresponding 5-SH analogue, followed by acid removal of 1,2-O-
isopropylidene group. Under these reaction conditions, the equilibrium between the 
hemiacetal and its ulose isomer and the furanose–pyranose equilibrium favoured the 
formation of the 5-thiopyranos-3-ulose, which by acetylation/1,2-elimination, gave the 










Results and Discussion 
 
1. Thiopyranose-fused butenolides 
 
The synthesis of a butenolide 2,3-fused to a 5-thio pentopyranose unit started with the 
commercially available 1,2-O-isopropylidene-α-D-xylofuranose, which was converted 
into the 5-O-tosyl derivative 1 [17] (Scheme 1) as a key intermediate for the 
introduction of a 5-thio group. Oxidation of 1 with PDC/Ac2O afforded the 3-ulose 2
along with its hydrate in 77% yield [18]. Wittig-type reaction of 2 with the stabilized 
ylide [(ethoxycarbonyl)methylene]triphenylphosphorane gave the (Z)-α,β-unsaturated 
ester 3a as the main product (77%) together with the E-adduct 3b (17%). Substitution 
of the tosylate of 3a by treatment with potassium thioacetate was efficintly achieved in 
DMF at 40 ºC, giving the desired product 4 in 84% yield. Use of a higher reaction 
temperature (90 ºC) also led to the formation of the thietane derivative 5, resulting from 
Michael addition, and of the allylic rearrangement product 6, both of which were 
inseparable from 4 by chromatography and were identified by NMR analysis of the 
mixture. Deacetylation and ester hydrolysis of 4 with sodium hydroxide in aq. methanol 
was followed by treatment with aq. acetic acid (70%) under reflux to cleave the 1,2-O-
isopropylidene group. Concomitant isomerization and i tramolecular lactonization 
furnished the target 5-thiosugar-fused butenolide 7 in 35% overall yield. In the 13C 
NMR spectrum of 7, the signal at δ = 174.8 ppm for the carbonyl group is consistent 
with an α,β-unsaturated lactone skeleton. Subsequent acetylation of 7 with Ac2O in 
pyridine, provided the corresponding diacetate derivative 8 as a mixture of both 
anomers (α/β ratio 1:0.3) in 80% yield, together with traces of the 5-thioglycal-fused 
butenolide 9. The structure of the elimination product 9 was supported by 1H NMR and 
HRMS data. A long-range coupling between H-1 and H-3’ with a constant of 1.5 Hz 
and the high chemical shift of H-1 (δ = 6.47 ppm) is indicative of the conjugated system 
of 9. 
 


























































a) b) c) to give only 4
( d) to give 4-6 )
H H
 
Scheme 1. Reactions and conditions: a) PDC/Ac2O, CH2Cl2, reflux, 2 h 30 min, 77%; b) 
Ph3P=CHCO2Et, CHCl3, reflux, 1h, 77% (3a) and 17% (3b); c) KSAc, DMF, 40 ºC, 1 h 
45 min, 84%; d) KSAc, DMF, 90 ºC, 2 h; e) NaOH, MeOH/H2O, room temp., 15 min; 
f) AcOH 70% aq., reflux, 2 h, 35%, 2 steps; g) Ac2O, py, room temp., 5 min, 80% (8) 
and traces of 9.  
 
The feasibility and scope of this approach were then studied for the preparation of 5-
thiohexopyranose-fused butenolides. The 5,6-diol 10 was prepared by Wittig olefination 
of 1,2;5,6-di-O-isopropylidene-α-D-ribo-hexofuranos-3-ulose, followed by selective 
hydrolysis of the primary acetonide as described previously [16a]. Silylation of the 
primary hydroxyl group (Scheme 2) was carried out wi h tert-butyldimethylsilyl 
chloride (TBDMSCl) and a catalytic amount of 4-dimethylaminopyridine (DMAP) in 
py (15 h) providing compound 11 (87%). Other standard methods such as imidazole in 
DMF (16%) and Et3N/cat. DMAP in CH2Cl2 (42%) were less efficient. Mesylation, 
chosen to avoid possible steric hindrance caused by the O-TBDMS group, was achieved 
by treatment of 11 with methanesulfonyl chloride in pyridine, giving 12 in 95% yield. A 
high temperature (90 ºC) was required to substitute he mesylate by a thioacetate in 
DMF. The desired compound 15 was obtained in 24% yield together with the furanose-
fused thietane 13 (15%) and 14 (19%) formed by migration of the exocyclic double 
bond.  
 





Separation of 14 from 15 could not be achieved by column chromatography. To 
overcome this drawback, a one-pot, two-step procedure consisting on 
triflation/nucleophilic substitution was employed. Treatment of 11 with 
trifluoromethanesulfonic anhydride (Tf2O)/py and then of the crude triflate 16 with 
potassium thioacetate in DMF gave 15 in modest yield (25%), together with a small 
amount of the 5-O-formyl derivative 17 (6%). The structure of 17 was established by 
NMR spectroscopy and HRMS. In the 1H NMR spectrum a broad triplet for H-5 
appeared at rather low field (δ = 5.21 ppm) and COSY experiments showed a weak 
coupling with the formyl proton (δ = 8.04 ppm). The 13C NMR spectrum showed a 
quaternary carbon atom at δ = 164.8 ppm, corresponding to the O-formyl carbonyl 
group. The unexpected formation of 17 can be explained by a reaction of the triflate 16 
and the solvent DMF. The formed iminium intermediate is readily converted into the 
formate 17 by hydrolysis during the workup (Scheme 3). A formylation method under 
similar conditions has been described previously [19]. 
 
Although the yield of 15 was not improved by the second approach, separation was 
easily achieved by column chromatography. Compound 15 was treated with NaOH in 
aq. methanol to provide the corresponding α,β-unsaturated acid derivative 18, 
containing a free sulfhydryl group at C-5, in 66% yield. Further hydrolysis of 18 with 
aq. TFA (60%) at 40 ºC afforded the desired 5-thiosugar-fused butenolide 19 
(quantitative). The 13C NMR spectrum showed the resonance of the carbonyl carbon of 
the lactone moiety at δ = 172.3 ppm. 
 
In contrast with the reaction described above, acetylation of 19 under conditions similar 
to those used for the analogous compound 7 (Scheme 1) proceeded with elimination to 
give the thioglycal-fused butenolide 21, isolated in 82% yield. The triacetate derivative 
20 was obtained only in trace amounts and was inseparably contaminated with 
compound 21, as determined by mass spectrometry. The difference i  the reaction 
modes found for compounds 7 and 19 may be explained either by electronic or 
conformational factors.  In both bicyclic compounds 8 and 20, elimination at C1-C2, 
results in a highly stable α,β,γ,δ-unsaturated carbonyl system. The main driving force 
for the conversion of 20 into 21, however, is the presence of a pseudoaxial 
acetyloxymethyl group at C-5 in 20, which further destabilizes the distorted chair 
conformation of the thiopyranose ring. Elimination from 20 to give the corresponding 
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thioglycal 21, which may adopt a sofa conformation, therefore occurs to overcome the 





















































































16  R1 = TBDMS, R2 = Tf
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Scheme 2. Reactions and conditions: a) TBDMSCl, py, catalytic DMAP, room temp., 
15h, 87%; b) MsCl, py, 0 ºC to room temp., 40 min, 95%; c) KSAc, DMF, 90 ºC, 24 h, 
15% (13), 19% (14) and 24% (15); d) Tf2O, py, CH2Cl2, –5 ºC, 15 min; e) KSAc, DMF, 
room temp., 1 h, 25% (15) and 6% (17), two steps; f) NaOH, MeOH/H2O, room temp., 
1 h, 66%; g) TFA 60% aq., 40 ºC, 20 min, quantitative; h) Ac2O, py, room temp., 5 min, 


































Scheme 3. Possible mechanism for the formation of the by-product 17. 





2. Synthesis of a Pyranoid Thiosugar Containing an α,β-Unsaturated Ketone 
Functionality 
 
Synthesis of a 5-thio-hex-1-enopyranos-3-ulose was accomplished by starting from the 
key intermediate hemiacetal 23 [20], obtained by selective hydrolysis of 1,2;5,6-di-O-
isopropylidene-α-D-ribo-hexofuranos-3-ulose 22 and subsequent cyclization of the 5,6-
diol formed (Scheme 4). In order to introduce a sulfur functionality at C-5, the synthesis 
of the tosylated derivative 24 was attempted. However, the conversion was slow and 
compound 24 was obtained only in 34% yield after 40 h. Moreover, substitution of 24 
with KSAc failed and no conversion was observed by TLC after 48 h at 40 ºC. 
Increasing the temperature to 70 ºC did not significantly improve the conversion and at 
90 ºC, decomposition was observed by TLC.  
 
Instead, 23 was triflated and the crude triflate 25 was directly treated with KSAc to give 
the desired 5-S-acetyl derivative 26 in 47% yield. Deacetylation with NaOH in aq. 
methanol afforded 27 in 90% yield. Treatment of this with aq. TFA (60%) produced the 
thiohexopyran-3-ulose 28 in quantitative yield as an α/β anomeric mixture. Subsequent 
acetylation and in situ β-elimination with Ac2O in pyridine gave the target thio sugar-
derived enone 29 in a nearly quantitative yield. This is consistent with the observation 
reported by Lichtenthaler and co-workers that β-acylated hexopyranuloses are prone to 
undergo β-elimination [21]. In accordance with the NMR spectroscopic data reported 
for sugar enones, the resonance of the C-3 carbonyl C-atom in the 13C NMR spectrum 
of 29 appeared at δ = 182.5 ppm, whereas in the 1H NMR spectrum a long-range 
coupling between H-1 and H-5 (J = 1.5 Hz) was observed [21b].  
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Scheme 4. Reactions and conditions: a) AcOH, 60% aq., room temp., 15 h, 92%; b) 
TsCl, py, room temp., 40 h, 34%; c) Tf2O, py, CH2Cl2, –5 ºC, 10 min; d) KSAc, DMF, 
room temp., 1 h 15 min, 47%, two steps; e) NaOH, MeOH/H2O, room temp., 5 min, 





This contribution has demonstrated synthetic approaches for new classes of highly 
functionalized thiosugar derivatives containing α,β-unsaturated carbonyl moieties, such 
as lactones and ketones, through the use of easily available furanos-3-uloses as starting 
materials. The methodologies include the introduction of a sulfhydryl group at C-5 on 
appropriate furanose intermediates, such as an unsaturated ester and a hemiacetal sugar, 
and take advantage of the furanose-pyranose equilibri m. The synthesised molecules 
are valuable intermediates for further chemical transformations, in particular for 
syntheses of miharamycins analogues. In addition these compounds are potential 




General Methods: Melting points were determined with a Stuart Scientific SMP 3 
apparatus and are uncorrected. Optical rotations were m asured on a Perkin–Elmer 343 
polarimeter at 20 ºC. 1H and 13C NMR spectra were recorded with a BRUKER Avance 





400 spectrometer operating at 400.13 MHz for 1H or 100.62 MHz for 13C. Chemical 
shifts are expressed in parts per million and are reported relative to  internal TMS, in the 
case of CDCl3, or relative to the respective solvent peak as reference. HRMS spectra 
were acquired with an Apex Ultra FTICR Mass Spectrometer fitted with an Apollo II 
Dual ESI/MALDI ion source, from Bruker Daltonics, and a 7T actively shielded magnet 
from Magnex Scientific. 
All reactions were monitored by TLC on Merck 60 F254 silica gel aluminium plates with 
detection under UV light (254 nm) and/or by spraying with a solution of 10% H2SO4 in 
EtOH or with a solution of 0.2% (w/v) cerium(IV) sulphate/5% ammonium molybdate 
in aq. H2SO4 (6%). Column chromatography (CC) was carried out on silica gel 60 G 
(0.040–0.063 mm, E. Merck). 
 
1,2-O-Isopropylidene-5-O-tosyl-α-D-erythro-pentofuranos-3-ulose (2): Ac2O (1.4 
mL) and PDC (1.44 g, 3.83 mmol) were added under argon to a solution of 1,2-O-
isopropylidene-5-O-tosyl-α-D-xylofuranose (1, 1.68 g, 4.88 mmol) [17] in dry CH2Cl2 
(24 mL). The resulting mixture was stirred under reflux for 2 h 30 min and was then 
allowed to cool to room temp. The solvent was removed in vacuum. EtOAc (15 mL) 
was added to the residue and the mixture was filtered through a short pad of Florisil. 
After evaporation of the solvent, the crude product was purified by CC 
(EtOAc/petroleum ether, 1:1) to afford 2 as colorless oil, along with its hydrate in a 
1:0.3 ratio (1.29 g, 77%). Rf = 0.25 (EtOAc/petroleum ether, 1:1).
1H NMR (400 MHz, 
CDCl3): δ = 7.75 (d, 2H, H-a, Ts, J = 8.1 Hz), 7.37 (d, 2H, H-b, Ts), 6.04 (d, 1H, H-1, 
J1,2 = 4.3 Hz), 4.51 (t, 1H, H-4), 4.35 (d, 1H, H-2), 4.31 (dd, part A of aBX system, 1H, 
H-5a, J4,5a = 2.5, J5a,5b = 11.1 Hz), 4.19 (dd, part B of ABX system, 1H, H-5b, J4,5b = 3.0 
Hz), 2.46 (s, 3H, Me, Ts), 1.44 (s, 3H, Me, isopr.), 1.40 (s, 3H, Me, isopr.) ppm. 13C 
NMR (100 MHz, CDCl3): δ = 206.7 (CO), 145.4 (Cq-a, Ts), 132.4 (Cq-b), 130.1 (CH-b, 
Ts), 127.9 (CH-a, Ts), 114.5 (Cq, isopr.) 103.2 (C-1), 76.8 (C-4), 76.0 (C-2), 68.1 (C-5), 
27.4 (Me, isopr.), 27.0 (Me, isopr.), 21.6 (Me, Ts) ppm. HRMS: calcd. for C15H18O7S 
[M + Na]+ 365.0665, found 365.0673. Hydrate, HRMS: calcd. for C15H20O8S [M + Na]
+ 
383.0771, found 383.0779. 
 




ylidene)acetate (3a) and Ethyl (3E)-(3-Deoxy-1,2-O-isopropylidene-6-O-tosyl-α-D-
erythro-pentofuranos-3-ylidene)acetate (3b): [(Ethoxycarbonyl)methylene]- 
triphenylphosphorane (0.47 g, 1.35 mmol) was added to a solution of the 3-ulose 2 
(0.35 g, 1.03 mmol) in dry CHCl3 (8.3 mL).  The mixture was stirred under reflux for1 
h. After evaporation of the solvent, the residue was purified by column chromatography 
(EtOAc/petroleum ether, 1:8 then 1:6) to afford the (Z)-adduct 3a (0.329 g, 77%) and its 
(E)-isomer 3b (0.074 g, 17%) as colorless oils. 
Data for 3a: Rf = 0.21 (EtOAc/petroleum ether, 1:8). [ ]20Dα  = +147 (c = 1.4, in CH2Cl2). 
1H NMR (400 MHz, CDCl3) δ = 7.78 (d, 2H, H-a, Ts, J = 8.1 Hz), 7.36 (d, 2H, H-b, 
Ts), 5.83 (t, 1H, H-3’, J2,3’ = J3’4 = 1.8 Hz), 5.79 (d, 1H, H-1, J1,2 = 4.0 Hz), 5.67 (dt, 1H, 
H-2, J2,3’ = J2,4), 4.98–4.93 (m, 1H, H-4), 4.28–4.21 (m, 3H, CH2 H3, H-5a, J = 7.1 Hz), 
4.12 (dd, 1H, H-5b, J4,5b = 3.5, J5a,5b = 11.1 Hz), 2.46 (s, 3H, Me, Ts), 1.45 (s, 3H, Me, 
isopr.), 1.40 (s, 3H, Me, isopr.), 1.32 (t, 3H, CH2 3) ppm. 
13C NMR (100 MHz, 
CDCl3) δ = 164.5 (CO), 153.4 (C-3), 145.4 (Cq-a, Ts), 132.4 (Cq-b), 130.  (CH-b, Ts), 
128.1 (CH-a, Ts), 117.8 (C-3’), 113.3 (Cq, isopr.), 105.2 (C-1), 78.2 (C-2, C-4), 69.4 
(C-5), 61.1 (CH2CH3), 27.5 (Me, isopr.), 27.2 (Me, isopr.), 21.8 (Me, Ts), 14.3 
(CH2CH3) ppm. HRMS: calcd. for C19H24O8S [M + Na]
+ 435.1084, found 435.1082. 
Data for 3b: Rf = 0.16 (EtOAc/petroleum ether, 1:6). [ ]20Dα  = +153 (c = 1.0, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 7.73 (d, 2H, H-a, Ts, J = 8.1 Hz), 7.34 (d, 2H, H-b, 
Ts), 6.09 (t, 1H, H-3’, J2,3’ = J3’4 = 1.8 Hz), 5.85 (d, 1H, H-1, J1,2 = 4.6 Hz), 5.63–5.60 
(m, 1H, H-4), 5.06 (dt, 1H, H-2, J2,3’ = J2,4), 4.46 (dd, 1H, H-5a, J4,5a = 1.8, J5a,5b = 10.4 
Hz), 4.20–4.09 (m, 3H, CH2CH3, H-5b, J = 7.1, J4,5b = 2.0 Hz) 2.45 (s, 3H, Me, Ts), 
1.41 (s, 3H, Me, isopr.), 1.36 (s, 3H, Me, isopr.), 1 28 (t, 3H, CH2CH3) ppm. 
13C NMR 
(100 MHz, CDCl3): δ = 165.3 (CO), 157.4 (C-3), 145.2 (Cq-a, Ts), 132.6 (Cq-b), 130.0 
(CH-b, Ts), 128.0 (CH-a, Ts), 118.5 (C-3’), 113.6 (Cq, isopr.), 104.5 (C-1), 81.7 (C-2), 
79.3 (C-4), 71.8 (C-5), 60.9 (CH2CH3), 27.9 (Me, isopr.), 27.8 (Me, isopr.), 21.8 (Me, 
Ts), 14.2 (CH2CH3) ppm. HRMS: calcd. for C19H24O8S [M + Na]




pentofuranos-3-ylidene)acetate (4): Potassium thioacetate (34 mg, 0.30 mmol) was 
added under argon to a solution of ethyl (3Z)-(3-deoxy-1,2-O-isopropylidene-6-O-tosyl- 





α-D-erythro-pentofuranos-3-ylidene)acetate (3a, 0.10 g,  0.25 mmol) in anhydrous DMF 
(2.5 mL). The whole solution was stirred at 40 ºC for 1 h 45 min. Water was added (12 
mL) and the organic phase was extracted with EtOAc (3×3 mL). The combined organic 
layers were washed with water and dried with MgSO4. After filtration and evaporation 
of the solvent, the residue was purified by CC (EtOAc/ petroleum ether, 1:11) to afford 
4 (66 mg, 84%) as a colorless oil. Rf = 0.35 (EtOAc/petroleum ether, 1:4).
 [ ]20Dα = +105 
(c = 1.1, CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 5.94 (t, 1H, H-3’, J2,3’ = J3’,4 = 1.5 
Hz), 5.88 (d, 1H, H-1, J1,2 = 4.0 Hz), 5.72 (dt, 1H, H-2, J2,3’ = J2,4), 5.01–4.96 (m, 1H, 
H-4), 4.28–4.21 (m, 2H, CH2CH3, J = 7.1 Hz), 3.41  (dd, part A of ABX system, 1H, H-
5a, J4,5a = 3.8, J5a,5b = 14.1 Hz), 3.09 (dd, part B of ABX system, 1H, H-5b, J4,5b = 6.3 
Hz), 2.36 (s, 3H, Me, SAc), 1.48 (s, 3H, Me, isopr.), 1.41 (s, 3H, Me, isopr.), 1.31 (t, 
3H, CH2CH3) ppm. 
13C NMR (100 MHz, CDCl3): δ = 194.9 (CO, SAc), 164.9 (CO), 
156.0 (C-3), 117.1 (C-3’), 112.9 (Cq, isopr.), 104.8 (C-1), 78.6 (C-4), 78.2 (C-2), 61.0 
(CH2CH3), 32.1 (C-5), 30.6  (Me, SAc), 27.4 (Me, isopr.), 27.2 (Me, isopr.), 14.3 
(CH2CH3) ppm. HRMS: calcd. for C14H20O6S [M + Na]
+ 339.0872, found 339.0867. 
 
Ethyl (3,5-Anhydro-1,2-O-isopropylidene-5-thio-α-D-erythro-pentofuranos-3-C-yl) 
acetate (5) and Ethyl (5-S-Acetyl-3-deoxy-1,2-O-isopropylidene-5-thio-α-D-glycero-
pent-3-enofuranos-3-C-yl)acetate (6):  These compounds were obtained in an 
inseparable mixture also containing 4 (ratio 1:2:0.8, 4/5/6, 38 mg starting from 49 mg of 
3a) after a similar procedure to that described previously for compound 4,  but with 
reaction being carried out at 90 ºC. 
Data for 5:  Rf = 0.52 (EtOAc/petroleum ether, 1:9).
 1H NMR (400 MHz, CDCl3): δ = 
6.02 (d, H-1, J1,2 = 3.0 Hz), 5.06 (d, H-2), 4.93 (brt, H-4), 4.28-4.18 (m, CH2CH3), 3.40 
(br. d, part A of AB system, H-5a, J5a,5b = 12.6 Hz), 3.26 (d, part A of AB system, H-
3’a, J3a,3b = 16.7 Hz), 3.18 (br. d, part B of AB system, H-5b), 2.80, 2.75 (d, part B of 
AB system, H-3’b), 1.53 (Me), 1.36 (Me), 1.29 (t, CH2CH3) ppm. 
Data for 6:  Rf = 0.45 (EtOAc/petroleum ether, 1:9).
 1H NMR (400 MHz, CDCl3): δ = 
5.98 (d, H-1, J1,2 = 5.3 Hz), 5.33 (d, H-2), 4.16 (qd, CH2CH3), 3.71 (d, part A of AB 
system, H-5a, J5a,5b = 14.4 Hz) 3.59 (d, part B of AB system, H-5b), 3.37 (d, part A of 
AB system, H-3’a, J3a,3b = 16.7 Hz), 3.18 (d, part B of AB system, H-3’b), 2.34 (s, Me, 
SAc), 1.44 (s, Me, isopr.), 1.36 (s, Me, isopr.), 131 (t, CH2CH3) ppm. 
 





3-ylidene)acetate (4, 0.45 g, 1.43 mmol) was dissolved in MeOH/H2O (20 mL , 1.5/1 
v/v) and NaOH solution (10 M, 0.27 mL)  was added. After the system had been stirred 
at room temp. for 15 min, Amberlite IR-120 H+ was added until neutralization. The 
resin was then filtered off and the solvents were evaporated. The resulting residue was 
dissolved in aq. AcOH (70%, 18 mL) and the solution was stirred under reflux for 2 h. 
The solvent was co-evaporated with toluene and the crude product was purified by CC 
(EtOAc/petroleum ether, 2:3 then 3:2) to afford 7 (93 mg, 35%, two steps) as a colorless 
oil. Rf = 0.26 (EtOAc/petroleum ether, 3:2). [ ]20Dα  = +130 (c = 1.1, in MeOH). 1H NMR 
(400 MHz, CD3OD, α anomer): δ = 6.02 (t, H-3’, J3’,4 = J2, 3’ = 1.5 Hz), 5.26–5.22 (m, 
2H, H-1, H-2), 4.68 (ddd, 1H, H-4, J4,5a = 6.1, J4,5b  = 10.9 Hz), 2.92 (dd, part A of ABX 
system,  H-5a, J5a,5b  = 12.6 Hz), 2.78 (dd, part B of ABX system,  H-5b) ppm. 
13C NMR 
(100 MHz, CD3OD): δ = 174.8 (CO, lac), 171.9 (C-3), 115.5 (C-3’), 84.6 (C-2), 73.3 





pentopyranose (8) and 4-O-Acetyl-l,5-anhydro-3-deoxy-2-O,3-C-(1-oxoethan-1-yl-
2-ylidene)-5-thio-D-glycero-pent-l-enitol (9): Ac2O (0.35 mL) was added  to a solution 
of 3-deoxy-2-O,3-C-(1-oxoethan-1-yl-2-ylidene)-5-thio-D erythro-pentopyranose (7, 7 
mg, 37 µmol) in py (0.7 mL), and the mixture was stirred at room temp. for 5 min. After 
coevaporation with toluene, the crude product was purified by CC (EtOAc/petroleum 
ether, 2:3) to afford 8 (8 mg, 80%) as a colorless oil and traces of the corresponding 
glycal 9.  
Data for 8: Rf = 0.21 (EtOAc/petroleum ether, 2:3).
 [ ]20Dα = +50 (c = 0.5, in CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ = 6.27 (d, H-1α, J1,2(α) = 3.8 Hz), 6.08 (t, H-3’α) 6.07 (t, H-
3’β, J2,3’(β)~ J3’,4(β) ~ 1.8 Hz), 5.78 (dddd, 1H, H-4α), 5.69 (dddd, 1H, H-4β), 5.60 (d, H-
1β, J1,2(β) = 9.1), 5.23 (ddd, 1H, H-2α), 5.13 (ddd, H-2β), 3.13 (dd, H-5aβ, J4,5a(β) = 5.3, 
J5a,5b(β)  = 13.1) 3.01 (dd, part A of ABX system, H-5aα, J4,5a(α) = 5.3, J5a,5b(α)  = 12.9 Hz), 
2.91 (dd, part B of ABX system, H-5bα, J4,5b(α)  = 10.9 Hz), 2.73 (dd,  H-5bβ, J4,5b(β)  = 
10.9 Hz), 2.21 (s, Meα, Ac), 2.08 (s, 3H, Meα, Ac) ppm. 13C NMR (100 MHz, CDCl3, 
major anomer): δ = 170.4 (CO), 169.4, 168.6 (CO, Ac), 162.3 (C-3), 116.4 (C-3’), 80.0 





(C-2), 70.7 (C-1), 69.3 (C-4), 28.9 (C-5), 20.9 (Me, Ac), 20.8 (Me, Ac) ppm. HRMS: 
calcd. for C11H12O6S [M + Na]
+ 295.0247, found 295.0254.  
Data for 9: Rf = 0.53 (EtOAc/petroleum ether, 3:2).
 1H NMR (400 MHz, CDCl3): δ = 
6.47 (d, 1H, H-1, 5J1,3’ = 1.5), 6.03 (t, 1H, H-3’, 
5J1,3’ = 
4J3’,4 = 1.5 Hz), 5.97 (td, 1H, H-
4, J4,5a = J4,5b = 7.3), 3.16 (br. d, 2H, CH2-5), 2.19 (s, 3H, Me, Ac) ppm. HRMS: calcd. 
for C9H8O4 [M + H]




hexofuranos-3-ylidene]acetate (11): DMAP (16  mg, 0.13 mmol), and TBDMSCl  
(0.58 g, 3.85 mmol) were added at room temp. under argon to a solution of ethyl (3Z)-
(3-deoxy-1,2-O-isopropylidene-α-D-ribo-hexofuranos-3-ylidene)acetate [16a]  (10, 0.52 
g, 1.8 mmol) in dry py (2 mL). After stirring for 15 h, the reaction mixture was poured 
into water (12 mL) and extracted with EtOAc (3 × 5 mL). The combined organic layers 
were washed with water and brine and dried with anhydrous MgSO4. After filtration 
and evaporation of the solvent, the residue was purified by CC (EtOAc/petroleum ether, 
1:6) to afford 11 (0.632 g, 87%) as colorless oil. Rf = 0.33 (EtOAc/cyclohexane, 1:5). 
[ ]20Dα = +111 (c = 1.2, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 6.44 (br. s, 1H, H-
3’), 5.82 (d, 1H, H-1, J1,2 = 3.8 Hz), 5.72 (br. d, 1H, H-2), 4.66 (br. d, 1H, H-4, J4,5 = 7.6 
Hz), 4.21 (q, 2H, CH2CH3, J = 7.1 Hz), 3.79–3.69 (m, H-6a, H-6b), 3.65–3.57 (m, 1H, 
H-5), 2.74 (d, 1H, OH-5, J = 6.1 Hz), 1.47 (s, 3H, Me, isopr.), 1.39 (s, 3H, Me, isopr.), 
1,28 (t, 3H, CH2CH3), 0.88 (s, 9H, tBu, TBDMS), 0.07 (2 × s, 6H, Me, TBDMS) 
ppm.13C NMR (100 MHz, CDCl3): δ = 165.5 (CO), 156.3 (C-3), 117.6 (C-3’), 112.8 
(Cq, isopr.), 104.9 (C-1), 78.9 (C-4), 78.4 (C-2), 73.2 (C-5), 63.8 (C-6), 60.7 (CH2CH3), 
27.4 (Me, isopr.), 27.3 (Me, isopr.), 25.9 (3 × Me, tBu), 18.4 (Cq, tBu), 14.3 (CH2CH3), 
-5.3 (Me, TBDMS), -5.3 (Me, TBDMS) ppm. HRMS: calcd. for C19H34O7Si [M + Na]
+ 
425.1966, found 425.1981. 
 
Ethyl (3Z)-[(6-O-(tert-Butyldimethylsilyl)-3-deoxy-1,2-O-isopropylidene-5-O-mesyl-
α-D-ribo-hexofuranos-3-ylidene]acetate (12): Methanesulfonyl chloride (0.03 mL, 
0.43 mmol) was added  under argon at 0 °C to a solution of ethyl (3Z)-[(6-O-(tert-
butyldimethylsilyl)-3-deoxy-1,2-O-isopropylidene-α-D-ribo-hexofuranos-3-ylidene]-
acetate (11, 0.116 g, 0.29 mmol) in dry py (2.9 mL). The ice bath was removed and the 
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solution was kept stirring at room temp. for 40 min. Water (12 mL) was added to the 
solution, and the mixture was extracted with EtOAc (3 × 5 mL). The combined organic 
layers were washed with water and dried with anhydrous MgSO4. After filtration and 
evaporation of the solvent, the residue was purified by CC (EtOAc/petroleum ether, 1:3) 
to afford 12 (0.131 g, 95%) as a colorless oil. Rf = 0.47 (EtOAc/petroleum ether, 
1.5:3.5). [ ]20Dα = +91 (c = 1.1, in CH2Cl2).1H NMR (400 MHz, CDCl3) δ = 6.07 (t, 1H, 
H-3’, J2,3’ = J3’,4 = 1.8 Hz), 5.89 (d, 1H, H-1, J1,2 = 4.0 Hz), 5.69 (dt, 1H, H-2, J2,3’ = 
J2,4), 5.15 (ddd, 1H, H-4), 4.71 (ddd, 1H, H-5), 4.23 (qd, 2H, CH2CH3, J = 7.1 Hz), 3.89 
(dd, part A of ABX system, 1H, H-6a, J5,6a = 6.6, J6a,6b = 11.4 Hz), 3.80 (dd, part B of 
ABX system, 1H, H-6b, J5,6b = 5.8 Hz), 3.08 (s, 3H, Me, Ms), 2.26 (br. s, 1H, OH-6), 
1.45 (s, 3H, Me, isopr.), 1.41 (s, 3H, Me, isopr.), 1.30 (t, 3H, CH2CH3), 0.87 (s, 9H, 
tBu, TBDMS), 0.07 (s, 3H, Me, TBDMS), 0.06 (s, 3H, Me, TBDMS) ppm.13C NMR 
(100 MHz, CDCl3) δ = 164.6 (CO), 153.7 (C-3), 118.6 (C-3’), 113.4 (Cq, isopr.), 105.6 
(C-1), 82.7 (C-5), 79.8 (C-4), 78.8 (C-2), 61.4 (C-6), 60.9 (CH2CH3), 38.8 (Me, Ms), 
27.6 (Me, isopr.), 27.4 (Me, isopr.), 25.9 (3 × Me, tBu), 18.4 (Cq, tBu), 14.2 (CH2CH3), 
5.3 (Me, TBDMS), -5.4 (Me, TBDMS) ppm. HRMS: calcd. for C20H36O9SSi [M + Na]
+ 
503.1742, found 503.1760. 
 
Ethyl [3,5-Anhydro-6-O-(tert-butyldimethylsilyl)-1,2-O-isopropylidene-5-thio-β-L-
ido-hexofuranos-3-C-yl]acetate (13) and Ethyl [5-S-acetyl-6-O-(tert-
butyldimethylsilyl)-3-deoxy-1,2-O-isopropylidene-5-thio-β-L-threo-hex-3-
enofuranos-3-C-yl]acetate (14): Potassium thioacetate (36 mg, 0.31 mmol) was added  
under argon to a solution of ethyl (3Z)-[(6-O-(tert-butyldimethylsilyl)-3-deoxy-1,2-O-
isopropylidene-5-O-mesyl-α-D-ribo-hexofuranos-3-ylidene]acetate (12, 0.125g, 0.26 
mmol) in anhydrous DMF (2.7 mL). The whole solution was stirred at 90 ºC for 24 h. 
Water was added (12 mL) and the organic phase was extracted with EtOAc (3 × 3 mL). 
The combined organic layers were washed with water nd dried over MgSO4. After 
filtration and evaporation of the solvent, the residue was purified by CC (EtOAc/ 
cyclohexane, 1:16) to afford 13 (12 mg, 15%) as a colorless oil, 14 (23 mg, 19%) and 
15 (29 mg, 24%). Separation of 14 from 15 by chromatography was not possible.  
Data for 13. Rf = 0.47 (EtOAc/cyclohexane, 1:6). [ ]20Dα = +14 (c = 0.5, in CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ = 6.03 (d, 1H, H-1, J1,2 = 3.0 Hz), 5.04 (d, 1H, H-2), 4.73 
(dd, 1H, H-4, J4,5 = 1.3 Hz), 4.56 (dd, 1H, H-6a, J5,6a = 9.9, J6a,6b = 13.6 Hz), 4.25–4.15 





(m, 2H, CH2CH3, J = 7.1), 3.86–3.78 (m, 2H, H-5, H-6b), 3.25 (d, part A of AB system, 
1H, H-3’a, J3’a,3’b = 16.9 Hz), 2.78 (d, part B of AB system, 1H, H-3’b), 1.51 (s, 3H, Me, 
isopr.), 1.35 (s, 3H, Me, isopr.), 1.29 (t, 3H, CH2 3), 0.89 (s, 9H, t-Bu, TBDMS), 0.07 
(br. s, 6H, Me, TBDMS) ppm. 13C NMR (100 MHz, CDCl3): δ = 113.3 (Cq, isopr.), 
106.7 (C-1), 89.9 (C-4), 86.5 (C-2), 64.0 (C-5), 61.4, 61.3 (C-6, CH2CH3), 27.7 (Me, 
isopr.), 27.2 (Me, isopr.), 26.0 (3 × Me, tBu), 18.4 (Cq, tBu), 14.3 (CH2CH3), -5.4 
(2×Me, TBDMS) ppm. HRMS: calcd. for C19H34O6SSi [M + Na]
+ 441.1738, found 
441.1756. 
Data for 14. Rf = 0.37 (EtOAc/cyclohexane, 1:6).
 1H NMR (400 MHz, CDCl3): δ = 5.96 
(d, 1H, H-1, J1,2 = 5.3 Hz), 5.40 (d, 1H, H-2), 4.48 (dd, 1H, H-5, J5,6a = 7.8, J5,6b = 6.8 
Hz), 4.17–4.10 (m, 2H, CH2CH3, J = 7.1 Hz), 3.83 (t, 1H, H-6a, J6a,6b = 10.1 Hz), 3.68 
(dd, 1H, H-6b), 3.41 (d, part A of AB system, H-3’a, J3’a,3’b = 16.9 Hz), 3.14 (d, part B 
of AB system, 1H, H-3’b), 2.32 (s, 3H, Me, SAc), 1.44 (s, 3H, Me, isopr.), 1.35 (s, 3H, 
Me, isopr.), 1.27 (t, 3H, CH2CH3), 0.85 (s, 9H, tBu, TBDMS), 0.04 (s, 3H, Me, 
TBDMS), 0.03 (s, 3H, Me, TBDMS) ppm.13C NMR (100 MHz, CDCl3): δ = 194.3 (CO, 
SAc), 170.8 (CO), 152.2 (C-4), 112.3 (Cq, isopr.), 106.6 (C-3), 104.5 (C-1), 85.3 (C-2), 
62.7 (C-6), 60.9 (CH2CH3), 41.0 (C-5), 30.6 (Me, SAc), 29.9 (C-3’), 28.1 (2 × Me, 
isopr.), 25.9 (3 × Me, tBu),  18.4 (Cq, tBu), 14.3 (CH2CH3), -5.3 (Me, TBDMS), -5.4 




5-thio-β-L-lyxo-hexofuranos-3-ylidene]acetate (15) and Ethyl (3Z)-[6-O-(tert-
Butyldimethylsilyl)-3-deoxy-5-O-formyl-1,2-O-isopropylidene-β-L-lyxo-
hexofuranos-3-ylidene]acetate (17): A solution of ethyl (3Z)-[(6-O-(tert-
butyldimethylsilyl)-3-deoxy-1,2-O-isopropylidene-α-D-ribo-hexofuranos-3-ylidene]-
acetate (11, 0.241 g, 0.6 mmol) and dry py (0.1 mL, 1.2 mmol) in dry CH2Cl2 (3 mL) 
was cooled to −11 ºC (MeOH/ice bath) under argon. Tf2O (0.11 mL, 0.66 mmol) was 
added dropwise and the reaction mixture was stirred for 15 min, whilst keeping the 
temperature below −5 ºC. The solution was diluted with EtOAc (10 mL) and 
sequentially washed with a satd. NaHCO3 solution (5 mL) and aq. HCl solution (2 M, 5 
mL). The aqueous layer was extracted twice with EtOAc and the combined organic 
phases were dried with anhydrous MgSO4. After filtration and concentration to dryness, 
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the crude triflate 16 was used immediately for the next step without further purification. 
Rf = 0.53 (EtOAc/cyclohexane, 1:5).  
Potassium thioacetate (75 mg, 0.66 mmol) was added to the crude triflate 16 in DMF (6 
mL). The solution was stirred at room temp. for 40 min. Water (12 mL) was then added 
to the solution and it was extracted with EtOAc (3 × 5 mL). The combined organic 
layers were washed with water and brine and dried with anhydrous MgSO4. After 
filtration and evaporation under vacuum, the residue was purified by CC (EtOAc/ 
petroleum ether, 1:14) to afford 15 (70 mg, 25%) and 17 (15 mg, 6%) as colorless oils.  
Data for 15: Rf = 0.41 (EtOAc/petroleum ether, 1:5). [ ]20Dα = +67 (c = 1.2, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 5.86 (d, 1H, H-1, J1,2 = 4.3 Hz), 5.83 (t, 1H, H-3’, J2,3’ 
= J3’,4 = 1.8 Hz), 5.70 (dt, 1H, H-2), 5.42–5.39 (m, 1H, H-4), 4.28–4.15 (m, 2H, 
CH2CH3, J = 7.1 Hz), 3.87 (ddd, 1H, H-5), 3.78 (t, 1H, H-6a, J5,6a = J6a,6b = 9.6 Hz), 3.67 
(dd, 1H, H-6b, J5,6b = 5.6 Hz), 2.31 (s, 3H, Me, SAc), 1.47 (s, 3H, Me, isopr.), 1.42 (s, 
3H, Me, isopr.), 1.30 (t, 3H, CH2CH3), 0.89 (s, 9H, tBu, TBDMS), 0.09 (s, 3H, Me, 
TBDMS), 0.08 (s, 3H, Me, TBDMS) ppm. 13C NMR (100 MHz, CDCl3): δ = 194.9 
(CO, SAc), 165.1 (CO), 156.3 (C-3), 116.3 (C-3’), 113.0 (Cq, isopr.), 105.4 (C-1), 78.5, 
78.2 (C-4, C-2), 63.0 (C-6), 60.9 (CH2CH3), 48.9 (C-5), 30.8 (Me, SAc), 27.5 (2 × Me, 
isopr.), 25.9 (3 × Me, tBu), 18.4 (Cq, tBu), 14.3 (CH2CH3), -5.2 (Me, TBDMS), -5.3 
(Me, TBDMS) ppm. HRMS: calcd. for C21H36O7SSi [M + Na]
+ 483.1843, found 
483.1856.  
Data for 17: Rf = 0.28 (EtOAc/petroleum ether, 1:5). [ ]20Dα = +88 (c = 1.1, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 8.04 (s, 1H, OCHO), 5.95–5.91 (m, 2H, H-1, H-3’, 
J1,2 = 4.3, J2,3’ = J3’,4 = 1.5 Hz), 5.69 (dt, 1H, H-2, J2,3’ = J2,4), 5.21 (td, 1H, H-5 J5,6a = 
J5,6b = 6.8 Hz), 5.14–5.12 (m, 1H, H-4), 4.28–4.18 (m, 2HC 2CH3, J = 7.1 Hz), 3.87–
3.77 (m, 1H, H-6a, H-6b, J6a,6b = 10.1 Hz), 1.48 (s, 3H, Me, isopr.), 1.44 (s, 3H, Me, 
isopr.), 1.30 (t, 3H, CH2CH3, J = 7.1 Hz), 0.88 (s, 9H, tBu, TBDMS), 0.08 (s, 3H, Me, 
TBDMS), 0.08 (s, 3H, Me, TBDMS) ppm. 13C NMR (100 MHz, CDCl3): δ = 164.8 
(CO, OCHO), 160.1 (CO), 154.7 (C-3), 117.4 (C-3’), 113.4 (Cq, isopr.), 105.6 (C-1), 
78.6, 78.5 (C-4, C-2), 73.6 (C-5), 61.1, 61.0 (CH2CH3, C-6), 30.8 (Me, SAc), 27.7 (Me, 
isopr.), 27.4 (Me, isopr.), 25.9 (3 × Me, tBu), 18.3 (Cq, tBu), 14.2 (CH2CH3), -5.3 (Me, 
TBDMS), -5.3 (Me, TBDMS) ppm. HRMS: calcd. for C17H30O6SSi [M + Na]
+ 
413.1915, found 453.1915; calcd. for [M + K]+ 469.1655, found 469.1656.  






lyxo-hexofuranos-3-ylidene]acetic acid (18): Ethyl (3E)-[5-S-acetyl-6-O-(tert- 
butyldimethylsilyl)-3-deoxy-1,2-O-isopropylidene-5-thio-β-L-lyxo-hexofuranos-3-
ylidene]acetate (15, 41 mg, 0.09 mmol) was dissolved in MeOH/H2O (2:1, 1.3 mL), and 
NaOH solution (10 M, 0.04 mL) was added. The solution was stirred at room temp. for 
1 h, and then neutralized with Amberlite IR-120 H+. After filtration of the resin and 
evaporation of the solvent, the residue was purified by CC (EtOAc/petroleum ether, 1:1) 
to afford 18 (23 mg, 66%) as a colorless oil. Rf = 0.4 (EtOAc/petroleum ether, 1:1).
 1H 
NMR (400 MHz, [D6]acetone): δ = 6.00 (d, 1H, H-1, J1,2 = 4.0 Hz), 5.97 (t, 1H, H-3’, 
J2,3’ = J3’,4 = 1.5 Hz), 5.72 (dt, 1H, H-2, J2,3’ = J2,4), 5.39–5.35 (m, 1H, H-4), 3.81 (dd, 
1H, H-6a, J5,6a = 5.6, J6a,6b = 9.9 Hz), 3.71 (t, 1H, H-6b, J5,6b = J6a,6b), 3.21 (tdd, 1H, H-
5), 1.71 (d, 1H, SH, JSH,H-5 = 10.1 Hz), 1.40 (s, 3H, Me, isopr.), 1.34 (s, 3H, Me, isopr.), 
0.92 (s, 9H, tBu, TBDMS), 0.12 (s, 3H, Me, TBDMS), 0.12 (s, 3H, Me, TBDMS) ppm. 
13C NMR (100 MHz, [D6]acetone): δ = 166.1 (COOH), 158.4 (C-3), 117.4 (C-3’), 112.9 
(Cq, isopr.), 106.7 (C-1), 79.6, 79.5 (C-2, C-4), 66.5 (C-6), 46.0 (C-5), 27.7 (Me, 
isopr.), 27.6 (Me, isopr.), 26.2 (3 × Me, tBu), 18.8 (Cq, tBu), 14.3 (CH2CH3), -5.2 (Me, 
TBDMS), -5.3 (Me, TBDMS) ppm. HRMS: calcd. for C17H30O6SSi [M + Na]
+ 
413.1425, found 413.1435; calcd. for [M + K]+ 429.1164, found 429.1171. 
 
3-Deoxy-[2-O,3-C-(1-oxoethan-1-yl-2-ylidene)]-5-thio-L-lyxo-hexopyranose (19):  
A solution of (3E)-[6-O-(tert-butyldimethylsilyl)-3-deoxy-1,2-O-isopropylidene-5-
sulfanyl-β-L-lyxo-hexofuranos-3-ylidene]acetic acid (18, 18 mg, 46 µmol) in aq. TFA 
(60%, 1 mL) was stirred at 40 ºC for 20 min. The solvent was co-evaporated with 
toluene and the crude product was purified by CC (EtOAc) to afford 19 (10 mg, 
quantitative) as a colorless oil. Rf = 0.41 (EtOAc). 
1H NMR (400 MHz, [D6]acetone): δ 
= 6.02 (br. d, H-3’β, J = 1.5 Hz), 6.00 (1, H-3’α, J = 1.8 Hz), 5.22–5.16 (m, H-1α, H-1β, 
H-2α) 5.10–5.05 (m, H-4α, H-4β), 4.98 (dd, H-2β, J1,2(β) = 8.6 Hz), 4.31 (dd, H-6a, J5,6a 
= 3.5, J6a,6b = 11.6), 3.90 (d, CH2-6, J5,CH2-6 = 5.8 Hz), 3.72 (dd, H-6b, J5,6b = 4.3 Hz), 
3.40 (ddd, H-5), 3.20 (q, H-5, J5,CH2-6 = J4,5) ppm.
13C NMR (100 MHz, [D6]acetone):  δ 
= 172.3, CO, lac), 170.7 (C-3), 116.1 (C-3’), 115.8 (C-3’), 86.3 (C-2β), 83.0, 76.6, 73.0 
(C-2α, C-1α, C-1β), 71.6, 70.2 (C-4α, C-4β), 62.7, 62.1 (C-6α, C-6β),  50.3, 49.2 (C-5α, 
C-5β) ppm. HRMS: calcd. for C8H10O5S [M + Na]
+ 241.0141, found 241.0147; calcd. 
for [M + K]+ 256.9881, found 256.9888. 




hexopyranose (20) and 4,6-Di-O-acetyl-l,5-anhydro-3-deoxy-[2-O,3-C-(1-oxoethan-
1-yl-2-ylidene)]-5-thio-L-threo-hex-l-enitol (21): Ac2O (0.35 mL) was added to a 
solution of 3-deoxy-[2-O,3-C-(1-oxoethan-1-yl-2-ylidene)]-5-thio-L lyxo-hexopyranose 
(19, 8 mg, 37 µmol) in py (0.7 mL), and the mixture was stirred at room temp. for 5 
min. After co-evaporation with toluene, the crude product was purified by CC 
(EtOAc/petroleum ether, 1:4) to afford the thioglycal-fused butenolide 21 (8.5 mg, 
82%) as colorless oil, together with traces of the triacetate derivative 20 (α/β ratio, 1:1). 
Data for 20: 1H NMR (400 MHz, CDCl3): δ = 6.27 (d, H-1α, J1,2(α) = 4.5 Hz), 6.22 (br. 
s, H-3’α), 6.11–6.07 (m, H-1β, H-3’β), 6.04 (br. dd, H-4α, J4,5a(α) = 6.1 Hz), 5.97 (br. dd, 
H-4β, J4,5a(β) = 6.6 Hz), 5.60 (d, H-1β, J1,2(β) = 9.1 Hz), 5.24 (br. d,  H-2α), 5.17 (ddd, 2β-
H , J1,2(β) = 8.6 Hz), 4.48–4.19 (m, H-6aα, H-6bα, H-6aβ, H-6bβ) 3.72 (ddd, H-5α), 3.58 
(ddd, H-5β) , 2.22, 2.21, 2.17, 2.12, 2.07, 2.06 (3 × Me, Ac,α, 3 × Me, Ac, β) ppm. 
HRMS: calcd. for C14H16O8S [M + Na]
+ 367.0458, found 367.0467. 
Data for 21: Rf = 0.15 (EtOAc/petroleum ether, 1:4). [ ]20Dα = +8 (c = 0.7, in CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ = 6.35 (d, 1H, H-1, 
5J1,3’ = 1.5 Hz), 6.16 (dd, 1H, H-4, J3’,4 
= 1.3, J4,5 = 4.0 Hz), 6.10 (t, 1H, H-3’), 4.40 (dd, 1H, H-6a, J5,6a = 5.3, J6a,6b = 11.6 Hz), 
4.25 (dd, 1H, H-6b, J5,6a = 7.8 Hz), 3.67 (ddd, 1H, H-5), 2.20 (s, 3H, Me, Ac), 2.09 (s, 
3H, Me, Ac) ppm. 13C NMR (100 MHz, CDCl3): δ = 170.5 (CO), 123.4 (C-2), 114.3 
(C-3’), 106.2 (C-1), 66.6 (C-4), 60.7 (C-6), 43.6 (C-5), 20.8 (CH3, Me, Ac) ppm. 
HRMS: calcd. for C12H12O6S [M + H]
+ 285.0427, found 285.0434; calcd. for [M + Na]+ 
307.0247, found 307.0254.  
 
(3R)-1,2-O-Isopropylidene-α-D-ribo-hexos-3-ulo-1,4:3,6-difuranose  (23): A similar 
protocol than that described in ref. [20] was used with slight modifications. A solution 
of 1,2;5,6-di-O-isopropylidene-α-D-ribo-hexofuranosid-3-ulose (22, 1.61 g, 6.23 mmol) 
in aq. AcOH (60%, 18 mL) was stirred at room temp. overnight. The solvent was co-
evaporated with toluene (3×) and the residue was purified by CC (EtOAc), to afford 23 
(1.25 g, 92%). Physical data were in agreement with those reported. 1H NMR (400 
MHz, CDCl3): δ = 
1H NMR (CDCl3, 400 MHz) δ 5.97 (d, 1H, H-1, J1,2 = 3.8 Hz), 4.56–
4.47 (m, 1H, H-5), 4.46–4-42 (m, 2H, H-2, OH-3), 4.31–4.22 (m, 2H, H-4, H-6a, J5,6a = 
6.3, J6a,6b = 9.3 Hz), 3.78 (dd, 1H, H-6b, J5,6b = 5.6 Hz), 2.87 (d, 1H, OH-5, JH-5,OH = 6.1 
Hz), 1.59 (s, 3H, Me, isopr.), 1.41 (s, 3H, Me, isopr.) ppm. 13C NMR (100 MHz, 





CDCl3): δ = 114.1 (Cq, isopr.), 111.0 (C-3), 107.1 (C-1), 84.2 (C-2), 82.9 (C-4), 73.9 
(C-6), 71.2 (C-5), 27.3 (Me, isopr.), 27.3 (Me, isopr.) ppm. 
 
(3R)-1,2-O-Isopropylidene-5-O-tosyl-α-D-ribo-hexos-3-ulo-1,4:3,6-difuranose (24): 
p-Toluenesulfonyl chloride (0.107 g, 0.56 mmol) was added under argon to a solution 
of (3R)-1,2-O-isopropylidene-α-D-ribo-hexos-3-ulo-1,4:3,6-difuranose (23, 0.111 g, 
0.51 mmol) in dry py (2 mL). The solution was kept stirring at room temp. for 40 h. 
Water (12 mL) was added to the solution, and the mixture was extracted with EtOAc (3 
× 5 mL). The combined organic layers were washed with water and dried with 
anhydrous MgSO4. After filtration and evaporation of the solvent, the residue was 
purified by CC (EtOAc/petroleum ether, 3:7) to afford 24 (65 mg, 34%) as a colorless 
oil. Rf = 0.35 (EtOAc/petroleum ether, 3:7). [ ]20Dα = +39 (c = 1.0, CH2Cl2). 1H NMR 
(400 MHz, CDCl3): δ = 7.83 (d, 2H, H-a, Ts, J = 8.3 Hz), 7.36 (d, 2H, H-b, Ts), 5.93 (d, 
1H, H-1, J1,2 = 4.0 Hz), 5.03 (ddd, 1H, H-5), 4.36 (d, 1H, H-2), 4.33 (d, 1H, H-4, J4,5 = 
4.3 Hz), 4.25 (dd, 1H, H-6a, J5,6a = 7.1, J6a,6b = 9.3 Hz), 3.94 (dd, 1H, H-6b, J5,6b = 7.1 
Hz), 2.46 (s, 3H, Me, Ts), 1.51 (s, 3H, Me, isopr.), 1.37 (s, 3H, Me, isopr.) ppm. 13C 
NMR (100 MHz, CDCl3): δ = 145.5 (Cq-a, Tos), 132.8 (Cq-b), 130.1 (CH-b, Tos), 
128.2 (CH-a, Ts), 114.1 (Cq, isopr.), 110.8 (C-3), 107.1 (C-1), 82.6, 82.4 (C-2, C-4), 
77.0 (C-5), 70.0 (C-6), 27.3 (Me, isopr.), 27.2 (Me, isopr.), 21.8 (Me, Ts) ppm. HRMS: 
calcd. for C16H20O8S [M + Na]
+ 395.0771, found 395.0785. 
 
(3R)-5-S-Acetyl-1,2-O-isopropylidene-5-thio-β-L-lyxo-hexos-3-ulo-1,4:3,6-
difuranose (26). A solution of (3R)-1,2-O-isopropylidene-α-D-ribo-hexos-3-ulo-
1,4:3,6-difuranose (23, 0.347 g, 1.59 mmol) and dry py (0.29 mL, 3.6 mmol) in dry 
dichloromethane (8 mL) was cooled to –11 ºC (MeOH/ice bath) under argon. 
Trifluoromethanosufonic anhydride (0.29 mL, 1.75 mmol) was added dropwise and the 
reaction was stirred whilst the temperature was kept b low –5 ºC. After 10 min, TLC 
showed total consumption of 23, and EtOAc (25 mL) was added. The solution was then
washed with a sat. NaHCO3 solution (12 mL) and aq. HCl solution (2 M, 12 mL). The 
aqueous layer was extracted twice with EtOAc and the combined organic phases were 
dried with anhydrous MgSO4. After filtration and concentration to dryness, the crude 
triflate 25 was used immediately for the next step without further purification. Rf = 0.76 
(EtOAc/petroleum ether, 2:3) [Rf (23) = 0.15 (EtOAc/petroleum ether, 2:3)]. 
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Potassium thioacetate (0.2 g, 1.75 mmol) was added to the crude triflate 25 in DMF (15 
mL). The solution was stirred at room temp. for 1 h5 min. Water (30 mL) was then 
added to the solution, and it was extracted with EtOAc (3 × 10 mL). The combined 
organic layers were washed with water and brine and dried with anhydrous MgSO4. 
After filtration and evaporation of the solvent, the residue was purified by column 
chromatography (EtOAc/cyclohexane, 1:5) to afford 26 (0.205 g, 47%) as a white solid. 
Rf = 0.35 (EtOAc/petroleum ether, 1.5:3.5). m.p. 68.8–69.9 ºC. [ ]20Dα = +36 (c = 1.0, in 
CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 5.91 (d, 1H, H-1, J1,2 = 4.3 Hz), 4.57–4.49 
(m, 1H, H-6a), 4.42 (d, 1H, H-2), 4.41 (s, 1H, H-4), .12-4.05 (m, 2H, H-5, H-6b), 3.75 
(s, 1H, OH) 2.37 (s, 3H, Me, SAc), 1.57 (s, 3H, Me, isopr.), 1.38 (s, 3H, Me, isopr.) 
ppm. 13C NMR (100 MHz, CDCl3): δ = 194.6 (CO, SAc), 117.1 (C-3’), 113.5 (Cq, 
isopr.), 111.8 (C-3), 106.2 (C-1), 88.8 (C-4), 81.3 (C-2), 75.2 (C-6), 44.8 (C-5), 30.6 
(Me, SAc), 27.3 (Me, isopr.), 27.3 (Me, isopr.) ppm. HRMS: calcd. for C11H16O6S [M + 
Na]+ 299.0560, found 299.0567; calcd. for [M + K]+ 315.0299, found 315.0310. 
 
(3R)-1,2-O-Isopropylidene-5-sulfanyl-β-L-lyxo-hexos-3-ulo-1,4:3,6-difuranose (27):  
(3R)-5-S-Acetyl-1,2-O-isopropylidene-5-thio-β-L-lyxo-hexos-3-ulo-1,4:3,6-difuranose 
(26, 50 mg, 0.18 mmol) was dissolved in MeOH/H2O (2/1, 2.6 mL) and NaOH solution  
(10 M, 0.02 mL) was added. After the system had been stirred at room temp. for 5 min, 
TLC showed total conversion of 27. The solution was then neutralized with Amberlite 
IR-120 H+, the resin was filtered off and the solvent was evaporated. The residue was 
purified by column chromatography (EtOAc/cyclohexane, 1:5) to afford 27 (37.5 mg, 
90%) as a white solid. Rf = 0.5 (EtOAc/petroleum ether, 1.5:3.5). m.p. 64.4–66.3 ºC. 
[ ]20Dα = +22 (c = 1.2, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 5.84 (d, 1H, H-1, J1,2 
= 4.0 Hz), 4.49 (s, 1H, H-4), 4.48–4-40 (m, 2H, H-2, H-6a, J5,6a = 6.3, J6a,6b = 9.3 Hz), 
4.15 (dd, 1H, H-6b, J5,6b = 3.0 Hz), 3.83 (s, 1H, OH-3), 3.39 (ddd, 1H, H-5), 2.24 (d, 
1H, SH, JSH,5 = 9.6 Hz), 1.59 (s, 3H, Me, isopr.), 1.39 (s, 3H, Me, isopr.) ppm. 
13C NMR 
(100 MHz, CDCl3): δ = 113.5 (Cq, isopr.), 112.1 (C-3), 105.8 (C-1), 91.0 (C-2), 81.8 
(C-4), 77.8 (C-6), 40.4 (C-5), 27.3 (Me, isopr.), 27.3 (Me, isopr.) ppm. HRMS: calcd. 
for C9H14O5S [M + Na]
+ 257.0454, found 257.0456. 
 
5-Thio-L-lyxo-hexopyran-3-ulose (28): A solution of (3R)-1,2-O-isopropylidene-5-
sulfanyl-β-L-lyxo-hexos-3-ulo-1,4:3,6-difuranose (27, 22 mg, 94 µmol) in aq. TFA 





(60%, 1 mL) was stirred at 40 ºC for 20 min. The solvent was co-evaporated with 
toluene and the crude product was purified by CC (EtOAc) to afford 28 (18 mg, 
quantitative) as a colorless oil. Rf = 0.22 (EtOAc). [ ]20Dα = +23 (c = 1.2, in MeOH). 1H 
NMR (400 MHz, CD3OD):  δ = 5.31 (d, H-1β, J1,2(β) =  8.6 Hz), 5.14 (d, 1H, H-1α, 
J1,2(α) = 4.0 Hz), 4.79 (dd, 1H, H-4α, J2,4(α) = 1.0, J4,5(α) = 6.8 Hz), 4.68–4.63 (m, H-2α, 
H-4β), 4.31 (dd, H-2β, J2,4(β) = 1.0 Hz), 4.16 (dd, H-6aα, J5,6a(α) = 4.0, J6a,6b(α) = 11.1 Hz), 
4.01 (dd, H-6aβ, J5,6a(β) = 4.0, J6a,6b(β) = 11.1 Hz), 3.72 (dd, H-6bβ, J5,6b(β) = 2.8 Hz), 3.62 
(dd, H-6bα, J5,6b(α) = 2.8 Hz), 3.52 (ddd, 1H, H-5α), 3.11 (ddd, H-5β) ppm. 
13C NMR 
(100 MHz, CD3OD, major anomer): δ = 207.7 (CO), 79.5 (C-2α), 79.3 (C-1α), 76.5 (C-
4α), 62.2 (C-6α), 52.4 (C-5α) ppm. HRMS: calcd. for C8H10O5S [M + Na]
+ 217.0141, 
found 217.0143; calcd. for [M + K]+ 232.9881, found 232.9883. 
 
2,4,6-Tri-O-acetyl-l,5-anhydro-5-thio-L-threo-hex-l-enopyran-3-ulose (29): Ac2O 
(0.35 mL) was added to a solution of 5-thio-L-lyxo-hexopyranos-3-ulose (28, 11 mg, 57 
µmol) in py (0.7 mL), and the mixture was stirred at room temp. for 5 min. After co-
evaporation with toluene, the crude product was purified by CC (EtOAc/petroleum 
ether, 2:3) to afford 29 (16 mg, 94%) as a colorless oil. Rf = 0.52 (EtOAc/petroleum 
ether, 2:3). [ ]20Dα = –6 (c = 0.2, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 6.98 (d, H-
1, 6J1,5 = 1.5 Hz), 5.97 (d, 1H, H-4, J4,5 = 5.1 Hz), 4.50–4.45 (m, 2H, H-6a, H-6b), 3.66 
(dddd, 1H, H-5), 2.22 (s, 3H, Me, Ac-2), 2.21 (s, 3H, Me, Ac-4), 2.08 (s, 3H, Me, Ac-6) 
ppm. 13C NMR (100 MHz, CDCl3): δ = 182.5 (CO), 170.6, 169.3, 168.6 (3 × CO, Ac), 
138.6 (C-2), 130.6 (C-1), 73.0 (C-4), 60.8 (C-6), 43.6 (C-5), 20.8, 20.6, 20.3 (3 × Me, 
Ac) ppm. HRMS: calcd. for C12H14O7S [M + Na]
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Results and Discussion – Nitrogen-Containing Carbohydrate Derivatives 





2.3.  Nitrogen-Containing Carbohydrate 
Derivatives Embodying an  
α,β-Unsaturated Carbonyl Functionality 
 
 
This subchapter includes the paper: 
 
“Exploitation of Furanoid 5-Azido-3-C-Branched-Chain Sugars Towards Highly 
Functionalized Nitrogen-Containing Carbohydrate Derivatives”, Xavier, N. M.; 
Queneau, Y.; Rauter, A. P. Eur. J. Org. Chem. 2010, in press. 
 
and reports on the synthesis of functionalized amides comprising an α,β-unsaturated 
carbonyl function and on that of a 1,2-dihydropyridin-3-one starting from furanoid δ-
amino α,β-unsaturated esters. This work also revealed interesting aspects about the 
reactivity of the furanoid 5-amino 3-C α,β-unsaturated ester precursors when compared 
to that of the corresponding 5-O- and 5-S-analogues, which gave, under similar reaction 
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The capability of easily accessed 5-azido-3-C (ethoxycarbonyl)methylene-1,2-O
protected furanoses to serve as precursors for the gen ration of imino sugar derivatives 
containing an α,β-unsaturated lactone or an α,β-unsaturated ketone functionality, was 
investigated. A key aspect was the propensity of the corresponding deprotected δ-amino 
α,β-unsaturated esters to undergo 5-aminofuranose/iminopyranose isomerization.  The 
δ-amino (Z)-α,β-unsaturated ester, when submitted to acid hydrolysis followed by 
treatment with base, led to a butenolide-containing N-ethylformamide, arising from the 
rearrangement of the imino sugar-fused butenolide int rmediate, induced by the 
conjugated system. When carrying out the ring expansion step under neutral conditions, 
a 2-keto imino sugar was obtained, which was readily converted into a 1,2-
dihydropyridin-3-one by acetylation. Furthermore, rduction of the  δ-azido (E)-α,β-
unsaturated ester to the amine was followed by spontaneous intramolecular cyclization, 
providing the related furanose-fused unsaturated δ-lactam.  






Imino sugars, in which the endocyclic oxygen atom of the sugar has been replaced by a 
nitrogen atom, constitute one of the most interesting classes of carbohydrate mimics, 
owing to their biological activities and therapeutic potential [1]. Probably the most 
intensively studied property of imino sugars is their aptitude to inhibit glycosidases by 
mimicking the natural substrates [1, 2]. Among such in ibitors are the naturally 
occurring nojirimycin and related compounds, including 1-deoxynojirimycin or 1-
deoxymannojirimycin [2a]. First reports on the synthesis of imino sugars came out 
during mid-1960's [3] and since then a variety of methods have been developed, starting 
either from commercially available sugars or from non-carbohydrate precursors [4]. 
Methods using carbohydrate starting materials frequently rely on the introduction of a 
nitrogen function (azide or amine) and subsequent intramolecular cyclization by amino 
group attack to a carbonyl group, to a carbon adjacent to a leaving group or to an 
activated double bond.   
 
As the search for original imino sugar structures rmains a topic of biological and 
synthetic interest, we were motivated to exploit the access to novel imino sugar 
derivatives bearing α,β-unsaturated carbonyl functions. Such conjugated systems are 
considered to be essential for the bioactivity exprssion of many compounds due to their 
propensity to undergo Michael-type addition of enzymes’ nucleophilic residues [5]. The 
inclusion of these functionalities in carbohydrates ha  provided advantageous scaffolds 
for derivatization and bioactive substances as well[6]. Particularly, some furanose C-C-
linked α,β-unsaturated γ-lactones were described as antifungal [7] and potent 
insecticidal agents [8]. This biological profile has prompted the acquisition of pyranose-
fused butenolides [9] and related thiosugar hybrid molecules [10].  These bicyclic 
compounds were synthesized by a strategy involving Wittig olefination of appropriately 
protected pento- or hexofuranos-3-ulose derivatives and subsequent acid hydrolysis of 
the intermediate furanose-3-C-branched α,β-unsaturated esters (Scheme 1). Within this 
latter step, cleavage of the protecting groups occurred with concomitant intramolecular 
lactonization and furanose to pyranose ring expansion. Introduction of additional 
sulphydryl functionality at C-5 of the intermediate α,β-unsaturated esters followed by 
deprotection, led to thiosugar analogues. 
 

























R = PG or H
R' = H or CH2OH
        or CH2OPG
R = PG
R' = H or CH2OPG
(Z)-isomer
R' = H or CH2OH
OR SR
 
Scheme 1. Synthetic approach for butenolides fused to pento- or hexopyranoses and 
thiosugar analogues starting from furanos-3-uloses. 
 
In this context, the aim of this work was to investiga e the approach Wittig 
olefination/intramolecular cyclization for the synthesis of new functionalized molecules 
in which an α,β-unsaturated carbonyl system is embodied in an imino sugar core. For 
that purpose, furanoid 3-C (ethoxycarbonyl)methylene-5-azido sugars were explored as 
key intermediates.  
 
The target compounds are intended to serve as precursors for the synthesis of highly 
functionalized nitrogen-containing sugars and as potential bioactive agents with 
functions of biological profile combined in a single molecule.  
 
 
Results and Discussion 
 
1. Iminopyranose-Fused Butenolide Acting as Intermediate for an Amide 
Functionalized Butenolide 
 
Synthesis of the suitable furanose precursors, carrying both the 5-nitrogen function and 
the exocyclic α,β-unsaturated ester moiety, started with 5-azido-pentofuranos-3-ulose 1 
(Scheme 2) which was prepared by PDC/Ac2O oxidation of 5-azido-5-deoxy-1,2-O
isopropylidene-α-D-pentofuranose [11], as previously reported [12]. Wittig-type 
olefination of 1 with [(ethoxycarbonyl)methylene]triphenylphosphorane in chloroform 
was completed within 30 min at room temp. to afford the (Z)- and (E)-α,β-unsaturated 
esters 2a,b in 74% yield and 13% yield, respectively. Subsequent Staudinger reduction 




of the azide group in 2a with triphenylphosphane in the presence of H2O gave the 
furanoid  δ-amino α,β-unsaturated ester 3 in 84% yield, which was acetylated with 
Ac2O in pyridine to the corresponding amide 4. Having a free amine at C-5, we 
proceeded to the removal of the 1,2-O-isopropylidene group towards the formation of 
the iminopyranose ring. Treatment of 3 with aq. TFA (60%) at room temp. for 10 min 
was sufficient to achieve acetonide cleavage, as judged by TLC. After co-evaporation of 
the acid with toluene, the crude was immediately acetylated (Ac2O/py) to afford 5 in 
80% overall yield. Since no ring expansion was possible under these conditions, likely 
due to the protonation of the amine, an alternative work-up was performed. Hence, 
evaporation of the aq. TFA solution was followed by dissolution of the residue in 
EtOH-water, which was then treated with base, namely aq. NaOH solution or 
triethylamine, until pH 8 or 10 was reached, respectiv ly. A single product was 
obtained, independently of the base used, and identified by NMR and HRMS as the 
butenolide-containing N-ethylformamide derivative 6. In the 1H NMR spectrum the 
singlet at δ 8.16 was indicative of a formyl proton and the HMBC correlation between 
this signal and C-1, which appeared at rather low chemical shift value 
(δ = 43.4 ppm), was in accordance with the presence of an amide group. The butenolide 
methylene protons (CH2-5’) were detected as a multiplet at δ 4.97–4.93 ppm, showing a 
weak coupling with H-3’, while the signal for C-5 appeared at δ 71.8 ppm. The 
resonances of the carbonyl carbon atoms were observed at δ = 173.7 ppm and at 
δ = 172.4 ppm, corresponding to the butenolide moiety and to the N-formyl group, 
respectively. Selective O-acetylation of 6 with Ac2O/py was achieved in 30 min 
affording 7 in 90% yield, while the addition of 4-dimethylaminopyridine (DMAP) in 
catalytic amount led to the product of further N-acetylation 8 in 84% yield. 
Mechanistically, the formation of 6 is thought to proceed via the iminopentopyranose-
fused butenolide intermediate, which in basic medium s deprotonated at the anomeric 
hydroxyl group. The formed enolate-type anion, stabilized by resonance, then 
undergoes protonation at C-5’ (Scheme 3). Addition of base is thus necessary to 
neutralize excess of acid, releasing the amine group f r cyclization. However its use in 
the presence of the α,β-unsaturated carbonyl moiety induced the rearrangement of the 
target bicyclic compound to derivative 6.  
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It is also worthy mention the potential use of furanoid δ-amino ester 3 as monomer for 
the generation of amide-linked oligomers. After storage for 1 month in a refrigerator (5 
ºC), ca. 50% of 3 spontaneously evolved towards the amide-linked disaccharide 9, 





Scheme 2. Reactions and conditions: a) Ph3P=CHCO2Et, CHCl3, room temp., 30 min; 
74% (2a) and 13% (2b); b) PPh3, H2O/THF, room temp., 16 h, 84%; c) Ac2O, py, room 
temp., 5 min, 90%; d) TFA 60% aq., room temp., 10 min; e) Ac2O, py, room temp., 5 
min, 80%, 2 steps; f) NaOH 1M, EtOH/H2O, until pH 8, 45%, 2 steps; g) NEt3, 
EtOH/H2O until pH 10, 65%, 2 steps; h) Ac2O, py, room temp., 30 min, 90%; i) Ac2O, 













2. Synthesis  of a Furanose-Fused α,β-Unsaturated-δ-Lactam 
 
In contrast with the amine 3, the furanoid  δ-amino-(E)-α,β-unsaturated ester 10, 
resulting from Staudinger reduction of the (E)-azido precursor 2b, could not be isolated 
and was obtained together with the furanose-fused δ-lactam 11 (Scheme 4). The 
intramolecular amidation of 10  was shown  to be spontaneous and a clean conversion to 
11 (89% overall yield) was attained simply by letting the referred mixture stand 
overnight in solution. DMAP-catalysed acetylation of 11 furnished the corresponding 


















2b 10 11   R = H





Scheme 4. Reactions and conditions: a) PPh3, H2O/THF, room temp., 16  h to give 10 
and 11 (ratio 0.35/1), then CH2Cl2, 16 h, 89% (11); b) Ac2O, catalytic DMAP, py, room 
temp., 16 h., 85%. 
 
3. Synthesis  of 1,2-Dihydropyridin-3-one 
 
Hydrolysis of the 1,2-O-isopropylidene group of 2a prior to azide reduction was figured 
to be a feasible alternative to the strategy depictd in Scheme 2, in order to allow the 
furanose to 5-aminofuranose/iminopyranose isomerization to occur under neutral 
conditions (Scheme 5). Hence, TFA-promoted hydrolysis of 2a gave the 1,2-diol 13 in 
94% yield. No intermolecular transesterification leading to the furanose-fused 
butenolide was observed, in accordance with the previously reported results for similar 
furanoid γ-hydroxy α,β-unsaturated carbonyl systems [9a]. Staudinger reduction was 
subsequently attempted, however leading to decomposition of diol 13. In order to check 
whether this result would be different with protection of the 1,2-hydroxyl groups, 
silylation of 13 was carried out. Silyl ethers can be cleaved by TBAF and, regarding the 
conditions required for the access to the target bicyclic compound, their use as 
protecting groups may be advantageous to the acetonid  functionality. Treatment of diol 
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13 with tert-butyldimethylsilyl chloride (TBDMSCl) and a catalytic amount of DMAP 
in pyridine (15 h) afforded the monoprotected derivative 14 as the major product (55%), 
together with the 1,2-di-O-silyl derivative 15 (14%). On the other hand, as expected, 
reaction of 13 with trimethylsilyl chloride (TMSCl) in the presence of triethylamine and 
DMAP gave only the disilylated compound 16. The ensuing experiments to selectively 
reduce the azide group of compounds 14 and 16 using the Staudinger method were not 
successful and only decomposition of the starting materials was observed by TLC.  
Instead, hydrogenation of 13 was performed. Exposure of 13 to hydrogen atmosphere in 
the presence of 10% Pd/C was followed by addition of tert-butoxycarbonyl anhydride 
(Boc2O) to give keto iminosugar 17, which upon acetylation (Ac2O/py) resulted in the 
1,2-dihydropyridin-3-one 18. The structure of 18 was readily established by NMR.  The 
13C NMR spectrum showed the signal of the carbonyl group at δ 192.5 ppm, which is 
typical of an α,β-unsaturated ketone. The olefinic proton (H-5’) was ob erved at δ 6.92 
ppm as a broad singlet and COSY experiments showed a weak coupling with the C-6’ 
protons. 
 
The formation of compound 17 is not surprising since imino sugars possessing an 
anomeric hydroxyl group are prone to dehydration due to the low stability of the 
hemiaminal function [13]. The resulting imine then isomerizes to the enol which in turn 
tautomerizes to the keto form, as shown in Scheme 6. Acetylation of 17 occurred with 
concomitant elimination of acetic acid to give the unsaturated enone system, which is 
consistent with the known tendency of β-acylated pyranuloses for α,β-elimination [14].  
 
1,2-Dihydropyridin-3-ones are generally obtained in low global yield by methodologies 
usually requiring various synthetic steps [15, 16]. Our approach provided compound 18 
after 5 steps and in 29% overall yield starting from the readily prepared 5-azido-3-ulose 
1. This molecule is structurally suitable to be a usef l synthon for new imino sugar 
derivatives. Enones of this family have been used as key intermediates for the synthesis 
of natural products [15, 17], including 1-deoxynojirimycin [17a], deoxymannojirimycin 
and deoxygulonojirimycin [15].   
 
 



























a) b) to give 14-15












15 R1, R2 = TBDMS
14 R1 = TBDMS, R2 = H











Scheme 5. Reactions and conditions: TFA 60% aq., room temp., 5 min, 94%; b) 
TBDMSCl, py, catalytic DMAP, room temp., 15 h, 55% (14) and 14% (15); c) TMSCl, 
NEt3, catalytic DMAP, CH2Cl2, room temp., 10 min, 67%; d) H2, 10% Pd/C, EtOH, 
room temp., 40 min; e) Boc2O, room temp., 1 h 30 min; f) Ac2O/py, room temp., 30 




Scheme 6. Generation of 2-keto imino sugar 17 by hydrogenation (H2, 10% Pd/C, 




Furanoid (Z)- and (E)-3-C-(ethoxycarbonyl)methylene 5-azido sugars proved to be 
useful precursors for the acquisition of carbohydrate or non-carbohydrate molecules 
comprising an α,β-unsaturated lactone or an α,β-unsaturated ketone functionality, by 
reliable approaches involving few synthetic steps. The corresponding (E)- and (Z)-δ-
amino α,β-unsaturated esters were converted, through intramolecular cyclization, to a 
furanose-fused α,β-unsaturated δ-lactam or to a butenolide-containing N-
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ethylformamide, respectively. The ring expansion of 5-aminofuranose to iminopyranose 
was shown to be the dependent of the pH. A basic-medium mediated the rearrangement 
of the imino sugar-fused butenolide intermediate to a N-ethylformamide derivative,  
elicited by the conjugated carbonyl functionality. On the other hand, under neutral 
conditions, a 2-keto imino sugar was obtained, which was subsequently converted into a 
1,2-dihydropyridin-3-one by acetylation. The α,β-unsaturated ester moiety also induced 
the spontaneous intermolecular amidation of the δ-amino (Z)-α,β-unsaturated ester 
along with concomitant Michael addition to give a pseudo dissacharide.  
 
The newly accessed final compounds may be regarded as structurally interesting 




General Methods: All reactions were followed by TLC on Merck 60 F254 silica gel 
aluminium plates with detection under UV light (254 nm) and/or by spraying with a 
solution of 10% H2SO4 in EtOH or with the Hanessian stain. Column chromatography 
(CC) was performed on silica gel 60 (0.040–0.063 mm, Merck). 1H and 13C NMR 
spectra were acquired with a Bruker Avance 400 spectrometer, operating at 400 MHz 
for 1H and 100 MHz for 13C. Chemical shifts are expressed in parts per million and are 
referenced to solvent residual peaks. Assignments were made by COSY, HMQC, and 
by HMBC experiments. HRMS spectra were acquired in an Apex Ultra FTICR Mass 
Spectrometer equipped with an Apollo II Dual ESI/MALDI ion source, from Bruker 
Daltonics, and a 7T actively shielded magnet from Magnex Scientific. Optical rotations 
were measured on a Perkin–Elmer 343 polarimeter at 20 ºC (589 nm, sodium D line). 
 
Ethyl (3Z)-(5-Azido-3,5-dideoxy-1,2-O-isopropylidene-α-D-erythro-pentofuranos-3-
ylidene)acetate (2a) and Ethyl (3E)-(5-Azido-3,5-dideoxy-1,2-O-isopropylidene-α-
D-erythro-pentofuranos-3-ylidene)acetate (2b): To a solution of the 3-ulose 1 [12] 
(0.2 g, 0.94 mmol) in dry CHCl3 (8 mL) was added [(ethoxycarbonyl)-
methylene]triphenylphosphorane (0.47 g, 1.35 mmol).  The mixture was stirred at room 
temp. for 30 min. After evaporation of the solvent, the residue was purified by CC 
(EtOAc/petroleum ether, 1:8 then 1:6) to afford the (Z)-adduct 2a (0.197 g, 74%) and its 
(E)-isomer 2b (0.034 g, 13%) as colorless oils. 




Data for 2a: Rf = 0.27 (EtOAc/petroleum ether, 1:6). [ ]20Dα = +224 (c = 1.1, in CH2Cl2). 
1H NMR (CDCl3, 400 MHz): δ = 5.91 (d, 1H, H-1, J1,2 = 4.0 Hz), 5.82 (t, 1H, H-3’, J2,3’ 
= J3’,4  = 1.8 Hz), 5.71 (dt, 1H, H-2, J2,3’ = J2,4), 4.98–4.93 (m, 1H, H-4), 4.20 (q, 2H, 
CH2CH3, J = 7.1 Hz), 3.61 (dd, part A of ABX system, 1H, H-5a, J4,5a = 3.5, J5a,5b = 
13.4 Hz), 3.36 (dd, part B of ABX system, 1H, H-5b, J4,5b = 4.2 Hz), 1.45 (s, 3H, Me, 
isopr.), 1.38 (s, 3H, Me, isopr.), 1.27 (t, 3H, CH2 3) ppm. 
13C NMR (CDCl3, 400 
MHz): δ = 164.5 (CO), 154.6 (C-3), 117.2 (C-3’), 113.0 (Cq, isopr.), 105.0 (C-1), 78.8 
(C-4), 78.2 (C-2), 60.9 (CH2CH3), 52.7 (C-5), 27.4 (Me, isopr.), 27.1 (Me isopr.), 14.1 
(CH2CH3). HRMS: calcd. for C12H17N3O5 [M + Na]
+ 306.1060, found 306.1063. 
Data for 2b: Rf = 0.35 (EtOAc/petroleum ether, 1:8). [ ]20Dα = +229 (c = 1.1, in CH2Cl2). 
1H NMR (CDCl3, 400 MHz):  δ = 6.18 (t, 1H, H-3’, J2,3’ = J3’,4 = 1.8 Hz), 5.96 (d, 1H, 
H-1, J1,2 = 4.5 Hz), 5.65–5.61 (m, 1H, H-4), 5.11 (dt, 1H, H-2, J2,3’ = J2,4), 4.18 (qd, 2H, 
CH2CH3), 3.71 (dd, part A of ABX system, 1H, H-5a, J4,5a = 2.8, J5a,5b = 12.9 Hz), 3.62 
(dd, part B of ABX system, 1H, H-5b, J4,5b = 3.0 Hz) 1.41 (s, 3H, Me, isopr.), 1.38 (3H, 
Me, isopr.), 1.29 (t, 3H, CH2CH3, J = 7.1 Hz) ppm. 
13C NMR (CDCl3, 400 MHz): δ = 
165.4 (CO), 159.2 (C-3), 118.1 (C-3’), 113.4 (Cq, isopr.), 104.3 (C-1), 81.8 (C-2), 80.5 
(C-4), 60.9 (CH2CH3), 54.9 (C-5), 27.9 (Me, isopr.), 27.8 (Me, isopr.), 14.2 (CH2CH3); 
HRMS: calcd. for C12H17N3O5 [M + H]
+ 284.1241, found 284.1239; calcd for [M + Na]+ 
306.1060, found 306.1062. 
 
Ethyl (3Z)-(5-Amino-3,5-dideoxy-1,2-O-isopropylidene-α-D-erythro-pentofuranos-
3-ylidene)acetate (3): A mixture of compound 2a (0.075 mg, 0.27 mmol) and 
triphenylphosphine (0.136 g, 0.52 mmol) in H2O (0.2 mL) and THF (2.6 mL) was 
stirred at room temp. for 16 h. After evaporation of the solvents, the residue was 
purified by CC (EtOAc then EtOAc/methanol, 6:1) to afford the title compound (0.057 
g, 84%) as a colorless oil. Rf = 0.26 (EtOAc/methanol, 4:1). [ ]20Dα = +117 (c = 0.9, in 
CH2Cl2). 
1H NMR (400 MHz, [D6]acetone): δ = 6.04 (t, 1H, H-3’, J2,3’ = J3’,4  = 1.8 Hz) 
5.89 (d, 1H, H-1, J1,2 = 4.0 Hz), 5.67 (dt, 1H, H-2, J2,3’ = J2,4), 5.03–4.98 (m, 1H, H-4), 
4.17 (q, 2H, CH2CH3, J = 7.1 Hz), 3.47–3.42 (m, 2H, CH2-5), 1.40 (s, 3H, Me, isopr.), 
1.33 (s, 3H, Me, isopr.), 1.26 (t, 3H, CH2CH3) ppm. 
13C NMR (100 MHz, [D6]acetone): 
δ = 165.5 (CO), 159.6 (C-3), 116.6 (C-3’), 112.6 (Cq, isopr.), 106.0 (C-1), 81.1 (C-4), 
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79.5 (C-2), 60.8 (CH2CH3), 56.0 (C-5), 27.7 (Me, isopr.), 27.5 (Me, isopr.), 14.5 
(CH2CH3) ppm. HRMS: calcd. for C12H19NO5 [M + H]
+ 258.1336, found 258.1339. 
 
Ethyl (3Z)-(5-N-Acetylamino-3,5-dideoxy-1,2-O-isopropylidene-α-D-erythro-
pentofuranos-3-ylidene)acetate (4): To a solution of compound 3 (20 mg, 0.08 mmol)  
in py (0.8 mL), was added Ac2O (0.4 mL) and the mixture was stirred at room temp. for 
5 min. After co-evaporation with toluene, the crude product was purified by CC 
(EtOAc/petroleum ether, 1:4) to afford the title compound as a colorless oil (21 mg, 
90%). Rf = 0.25 (EtOAc/petroleum ether, 4:1). 
1H NMR (400 MHz, CDCl3): δ = 5.93 (t, 
1H, H-3’, J2,3’ = J3’,4 = 1.8 Hz), 5.89 (d, 1H, H-1, J1,2 = 4.0 Hz), 5.81 (br. t, 1H, NH), 
5.77 (br. d, 1H, H-2), 4.91–4.86 (m, 1H, H-4), 4.27–4.18 (m, 2H, CH2CH3), 3.84 (ddd, 
1H, H-5a, J4,5a = 3.3, J5a,NH  = 6.8, J5a,5b = 14.1 Hz), 3.30 (ddd, 1H, H-5b, J4,5b = 5.1, 
J5b,NH = 7.1 Hz),  1.99 (s, 3H, Me, NHAc), 1.50 (s, 3H, Me, isopr.), 1.41 (s, 3H, Me, 
isopr.), 1.30 (t, 3H, CH2CH3, J = 7.1 Hz) ppm.
13C NMR (100 MHz, CDCl3): δ = 170.4 
(CO, Ac), 165.0 (CO), 154.1 (C-3), 117.1 (C-3’), 113.0 (Cq, isopr.), 104.6 (C-1), 78.5 
(C-4), 78.0 (C-2), 61.0 (CH2CH3), 41.1 (C-5), 27.3 (Me, isopr.), 27.1 (Me, isopr.), 23.4 





3-ylidene)acetate (5): A solution of compound 3 (12 mg, 0.05 mmol) in aq. TFA (60%, 
0.7 mL) was stirred at room temp. After 10 min, TLC showed complete conversion [Rf 
= 0.33 (CH2Cl2/EtOH, 5:1); Rf (3) = 0.5 (CH2Cl2/EtOH, 5:1)] and the solution was co-
evaporated with toluene. The residue was dissolved in py (0.5 mL) and Ac2O (0.3 mL) 
was added. After stirring at room temp. for 5 min, the solvents were co-evaporated with 
toluene and the crude product was purified by CC (EtOAc) to afford the title compound 
(13 mg, 80%, ratio α/β: 0.3/1) as a colorless oil. Rf = 0.35 (EtOAc). [ ]20Dα = +2 (c = 0.3, 
in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 6.50 (d, H-1α, J1,2 = 5.1 Hz), 6.21 (s, H-
1β), 6.20 (t, H-2β, J2,3’(β) = J2,4(β) =  1.5 Hz), 6.15 (dt, H-2α), 6.12 (t, H-3’β, J2,3’(β) = 
J3’,4(β)), 6.04 (t, H-3’α, J2,3’(α) = J3’,4(α) = 2.5 Hz), 5.91 (br. t, NH-β), 5.82 (br. t, NH-α), 
5.00–4.95 (m, H-4β), 4.93–4.87 (m, H-4α), 4.25–4.13 (m, CH2CH3, J = 7.1 Hz), 3.85 
(ddd, H-5aβ, J4,5a (β) = 3.3, J5a,NH (β) = 7.3, J5a,5b (β)  = 14.1 Hz), 3.77 (ddd, H-5aα, J4,5a (α) = 
3.0, J5a,NH (α) = 6.3, J5a,5b (α) = 14.4 Hz), 3.41 (dt, H-5bα, J4,5b (α) = J5b,NH (α)= 6.3), 3.17 




(ddd, H-5bβ), 2.10, 2.09 (2 × s, 6H, Me, Ac, β), 2.08, 2.05 (2 × s, Me, Ac, α), 2.01 (s, 
3H, Me, NHAc, β), 1.99 (s, Me, NHAc, α), 1.32 (t, CH2CH3) ppm. 
13C NMR (100 
MHz, CDCl3, major anomer, β): δ = 170.4 (CO), 169.7 (CO), 169.2 (CO), 164.1 
(CO2Et), 151.5 (C-3), 120.0 (C-3’), 99.6 (C-1), 82.1 (C-4), 74.7 (C-2), 61.3 (CH2CH3), 
44.6 (C-5), 23.4 (Me, NHAc), 21.4, 20.7 (2 × Me, Ac), 14.3 (CH2CH3) ppm. HRMS: 
calcd. for C15H21NO8 [M + Na]
+ 366.1159, found 366.1169. 
 
N-[(S)-2-(2,5-dihydro-2-oxofuran-4-yl)-2-hydroxyethyl]formamide (6): A solution 
of compound 3 (30 mg, 0.12 mmol) in aq. TFA (60%, 1.7 mL) was stirred at room 
temp. After 10 min, TLC showed complete conversion [Rf = 0.33 (CH2Cl2/EtOH, 5:1); 
Rf (3) = 0.5 (CH2Cl2/EtOH, 5:1)] and the solution was co-evaporated with toluene. The 
residue was dissolved in EtOH and water and treated with aq. NaOH solution (0.1 M) 
until pH 8 was reached [Rf = 0.47 (CH2Cl2/EtOH, 5:1]. After evaporation of the 
solvents, the crude product was purified by CC (CH2 l2/acetone, 3:2) to afford the title 
compound (9 mg, 45%) as a colorless oil. Alternatively, treatment of the residue with 
NEt3 until pH 10 was reached, also led to 6 (39 mg, 65%, starting from 90 mg of 3). Rf 
= 0.2 (CH2Cl2/acetone, 3:2).[ ]20Dα = −20 (c = 1.3, in MeOH).1H NMR (400 MHz, 
[D6]acetone):  δ = 8.16 (s, 1H, COH), 7.50 (br. s, 1H, NH), 6.01 (q, 1H, H-3’, J5’a,3’ = 
J5’b,3’ = J2,3’  = 1.8 Hz), 4.97−4.93 (m, 2H, CH2-5’), 4.81 (br. t, 1H, H-2, J2,CH2-1 = 5.3 
Hz), 3.57 (d, 2H, CH2-1) ppm. 
13C NMR (100 MHz, [D6]acetone): δ = 173.7 (CO, 
lactone), 172.4 (CO), 162.5 (C-4’), 116.0 (C-3’), 71.8 (C-5’), 68.5 (C-2), 43.5 (C-1) 
ppm. HRMS: calcd. for C7H9NO4 [M + Na]
+ 194.0424, found 194.0428; calcd. for 
C7H9NO4 [M + H] 170.0459, found 170.0460. 
 
(S)-[1-(2,5-dihydro-2-oxofuran-4-yl)-2-N-formylamino]ethyl acetate (7): To a 
solution of compound 6 (21 mg, 0.12 mmol) in py (0.8 mL), was added Ac2O (0.4 mL) 
and the mixture was stirred at room temp. for 30 min. After co-evaporation with 
toluene, the crude product was purified by CC (EtOAc) to afford the title compound as 
a colorless oil (23 mg, 90%). Rf = 0.17 (EtOAc). [ ]20Dα = +7 (c = 0.7, in CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ = 8.21 (br. s, 1H, COH), 6.13 (br. t, 1H, NH), 6.05 (q, 1H, 
H-3’, J3’,5’a = J3’,5’b = J2,3’  = 1.8 Hz), 5.73 (br. t, 1H, H-2, J2,CH2-1 = 5.0 Hz), 4.89 (br. d, 
2H, CH2-5’, J = 1.8 Hz), 3.75–3.69 (m, 2H, CH2-1), 2.16 (s, 3H, CH3, Ac) ppm. 
13C 
NMR (100 MHz, CDCl3): δ = 172.6 (CO, lactone), 169.8 (CO, Ac), 164.7 (CO), 161.5 
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(C-4’), 117.9 (C-3’), 71.2 (C-5’), 69.1 (C-2), 40.1 (C-1), 20.9 (Me, Ac) ppm. HRMS: 
calcd. for C9H11NO5 [M + H]
+ 214.0710, found 214.0717; calcd for [M + Na]+ 
236.0529, found 236.0537; calcd for [M + K]+ 257.0269, found 257.0278. 
 
(S)-[1-(2,5-dihydro-2-oxofuran-4-yl)-2-N-formylacetamido]ethyl acetate (8): To a 
solution of compound 6 (12 mg, 0.07 mmol) in py (1 mL), was added Ac2O (0.5 mL) 
and DMAP (3 mg) and the mixture was stirred at room te p. for 1 h. After co-
evaporation with toluene, the crude product was purified by CC (EtOAc/petroleum 
ether, 3:2) to afford the title compound as a colorless oil (15 mg, 84%). Rf = 0.27 
(EtOAc/petroleum ether, 3:2). [ ]20Dα = +8 (c = 0.5, in CH2Cl2). 1H NMR (400 MHz, 
CDCl3): δ = 9.11 (br. s, 1H, COH), 6.08 (br. s, 1H, H-3’), 5.87 (br. dd, 1H, H-2, J1a,2 = 
7.3, J1b,2 = 3.5 Hz), 4.92 (br. s, 2H, CH2-5’), 4.20 (dd, 1H, H-1a, J1a,1b = 13.9 Hz), 3.98 
(dd, 1H, H-1b), 2.44 (s, 3H, CH3, NAc), 2.09 (s, 3H, CH3, Ac) ppm. 
13C NMR (100 
MHz, CDCl3): δ = 172.4 (CO, lactone), 170.9 (CO, NAc), 170.0 (CO, Ac), 164.3 (CO), 
162.6 (C-4’), 117.9 (C-3’), 71.0 (C-5’), 68.0 (C-2), 41.7 (C-1), 22.8 (Me, NAc), 20.8 
(Me, Ac) ppm. HRMS: calcd. for C9H11NO5 [M + H]
+ 256.0816, found 256.0812; calcd 




pentofuranos-3-ylidene]acetate (9): 50% of compound 3 evolved towards 9 after  
storage for 1 month at 5 ºC. Rf = 0.29 (EtOAc). [ ]20Dα = +108 (c = 1, in CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ = 6.41 (br. s, 1H, NH), 5.89 (br. s, 1H, H-3’’’), 5.87 (d, 1H, 
H-1’, J1’,2’ = 3.3 Hz), 5.79 (d, 1H, H-1, J1,2 = 3.0 Hz), 5.69 (br. d, 1H, H-2’), 4.85 (brd, 
1H, H-4’), 4.27–4.16 (m, 3H, H-2, CH2CH3), 3.84 (brs, 1H, H-4), 3.59 (d, 1H, part A of 
AB system, 1H, H-5a, J5a,5b  = 14.4 Hz),  3.52 (d, part B of AB system, 1H, H-5b), 2.91 
(dd, part A of ABX system, 1H, H-5’a, J4’,5’a = 2.0, J5’a,5’b = 10.9 Hz), 2.71 (dd, part B of 
ABX system, 1H, H-5’b, J4’,5’b = 8.3 Hz), 2.52 (d, part A of AB system, H-3’a, J3’a,3’b = 
16.9 Hz), 2.02 (d, part B of AB system, H-3’b),  1.5 , 1.47, 1.39, 1.31 (4 × s, 4 × 3H, 
Me, isopr.), 1.27 (t, 3 H, CH2CH3, J = 7.1 Hz) ppm. 
13C NMR (100 MHz, CDCl3): δ = 
169.8 (CO), 164.9 (CO, amide), 155.9 (C-3’’), 116.4 (C-3’’’), 112.9, 112.7 (2 × Cq, 
isopr.), 104.8 (C-1’), 104.3 (C-1), 81.8 (C-2), 79.3 (C-4’), 78.3 (C-2’), 74.5 (C-4), 64.5 
(C-3), 60.9 (CH2CH3), 46.1 (C-5’), 41.5 (C-5), 34.1 (C-3’), 27.4, 27.2, 26.6, 26.5 (4 × 




Me, isopr.), 14.2 (CH2CH3) ppm. HRMS: calcd. for C22H32N2O9 [M + H]
+ 469,2181, 
found 469,2185;  calcd for [M + Na]+ 491.2000, found 491.2008. 
 
Ethyl (3Z)-(5-Amino-3,5-dideoxy-1,2-O-isopropylidene-α-D-erythro-pentofuranos-
3-ylidene)acetate (10) and 5-Amino-3,5-dideoxy-3-C,5-N-(1-oxoethan-1-yl-2-
ylidene)-1,2-O-isopropylidene-α-D-erythro-pentopyranose (11): A mixture of 
compound 2b (0.523 g, 1.85 mmol) and triphenylphosphine (0.968 g, 3.69 mmol) in 
H2O (1.4 mL) and THF (18 mL) was stirred at room temp. for 16 h. After evaporation 
of the solvents, the residue was chromatographed on silica gel (CH2Cl2 then 
CH2Cl2/methanol, 6:1) to afford compound 10 (not isolated due to spontaneous 
conversion into 11) and compound 11 (0.372 g, ratio 10/11: 0.35/1, 23% and 67%, 
respectively). After standing overnight in a CH2Cl2 solution, 10 was completely 
converted into 11 (89% from 2b). 
Data for 10: Rf = 0.28 (CH2Cl2/methanol, 6:1). 
1H NMR (400 MHz, [D6]acetone): δ = 
6.02 (t, 1H, H-3’, J2,3’ = J3’,4  = 1.8 Hz) 5.84 (d, 1H, H-1, J1,2 = 4.8 Hz), 5.67–5.63 (m, 
1H, H-4), 5.13 (dt, 1H, H-2), 4.16 (q, 2H, CH2CH3, J = 7.1 Hz), 3.54 (dd, part A of 
ABX system, 1H, H-5a, J4,5a = 2.5, J5a,5b = 14.9 Hz), 3.43 (dd, part B of ABX system, 
1H, H-5b, J4,5b = 3.3 Hz), 1.34 (s, 3H, Me, isopr.), 1.32 (s, 3H, Me, isopr.), 1.26 (t, 3H, 
CH2CH3) ppm. 
13C NMR (100 MHz, [D6]acetone): δ = 166.1 (CO), 164.1 (C-3), 115.9 
(C-3’), 113.1 (Cq, isopr.), 105.3 (C-1), 83.4 (C-2), 82.7 (C-4), 60.9 (CH2CH3), 56.0 (C-
5), 28.0 (Me, isopr.), 28.0 (Me, isopr.), 14.4 (CH2 3) ppm. 
Data for 11: Rf = 0.4 (EtOAc). [ ]20Dα = −8 (c = 0.8, in CH2Cl2). 1H NMR (400 MHz, 
CDCl3): δ = 6.41 (br. s, 1H, NH), 6.02 (d, 1H, H-1, J1,2 = 3.8 Hz), 5.97 (t, 1H, H-3’, J2,3’ 
= J3’,4 = 1.8 Hz) 5.07–5.00 (m, 2H, H-2, H-4), 3.67 (ddd, 1H, H-5a, J4,5a = 5.3, J5a,NH = 
7.3, J5a,5b = 11.6 Hz), 3.30 (t, 1H, H-5b, J4,5b = 11.6 Hz),  1.54 (s, 3H, Me, isopr.), 1.38 
(s, 3H, Me, isopr.) ppm. 13C NMR (100 MHz, CDCl3): δ = 165.9 (CO, lactam), 152.8 
(C-3), 118.9 (C-3’), 114.0 (Cq, isopr.), 107.0 (C-1), 78.7 (C-2), 72.3 (C-2), 45.3 (C-5), 
27.2 (Me, isopr.), 26.9 (Me, isopr.) ppm. HRMS: calcd. for C10H13NO3 [M + H]
+ 
212.0917, found 212.0917; calcd for [M + Na]+ 234.0737, found 234.0737; calcd for [M
+ K]+ 250.0476, found 250.0477. 
 
5-N-Acetylamino-3,5-dideoxy-3-C,5-N-(1-oxoethan-1-yl-2-ylidene)-1,2-O-
isopropylidene-α-D-erythro-pentopyranose (12): To a solution of compound 11 (15 
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mg, 0.07 mmol) in py (1 mL), was added Ac2O (0.6 mL) and DMAP (3 mg) and the 
mixture was stirred at room temp. for 16 h. After co-evaporation with toluene, the crude 
product was purified by column chromatography (EtOAc/petroleum ether, 1:3) to afford 
the title compound as a colorless oil (15 mg, 85%). Rf = 0.32 (EtOAc/petroleum ether, 
1:3). [ ]20Dα = −22 (c = 0.8, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 6.07–6.03 (m, 
2H, H-1, H-3’, J1,2 = 3.8, J2,3’ = J3’,4 = 1.8 Hz), 5.06 (d, 1H, H-2),  5.02 (dd, 1H, H-5a, 
J4,5a = 6.3, J5a,5b = 11.9 Hz), 4.94 (br. dd, 1H, H-4, J4,5b  = 10.9 Hz),  3.06 (t, 1H, H-5b),  
2.53 (s, 3H, NAc), 1.55 (s, 3H, Me, isopr.), 1.39 (s, 3H, Me, isopr.) ppm. 13C NMR (100 
MHz, CDCl3): δ = 173.0 (CO), 164.9 (CO, lactam), 156.1 (C-3), 119.6 (C-3’), 114.5 
(Cq, isopr.), 106.9 (C-1), 78.6 (C-2), 72.2 (C-2), 46.3 (C-5), 27.2 (Me, isopr.), 27.2 (Me, 
NAc), 26.9 (Me, isopr.) ppm. HRMS: calcd. for C12H15NO5 [M + H]
+ 254.1023, found 
254.1025; calcd for [M + Na]+ 276.0842, found 276.0844. 
 
Ethyl (3Z)-(5-Azido-3,5-dideoxy-D-erythro-pentofuranos-3-ylidene)acetate (13): A 
solution of compound 2a (0.536 g, 1.89 mmol) in aq. TFA (60%, 13 mL) was stirred at 
room temp. for 5 min. After co-evaporation with toluene, the crude product was purified 
by CC (EtOAc/petroleum ether, 1:1) to afford the title compound (0.43 mg, 94%, ratio 
α/β: 1/0.35) as a colorless oil. Rf = 0.28 (EtOAc/petroleum ether, 2:3). 
1H NMR (400 
MHz, CDCl3): δ = 5.99–5.91 (m, H-3’α, H-3’β, J = 2.0 Hz), 5.61 (d, H-1α, J1,2 = 5.1 
Hz), 5.51 (br. s, 1H, H-1β), 5.06–4.89 (m, H-2α, H-2β, H-4α, H-4β), 4.32-4.18 (m, 
CH2CH3, J = 7.1 Hz), 3.66–3.56 (m, H-5aα, H-5aβ, J4,5a (α) = 3.3, J5a,5b (α)= 12.9 Hz), 
3.47-3.34 (m, H-5bα, H-5bβ, J4,5b (α) = 5.3, J4,5b (β) = 4.3, J5a,5b (β) = 13.1 Hz), 1.32 (t, 3, 
CH2CH3) ppm. 
13C NMR (100 MHz, CDCl3): δ = 167.8 (CO), 166.8 (CO, β), 161.9 (C-
3α), 161.4 (C-3β), 116.7 (C-3’β), 115.9 (C-3’α), 103.5 (C-1β), 96.8 (C-1α), 80.7 (C-
4β), 78.6 (C-4α), 73.1 (C-2α), 61.9 (CH2CH3, α), 61.6 (CH2CH3, β), 55.7 (C-5β), 53.7 
(C-5α), 14.2 (CH2CH3) ppm. HRMS: calcd. for C9H13N3O5 [M + Na]
+ 266.0747, found 
266.0758. 
 
Ethyl (3Z)-[5-Azido-3,5-dideoxy-1-O-(tert-butyldimethylsilyl)- α-D-erythro- 
pentofuranos-3-ylidene]acetate (14) and Ethyl (3Z)-[5-Azido-3,5-dideoxy-1,2-di-O-
(tert-butyldimethylsilyl)- β-D-erythro-pentofuranos-3-ylidene]acetate (15): To a  
solution of compound 13 (37 mg, 0.15 mmol) in dry py (1 mL) was added DMAP (3 
mg, 0.02 mmol), and TBDMSCl (0.16 g, 1.06 mmol) at room temp. under argon 




atmosphere. After stirring for 15 h at room temp., the reaction was poured into water (3 
mL) and the mixture was extracted with EtOAc (3 × 2 mL). Combined organic layers 
were washed with water and brine and dried with anhydrous MgSO4. After filtration 
and evaporation of the solvent, the residue was purified by CC (EtOAc/petroleum ether, 
1:16) to afford 14 (30 mg, 55%) and 15 (10 mg, 14%) and as colorless oils.  
Data for 14: Rf = 0.22 (EtOAc/petroleum ether, 1:16). [ ]20Dα = +134 (c = 1.1, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 5.86 (t, 1H, H-3’, J2,3’ = J3’,4  = 2.3 Hz), 5.56 (d, 1H, 
H-1, J1,2 = 4.5 Hz), 4.98–4.85 (m, 3H, H-2, H-4, OH), 4.23 (q, 2H, CH2CH3, J = 7.1 
Hz), 3.52 (dd, part A of ABX system, 1H, H-5a, J4,5a = 3.5, J5a,5b = 12.9 Hz), 3.37 (dd, 
part B of ABX system, 1H, H-5b, J4,5b = 5.3 Hz), 1.31 (t, 3H, CH2CH3), 0.92 (s, 9H, 
tBu, TBDMS), 0.17, 0.16 (2 × s, 6H, Me, TBDMS) ppm. 13C NMR (100 MHz, CDCl3): 
δ = 167.1 (CO), 161.5 (C-3), 115.3 (C-3’), 97.3 (C-1), 78.2 (C-4), 74.2 (C-2), 61.4 
(CH2CH3), 53.7 (C-5), 25.8 (3 × Me, tBu), 18.3 (Cq, tBu), 14.2 (CH2CH3), -4.5 (Me, 
TBDMS), -4.8 (Me, TBDMS) ppm. HRMS: calcd. for C15H27N3O5Si [M + H]
+ 
358.1793, found 358.1794; calcd for [M + Na]+ 380.1612, found 380.1615. 
Data for 15: Rf = 0.55 (EtOAc/petroleum ether, 1:16). [ ]20Dα = +13 (c = 0.6, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 5.86 (br. d, 1H, H-3’), 5.26–5.22 (m, 2H, H-1, H-2), 
4.91–4.85 (m, H-4), 4.29–4.12 (m, 2H, CH2CH3), 3.52 (dd, part A of ABX system, 1H, 
H-5a, J4,5a = 8.3, J5a,5b = 12.6 Hz), 3.21 (dd, part B of ABX system, 1H,  H-5b, J4,5b = 4.5 
Hz), 1.30 (t, 3H, CH2CH3, J = 7.1 Hz), 0.87 (s, 9H, tBu, TBDMS), 0.85 (s, 9H, tBu, 
TBDMS), 0.16, 0.13, 0.12, 0.07 (4 × s, 12H, Me, TBDMS) ppm. 13C NMR (100 MHz, 
CDCl3): δ = 164.8 (CO), 159.1 (C-3), 116.0 (C-3’), 103.4 (C-1), 79.5 (C-4), 75.3 (C-2), 
60.6 (CH2CH3), 56.3 (C-5), 25.8 (3 × Me, tBu), 25.8 (3 × Me, tBu),  18.2 (Cq, tBu), 
18.0 (Cq, tBu), 14.4 (CH2CH3), -4.2, -4.6, -4.7, 5.1 (4 × Me, TBDMS) ppm. HRMS: 
calcd. for C21H41N3O5Si2 [M + Na]
+ 494.2477, found 494.2479; calcd for [M + K]+ 
510.2216, found 510.2209. 
 
Ethyl (3Z)-[5-Azido-3,5-dideoxy-1,2-di-O-(trimethylsilyl)- β-D-erythro- 
pentofuranos-3-ylidene]acetate (16): To a solution of compound 13 (0.38 g, 1.56  
mmol) in dry dichloromethane (15 mL) were added NEt3 (1.5 mL, 10.9 mmol), DMAP 
(40 mg), and TMSCl (0.79 mL, 6.24 mmol) at room temp. under argon atmosphere. 
After stirring for 10 min, TLC showed complete conversion and the reaction mixture 
was quenched into water (20 mL). The aqueous phase w  extracted with CH2Cl2 (3 × 8 
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mL) and the combined organic layers were washed with ater and dried with MgSO4. 
After filtration and evaporation of the solvent, the residue was purified by CC 
(EtOAc/cyclohexane, 1:14) to afford the title compound (0.403 g, 67%) as a colorless 
oil. Rf = 0.31 (EtOAc/cyclohexane, 1:14). [ ]20Dα = +44 (c = 1.1, in CH2Cl2). 1H NMR 
(400 MHz, CDCl3): δ = 5.87 (br. s, 1H, H-3’), 5.22–5.18 (br. d, 2H, H-1, H-2), 4.90–
4.84 (m, H-4), 4.26–4.10 (m, 2H, CH2CH3), 3.49 (dd, part A of ABX system, 1H, H-5a, 
J4,5a = 8.1, J5a,5b = 12.6 Hz), 3.21 (dd, part B of ABX system, 1H, H-5b, J4,5b = 4.5 Hz), 
1.27 (t, 3H, CH2CH3, J = 7.1 Hz), 0.14 (s, 18H, Me, TMS) ppm. 
13C NMR (100 MHz, 
CDCl3): δ = 164.6 (CO), 158.7 (C-3), 116.4 (C-3’), 103.4 (C-1), 79.5 (C-4), 75.5 (C-2), 
60.5 (CH2CH3), 56.0 (C-5), 14.3 (CH2CH3), 0.4, 0.1 (Me, TMS) ppm. HRMS: calcd. for 
C15H29N3O5Si2 [M + H]
+ 388.1719, found 388.1719; calcd for [M + Na]+ 410.1538, 
found 410.1538; calcd for [M + K]+ 424.1277, found 424.1279. 
 
Ethyl [5-N-(tert-Butoxycarbonyl)amino-1,3-dideoxy-D-erythro-pentopyran-2-ulos-
3-C-yl]acetate (17) and Ethyl [N-(tert-butoxycarbonyl)-1,2-dihydro-pyridin-3-on-4-
C-yl]acetate (18): To a solution of compound 13 (33 mg, 0.14 mmol) in ethanol (2 mL) 
was added 10% Pd/C (one spatula point). The mixture was stirred at room temp. under 
hydrogen atmosphere for 40 min and Boc2O (50 mg, 0.23 mmol) was added. The 
resulting mixture was stirred at room temp. for 1 h30 min, filtered over celite and the 
solvent was evaporated. After column chromatography (EtOAc/petroleum ether, 2:3 
then 3:2), 17 was dissolved in py (2 mL) and Ac2O (1 mL) was added. The solution was 
stirred at room temp. for 30 min and then concentrated in vacuum, by co-distillation 
with toluene. The residue was purified by CC (EtOAc/petroleum ether, 1:4) to afford 18 
(16 mg, 42% overall yield) as a colorless oil. 
Data for 17: Rf = 0.26 (EtOAc/petroleum ether, 2:3). 
1H NMR (400 MHz, CDCl3): δ = 
4.41–4.35 (m, 1H, H-4), 4.27 (d, 1H, H-1a, J1a,1b = 17.7 Hz), 4.20–4.09 (m, 2H, 
CH2CH3), 3.88–3.80 (m, 1H, H-5a), 3.71 (d, 1H, H-1b), 3.01 (ddd, 1H, H-3, J3,4 = 2.5, 
J3,3’a = 5.6 , J3,3’b = 6.8 Hz), 2.90 (dd, 1H, H-3’a, J3’a,3’b = 17.2 Hz), 2.78 (m, 1H, H-5b), 
2.53 (dd, 1H, H-3’b), 1.45 (s, 9H, Me, tBu, Boc), 1.25 (t, 3H, CH2CH3, J = 7.1 Hz) ppm. 
13C NMR (100 MHz, CDCl3): δ = 204.6 (CO), 173.0 (CO), 155.2 (Cq, tBu, Boc), 80.5 
(Cq, Boc), 68.3 (C-4), 61.2 (CH2CH3), 53.6 (C-1), 30.6 (C-3’), 28.4 (Me, tBu, Boc), 
14.2 (CH2CH3) ppm. HRMS: calcd. for C14H23NO6 [M + Na]
+ 324.1418, found 
324.1409; calcd for [M + K]+ 340.1157, found 340.1161. 




Data for 18: Rf = 0.46 (EtOAc/petroleum ether, 2:3). 
1H NMR (400 MHz, CDCl3): δ = 
6.92 (br. s, 1H, H-5’), 4.28 (br. d, 2H, CH2-6’), 4.19–4.10 (m, 4H, CH2-2’, CH2CH3), 
3.25 (br. d, 2H, CH2-2), 1.47 (s, 9H, Me, tBu, Boc), 1.26 (t, 3H, CH2CH3, J = 7.1 Hz) 
ppm. 13C NMR (100 MHz, CDCl3):  δ = 192.5 (CO), 170.7 (CO), 81.2 (Cq, tBu, Boc), 
61.2 (CH2CH3), 51.3 (C-2’)*, 42.4 (C-6’)*, 34.5 (C-2), 28.5 (Me, tBu, Boc), 14.3 
(CH2CH3) ppm. HRMS: calcd. for C14H21NO5 [M + Na]
+ 306.1312, found 306.1320; 
calcd for [M + K]+ 322.1051, found 322.1061. 
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2.4. Carboxymethyl Glycoside Lactones as 
Synthons for Sugar Derivatives 
Embodying Conjugated Carbonyl 
Systems 
 
This subchapter includes the folowing paper: 
  
“Synthesis of Sugars Embodying Conjugated Carbonyl Systems and Related Triazole 
Derivatives from Carboxymethyl Glycoside Lactones. Evaluation of Their 
Antimicrobial Activity and Toxicity”, Xavier, N. M.; Goulart, M.;  Neves, A.;  Justino, 
J.; Chambert, S.; Rauter, A. P.;  Queneau, Y. Bioorg. Med Chem. 2010, in press. 
 
and reports on the use of bicyclic lactones derived from carboxymethyl glycosides as 
synthons towards 3-enopyranosid-2-uloses, 2-C-branched-chain conjugated 
dienepyranosides and related triazole derivatives. The biological activity of the new 
compounds was evaluated. 
 
The role of the co-autors (besides the supervisors Rauter, A. P. and Queneau, Y.) is 
specified as follows: 
 
- Goulart, M.; Neves, A. and Justino, J. carried out the biological tests. 
 
- Chambert., S. collaborated in the synthesis of the bicyclic lactone precursors. 
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The synthesis of a series of pyranoid derivatives comprising a conjugated carbonyl 
function and related triazole derivatives, structurally suitable for bioactivity evaluation, 
was achieved in few steps starting from readily avail ble carboxymethyl glycoside 
lactones (CMGLs). 3-Enopyranosid-2-uloses were generated by oxidation/elimination 
of tri-O-acylated 2-hydroxy pyranosides. Subsequent Wittig olefination provided 
stereoselectively 2-C-branched-chain conjugated dienepyranosides with (E)-
configuration around the exocyclic double bond. A heterogeneous CuI/Amberlyst- 
catalysed “click” chemistry protocol was used to convert glycosides bearing a propargyl 
moiety into the corresponding 1,2,3-triazoles. These new molecules were screened for 
their in vitro antibacterial and antifungal activities and those containing conjugated 




carbonyl systems demonstrated the best efficacy. (N-Dodecylcarbamoyl)methyl enone 
glycerosides were the most active ones among the enones tested. The α-anomer 
displayed very strong activities against Bacillus cereus and Bacillus subtillis and strong 
activity toward Enterococcus faecalis and the fungal pathogen Penicillium 
aurantiogriseum. The corresponding β-anomer presented a very strong inhibitory effect 
against two fungal species (Aspergillus niger and Penicillium aurantiogriseum). (N-
Dodecyl-/N-propargyl/ or N-Benzylcarbamoyl)methyl dienepyranosides exhibited 
selectively a strong activity toward Enterococcus faecalis. Further acute toxicity 
evaluation indicated low toxic effect of the (N-dodecylcarbamoyl)methyl enone 
glyceroside α-anomer and of the carbamoylmethyl dienepyranosides N-protected with 





α,β-Unsaturated carbonyl compounds occupy a prominent place among various classes 
of molecular targets due to their broad spectrum of bi logical and pharmacological  
activities [1]. Their conjugated functionality, whic  is prompted to Michael-type 
addition, may represent a receptor site for bionucleophiles, notably enzyme sulfhydryl 
groups [2], and therefore makes them suitable compounds for bioactivity screening. In 
particular, the incorporation of conjugated carbonyl functions in carbohydrates has led 
to useful substrates for derivatization in view of their ability to undergo a variety of 
transformations [3]. Moreover, some of these sugar derivatives have shown significant 
biological properties. Among them, furanose C-C-linked α,β-unsaturated lactones 
displayed antifungal [4] and insecticidal effects [5]. These findings have motivated the 
development of synthetic methodologies towards bicycli  fused derivatives [6] and 
thiosugar analogues [7]. Sugar enones have also proven t  be versatile building blocks 
for a variety of natural products and relevant chiral molecules, such as branched-chain 
sugars, C-glycosyl compounds or disaccharides [3]. One of the most well-explored 
enone scaffolds in terms of synthetic uses is levoglucosenone, a 1,6-anhydro-3-
enopyran-2-ulose, which is accessible by pyrolysis of cellulose [8]. A few examples of 
naturally occurring enone-containing sugars have been r ported, and those include the 
fungal metabolites Microthecin [9], a 3-enopyranos-2-ulose which exhibited 
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antibacterial and cytotoxic effects, and Ascopyrone P [10], a 1-enopyranos-3-ulose 
known to possess antioxidant and antibacterial activities.  
 
A number of methods for the synthesis of pyranoid enon s have appeared in the 
literature [3] and some of them employ easily available glycals as starting materials.  
Oxidation of unprotected glycals, e.g. with PDC [11] or Pd(OAc)2 [12], and of their 3-
O-protected derivatives, using hypervalent iodine reagents [13], leads to 1-enopyranos-
3-uloses. Hex-3-enopyranos-2-uloses comprise stereog nic centers next to the 
conjugated system which may induce stereoselectivity in addition reactions. Enones of 
this type can be prepared from 2-acyloxyglycal esters by simple transformations, such 
as chlorination followed by elimination [14], peroxidation and subsequent acetylation 
[15], or glycosylation of alcohols with these glycal donors in the presence of a Lewis 
acid [16]. Nevertheless, methods that involve β-acylated hexopyranosuloses as 
intermediates are preferred since these compounds are prone to undergo β-elimination 
of acyloxy groups [17]. This tendency for elimination appears to be general and has 
given rise either to the formation of 1-enopyranos-3-uloses, from easily available 
furanos-3-uloses [7, 17c], or to 3-enopyranos-2-uloses from the corresponding acylated 
pyranos-2-uloses [17a-b, 17d]. However methodologies for the synthesis of 2-uloses, 
which require partially acylated 2-hydroxy pyranosyl precursors, are not 
straightforward, involving protection and deprotection steps and low global yields. This 
issue can be overcome starting from carboxymethyl glycoside lactones (CMGLs) [18]. 
The opening of the lactone moiety of these compounds, especially by amines, has 
enabled the acquisition of various pseudo glycoconjugates, such as pseudo glycoamino 
acids [18a], pseudo disaccharides [19], nucleotide sugars [19], pseudo glycolipids [20], 
or more recently new glycoprobes for membranes nonli ear imaging [21]. Moreover, 
the connection of the sugar to another molecular block by this strategy provides adducts 
containing a free and unique hydroxyl group at positi n 2, available for 
functionalization [18c].  
 
Thus, we were motivated to explore the feasibility of the oxidation at C-2 of these 
adducts as concomitant 3,4-elimination would be expected, giving the target 3-
enopyranosid-2-uloses. Tri-O acylated 2-hydroxy gluco- and galactopyranosides, which 
differ in the configuration at C-1, were synthesized and different oxidation methods 
were used in order to investigate the influence of these factors on the efficiency of the 




oxidation-elimination process. Variations on the nature of the aglycon moiety also 
widened the panel of compounds for subsequent biological acitivity evaluation.  
 
Branching at C-2 of the α-enulosides by Wittig olefination was further accomplished 
leading to conjugated dienepyranosides. (N-Propargylcarbamoyl)methyl glycosides 
were used for the inclusion of an additional triazole motif, an heterocycle commonly 
related to a variety of bioactivities, and pyranoid derivatives comprising both the 
triazole and the conjugated carbonyl system were synthesized. The structural diversity 
of these highly functionalized pyranosidic derivaties allowed a rational study of their 
antimicrobial activities. Compounds’ acute cytotoxicity in eukaryotic cells was also 
performed. In this paper both the synthetic work and the results of the biological assays 
are presented and discussed. 
 




1.1. Synthesis of 3-Enopyranosid-2-uloses 
 
The α-gluco CMGL 1 was synthesized following the reported procedure based on 
isomaltulose oxidation followed by acetylation [18a]. The bicyclic lactones having α-
galacto (2) and β-gluco configuration (3) were prepared by anomeric alkylation of 
glucose or 2,3,4,6-tetra-O acetyl-α-D-galactopyranose with tert-butyl bromoacetate and 
successive ester cleavage and cyclization [18c]. A series of primary amines were then 
employed for the lactone ring-opening of CMGLs 1–3 (Scheme 1). Propargylamine was 
chosen aiming to a further derivatization of the terminal triple bond whereas 
benzylamine and dodecylamine were selected for the connection of a hydrophobic 
portion to the carbohydrate moiety, in order to investigate their effect in terms of 
antimicrobial action. The expected amides 4–10 were obtained in 66-94% yields, 
simply by treatment of 1–3 with the amines in CH2Cl2 at room temperature. Having a 
free hydroxyl group at C-2, the oxidation/elimination of these adducts was subsequently 
exploited. The preliminary experiments were carried out with (N-
propargylcarbamoyl)methyl α-glycosides. For both α-gluco (4) and α-galacto (10) 
Bioorg. Med. Chem. 2010, in press 
207 
 
derivatives, different oxidizing agents and conditions were used in the search of the 
most appropriate method (Table 1). The system DMSO/Ac2O proved to be the most 
effective one, giving the desired 3-enopyranosid-2-ulose 13 in better yield (ca. 60%) 
and as the single product. In its 13C NMR spectrum, the carbonyl group was observed at 
δ = 181.7 ppm, characteristic of an α,β-unsaturated ketone. Diagnostic signals in the 1H 
NMR spectra were the olefinic proton (H-4), observed at δ = 6.61 ppm as a doublet with 
a coupling constant J4,5 = 1.9 Hz, suggesting the adoption of an 
OE envelope (sofa) 
conformation [17b], and H-1, which was assigned at δ 4.99 as a singlet. Moreover, no 
significant differences in yields were obtained starting from each of the epimers 
suggesting that configuration at C-4 does not play a crucial role in the reaction outcome. 
3,4,6-Tri-O-acetyl-glycopyranosid-2-uloses (11 and 12) could be detected in the 
oxidation of 4/7 with PDC/Ac2O, and were the major products when using the Dess-
Martin periodinane as milder oxidizing agent. However, isolation of the 2-ulosides was 
not possible by column chromatography probably due to their facile conversion to the 
pyranoid enone system.  
 
Table 1. Results of the oxidation of (N-propargylcarbamoyl)methyl 3,4,6-tri-O
acetylglycopyranosides 4 and 10. 
Oxidation Method and 
Conditions 
Yield for 13* 
4 (gluco)           13 7 (galacto)           13 
DMSO/Ac2O, r.t., 16 h 61 59 
PDC/Ac2O, CH2Cl2, 
reflux, 1 h 
28 (15) 35 (5) 
Dess-Martin Periodinane 
CH2Cl2, r.t., 16 h 
6 (15) 6 (22) 
*Yield for the obtained 2-uloside (11, 12) indicated in parenthesis. 
 
The DMSO/Ac2O procedure was thus chosen for the oxidation/elimination of the other 
glycosides. Hence the α-glucosides bearing benzylcarbamoyl (5) and dodecylcarbamoyl 
moieties (6) were converted into the corresponding enones 14–15 in nearly quantitative 
yields.   
 




 The effect of the anomeric configuration was then examined.  Performed under same 
conditions as those used previously, the DMSO/Ac2O oxidation of the 2-hydroxy 
carbamoylmethyl β-glycosides 8–10 led to β-3-enopyranosid-2-uloses 16–18, although 
in lower yields (32–45%) than those obtained for their α-counterparts and with some 
tendency to undergo decomposition. The results obtained reflect the lower stability of 
the products formed, due to the adopted EO envelope conformation, indicated by the 
values of J4,5 (3.3 Hz), involving energetically unfavorable 1,3-diaxial interactions 




Scheme 1. Reactions and conditions: a) RNH2, CH2Cl2, room temp., 16 h, 66–94%; b) 
see Table 1; c) DMSO/Ac2O, room temp., 16 h, 96−99% (14, 15), 32–45% (16–18). 
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1.2. Synthesis of 2-C-Branched-Chain Conjugated Dienepyranosides 
 
Generation of 2-C-branched-chain sugars from 3-enopyranosid-2-uloses was 
subsequently explored. Oxidation of (N-allylcarbamoyl)methyl α-glucopyranoside 19 
[18c] with DMSO/Ac2O to enone 20 was followed by Wittig-type treatment with the 
stabilized ylide [(ethoxycarbonyl)methylene]triphenylphosphorane in chloroform to 
provide 21 as the single product (Scheme 2). Since no other diastereomer was obtained, 
which would be helpful for comparison purposes, the(E)-configuration around the 
double bond for 21 was assigned on the basis of its 1H-NMR shift for H-1, which 
appeared  1.3 ppm downfield from the corresponding signal in 20, and on NOE 
experiments, which showed a strong  correlation betwe n H-2’ and CH3 (Ac-3) protons. 
This suggested the given orientation for the ethoxycarbonyl group. Similarly, Wittig 
olefination of 3-enopyranosid-2-uloses 13–15 furnished conjugated dienepyranosides 
22−24 in moderate yields (54−61%), presenting identical 1H NMR features as those 
observed for 21, in accord with the proposed (E)-configuration. While a few examples 
of olefination reactions of pyranoid enones have appe red in the literature [22], to the 
best of our knowledge there was only one report involving a 3-enopyranoside-2-ulose 
[22a]. These pyranoid α,β,γ,δ-unsaturated esters are not only interesting for biact vity 
studies but may also constitute original templates for further synthetic elaboration 




Scheme 2. Reactions and conditions: a) DMSO/Ac2O, room temp., 16 h; b) 
Ph3P=CHCO2Et, CHCl3, 40 ºC, 1 h 15 min, 33% overall yield; c) Ph3 =CHCO2Et, 
CHCl3, 40 ºC,  1 h−2 h 30 min, 54–61%.  




1.3. Synthesis of Triazole Derivatives 
 
Glycosides containing alkynyl moieties were engaged in Cu(I)-catalysed Huisgen 1,3-
dipolar cycloadditions with a terminal azide [23] aiming at the insertion of a 1,2,3-
triazole ring  which is generally recognized as onef the most biologically active motifs 
amongst heterocyclic nucleus [24]. Various examples of this so-called “click” chemistry 
employing carbohydrates have been reported, namely in polysaccharide modification 
[25] or in the synthesis of carbohydrate macrocycles [26], oligosaccharides [27], and 
glycoconjugates [28], in which the triazole unit may serve as a linker between 
saccharide moieties, or a spacer entity for the genration of glycopeptide mimics.   
 
We have applied a mild and simple catalytic procedur  consisting on the use of 
copper(I) iodide supported on Amberlyst A-21 resin and dichloromethane as solvent 
[29]. The resin is a polystyrene-based polymer containing a dimethylamine group which 
may serve both as a chelating agent for the cooper salt and as a base [29]. The first 
attempted cycloaddition reactions between the galactoside 7 and benzyl or hexenyl 
azide [30] (Scheme 3) were completed after overnight stirring at room temperature and 
afforded the corresponding 1,2,3-triazole derivatives 25 and 26 in good isolated yields 
(70-74%).  Similar conditions for the coupling of the α- and β-glucosides 4 and 8 with 
benzyl azide gave successfully the expected triazoles 28 and 29. Furthermore, "click" 
reactions that lead to 26 or 29 afforded a small amount (4%) of a secondary product, 
identified by NMR and HRMS as the 5-iodo-1,2,3-triazole derivatives 27 or 30, 
respectively. 5-Iodo triazoles have already been report d as minor products in CuI-
catalysed alkyne-azide cycloadditions when organic bases such as NEt3 or DIPEA 
(diisopropylethylamine), were used. Their formation may be due to I2 contamination in 
CuI, acting as source of I+ [31]. The role of the base and the influence of its nature in 
facilitating the formation of 5-iodo triazoles, was recently investigated and a mechanism 
involving the stabilization of intermediate bis-copper complexes by the base [DMAP (4-
dimethylaminopyridine) or DMA (dimethylaniline)], allowing a further intermolecular 
delivery of iodine, was proposed [32]. Although such a mechanism remains to be 
clarified, in our case the presence of the basic dimethylamino groups in Amberlyst A-21 
seems to be important for the iodination.  
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This protocol proved to be convenient due to the easy separation of the catalyst from the 
reaction medium, simply by filtration, and to the fully compatibility with the presence 
of the acetate functionality, avoiding the addition f base and the use of an 
organo/aqueous solvent system. To date, only one example of “click” chemistry on 
carbohydrate templates by means of heterogeneous catalysis was reported, in which 
Cu(I)-modified zeolites were applied [33]. 
 
Variations on the sugar backbone substitution were also carried for investigating its 
influence on the bioactivity. The replacement of the acetyl protecting groups of 26 by 
allyl functions was achieved directly, along with OH-2 and N-allylation, by treatment 
with sodium hydride and allyl bromide in DMF at 50 ºC. The fully allylated derivative 
31 was thus obtained in 32% overall yield, together with 32, having a free OH-3 (20%). 
 
The combination of a triazole ring with a conjugated carbonyl system was then 
undertaken. Thus, oxidation of 28 by the DMSO/Ac2O method furnished triazole-
containing enuloside 33 in reasonable yield (60%).  Dienepyranoside 22 was coupled 
through the alkynyl residue with benzyl azide using CuI/Amberlyst A-21 as catalyst at 
room temperature to generate the triazole derivative 34 in 87% yield. No competitive 
cycloaddition at the conjugated system was observed, even though such reactions 
between azides and α,β-unsaturated esters or conjugated dienes are known t  occur, 
leading to triazolines [34] or  aziridines [35].   
 
Deprotection of the triazole-containing glycosides 25, 26, 28, 29 with triethylamine in 
methanol and water gave 35–38 (82 to 95%), a series of compounds bearing a 
hydrophilic part and a benzyl or a hexenyl moiety as a hydrophobic substituent at 
position 4 of the triazole ring.  
 




7 25  R1 = Ac, R2 = Bn














































 4  α-gluco
8  β-gluco
 28  α-gluco, R = Ac
29  β-gluco, R = Ac
d)
35  R1 = H, R2 = Bn





































































 37  α-gluco, R = H













Scheme 3. Reactions and conditions: a) BnN3 or N3CH2(CH2)3CH=CH2 (to give 26), 
CuI/Amberlyst A-21 (cat.), CH2Cl2, room temp., 16 h, 71% (25),  74% (26, along with 
27, 4%), 60% (28), 77% (29, along with 30, 4%), 87% (34); b) NaH, CH2=CHCH2Br, 
DMF, 50 ºC, 1 h, 32% (31) and 20% (32); c) DMSO/Ac2O, room temp., 16 h, 60%; d) 
NEt3/H2O/MeOH, 40 ºC, 16 h, 82-95% (35–38). Aglycons’ carbon atoms numbering do 
not follow any nomenclature rules and were chosen to simplify the description of the 
NMR signals. 
 
2. Biological Evaluation 
 
2.1. Antimicrobial activity 
 
The antimicrobial activities of 3-enopyranosid-2-uloses 13−15 and 18, dienepyranosides 
21–24 and triazole derivatives 25−26, 28−29, 31−38 were investigated using the paper 
disk diffusion method [36].  Their in vitro antibacterial activity was evaluated against 
Gram-negative strains such as E cherichia coli and Salmonella enteritidis, and the 
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following Gram-positive bacteria: Enterococcus faecalis, Listeria monocytogenes, 
Staphylococcus aureus, Bacillus cereus and Bacillus subtilis. The antifungal activity 
was studied on a panel of plant pathogenic fungi which may also cause human allergies 
including Aspergillus niger, Aspergillus brasiliensis, Botrytis cinerea and Fusarium 
solani, the fungal plant pathogens Penicillium aurantiogriseum and Fusarium 
culmorum and the human pathogen Candida albicans. The significant results are 
presented in Table 2. Given the variability of the m thod, the results are expressed by 
the average diameter of the inhibition zone detected in two replicates, as well as by the 
symbols −, +, ++, +++, ++++, +++++, corresponding to a range of diameters, for 
increasing sensitivity of the microorganism to the substance tested according to 
Miyazawa et al [37]. Chloramphenicol was used as control for all bacteria tested, 
whereas for fungi, actidione and amphotericin B were used.  
 
Despite the presence of a triazole nucleous, which is known to play a vital role in the 
efficacy of many bioactive agents, compounds 25−26, 28−29, 31−38 did not show any 
significant antimicrobial activity in this screening. Pyranoid derivatives bearing 
conjugated carbonyl systems were found to be the relevant bioactive compounds of this 
set. From the 3-enopyranosid-2-uloses assayed, only those carrying a dodecyl chain 
were active (15, 18) and their efficacy proved to be dependent on their anomeric 
configuration.   The α-enuloside 15 displayed strong activity against E. faecalis, while 
the β-anomer 18 showed virtually no activity at all. Moreover 15 showed a very strong 
effect against the two species of Bacillus tested, with zones of inhibition presenting a 
diameter similar or greater than that of the standard antibiotic. Moderate and good 
activities were displayed by 18 against B. cereus and B. subtilis, respectively. The latter 
compound was more effective than its α-counterpart toward S. enteritidis, showing 
moderate activity, and toward the fungal pathogen A. niger, for which a very strong 
inhibitory effect was observed. In addition, both enones exhibited similar activity 
against Listeria monocytogenes (moderate effect) and Penicillium aurantiogriseum. In 
the latter case the activities were found to be greater than those of the standard 
antibiotics. 
 
Dienepyranosides 22−24 were shown to selectively inhibit the growth of bacteria, 
namely a strong activity against E. faecalis was detected. Compound 24 was the most 
active one toward S. aureus, with good effect. 




Although no complete correlation between bioactivity and structure was found in these 
series of compounds, one obvious effect is that the bioactivity observed for the 3-
enopyran-2-uloses depends strongly on the aglycon miety. Since enones 13 and 14, 
having propargyl and benzyl moieties, did not exhibit any effect, the long and straight 
chain in 15 and 18 must play a role in eliciting the activity. The hydrophobic portion 
may allow these molecules to interact with the lipid b layer of the microorganism cell 
membrane, or to pass through it. Once inside the lipid membrane or in the cytoplasm, 
the compound may act by binding to specific targets, specially enzymes involved in 
key biochemical pathways for microorganism growth. Such inhibition might arise from 
Michael type addition of enzymes’ nucleophilic groups to the enone system, despite the 
presence of the electron donating acetoxy group at C-3. Concerning dienepyranosides 
22−24, the hydrophobic nature of the N-substituent does not seem to be a major 
contributor for the observed bioactivity, with the exception of the effect on S. aeurus, a 
microbe only susceptible to compound 24.  
 
2.2. Acute Toxicity 
 
In the search for new therapeutic agents, one of the main prerequisites is that the new 
bioactive molecules should be toxic to the pathogen and exhibit minimal toxicities to 
the host cells. Hence, our further interest was to evaluate the potential toxicity of the 
new series of compounds, particularly that of the most bioactive ones. The in vitro acute 
toxicity in eukaryotic cells of all molecules submitted to antimicrobial evaluation was 
assessed using the MTT cell viability assay [38]. The results quantified as IC50 values 
are summarized in Table 3. Most of the compounds exhibited low toxicity; the higher 
toxic effect was observed for the β-enuloside 18 with an IC50 value of 0.045 mg/mL, 
while the less toxic molecule appeared to be the triazole-containing dienepyranoside 34
with an IC50 value of 12 mg/mL. Among the molecules that displayed significant 
antimicrobial effects, 18 and 24 (IC50 value of 0.076 mg/mL) showed the highest 
toxicity. The α-enuloside 15 and dienepyranosides 22 and 23 showed low toxic effect, 
with IC50 values of the same order of magnitude as that of the negative control 
(DMSO).  
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Table 2.  Antimicrobial activitites of the newly synthesized 3-enopyran-2-uloses 15, 18, and dienepyranosides 22−24. 
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Diameter of inhibition zones (∅): +++++, ∅≥26 mm; ++++, 22 mm≤∅<26 mm; +++, 18 mm≤∅<22 mm; ++, 14 mm≤∅<18 mm;  
+, 12 mm≤∅<14 mm; −, ∅<12mm; 
aChloramphenicol for all bacteria tested with the exception of  fungi for which bactidione and camphotericine B was used; 
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Table 3. IC50 values of in vitro acute toxicity of 3-enopyran-2-uloses 13−15 and 18, 
dienepyranosides 21−24 and triazole derivatives 25−26, 28−29, 32−38 in eucaryotic 





















Highly functionalized sugar derivatives, structurally suitable for derivatization and for 
bioactivity screening, namely 3-enopyranosid-2-uloses and 2-C-branched-chain 
dienepyranosides, were straightforwardly accessed starting from CMGLs. Tri-O-
acylated 2-hydroxy pyranosides, arising from the opning of the bicyclic lactones, were 
directly converted to the target enones by oxidation/elimination. The anomeric 
configuration influences the conformational stability of such enulosides and thus the 
yields obtained for their preparation. A further Wittig-type olefination afforded 
dienepyranosides with (E)-configuration around the exocyclic double bond. Conversion 
of (N-propargylcarbamoyl)methyl glycosides into 1,2,3-triazole derivatives by 
 IC50 (mg/mL) StDev  
DMSO 0,199 0,037  
H2O2 0,002 0,002  
13 0,282 0,021  
14 0,163 0,012  
15 0,136 0,010  
18 0,045 0,003  
21 0.352 0.026  
22 0,257 0,019  
23 0,128 0,010  
24 0,076 0,006  
25 0,879 0,066  
26 0,063 0,005  
28 0,069 0,005  
29 0,505 0,038  
32 1,186 0,089  
33 10,313 0,773  
34 11,987 0,899  
35 0,617 0,046  
36 0,394 0,030  
37 0,193 0,014  
38 0,426 0,032  




cycloaddition with a terminal azide was accomplished in smooth condition using a 
heterogeneous CuI/Amberlyst catalytic system.   
 
The antimicrobial evaluation demonstrated relevant activity for some of the synthesized 
enones and diene pyranosides. Only the most hydrophobic enones, i.e. those containing 
dodecyl chains, were active and different antifungal and antibacterial response was 
observed for α- and β-anomers. Since the hydrofobicity appears to be essntial for the 
bioactivity of the synthesized enones, is plausible to suppose that their mechanism of 
action is related to incorporation or penetration across the cell membrane. In both cases 
binding to specific receptors or enzymes may occur. Although the electrophilicity of the 
enone system is reduced by the presence of the acetoxy group at C-3, Michael acceptor 
ability of enones 15, 18 could be considered to act as a second structural requirement for 
bioactivity expression, particularly if enzymatic inh bitory activity is involved. Among 
the dienepyranosides tested, the contribution for the activity of the N-substituent 
hydrophobicity was only observed for S. aureus, which was susceptible only to 24. 
 
The results of acute toxicity indicate that from the nineteen newly synthesized 
compounds, only four (18, 24, 26, 28) can be considered toxic. Compounds 15, 22 and 
23, included among those which exhibited significant imicrobial activities, showed 
low toxicity. This encourages further investigation  their use for the control of the 
pathogens for which efficacy was detected. Moreover, the low acute toxicity observed 







General Methods: All reactions were monitored by TLC on Macherei-Nagel 60 F254 
silica gel aluminium plates with detection under UV light (254 nm) and/or by charring 
with a solution of 10% H2SO4 in EtOH. Column chromatography (CC) was carried out 
on silica gel 60 (0.040–0.063 mm, Macherey-Nagel). 1H and 13C NMR spectra were 
acquired with a Bruker ALS 300, DRX300, (300 MHz for 1H and 75 MHz for 13C) or 
DRX 400 (400 MHz for 1H and 100 MHz for 13C) spectrometer. Chemical shifts are 




expressed in parts per million and are referenced to solvent residual peaks. Assignments 
were made by COSY, HSQC, HMBC and, when necessary, by NOESY experiments. 
HRMS spectra were recorded by the C ntre Commun de Spectrometrie de Masse, 
Université Claude Bernard Lyon 1 (Villeurbanne) using ESI technique. Optical 
rotations were measured on a Perkin–Elmer 241 polarimeter at 20 ºC (589 nm, sodium 
D line). Melting points were determined with a Stuar  Scientific SMP 3 apparatus and 
are uncorrected. 
 
General Procedure for the Opening of the CMGLs with Amines: To a solution of 
CMGL (0.150 g, 0.43 mmol) in anhydrous CH2Cl2 (2.5 mL) was added the amine (0.47 
mmol, 1.1 equiv.) and the reaction mixture was stirred overnight at room temp. under 
nitrogen atmosphere. After concentration under vacuum, the residue was purified by 
column chromatography (CC) on silica gel.  
 
(N-Benzylcarbamoyl)methyl 3,4,6-tri-O-acetyl-α-D-glucopyranoside (5): Reaction of 
α-CMG lactone 1 [18a] (0.10 g, 0.29 mmol) with N-benzylamine according to general 
procedure gave the title compound (87 mg, 66%) as a colorless oil after purification by 
CC (from EtOAc/ pentane, 3:2 to EtOAc). Rf = 0.21 (EtOAc/pentane, 1:1). [ ]20Dα = +60 
(c = 0.8, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 7.88 (t, 1H, NH, J = 5.8 Hz), 
7.27−7.12 (m, 5H, Ph), 5.18 (t, 1H, H-3, J2,3 = J3,4 = 9.8 Hz), 4.90 (t, 1H, H-4, J3,4 = J4,5 
Hz), 4.79 (d, 1H, H-1, J1,2 = 3.8 Hz), 4.33−4.23 (m, 3H, CH2-9, OH), 4.18 (dd, part A of 
ABX system, H-6a, J5,6a = 4.5, J6a,6b = 12.3 Hz), 4.10−3.87 (m, 4H, H-5, H-6b, CH2-7, 
J7a,7b = 15.6 Hz), 3.70−3.61 (m, 1H, H-2), 1.99 (s, 3H, Me, Ac), 1.94 (s, 6H, 2 × Me, 
Ac) ppm. 13C NMR (100 MHz, CDCl3): δ = 171.7, 170.7, 169.6, 169.3 (3 × CO-Ac, 
CO-8), 137.9 (Cq, Ph), 128.6, 127.5, 127.4 (CH, Ph), 99.3 (C-1), 73.3 (C-3), 70.2 (C-2), 
68.1, 68.0, 67.4 (C-4, C-5, C-7), 61.9 (C-6), 42.8 (C-9), 20.8, 20.7, 20.6 (3 × Me, Ac) 
ppm. HRMS: calcd. for C21H27NO10 [M + Na]
+ 476.1533, found 476.1535.  
 
(N-Propargylcarbamoyl)methyl 3,4,6-tri-O-acetyl-β-D-glucopyranoside (8):  
Reaction of β-CMG lactone 3 [18c] (0.11 g, 0.32 mmol) with N-propargylamine 
according to general procedure gave the title compound (0.11, 86%) as a pale oil after 
purification by CC (from EtOAc/ pentane, 3:2 to 4:1). Rf = 0.35 (EtOAc/pentane, 4:1). 
[ ]20Dα = −3 (c = 0.4, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 5.09−5.01 (m, 2H, H-




3, H-4), 4.41 (d, 1H, H-1, J1,2 = 7.9 Hz), 4.37−4.21 (m, 3H, H-6a, CH2-7, J5,6a = 5.1, 
J6a,6b = 12.4, J7a,7b = 16.1 Hz), 4.15−4.06 (m, 3H, H-6b, CH2-9), 3.74−3.62 (m, 2H, H-2, 
H-5), 2.23 (t, 1H, H-11, J = 2.6 Hz), 2.11 (s, 3H, Me, Ac), 2.09 (s, 3H, Me, Ac), 2.04 (s, 
3H, Me, Ac) ppm. 13C NMR (100 MHz, CDCl3): δ = 171.7, 170.8, 169.7, 169.0 (3 × 
CO-Ac, CO-8), 103.4 (C-1), 79.2 (C-10), 75.6 (C-3), 72.4, 72.3 (C-2, C-5), 71.8 (C-11), 
69.4 (C-7), 67.9 (C-4), 62.0 (C-6), 28.8 (C-9), 21.0, 20.9, 20.8 (3 × Me, Ac) ppm. 
HRMS: calcd. for C17H23NO10 [M + Na]
+ 424.1220, found 424.1219. 
 
(N-Benzylcarbamoyl)methyl 3,4,6-tri-O-acetyl-β-D-glucopyranoside (9): Reaction of 
β-CMG lactone 3 [18c] (0.15 g, 0.43 mmol) with N-benzylamine according to general 
procedure gave the title compound (0.185 g, 94%) as a colorless oil after purification by 
CC (EtOAc/ pentane, 3:2 to 4:1). Rf = 0.38 (EtOAc/pentane, 4:1). [ ]20Dα = −6 (c 0.9, 
CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 7.40 (t, 1H, NH), 7.29−7.15 (m, 5H, Ph), 
5.06−4.93 (m, 2H, H-3, H-4, J2,3 = J3,4 = J4,5 = 9.3 Hz), 4.48 (dd, part A of ABX system, 
1H, H-9a, J9a,NH = 6.0, Ja,b = 14.9 Hz),  4.40−4.15 (m, 5H, H-1, H-9b, H-6a, CH2-7, J1,2 
= 7.8,  J5,6a = 4.8, J6a,6b = 12.6, J7a,7b = 15.9, J9b,NH  = 5.8 Hz), 4.03 (dd, part B of ABX 
system, H-6b, J5,6b = 2.0 Hz), 3.64 (ddd, 1H, H-5),  3.57 (dd, 1H, H-2), .04 (s, 3H, Me, 
Ac), 2.03 (s, 3H, Me, Ac), 2.01 (s, 3H, Me, Ac) ppm. 13C NMR (100 MHz, CDCl3): δ = 
171.2, 170.7, 169.7, 169.3 (3 × CO-Ac, CO-8), 137.9 (Cq, Ph), 128.8, 127.7, 127.6 
(CH, Ph), 103.4 (C-1), 75.2 (C-3), 72.1, 72.0 (C-2, C-5), 69.2 (C-7), 68.1 (C-4), 61.9 
(C-6), 43.0 (C-9), 20.9, 20.8, 20.7 (3 × Me, Ac) ppm. HRMS: calcd. for C21H27NO10 [M 
+ Na]+ 476.1533, found 476.1533. 
 
 (N-Dodecylcarbamoyl)methyl 3,4,6-tri-O-acetyl-β-D-glucopyranoside (10):  
Reaction of β-CMG-2-O-lactone 3 [18c] (0.107 g, 0.31 mmol) with N-dodecylamine 
according to general procedure gave the title compound (0.146 g, 89%) as a colorless oil 
after purification by CC (EtOAc/ pentane, 3:2). Rf = 0.31 (EtOAc/pentane, 3:2). [ ]20Dα = 
−11 (c = 0.7, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 7.04 (t, 1H, NH, J = 5.7 Hz), 
5.08−4.97 (m, 2H, H-3, H-4), 4.38 (d, 1H, H-1, J1,2 = 7.9 Hz), 4.31−4.22 (m, 2H, H-6a, 
H-7a, J5,6a = 5.1, J6a,6b = 12.4, J7a,7b = 15.8 Hz), 4.16 (d, part B of AB system, 1H, H-7b), 
4.07 (dd, part B of ABX system, 1H, H-6b, J5,6b = 2.3 Hz), 3.93 (d, 1H, OH), 3.73−3.57 
(m, 2H, H-2, H-5), 3.31−3.14 (m, 2H, CH2-9), 2.07 (s, 3H, Me, Ac), 2.06 (s, 3H, Me, 
Ac), 2.02 (s, 3H, Me, Ac), 1.54−1.41 (m, 2H, CH2-10), 1.32−1.19 (m, 18 H, C9H18), 




0.86 (t, 3H, CH3-20, J = 6.6 Hz) ppm. 
13C NMR (100 MHz, CDCl3): δ = 171.4, 170.7, 
169.7, 169.2 (3 × CO-Ac, CO-8), 103.3 (C-1), 75.5 (C-3), 72.2, 72.2 (C-2, C-5), 69.1 
(C-7), 68.0 (C-4), 62.0 (C-6), 39.3 (C-9), 32.0, 29.7, 29.7, 29.5, 29.4, 29.4, 27.0, 22.8 
(C-10−C-19), 20.9, 20.8, 20.7 (2 × Me, Ac), 14.2 (CH3-20) ppm. HRMS: calcd. for 
C26H45NO10 [M + Na]
+ 554.2941, found 554.2940. 
 
General Procedure for PDC/Ac2O Oxidation of 4, 7: A solution of 3,4,6-tri-O-
acetylglycopyranoside (0.1 g, 0.25 mmol) in dry CH2Cl2 (0.7 mL) was added to a 
mixture of PDC (70 mg, 0.19 mmol) and Ac2O (0.07 mL, 0.8 mmol) in dry CH2Cl2 (1.5 
mL) under nitrogen atmosphere  The resulting mixture was stirred under reflux for 1 h, 
then cooled to room temp. The solvent was removed in vacuo. The gummy residue was 
triturated with ethyl acetate (15 mL) and the mixture was filtered through a short pad of 
Florisil. After evaporation of the solvent, the crude was purified by CC (EtOAc/pentane, 
3:2). 
 
General Procedure for Dess-Martin Oxidation of 4, 7: To a solution of 3,4,6-tri-O-
acetylglycopyranoside (0.3 mmol) in dry CH2Cl2 (6 mL) was added Dess-Martin 
periodinane (0.165 g, 0.39 mmol), and the reaction mixture was stirred overnight at 
room temp. under nitrogen atmosphere. A saturated NaHCO3 solution was added, and 
the aqueous phase was extracted twice with dichlorometane. The combined organic 
layers were washed with water and dried with Na2SO4. After filtration and evaporation 
of the solvent, the residue was purified by CC (EtOAc/pentane, 3:2). 
 
(N-Propargylcarbamoyl)methyl 3,4,6-tri-O-acetyl-α-D-arabino-hexopyranosid-2-
ulose (11): Oxidation of 4 [18a] with PDC/Ac2O (0.1 g, 0.25 mmol of 4) or with Dess- 
Martin periodinane (0.12 g, 0.3 mmol of 4), according to general procedures, afforded 
11 (15 mg and 18 mg, respectively, 15% yield in both cases), inseparably contaminated 
with compound 13. Rf = 0.22 (EtOAc/pentane, 1:1). 
1H NMR (300 MHz, CDCl3): δ = 
5.53 (d, 1H, H-3, J3,4 = 9.6 Hz), 5.20 (t, 1H, H-4, J3,4 ~ J4,5), 5.38, 4.91 (s, 1H, H-1), 
4.54−4.49 (d, part A of AB system, H-7a, J7a,7b = 16.9 Hz), 4.38 (d, part B of AB 
system part, H-7b), 4.34−4.25 (m, 3H, H-5, H-6a, H-9a) 4.16−4.10 (m, 2H, H-6b, H-
9b), 2.15 (t, 1H, H-11, J = 2.5 Hz), 2.12 (s, 3H, Me, Ac), 2.08 (m, 3H, Me, Ac), 2.08 (s, 
3H, Me, Ac) ppm. 13C NMR (75 MHz, CDCl3): δ = 170.9, 170.1, 169.9, 165.7 (2 × CO-




Ac, CO-8), 97.5 (C-1), 79.5 (C-10), 75.0 (C-3), 70.7 (C-5), 70.4 (C-11), 67.6 (C-4), 
66.8 (C-7), 62.2 (C-6), 30.5 (C-9), 21.5, 20.9, 20.8 (3 × Me, Ac) ppm. LRMS (ESI) m/z 




(12): Oxidation of 7 [18b] with PDC/Ac2O  or with Dess-Martin periodinane according 
to general procedures, afforded 12 in 5% yield (5 mg, starting from 0.1 g of 7), and in 
22% yield (23 mg, starting from 0.105 g of 7), respectively, inseparably contaminated 
with compound 13. Rf = 0.22 (EtOAc/pentane, 1:1). 
1H NMR (300 MHz, CDCl3) δ = 
5.50 (dd, 1H, H-4, J3,4 = 3.5, J4,5 = 1.5 Hz), 5.38 (d, 1H, H-3), 4.91 (s, 1H, H-1), 
4.56−4.49 (m, 2H, H-5, H-7a, J7a,7b = 16.9 Hz), 4.38 (d, part B of AB system part, H-
7b), 4.29 (dd, part A of ABX system, 1H, H-9a, J9a,H-11 = 2.0, J9a,9b = 16.9 Hz), 
4.26−4.09 (m, 3H, CH2-6, H-9b, J5,6a = 6.0, J5,6b = 7.1, J6a,6b = 11.6 Hz), 2.21 (s, 3H, Me, 
Ac), 2.14−2.10 (m, 4H, H-11, Me, Ac), 2.06 (s, 3H, Me, Ac) ppm. 13C NMR (75 MHz, 
CDCl3): δ = 170.5, 169.5, 169.1, 165.3 (2 × CO-Ac, CO-8), 98.7 (C-1), 80.7 (C-10), 
71.3 (C-3), 70.2 (C-11), 68.6 (C-5), 67.5 (C-4), 66.8 (C-7), 61.3 (C-6), 30.8 (C-9), 21.3, 
20.8, 20.8 (3 × Me, Ac) ppm. HRMS: calcd. for C17H21NO10 [M + Na]
+ 422.1063, found 
422.1059. 
 
General Procedure for DMSO/Ac2O Oxidation: To a solution of 3,4,6-tri-O-
acetylglycopyranoside (0.38 mmol) in anhydrous DMSO (25 mL) was added Ac2O 
(12.5 mL). The mixture was stirred at room temp. overnight under nitrogen atmosphere.  
Water (50 mL) was added and the resulting mixture was extracted with EtOAc (3 × 25 
mL). The combined organic layers were washed with water and brine and dried with 
Na2SO4. After filtration, the solvent was removed under vacuum and the crude was 
purified by CC.  
 
(N-Propargylcarbamoyl)methyl 3,6-di-O-acetyl-4-deoxy-α-D-glycero-hex-3-
enopyranosid-2-ulose (13): DMSO/Ac2O oxidation of compound 4 [18a] (0. 123 g,  
0.31 mmol) or 7 (0. 15 g, 0.37 mmol) according to general procedure gave the 
corresponding 3-enopyranosid-2-ulose 13 (63 mg, 61% and 74 mg, 59%, respectively) 
as a colorless oil after purification by CC (EtOAc/ pentane, 1:1). Rf = 0.31 
(EtOAc/pentane, 1:1). [ ]20Dα = +7 (c = 0.9, in CH2Cl2). 1H NMR (300 MHz, CDCl3): δ = 




6.77 (t, 1H, NH), 6.65 (d, 1H, H-4, J4,5 = 1.9 Hz), 5.07 (s, 1H, H-1), 4.95 (td, 1H, H-5), 
4.42 (dd, part A of ABX system, 1H, H-6a, J5,6a = 5.3, J6a,6b = 11.7 Hz), 4.31 (d, part A 
of AB system, 1H, H-7a, J7a,7b = 15.3 Hz), 4.22 (dd, part B of ABX system, 1H, H-6b, 
J5,6b = 4.5 Hz), 4.16 (d, part B of AB system, 1H, H-7b), 4.09−4.02 (m, 2H, CH2-9), 
2.24 (s, 3H, Me, Ac), 2.23 (t, 1H, H-11, J = 2.6 Hz), 2.08 (s, 3H, Me, Ac) ppm. 13C 
NMR (75 MHz, CDCl3): δ = 181.7 (CO-2), 170.7, 168.0, 167.8 (2 × CO-Ac, CO-8), 
141.9 (C-3), 133.3 (C-4), 98.1 (C-1), 79.1 (C-10), 71.8 (C-11), 68.4, 68.3 (C-5, C-7), 
64.3 (C-6), 28.8 (C-9), 20.8, 20.4 (2 × Me, Ac) ppm. HRMS: calcd. for C15H17NO8 [M 
+ Na]+ 362.0852, found 362.0851. 
 
(N-Benzylcarbamoyl)methyl 3,6-di-O-acetyl-4-deoxy-α-D-glycero-hex-3-
enopyranosid-2-ulose (14): DMSO/Ac2O oxidation of compound 5 (80 mg, 0.18  
mmol) according to general procedure gave the corresponding 3-enopyranosid-2-ulose  
14 (66 mg, 96%) as a colorless oil after purification by CC (EtOAc/ pentane, 3:2). Rf = 
0.31 (EtOAc/pentane, 1:1). [ ]20Dα = +13 (c = 0.7, in CH2Cl2). 1H NMR (400 MHz, 
CDCl3): δ = 7.36−7.24 (m, 5H, Ph), 6.86 (br. t, 1H, NH), 6.62 (d, 1H, H-4, J4,5 = 1.9 
Hz), 5.04 (s, 1H, H-1), 4.93 (td, 1H, H-5), 4.51−4.32 (m, 4H, H-6a, H-7a, CH2-9, J5,6a = 
5.3, J6a,6b = 11.9, J7a,7b = 15.6 Hz), 4.26−4.18 (m, 2H, H-6b, H-7b, J5,6b = 4.5 Hz), 2.24 
(s, 3H, Me, Ac), 2.10 (s, 3H, Me, Ac) ppm. 13C NMR (100 MHz, CDCl3): δ = 181.8 
(CO-2), 170.7, 168.0, 167.9 (2 × CO-Ac, CO-8), 141.9 (C-3), 137.9 (Cq, Ph), 133.2 (C-
4), 128.8, 127.9, 127.7 (CH, Ph), 98.2 (C-1), 68.3 (C-5, C-7), 64.4 (C-6), 99.3 (C-1), 
73.3 (C-3), 70.2 (C-2), 68.4 (C-5, C-7), 64.3 (C-6), 43.1 (C-9), 20.8, 20.4 (2 × Me, Ac) 
ppm. HRMS: calcd. for C19H21NO8 [M + Na]
+ 414.1165, found 414.1167. 
 
(N-Dodecylcarbamoyl)methyl 3,6-di-O-acetyl-4-deoxy-α-D-glycero-hex-3-
enopyranosid-2-ulose (15): DMSO/Ac2O oxidation of compound 6 [18a] (0. 12 g, 0.23  
mmol) according to general procedure gave the corresponding 3-enopyranosid-2-ulose 
15 (0.105 g, 99%) as a yellow oil after purification by CC (EtOAc/ pentane, 1:1). Rf = 
0.25 (EtOAc/pentane, 2:3); [ ]20Dα = +30 (c = 1, in CH2Cl2). 1H NMR (300 MHz, CDCl3): 
δ = 6.65 (d, 1H, H-4, J4,5 = 1.9 Hz), 6.49 (t, 1H, NH), 5.02 (s, 1H, H-1), 4.95 (td, 1H, H-
5), 4.42 (dd, part A of ABX system, 1H, H-6a, J5,6a = 5.5, J6a,6b = 11.8 Hz), 4.31−4.21 
(m, 2H, H-6b, H-7a, J5,6b = 4.5, J7a,7b = 15.1 Hz), 4.15 (d, part B of AB system, 1H, H-
7b), 3.33−3.18 (m, 2H, CH2-9), 2.26 (s, 3H, Me, Ac), 2.10 (s, 3H, Me, Ac), 1.55−1.45 




(m, 2H, CH2-10), 1.33−1.20 (m, 18 H, C9H18), 0.86 (t, 3H, CH3-20, J = 7.1 Hz) ppm. 
13C NMR (75 MHz, CDCl3): δ = 181.9 (CO-2), 170.7, 167.9, 167.8 (2 × CO-Ac, CO-8), 
142.0 (C-3), 133.2 (C-4), 98.2 (C-1), 68.3 (C-5, C-7), 64.4 (C-6), 39.3 (C-9), 32.0, 29.8, 
29.7, 29.6, 29.5 29.4, 29.4, 27.0, 22.8 (C-10−C19), 20.8 , 20.4 (2 × Me, Ac), 14.2 (CH3-
20) ppm. HRMS: calcd. for C24H39NO8 [M + Na]
+ 492.2573, found 492.2574. 
 
(N-Propargylcarbamoyl)methyl 3,6-di-O-acetyl-4-deoxy-β-D-glycero-hex- 
3-enopyranosid-2-ulose (16): DMSO/Ac2O oxidation of compound 8 (0.1 g, 0.25 
mmol) according to general procedure gave the corresponding 3-enopyranosid-2-ulose 
16 (27 mg, 32%) as a colorless oil after purification by CC (EtOAc/ pentane, 3:2). Rf = 
0.48 (EtOAc/pentane, 4:1). 1H NMR (300 MHz, CDCl3): δ = 7.00 (t, 1H, NH), 6.70 (d, 
1H, H-4, J4,5 = 3.0 Hz), 5.07 (s, 1H, H-1), 4.95−4.89 (ddd, 1H, H-5), 4.47−4.25 (m, 3H, 
H-6a, H-6b, H-7a, J5,6a = 6.6, J5,6b = 4.9, J6a,6b = 11.7, J7a,7b = 15.7 Hz), 4.21 (d, part B of 
AB system, 1H, H-7b), 4.12−4.06 (m, 2H, CH2-9), 2.27 (s, 3H, Me, Ac), 2.23 (t, 1H, H-
11, J = 2.6 Hz), 2.12 (s, 3H, Me, Ac) ppm. HRMS: calcd. for C15H17NO8 [M + Na]
+ 
362.0852, found 362.0852. 
 
(N-Benzylcarbamoyl)methyl 3,6-di-O-acetyl-4-deoxy-β-D-glycero-hex- 
3-enopyranosid-2-ulose (17): DMSO/Ac2O oxidation of compound 9 (0.11 g, 0.24 
mmol) according to general procedure gave the corresponding 3-enopyranosid-2-ulose 
17 (42 mg, 45%) as a colorless oil after purification by CC (from EtOAc/ pentane, 3:2 
to 4:1). Rf = 0.49 (EtOAc/pentane, 4:1). 
1H NMR (400 MHz, CDCl3): δ = 7.36−7.24 (m, 
5H, Ph), 7.13 (br. t, 1H, NH), 6.67 (d, 1H, H-4, J4,5 = 3.0 Hz), 5.05 (s, 1H, H-1), 4.89 
(ddd, 1H, H-5), 4.53−4.33 (m, 4H, H-6a, H-7a, CH2-9, J7a,7b = 15.4, J9,NH = 5.8, J9a,9b = 
9.2 Hz), 4.32−4.18 (m, 2H, H-6b, H-7b, J5,6b = 5.1, J6a,6b = 11.7 Hz), 2.24 (s, 3H, Me, 
Ac), 2.08 (s, 3H, Me, Ac). HRMS: calcd. for C19H21NO8 [M + Na]




3-enopyranosid-2-ulose (18): DMSO/Ac2O oxidation of compound 10 (0.1 g, 0.19 
mmol) according to general procedure gave the corresponding 3-enopyranosid-2-ulose 
18 (33 mg, 37%) as a colorless oil after purification by CC (from EtOAc/pentane, 3:2 to 
4:1). Rf = 0.43 (EtOAc/pentane, 3:2). 
1H NMR (300 MHz, CDCl3) δ = 6.74 (t, 1H, NH), 




6.69 (d, 1H, H-4, J4,5 = 3.2 Hz), 5.03 (s, 1H, H-1), 4.94−4.87 (m, 1H, H-5), 4.43−4.26 
(m, 3H, H-6a, H-6b, H-7a, J5,6a = 6.8, J5,6b = 5.1, J6a,6b = 11.5, J7a,7b = 15.5 Hz), 
3.31−3.22 (m, 2H, CH2-9), 2.26 (s, 3H, Me, Ac), 2.11 (s, 3H, Me, Ac), 1.57−1.44 (m, 
2H, CH2-10), 1.33−1.21 (m, 18 H, C9H18), 0.87 (t, 3H, CH3-20, J = 6.8 Hz) ppm. 
13C 
NMR (75 MHz, CDCl3) δ = 182.5 (CO-2), 170.6, 168.3, 168.0 (2 × CO-Ac, CO-8), 
142.4 (C-3), 133.1 (C-4), 99.1 (C-1), 71.2, 68.7 (C-5, C-7), 65.2 (C-6), 39.3 (C-9), 32.0, 
29.8, 29.7, 29.6, 29.5, 29.4, 27.0, 22.8 (C-10−C19), 20.8, 20.4 (2 × Me, Ac), 14.2 (CH3-
20) ppm. HRMS: calcd. for C24H39NO8 [M + Na]
+ 492.2573, found 492.2574. 
 
General Procedure for Wittig Olefination of 3-Enopyranosid-2-uloses: To a 
solution of 3-enopyranosid-2-ulose (0.10 mmol) in CHCl3 (1 mL) was added 
[(ethoxycarbonyl)methylene]triphenylphosphorane (45 mg, 0.13 mmol). The whole 
solution was stirred at 40 ºC until complete conversion, as indicated by TLC. The 
solvent was removed under vacuum and the residue was purified by column 
chromatography on silica gel. 
 
(N-Allylcarbamoyl)methyl 3,6-di-O-acetyl-4-deoxy-β-D-glycero-hex- 
3-enopyranosid-2-ulose (20) and (N-Allylcarbamoyl)methyl 3,6-di-O-acetyl-2,4-
dideoxy-2-C-[(E)-(ethoxycarbonyl)methylene]-α-D-glycero-hex-3-enopyranoside 
(21): DMSO/Ac2O oxidation of compound 19 [18c] (75 mg, 0.19 mmol) to 3-
enopyranosid-2-ulose 20 was performed according to general procedure. After CC 
(EtOAc/pentane, 3:2), 20 was subjected to Wittig olefination which was completed 
within 1 h 15 min.  Purification by CC (from Et2O/hexane, 9:1 to Et2O) afforded 21 (25 
mg, 33% overall yield), as white solid.  
Data for 20: Rf = 0.42 (EtOAc/pentane, 3:2); 
1H NMR (300 MHz, CDCl3): δ = 6.65 (d, 
1H, H-4, J4,5 = 1.9), 6.61 (br. t, 1H, NH), 5.91−5.74 (m, 1H, H-10), 5.24−5.01 (m, 2H, 
CH2-11), 5.04 (s, 1H, H-1), 4.96 (td, 1H, H-5), 4.42 (dd, part A of ABX system, 1H, H-
6a, J5,6a = 5.3, J6a,6b = 11.7 Hz), 4.32 (d, part A of AB system, 1H, H-7a, J7a,7b = 15.3 
Hz), 4.23 (dd, part B of ABX system, 1H, H-6b, J5,6a = 4.7 Hz), 4.18 (d, part B of AB 
system 1H, H-7b) 3.95−3.87 (m, 2H, CH2-9), 2.25 (s, 3H, Me, Ac), 2.10 (s, 3H, Me, 
Ac) ppm. 13C NMR (75 MHz, CDCl3): δ = 181.8 (CO-2), 170.7, 167.9, 167.9 (2×CO-
Ac, CO-8), 141.9 (C-3), 133.3, 133.5 (C-4, C-10), 116.8 (C-11) 98.2 (C-1), 68.3, 68.3 
(C-5, C-7), 64.3 (C-6), 41.5 (C-9), 20.8, 20.4 (2 × Me, Ac) ppm. 




Data for 21: Rf = 0.24 (EtOAc/pentane, 2:3). m.p. 101−103 ºC. [ ]20Dα = +50 (c 0.7, 
CH2Cl2). 
1H NMR (400 MHz, CDCl3) δ = 7.11 (t, 1H, NH), 6.39 (s, 1H, H-1), 5.95 (dd, 
1H, H-4, J2’,4 = 0.8, J4,5 = 2.0 Hz), 5.91 (br. d, 1H, H-2’), 5.89−5.80 (m, 1H, -10), 5.19 
(dq, 1H, H-11a, J11a,11b = J9a,11a = J9b,11a= 1.5, J10,11a = 17.1 Hz), 5.11 (dq, 1H, H-11b, 
J9a,11b = J9b,11b = J11a,11b, J10,11b = 10.3 Hz), 4.72 (ddd, 1H, H-5), 4.40−4.30 (m, 2H, H-6a, 
H-7a, J5,6a = 5.8, J6a,6b = 11.8, J7a,7b = 15.6 Hz), 4.27 (d, part B of AB system, 1H, H-7b), 
4.23-4.15 (m, 2H, H-6b, CH2CH3, J5,6a = 4.3, J = 7.1 Hz), 3.97-3.91 (m, 2H, CH2-9), 
2.27 (s, 3H, Me, Ac), 2.10 (s, 3H, Me, Ac), 1.29 (t, 3H, CH2CH3) ppm. 
13C NMR (100 
MHz, CDCl3) δ = 170.9, 168.9, 168.0 (2 × CO-Ac, CO-8), 165.4 (CO), 142.1, 140.3 (C-
2, C-3), 134.2 (C-10), 121.4 (C-4), 116.4 (C-11), 114.3 (C-2’), 94.2 (C-1), 67.1, 66.7 
(C-5, C-7), 64.9 (C-6), 61.2 (CH2CH3), 41.5 (C-9), 21.0, 20.9 (2 × Me, Ac), 14.3 
(CH2CH3) ppm. HRMS: calcd. for C19H25NO9 [M + Na]
+ 434.1427, found 434.1426. 
 
(N-Propargylcarbamoyl)methyl 3,6-di-O-acetyl-2,4-dideoxy-2-C-[(E)-
(ethoxycarbonyl)methylene]-α-D-glycero-hex-3-enopyranoside (22): Wittig 
olefination of the 3-enopyranosid-2-ulose 13 (28 mg, 0.08 mmol) according to general 
procedure, was completed within 2 h 30 min. The titl  compound was obtained as a 
white solid (19 mg, 56%) after purification by CC (diethyl ether/hexane, 9:1 to diethyl 
ether). Rf = 0.30 (EtOAc/pentane, 2:3), m.p. 106−108 ºC, [ ]20Dα = +31 (c = 0.4, in 
CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 7.34 (t, 1H, NH), 6.38 (s, 1H, H-1), 5.95 (dd, 
1H, H-4, J2’,4 = 1.0, J4,5 = 2.0 Hz), 5.92 (br. d, 1H, H-2’), 4.72 (ddd, 1H, H-5), 4.39−4.31 
(m, 2H, H-6a, H-7a, J5,6a = 5.8, J6a,6b = 11.8, J7a,7b = 15.6 Hz), 4.29−4.14 (m, 4H, H-6b, 
H-7b, CH2CH3, J5,6a = 4.3, J = 7.1 Hz), 4.13−4.06 (m, 2H, CH2-9, JH-9,H-11 = 2.5, JH-9,NH 
= 5.5 Hz), 2.27 (s, 3H, Me, Ac), 2.19 (t, 1H, H-11), 2.10 (s, 3H, Me, Ac), 1.31 (t, 1H, 
CH2CH3) ppm. 
13C NMR (100 MHz, CDCl3): δ = 170.9, 168.9, 168.0 (2 × CO-Ac, CO-
8), 165.5 (CO), 142.1, 140.2 (C-2, C-3), 121.4 (C-4), 114.4 (C-2’), 94.3 (C-1), 79.6 (C-
10), 71.3 (C-11), 67.1, 66.7 (C-5, C-7), 64.9 (C-6), 61.3 (CH2CH3), 28.6 (C-9), 20.9, 
20.9 (2 × Me, Ac), 14.3 (CH2CH3) ppm. HRMS: calcd. for C19H23NO9 [M + Na]
+ 
432.1271, found 432.1272. 
 
(N-Benzylcarbamoyl)methyl 3,6-di-O-acetyl-2,4-dideoxy-2-C-[(E)-(ethoxycarbonyl) 
methylene]-α-D-glycero-hex-3-enopyranoside (23): Wittig olefination of the 3-
enopyranosid-2-ulose 14 (40 mg, 0.1 mmol) according to general procedure, was 




completed within 2 h. The title compound was obtained as a white solid (29 mg, 61%) 
after purification by CC (diethyl ether/hexane, 7:3 to diethyl ether). Rf = 0.23 
(EtOAc/pentane, 2:3). m.p. 123−125 ºC. [ ]20Dα = +27 (c = 0.3, in CH2Cl2). 1H NMR (400 
MHz, CDCl3): δ =  7.52 (t, 1H, NH), 7.32−7.28 (m, 3H, Ph), 7.27−7.25 (m, 2H, Ph), 
6.38 (s, 1H, H-1), 5.93 (dd, 1H, H-4, J2’,4 = 1.0, J4,5 = 2.3 Hz), 5.86 (br. d, 1H, H-2’), 
4.70 (ddd, 1H, H-5), 4.54 (dd, part A of ABX system, H-9a, J9a,NH = 6.0, J9a,9b = 14.9 
Hz), 4.46 (dd, part B of ABX system, H-9b, J9b,NH = 5.8 Hz), 4.41−4.32 (m, 2H, H-6a, 
H-7a, J5,6a = 5.8, J6a,6b = 11.6, J7a,7b = 15.6 Hz), 4.29 (d, part B of AB system, H-7a), 
4.16 (dd, part B of ABX system, H-6b, J5,6b = 4.0 Hz), 4.10−3.97 (m, 2H, CH2CH3), 
2.24 (s, 3H, Me, Ac), 2.10 (s, 3H, Me, Ac), 1.21 (t, 1H, CH2CH3, J = 7.1 Hz) ppm. 
13C 
NMR (100 MHz, CDCl3): δ =  170.9, 169.0, 168.0 (2 × CO-Ac, CO-8), 165.4 (CO), 
142.1, 140.3 (C-2, C-3), 138.3 (Cq, Ph), 128.6, 128.0, 127.4 (CH, Ph), 121.4 (C-4), 
114.3 (C-2’), 94.3 (C-1), 67.1, 66.6 (C-5, C-7), 64.9 (C-6), 61.2 (CH2CH3), 43.1 (C-9), 
20.9, 20.9 (2 × Me, Ac), 14.2 (CH2CH3) ppm. HRMS: calcd. for C23H27NO9 [M + Na]
+ 
484.1584, found 484.1591. 
 
(N-Dodecylcarbamoyl)methyl 3,6-di-O-acetyl-2,4-dideoxy-2-C-[(E)-
(ethoxycarbonyl)methylene]-α-D-glycero-hex-3-enopyranoside (24): Wittig  
olefination of the 3-enopyranosid-2-ulose 15 (40 mg, 0.09 mmol) according to general 
procedure, was completed within 1 h. The title compund was obtained as a white solid 
(25 mg, 54%) after purification by CC (diethyl ether/ xane, 4:1 to diethyl ether). Rf = 
0.43 (EtOAc/pentane, 2:3). [ ]20Dα = +26 (c = 0.5, in CH2Cl2). 1H NMR (400 MHz, 
CDCl3): δ =  7.04 (t, 1H, NH), 6.37 (s, 1H, H-1), 5.95 (dd, 1H, H-4, J2’,4 = 0.8, J4,5 = 2.0 
Hz), 5.91 (br. d, 1H, H-2’), 4.71 (ddd, 1H, H-5), 4.37 (dd, part A of ABX system, H-6a, 
J5,6a = 5.8, J6a,6b = 11.6 Hz), 4.31 (d, part A of AB system, H-7a, J7a,7b = 15.6 Hz), 
4.26−4.14 (m, 4H, H-6b, H-7b, CH2CH3, J5,6a = 4.3, J = 7.1 Hz), 3.32−3.24 (m, 2H, 
CH2-9), 2.27 (s, 3H, Me, Ac), 2.10 (s, 3H, Me, Ac), 1.57−1.47 (m, 2H, CH2-10), 
1.34−1.20 (m, 21 H, CH2CH3, C9H18), 0.88 (t, 3H, CH3-20, J = 7.1 Hz) ppm. 
13C NMR 
(100 MHz, CDCl3): δ = 170.9, 168.9, 168.0 (2 × CO-Ac, CO-8), 165.4 (CO), 142.1, 
140.4 (C-2, C-3), 121.4 (C-4), 114.3 (C-2’), 94.1 (C-1), 67.1, 66.6 (C-5, C-7), 64.9 (C-
6), 61.2 (CH2CH3), 39.3 (C-9), 32.1, 29.8, 29.8, 29.5, 29.5, 27.1, 22.8 (C-10−C-19), 
20.9 , 20.9 (2 × Me, Ac), 14.3 (CH2CH3), 14.3 (CH3-20) ppm. HRMS: calcd. for 
C28H45NO9 [M + Na]
+ 562.2992, found 562.2996. 




General Procedure for the CuI/Amberlyst A21-Catalyzed Cycloaddition of (N- 
Propargylcarbamoyl)methyl Glycosides with a Terminal Azide: To a solution of (N-
propargylcarbamoyl)methyl glycoside (0.17 mmol) in dichloromethane (1.5 mL) was 
added azide  (0.2 mmol) and CuI/Amberlyst A21 catalyst 0.8 mmol/g (17 mg, 0.08 
equiv.). The suspension was stirred at room. temp. overnight. After filtration of the 
catalyst and evaporation of the solvent, the crude was purified by CC. 
 
{[N-(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]carbamoyl}methyl 3,4,6-tri- O-acetyl-α-
D-galactopyranoside (25): CuI/Amberlyst A21-catalysed coupling of (N-
propargylcarbamoyl)methyl glycoside 7 (0.07 g, 0.17 mmol) with benzyl azide 
according to general procedure gave the triazole  derivative 25 (66 mg, 71%) as a 
colorless oil after purification by CC (from EtOAc to EtOAc/methanol, 9:1). Rf = 0.22 
(EtOAc). [ ]20Dα = +92 (c = 1.3, in CH2Cl2). H NMR (400 MHz, CDCl3): δ = 8.29 (br. s, 
1H, NH), 7.50 (br. s, 1H, H-11), 7.38−7.31 (m, 3H, Ph), 7.26−7.21 (m, 2H, Ph), 5.44 (s, 
2H, CH2Ph), 5.39 (br. d, 1H, H-4), 5.21 (dd, 1H, H-3, J2,3 = 10.6, J3,4 = 3.3 Hz), 4.92 (d, 
1H, H-1, J1,2 = 3.8 Hz), 4.55 (brd, part A of ABX system, H-9a, J9a,9b = 12.8 Hz), 4.32 
(brd, part B of ABX system, H-9b), 4.25−4.18 (m, 2H, -5, H-7a), 4.10−4.00 (m, 4H, 
H-2, H-6a, H-6b, H-7b), 2.10 (s, 3H, Me, Ac), 2.01 (s, 3H, Me, Ac), 1.97 (s, 3H, Me, 
Ac) ppm. 13C NMR (100 MHz, CDCl3): δ = 170.7, 170.6, 170.2, 169.5 (3 × CO-Ac, 
CO-8), 134.2 (Cq, Ph), 129.3, 129.0, 128.3 (CH, Ph), 100.0 (C-1), 70.1 (C-3), 68.1, 
67.6, 67.3 (C-4, C-5, C-7), 66.5 (C-2), 61.8 (C-6), 54.5 (C-1’), 34.1 (C-9), 20.9, 20.8, 
20.7 (3 × Me, Ac) ppm. HRMS: calcd. for C24H30N4O10 [M + Na]




acetyl-α-D-galactopyranoside (26) and ({N-[1-(hex-5-en-1-yl)-5-iodo-1,2,3-triazol-4-
yl]methyl}carbamoyl)methyl 3,4,6-tri-O-acetyl-α-D-galactopyranoside (27): 
CuI/Amberlyst A21-catalysed coupling of (N-propargylcarbamoyl)methyl glycoside 7 
(0.099 g, 0.25 mmol) with 5-hexenyl azide according to general procedure gave the 
triazole 26 (96 mg, 74%) and its 5-iodo triazole derivative 27 (7 mg, 4%) as colorless 
oils after purification by CC (from EtOAc to EtOAc/methanol, 9:1).  
Data for 26:
 
Rf = 0.22 (EtOAc). [ ]20Dα = +71 (c = 0.8, in CH2Cl2). 1H NMR (400 MHz, 
CDCl3): δ = 8.33 (t, 1H, NH), 7.55 (s, 1H, H-11), 5.78−5.66 (m, 1H, H-5’), 5.38 (br. d, 




1H, H-4, J3,4 = 3.3, J4,5 = 1.0 Hz), 5.21 (dd, 1H, H-3, J2,3 = 10.6 Hz), 5.05 (br. d, 1H, 
OH), 5.01−4.92 (m, 2H, H-6’a, H-6’b), 4.91 (d, 1H, -1, J1,2 = 3.5 Hz), 4.58 (dd, part A 
of ABX system, 1H, H-9a, J9a,NH = 6.3, J9a,9b = 15.4 Hz), 4.38−4.18 (m, 5H, H-5, H-7a, 
H-9b, H-1’a, H-1'b, J7a,7b = 15.6 Hz), 4.10−4.00 (m, 4H, H-2, H-6a, H-6b, H-7b), 
2.12−2.03 (m, 5H, CH2-4’, Me, Ac), 2.01 (s, 3H, Me, Ac), 1.97 (s, 3H, Me, Ac), 1.91-
1.82 (m, 2H, CH2-2’), 1.44-1.34 (m, 2H, CH2-3’) ppm. 
13C NMR (100 MHz, CDCl3): δ 
= 170.7, 170.5, 170.2, 169.5 (3 × CO-Ac, CO-8), 144.6 (C-10), 137.7 (C-5’), 122.4 (C-
11), 115.5 (C-6’), 100.0 (C-1), 70.1 (C-3), 68.1 (C-4), 67.6, (C-7), 67.2 (C-5), 66.5 (C-
2), 61.8 (C-6), 50.4 (C-1’), 34.0 (C-9), 33.0 (C-4’), 29.5 (C-2’), 25.7 (C-3’), 20.9, 20.8, 
20.7 (3 × Me, Ac) ppm. HRMS: calcd. for C23H34N4O10 [M + Na]
+ 549.2173, found 
549.2174. 
Data for 27: Rf = 0.48 (EtOAc). 
1H NMR (400 MHz, CDCl3): δ = 8.12 (t, 1H, NH), 
5.91−5.66 (m, 1H, H-5’), 5.43 (dd, 1H, H-4, J3,4 = 3.3, J4,5 = 1.0 Hz), 5.26 (dd, 1H, H-3, 
J2,3 = 10.5 Hz), 5.09−4.96 (m, 2H, H-6’a, H-6’b), 4.93 (d, 1H, H-1, J1,2 = 3.7 Hz), 4.79 
(dd, part A of ABX system, 1H, H-9a, J9a,NH = 7.6, J9a,9b = 15.9 Hz), 4.44 (br. s, 1H, 
OH), 4.40−4.22 (m, 5H, H-5, H-7a, H-9b, CH2-1’, J7a,7b = 15.6 Hz), 4.21−4.05 (m, 4H, 
H-2, H-6a, H-6b, H-7b), 2.17−2.06 (m, 5H, CH2-4’, Me, Ac), 2.05 (br. s, 6H, 2 × Me, 
Ac), 1.97 (s, 3H, Me, Ac), 1.98−1.85 (m, 2H, CH2-2’), 1.52−1.38 (m, 2H, CH2-3’) ppm. 
13C NMR (100 MHz, CDCl3): δ = 170.8, 170.6, 170.3, 169.3 (3 × CO-Ac, CO-8), 144.4 
(C-10), 137.8 (C-5’), 115.6 (C-6’), 100.0 (C-1), 69.9 (C-3), 68.2 (C-4), 67.7, (C-7), 67.4 
(C-5), 66.7 (C-2), 61.8 (C-6), 51.0 (C-1’), 34.7 (C-9), 33.1 (C-4’), 29.3 (C-2’), 25.7 (C-
3’), 21.0, 20.8, 20.8 (3 × Me, Ac) ppm. HRMS: calcd. for C23H34IN4O10 [M + Na]
+ 
675.1139, found 675.1140. 
 
{[N-(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]carbamoyl}methyl 3,4,6-tri- O-acetyl-α-
D-glucopyranoside (28): CuI/Amberlyst A21-catalysed coupling of (N-
propargylcarbamoyl)methyl glycoside 4 [18a] (0.115 g, 0.29 mmol) with benzyl azide 
according to general procedure gave the triazole  derivative 28 (92 mg, 60%) as a 
colorless oil after purification by CC (from EtOAc to EtOAc/methanol, 9:1); Rf = 0.21 
(EtOAc). [ ]20Dα = +64 (c = 0.9, in CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 8.24 (br. t, 
1H, NH), 7.45 (br. s, 1H, H-11), 7.40−7.33 (m, 3H, Ph), 7.29−7.23 (m, 2H, Ph), 5.47 (s, 
2H, CH2Ph), 5.34 (br. d, 1H, H-3, J2,3 = J3,4 = 10.0 Hz), 5.02 (t, 1H, H-4, J3,4 = J4,5), 4.86 
(d, 1H, H-1, J1,2 = 3.8 Hz), 4.69 (dd, 1H, H-9a, J9a,NH = 7.3, J9a,9b = 15.5 Hz), 4.35−4.19 




(m, 3H, H-6a, H-7a, H-9b), 4.09−4.00 (m, 3H, H-5, H-6b, H-7b), 3.84 (dd, 1H, H-2), 
2.08 (s, 3H, Me, Ac), 2.06 (s, 3H, Me, Ac), 2.02 (s, 3H, Me, Ac) ppm. 13C NMR (100 
MHz, CDCl3): δ = 171.2, 170.8, 169.8, 169.5 (3 × CO-Ac, CO-8), 145.0 (C-10), 134.2 
(Cq, Ph), 129.3, 129.1, 128.3 (CH, Ph), 122.1 (C-11), 99.5 (C-1), 72.8 (C-3), 70.3 (C-2), 
68.3, 68.2, 67.7 (C-4, C-5, C-7), 62.0 (C-6), 54.5 (C-1’), 34.0 (C-9), 21.0 20.9, 20.8 (3 × 
Me, Ac) ppm. HRMS: calcd. for C24H30N4O10 [M + Na]
+ 557.1860, found 557.1859. 
 
{[N-(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]carbamoyl}methyl 3,4,6-tri- O-acetyl-β-
D-glucopyranoside (29) and {[N-(1-benzyl-5-iodo-1,2,3-triazol-4-yl)methyl] 
carbamoyl}methyl 3,4,6-tri-O-acetyl-β-D-glucopyranoside (30): CuI/Amberlyst A21-
catalysed coupling of (N-propargylcarbamoyl)methyl glycoside 8 [18b] (51 mg, 0.13 
mmol) with benzyl azide according to general procedur  gave the triazole 29 (52 mg, 77 
%) as a white solid and its 5-iodo triazole derivative 30 (3 mg, 4%)  a a colorless oil 
after purification by CC (from EtOAc to EtOAc/MeOH, 9:1). 
Data for 29: Rf = 0.24 (EtOAc). m.p. 147−149 ºC. [ ]20Dα = +2 (c = 0.5, in CH2Cl2). 1H 
NMR (400 MHz, CDCl3): δ = 8.01 (t, 1H, NH, J = 5.8), 7.47 (br. s, 1H, H-11), 
7.37−7.32 (m, 3H, Ph), 7.26−7.22 (m, 2H, Ph), 5.48 (d, 1H, OH, J = 5.8 Hz), 5.45 (br. s, 
2H, CH2Ph), 5.14 (d, 1H, H-3, J2,3 = J3,4 = 9.6 Hz), 4.99 (t, 1H, H-4, J3,4 = J4,5), 
4.51−4.37 (m, 3H, H-1, CH2-9, J1,2 = 7.8, J9a,9b = 15.4 Hz), 4.34 (d, part A of AB 
system, 1H, H-7a, J7a,7b = 15.6 Hz), 4.25 (dd, part A of ABX system, 1H, H-6a, J5,6a = 
4.8, J6a,6b = 12.3 Hz), 4.12 (d, part B of AB system, 1H, H-7b), 4.07 (dd, part B of ABX 
system, 1H, H-6b, J5,6b = 2.0 Hz), 3.69 (ddd, 1H, H-5), 3.61 (ddd, 1H, 2H), 2.05 (s, 3H, 
Me, Ac), 2.01 (s, 3H, Me, Ac), 2.00 (s, 3H, Me, Ac) ppm. 13C NMR (100 MHz, 
CDCl3): δ = 170.9, 170.8, 169.7, 169.6 (3 × CO-Ac, CO-8), 145.5 (C-10), 134.2 (Cq, 
Ph), 129.3, 129.0, 128.3 (CH, Ph), 122.6 (C-11), 103.1 (C-1), 74.9 (C-3), 72.1 (C-5), 
71.8 (C-2), 68.8 (C-7), 68.3 (C-4), 62.0 (C-6), 54.4 (C-1’), 34.1 (C-9), 20.9, 20.8, 20.7 
(3 × Me, Ac) ppm. HRMS: calcd. for C24H30N4O10 [M + Na]
+ 557.1860, found 
557.1861. 
Data for 30: Rf = 0.41 (EtOAc). 
1H NMR (400 MHz, CDCl3): δ = 7.81 (br. t, 1H, NH), 
7.40−7.32 (m, 3H, Ph), 7.30-7.23 (m, Ph), 5.58 (br. s, 2H, CH2Ph), 5.12 (d, 1H, H-3, J2,3 
= J3,4 = 9.6 Hz), 5.03 (t, 1H, H-4, J3,4 = J4,5), 4.61 (dd, part A of ABX system, 1H, H-9a, 
J9a,NH = 5.5, J9a,9b= 15.4 Hz), 4.49−4.35 (m, 3H, H-1, H-9b, H-7a J1,2 = 8.1, J7a,7b = 16.1, 
J9a,9b = 15.4 Hz), 4.29−4.18 (m, 1H, H-6a, H-7b, J5,6a = 4.8, J6a,6b = 12.3 Hz), 4.09 (dd, 




part B of ABX system, 1H, H-6b, J5,6b = 2.0 Hz), 3.68 (ddd, 1H, H-5), 3.62 (dd, 1H, 
2H), 2.09 (s, 3H, Me, Ac), 2.07 (s, 3H, Me, Ac), 2.03 (s, 3H, Me, Ac) ppm. 13C NMR 
(100 MHz, CDCl3): δ = 171.1, 170.8, 169.7, 169.4 (3 × CO-Ac, CO-8), 133.9 (Cq, Ph), 
129.1, 128.8, 128.1 (CH, Ph), 103.1 (C-1), 75.3 (C-3), 72.3 (C-5), 72.1 (C-2), 68.7 (C-
7), 68.1 (C-4), 62.0 (C-6), 54.6 (C-1’), 34.9 (C-9), 21.0, 20.9, 20.8 (3 × Me, Ac) ppm. 
HRMS: calcd. for C24H29IN4O10 [M + Na]
+ 683.0827, found 683.0827. 
 
({N-Allyl, N-[1-(hex-5-en-1-yl)-1H-1,2,3-triazol-4-yl]methyl}carbamoyl)methyl 
2,3,4,6-tetra-O-allyl-α-D-galactopyranoside (31) and ({N-Allyl, N-[1-(hex-5-en-1-
yl)-1H-1,2,3-triazol-4-yl]methyl}carbamoyl)methyl 2,4,6-tri- O-allyl-α-D- 
galactopyranoside (32): To a solution of compound 26 (44 mg, 0.08 mmol) in dry 
DMF (1.2 mL) was added NaH (0.42 mmol, 60%, 17 mg). After a few minutes, allyl 
bromide (0.42 mmol, 36 µL) was added and the mixture was stirred at 50 ºC for 1 h. 
Water was added (8 mL) and the aqueous phase was extr ct d with EtOAc (3 × 3 mL). 
The combined organic layers were washed with water nd dried with Na2SO4. After 
filtration and evaporation of the solvent, the residue was purified by CC (from 
EtOAc/pentane, 7:3 to EtOAc) to afford 31 (16 mg, 32%) and 32 (9 mg, 20%) as 
colourless oils. 
Data for 31: Rf = 0.56 (EtOAc/pentane, 7:3). [ ]20Dα = +19 (c = 1.2, in CH2Cl2). 1H NMR 
(400 MHz, CDCl3): δ = 7.58 (s, 1H, H-11), 6.02−5.67 (m, 6H, 5 × CH allylic, H-5’), 
5.37−5.08 (m, 11H, H-1, 5 × =CH2 allylic), 5.06−4.93 (m, 2H, =CH2-6’), 4.60 (d, part A 
of AB system, H-9a, J9a,9b = 14.9 Hz), 4.53 (d, part A of AB system, H-9b), 4.44−3.83 
(m, 16H, 5 × CH2 allylic, H-2, H-5, CH2-7, CH2-1’, J1,2 = 3.7 Hz), 3.81 (brd, 1H, H-4, 
J3,4 = 3.1), 3.75 (dd, 1H, H-3, J3,4 = 2.9, J2,3 = 10.1 Hz), 3.62−3.45 (m, 2H, CH2-6, J5,6a = 
6.4, J5,6b = 6.4, J6a,6b = 9.3 Hz), 2.14−2.04 (m, 2H, CH2-4’), 1.96−1.82 (m, 2H, CH2-2’), 
1.48−1.35 (m, 2H, CH2-3’) ppm. 
13C NMR (100 MHz, CDCl3): δ = 168.8 (CO-8), 144.2 
(C-10), 137.9, 135.5 135.3, 135.3, 134.6, 132.6 (C-5’, 5 × CH allylic), 123.4 (C-11), 
117.5, 117.3, 117.2, 117.0, 116.3 (5 × =CH2 allylic) 115.5 (C-6’), 97.2 (C-1), 78.0 (C-
3), 76.0 (C-2), 75.1 (C-4), 74.2 (CH2 allylic-4), 72.5 (CH2 allylic-6), 72.1, 72.1 (CH2 
allylic-2, CH2 allylic-3), 70.0 (C-5), 69.0 (C-6), 64.5 (C-7), 50.3 (C-1’), 49.5 (N-CH2 
allylic), 41.0 (C-9), 33.1 (C-4’), 29.7 (C-2’), 25.8 (C-3’) ppm. HRMS: calcd. for 
C32H48N4O7 [M + Na]
+ 623.3421, found 623.3423. 




Data for 32: Rf = 0.23 (EtOAc/pentane, 7:3). [ ]20Dα = +32 (c = 0.7, in CH2Cl2). 1H NMR 
(400 MHz, CDCl3): δ = 7.58 (s, 1H, H-11), 6.04-5.58 (m, 5H, 4 × CH allylic, H-5’), 
5.35−5.11 (m, 9H, H-1, 4 × =CH2 allylic), 5.07−4.94 (m, 2H, =CH2-6’), 4.62 (d, part A 
of AB system, H-9a, J9a,9b = 15.1 Hz), 4.53 (d, part A of AB system, H-9b), 4.40−3.83 
(m, 14H, 4 × CH2 allylic, H-3, H-5, CH2-7, CH2-1’), 3.82 (br. d, 1H, H-4, J3,4 = 3.1 Hz), 
3.73 (dd, 1H, H-2, J1,2 = 3.7, J2,3 = 10.3 Hz), 3.62−3.50 (m, 2H, CH2-6, J5,6a = 6.5, J5,6b = 
6.5, J6a,6b = 9.3 Hz), 2.17−2.02 (m, 2H, CH2-4’), 1.99−1.82 (m, 2H, CH2-2’), 1.52−1.34 
(m, 2H, CH2-3’) ppm. 
13C NMR (100 MHz, CDCl3): δ = 168.8 (CO-8), 144.1 (C-10), 
137.9, 135.1, 134.8, 134.5, 132.4 (C-5’, 4 × CH allylic), 123.4 (C-11), 117.9, 117.6, 
117.4, 117.3 (4 × =CH2 allylic) 115.5 (C-6’), 96.1 (C-1), 76.5 (C-4, C-2), 74.5 (CH2 
allylic-4), 72.5 (CH2 allylic-6), 71.3 (CH2 allylic-2), 69.9, 69.9 (C-3, C-5), 69.0 (C-6), 
64.1 (C-7), 50.4 (C-1’), 49.5 (N-CH2 allylic), 41.0 (C-9), 33.1 (C-4’), 29.7 (C-2’), 25.8 
(C-3’) ppm. HRMS: calcd. for C29H44N4O7 [M + Na]
+ 583.3108, found 583.3105. 
 
{[N-(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]carbamoyl}methyl 3,6-di-O-acetyl-4-
deoxy-α-D-glycero-hex-3-enopyranosid-2-ulose (33): DMSO/Ac2O oxidation of 
compound 28 (88 mg, 0.17 mmol) according to general procedure gave the 
corresponding 3-enopyranosid-2-ulose 33 (47 mg, 60%) as a colorless oil after 
purification by CC (from EtOAc/pentane, 4:1 to EtOAc). Rf = 0.40 (EtOAc. [ ]20Dα = +6 
(c = 0.4, in CH2Cl2). 
1H NMR (300 MHz, CDCl3): δ = 7.47 (br. s, 1H, H-11), 7.40−7.33 
(m, 3H, Ph), 7.29−7.23 (m, 2H, Ph), 7.04 (br. t, 1H, NH), 6.64 (d, 1H, H-4, J4,5 = 1.7 
Hz), 5.49 (br. s, 2H, CH2Ph), 5.02 (s, 1H, H-1), 4.95 (td, 1H, H-5), 4.57−4.51 (m, 2H, 
CH2-9) 4.41 (dd, part A of ABX system, 1H, H-6a, J5,6a = 5.3, J6a,6b = 11.7 Hz), 4.31 (d, 
part A of AB system, 1H, H-7a, J7a,7b = 15.1 Hz), 4.25−4.14 (m, 2H, H-6b, H-7b, J5,6b = 
4.5 Hz), 2.25 (s, 3H, Me, Ac), 2.10 (s, 3H, Me, Ac) ppm. 13C NMR (100 MHz, CDCl3): 
δ = 181.6 (CO), 170.7, 168.1, 167.9 (2 × CO-Ac, CO-8), 141.8 (C-4), 134.6 (Cq, Ph), 
133.2 (C-3), 129.2, 128.9, 128.2 (CH, Ph), 98.1 (C-1), 68.4, 68.3 (C-5, C-7), 64.3 (C-6), 
54.3 (C-1’), 34.7 (C-9), 20.8, 20.4 (2 × Me, Ac) ppm. HRMS: calcd. for C22H24N4O8 [M 




(34): CuI/Amberlyst A21-catalysed coupling of (N-propargylcarbamoyl)methyl 




glycoside 22 (20 mg, 0.05 mmol) with benzyl azide according to general procedure 
gave the triazole derivative 34 (23 mg, 87%) as a white solid after purification by CC 
(from EtOAc/pentane, 7:3 to EtOAc). Rf = 0.43 (EtOAc). m.p. 172−174 ºC. [ ]20Dα = +10 
(c = 0.2, in CH2Cl2). 
1H NMR (400 MHz, CDCl3): δ = 7.57 (br. t, 1H, NH), 7.48 (s, 1H, 
H-11), 7.39−7.32 (m, 3H, Ph), 7.29−7.23 (m, 2H, Ph), 6.36 (s, 1H, H-1), 5.93 (dd, 1H, 
H-4, J2’,4 = 0.8, J4,5 = 2.0 Hz), 5.89 (br. d, 1H, H-2’), 5.48 (s, 2H, CH2Ph), 4.69 (ddd, 
1H, H-5), 4.60 (dd, part A of ABX system, 1H, H-9a, J9a,NH = 6.3, J9a,9b= 15.4 Hz), 4.50 
(dd, part B of ABX system, 1H, H-9b, J9a,NH = 6.0 Hz), 4.37−4.27 (m, 2H, H-6a, H-7a, 
J5,6a = 5.8, J6a,6b = 11.6, J7a,7b = 15.6 Hz), 4.24 (d, part B of AB system, 1H, H-7b), 
4.18−4.09 (m, 3H, H-6b, CH2CH3, J5,6b = 4.0, J = 7.1 Hz), 2.26 (s, 3H, Me, Ac-3), 2.09 
(s, 3H, Me, Ac-6), 1.25 (t, 1H, CH2CH3) ppm. 
13C NMR (100 MHz, CDCl3): δ = 170.9, 
169.2, 168.0 (2 × CO-Ac, CO-8), 165.4 (CO), 145.4 (C-10), 142.0, 140.1 (C-2, C-3), 
134.7 (Cq, Ph), 129.3, 128.9, 128.2 (CH, Ph), 122.5 (C-11), 121.3 (C-4), 114.4 (C-2’), 
94.3 (C-1), 67.1, 66.8 (C-5, C-7), 68.7 (C-7), 64.9 (C-6), 61.3 (CH2CH3), 54.3 (C-1’), 
34.7 (C-9), 21.0, 20.9 (2 × Me, Ac), 14.3 (CH2CH3) ppm. HRMS: calcd. for 
C26H30N4O9 [M + Na]
+ 565.1910, found 565.1914. 
 
General Procedure for Deacetylation of Compounds 25, 26, 28 and 29: A solution of 
2,3,4,6-tetra-O-acetylated glycoside (0.03 mmol) in CH3OH/H2O/NEt3 (8/1/1, 2 mL) 
was stirred overnight at 40 ºC. After evaporation of the solvents under vaccum, the 
residue was purified by CC. 
 
{[N-(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]carbamoyl}methyl-α-D-
galactopyranoside (35): Deacetylation (CH3OH/H2O/NEt3) of  glycoside  25 (19 mg, 
0.036 mmol), according to general procedure afforded compound 35 (12 mg, 82%) as a 
colorless oil after purification  by CC (EtOAc/MeOH, 4:1). Rf = 0.23 (EtOAc/methanol, 
4:1). [ ]20Dα = +61 (c = 1, in MeOH/CH2Cl2, 1:1). 1H NMR (400 MHz, MeOD): δ = 7.87 
(br. s, 1H, H-11), 7.42−7.28 (m, 3H, Ph), 5.57 (s, 2H CH2Ph), 4.85 (d, 1H, H-1, J1,2 = 
3.5 Hz), 4.51 (s, 2H, CH2-9), 4.21 (d, part A of AB system, H-7a, J7a,7b = 15.9 Hz), 4.03 
(d, part B of AB system, H-7b), 3.88 (br. d, 1H, H-4, J3,4 = 3.3 Hz), 3.84−3.63 (m, 5H, 
H-2, H-3, H-5, H-6a, H-6b, J2,3 = 10.3, J5,6b = 5.0,  J6a,6b = 11.3 Hz) ppm. 
13C NMR (100 
MHz, MeOD): δ = 172.3 (CO-8), 136.7 (Cq, Ph), 130.0, 129.6, 129.2 (CH, Ph), 124.3 
(C-11), 101.2 (C-1), 73.1 (C-3), 71.3 (C-5), 71.0 (C-4), 70.0 (C-2), 67.9 (C-7), 62.8 (C-









galactopyranoside (36): Deacetylation (CH3OH/H2O/NEt3) of  glycoside  26 (17 mg, 
0.032 mmol), according to general procedure afforded compound 36 (12 mg, 95%) as a 
colorless oil after purification  by CC (EtOAc/MeOH, 4:1). [ ]20Dα = +33 (c = 0.6, in 
MeOH/CH2Cl2, 1:1). Rf = 0.32 (EtOAc/methanol, 5:1). 
1H NMR (400 MHz, MeOD): δ 
= 7.88 (br. s, 1H, H-11), 5.88−5.71 (m, 1H, H-5’), 5.07−4.91 (m, 2H, H-6’a, H-6’b), 
4.86 (d, 1H, H-1), 4.52 (s, 2H, CH2-9), 4.39 (t, 2H, CH2-1’), 4.24 (d, part A of AB 
system, H-7a, J7a,7b = 15.5 Hz), 4.05 (d, part B of AB system, H-7b), 3.89 (br. d, 1H, H-
4, J3,4 = 3.1, J4,5 = 1.0 Hz), 3.85−3.64 (m, 5H, H-2, H-3, H-5, H-6a, H-6b, J1,2 = 3.1, J2,3 
= 10.1, J5,6b = 5.3, J6a,6b = 11.1 Hz), 2.14−2.06 (m, 5H, CH2-4’), 1.98−1.84 (m, 2H, CH2-
2’), 1.46−1.35 (m, 2H, CH2-3’) ppm. 
13C NMR (100 MHz, MeOD): δ = 172.3 (CO-8), 
146.0 (C-10), 139.2 (C-5’), 124.2 (C-11), 115.5 (C-6’), 101.3 (C-1), 73.1 (C-3), 71.3 
(C-5), 71.0 (C-4), 70.0 (C-2), 68.0 (C-7), 62.8 (C-6), 51.2 (C-1’), 35.2 (C-9), 34.1 (C-





glucopyranoside (37): Deacetylation (CH3OH/H2O/NEt3) of glycoside 28 (17 mg, 
0.032 mmol), according to general procedure afforded compound 37 (12 mg, 92%) as a 
colorless oil after purification by CC (EtOAc/MeOH, 4:1). Rf = 0.24 (EtOAc/methanol, 
4:1). [ ]20Dα = +57 (c = 1.1, in MeOH/CH2Cl2, 1:1). 1H NMR (400 MHz, MeOD): δ = 
7.88 (br. s, 1H, H-11), 7.41−7.29 (m, 3H, Ph), 5.57 (s, 2H, CH2Ph), 4.81 (d, 1H, H-1, 
J1,2 = 3.8 Hz), 4.51 (s, 2H, CH2-9), 4.22 (d, part A of AB system, H-7a, J7a,7b = 15.6 Hz), 
4.03 (d, part B of AB system, H-7b), 3.80 (dd, part A of ABX system, H-6a, J5,6a = 2.2, 
J6a,6b = 11.8 Hz), 3.68−3.61 (m, 2H, H-3, H-6b), 3.54 (ddd, 1H, H-5, J4,5 = 9.8, J5,6b = 
5.8 Hz), 3.43 (dd, 1H, H-2, J2,3 = 9.6 Hz), 3.33 (dd, 1H, H-4, J3,4 = 9.1 Hz) ppm. 
13C 
NMR (100 MHz, MeOD): δ = 172.2 (CO-8), 146.3 (C-10), 136.7 (Cq, Ph), 130.0, 
129.6, 129.2 (CH, Ph), 124.3 (C-11), 101.0 (C-1), 74.9 (C-3), 74.4 (C-5), 73.3 (C-2), 
71.6 (C-4), 67.8 (C-7), 62.5 (C-6), 55.0 (C-1’), 35.2 (C-9) ppm. HRMS: calcd. for 
C18H24N4O7 [M + Na]
+ 431.1543, found 431.1541. 





glucopyranoside (38): Deacetylation (CH3OH/H2O/NEt3) of glycoside 29 (16 mg, 0.03 
mmol), according to general procedure afforded compound 38 (11 mg, 90%) as a white 
solid after purification by CC (EtOAc/MeOH, 4:1). Rf = 0.24 (EtOAc/methanol, 4:1). 
m.p. 154−155 ºC. [ ]20Dα = −11 (c 0.8, in MeOH/CH2Cl2, 1:1). 1H NMR (400 MHz, 
MeOD): δ = 7.87 (br. s, 1H, H-11), 7.41−7.29 (m, 5H, Ph), 5.57 (s, 2H, CH2Ph), 4.53 
(d, part A of AB system, H-9a, J7a,7b = 15.4 Hz), 4.48 (d, part B of AB system, H-9b), 
4.35−4.28 (m, 2H, H-1, H-7a, J1,2 = 7.8, J7a,7b = 15.9 Hz), 4.17 (d, part B of AB system, 
H-7b), 3.83 (dd, part A of ABX system, H-6a, J5,6a = 1.8, J6a,6b = 12.1 Hz), 3.65 (dd, part 
A of ABX system, H-6b, J5,6b = 5.3 Hz) 3.89−3.21 (m, 4H, H-2, H-3, H-4, H-5) ppm. 
13C NMR (100 MHz, MeOD): δ = 172.4 (CO-8), 136.7 (Cq, Ph), 130.0, 129.6, 129.2 
(CH, Ph), 124.3 (C-11), 104.7 (C-1), 78.2 (C-5), 77.8 (C-3), 74.9 (C-2), 71.4 (C-4), 69.5 
(C-7), 62.5 (C-6), 55.0 (C-1’), 35.2 (C-9) ppm. HRMS: calcd. for C18H24N4O7 [M + 
Na]+ 431.1543, found 431.1543. 
 
2. Biological evaluation 
 
2.1. Antimicrobial Activity 
The antibacterial and antifungal activity of compounds 13–15, 18, 21–24 and 25−26, 
28−29, 31–38 was evaluated using the paper disk diffusion method according to the 
standard procedure CLSI (Clinical Laboratory Standards Institute/National Committee 
for Clinical Laboratory Standards) [36]. The following bacteria and fungi were used in 
the tests: Enterococcus faecalis (ATCC 7080), Escherichia coli (ATCC 25922), Listeria 
monocytogenes (ATCC 19115), Salmonella enteritidis (ATCC 13076), Staphylococcus 
aureus (ATCC 6538), Bacillus cereus (ATCC 11778), Bacillus subtillis (ATCC 6633), 
Aspergillus niger (ATCC 16404) Botrytis cinerea (ESAS), Candida albicans (ATCC 
10231), Penicillium aurantiogriseum (ATCC 16025). The overnight cultures of the 
microorganisms were spread over the appropriate media, nutrient agar for all bacteria 
except Listeria, where triptone soya agar was used. Potato dextros agar was used for 
fungi. Paper disks of 6.4 mm were placed on the agar nd a solution of each substance 
(300 µg) in DMSO (15 µL) was applied on each disk. Chloramphenicol (for Bacillus 
cereus, Bacillus subtillis, Enterococcus faecalis, Escherichia coli, Listeria 




monocytogenes, Salmonella enteritidis, Staphylococcus aureus) and actidione and 
amphotericine B (for Aspergillus niger, Botrytis cinerea, Candida albicans, Penicillium 
aurantiogriseum) were used as positive controls and DMSO was used as negative 
control. Bacteria were incubated at 37 ºC for 24 h and fungi at 25 ºC for 24 h to 48 h. 
After incubation, the plates presented a biomass lawn nd, when applicable, the nearest 
diameter of the inhibition zones formed was measured.  Results were the average of two 
replicates.  
The antimicrobial activity was classified according to the diameter of inhibition zones 
(∅), as follows: very strong activity, ∅≥26 mm, +++++; strong activity, 22 mm≤∅<26 
mm, ++++; good activity, 18 mm≤∅<22 mm, +++; moderate activity, 14 mm≤∅<18 
mm, ++; weak activity, 12 mm≤∅<14 mm, +; no activity, ∅<12mm, −.   
 
2.2. Acute Toxicity 
 
Acute cytotoxicity measurements were performed by the MTT method [38]. The 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to 
quantify metabolically viable cells in all samples. Adherent cells (mouse HII4E 
hepatoma cells) were seeded onto 96-well plates, allowed to attach for 24 h and exposed 
to the test compound for the following 24 h. Positive control (hydrogen peroxide) and 
negative control (DMSO) were also included. At 48 h of culture MTT was added to the 
cells at a final concentration of 0.5 mg/mL, followed by an incubation period of 3 h to 
allow the formazan crystals to form. After incubation, medium was removed, cells were 
washed twice to remove traces of medium and un-metabolized MTT, and DMSO (100 
µL) was added to each well. Solubilization of formazan crystals was performed by 
agitation in a 96-well plate shaker for 20 min at room temperature. Absorbance of each 
well was quantified at 550 nm using 620 nm as reference wavelength on a scanning 
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Bicyclic carbohydrate lactones were explored as targets and as precursors for the 
inclusion of α,β-unsaturated carbonyl systems in sugar backbones.  
 
Butenolide-containg sugars were prepared in few steps by intramolecular cyclization 
approaches, based on the Wittig reaction of furanos-3-uloses or furanos-5-uloses with a 
resonance stabilized ylide and lactonization of intermediate γ-hydroxyl α,β-unsaturated 
esters.  
 
For the synthesis of butenolides C-C-linked to a furanose moiety, the configuration at 
C-3 was an important structural feature which controlled the stereochemistry of the 
Wittig product and consequently the lactonization. Only ribo-furanos-5-ulose 
derivatives gave the target butenolides, while xylo-5-uloses did not allow the formation 
of the suitable stereoisomers for spontaneous cyclization. 
 
Protected furanos-3-uloses were converted in 2-4 steps into bicyclic pento- or 
hexopyranose-based systems comprising a butenolide moi ty fused to positions 2,3 or 
to positions 3,4 of the sugar ring. Their Wittig olefination to the corresponding 
furanose-3-C-branched α,β-unsaturated esters was followed by acid hydrolysis, which 
elicited both intramolecular lactonization and furanose to pyranose ring expansion. 
 
The scope of this method was widened to thiosugar analogues and new highly 
functionalized and potential biologically interesting bicyclic thiosugar derivatives were 
generated.  
 
When applying a similar approach to related furanoid 5-amino α,β-unsaturated ester 
precursors, aiming at the synthesis of imino sugar-fused butenolides, a different 
outcome for the 5-aminofuranose/iminopyranose isomerization was observed and it was 
shown to be dependent of the pH. The target bicycli butenolide could not be isolated 
after deprotection of the (Z)-δ-amino α,β-unsaturated ester, instead it underwent 
rearrangement in basic medium to a butenolide-containi g N-ethylformamide 
derivative. In neutral conditions, dehydration of the iminoalditol occurred, which was 
followed by tautomerization to a 2-keto imino sugar. The latter, upon acetylation, 
furnished a 1,2-dihydropyridin-3-one. This is an inovative and facile method to obtain 





This molecule is structurally suitable to be a usefl synthon for new imino sugar 
derivatives. Enones of this family have been used as key intermediates for the synthesis 
of natural products including glycosidase inhibitors such as 1-deoxynojirimycin, 
deoxymannojirimycin and deoxygulonojirimycin. 
 
In contrast to the (Z)-δ-amino α,β-unsaturated ester, its (E)-isomer suffers a pontaneous 
intramolecular cyclization to afford a bicyclic α,β-unsaturated δ-lactam in very good 
yield. 
 
These new nitrogen-containing sugar derivatives constitute interesting synthons for 
derivatization and novel candidates for bioactivity expression.   
 
The Wittig olefination-intramolecular cyclization method thus allowed to get a variety 
of carbohydrate derivatives, including S- or NH- analogues, comprising moieties which 
make them structurally suitable for derivatization and for evaluation of their biological 
activity, in few and simple steps and good overall yields. 
 
Bicyclic lactones derived from carboxymethyl glycosides proved to be useful synthons 
for the acquisition of pyranoid systems comprising conjugated carbonyl functions, such 
as 3-enopyranosid-2-uloses and pyranoid 2-C-branched-chain conjugated diene esters. 
 
The ability of these lactones to be readily opened by amines was the key aspect of the 
synthetic methodology implemented since the release of a free hydroxyl group at C-2 
allowed further derivatization at this position. Henc , oxidation of the resulting tri-O
acetyl glycopyranosides occurred with concomitant elimination to afford the target 
enones. The yields obtained were far better for α-enulosides than for the β-anomers, due 
to their higher conformational stability. The α-enones were converted in pyranoid 
conjugated diene esters by Wittig reaction. Glycoside  bearing N-propargyl moieties 
were coupled with a terminal azide in the presence of a heterogeneous CuI/Amberlyst 
catalytic system to give the corresponding 1,2,3-triazoles in good yields.  
 
The biological evaluation performed in some of the newly synthesized compounds 




antibacterial and antifungal effects observed for the bicyclic derivatives comprising a 
butenolide moiety reflect their poor Michael acceptor ability.  
 
3-Enopyranosid-2-uloses containing a (N-dodecylcarbamoyl)methyl aglycon moiety 
exhibited strong and very strong activities against some of the pathogens tested. The α-
enuloside showed very strong effect towards two Bacillus species, namely Bacillus 
subtillis and the pathogenic Bacillus cereus, which is is commonly involved in food-
borne diseases and is recognized as a causative agent in both gastrointestinal and in 
nongastrointestinal infections.  The inhibition diameters observed were equal or even 
higher as those of chloramphenicol, the control used for the bacteria tested. Its 
inhibitory effect against the fungal pathogen Penicillium aurantiogriseum also 
surpassed that of the control actidione. The β-anomer displayed very strong activity 
against the fungi Penicillium aurantiogriseum and Aspergillus niger with inhibition 
diameters similar or higher than those obtained for the standard antibiotic. The latter 
fungus is recognized to cause plant infections, such as black mold on certain fruits and 
vegetables and is a common contaminant of food. Its pa hogenicity in humans includes 
the lung disease aspergillosis, common in horticultura  workers, and ear infections 
(otomycosis). P. aurantiogriseum has been described as responsible for blue mold decay 
in storage apple fruits. It is a producer of a number of mycotoxins, whose health effects 
were not reported yet. 
 
These bioassays suggest that the hydrophobic portion of the enulosides must play a key 
role in the bioactivity, since enones possessing propargyl and benzyl moieties were 
virtually ineffective. 
 
Enterococcus faecalis is one of the most common bacteria involved in a variety of 
serious infections amongst hospitalised patients, including urinary tract infections, 
wound infections, peritonitis or endocarditis. This microbe was susceptible to the 
dodecyl-containing α-enuloside and to the pyranoid conjugated diene esters and a strong 
effect was observed.  
 






Among the bioactive compounds, three showed low acute toxicity values, including the 
α-(N-dodecylcarbamoyl)methyl enuloside. The strong activity observed for the latter 
compound, associated with low toxicity, motivates the investigation of its mechanism of 
action. The promising results obtained also encourage further studies on the effect of the 
relevant bioactive molecules towards other biological targets. Synthesis of lead series 
based on their structure to evaluate their potency, i  particular against these pathogenic 
microbes, and to minimize toxicity will also be required for application as therapeutic 
agents against the affected pathogens. 
 
In summary, in the present work, highly functionalized carbohydrate derivatives 
comprising an α,β-unsaturated carbonyl function were synthesized by new, simple and 
efficient approaches. The presence of the conjugated carbonyl functionality rends them 
suitable bioactive candidates and potential scaffolds for derivatization. In particular, 
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